
<html lang="en"     class="pb-page"  data-request-id="63ead5d7-659d-4b62-a7a3-4a559420ccec"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-21;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b01444;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox" /></meta><meta name="dc.Creator" content="Paul  Hermant" /></meta><meta name="dc.Creator" content="Damien  Bosc" /></meta><meta name="dc.Creator" content="Catherine  Piveteau" /></meta><meta name="dc.Creator" content="Ronan  Gealageas" /></meta><meta name="dc.Creator" content="BaoVy  Lam" /></meta><meta name="dc.Creator" content="Cyril  Ronco" /></meta><meta name="dc.Creator" content="Matthieu  Roignant" /></meta><meta name="dc.Creator" content="Hasina  Tolojanahary" /></meta><meta name="dc.Creator" content="Ludovic  Jean" /></meta><meta name="dc.Creator" content="Pierre-Yves  Renard" /></meta><meta name="dc.Creator" content="Mohamed  Lemdani" /></meta><meta name="dc.Creator" content="Marilyne  Bourotte" /></meta><meta name="dc.Creator" content="Adrien  Herledan" /></meta><meta name="dc.Creator" content="Corentin  Bedart" /></meta><meta name="dc.Creator" content="Alexandre  Biela" /></meta><meta name="dc.Creator" content="Florence  Leroux" /></meta><meta name="dc.Creator" content="Benoit  Deprez" /></meta><meta name="dc.Creator" content="Rebecca  Deprez-Poulain" /></meta><meta name="dc.Description" content="Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas. Some hydroxamic acids display a high pl..." /></meta><meta name="Description" content="Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas. Some hydroxamic acids display a high pl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 24, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01444" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01444" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01444" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01444" /></link>
        
    
    

<title>Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01444" /></meta><meta property="og:title" content="Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0023.jpeg" /></meta><meta property="og:description" content="Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas. Some hydroxamic acids display a high plasma clearance resulting in poor in vivo activity, though they may be very potent compounds in vitro. We designed a 57-member library of hydroxamic acids to explore the structure–plasma stability relationships in these series and to identify which enzyme(s) and which pharmacophores are critical for plasma stability. Arylesterases and carboxylesterases were identified as the main metabolic enzymes for hydroxamic acids. Finally, we suggest structural features to be introduced or removed to improve stability. This work thus provides the first medicinal chemistry toolbox (experimental procedures and structural guidance) to assess and control the plasma stability of hydroxamic acids and realize their full potential as in vivo pharmacological probes and therapeutic agents. This study is particularly relevant to preclinical development as it allows obtaining compounds equally stable in human and rodent models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01444"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01444">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01444&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01444&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01444&amp;href=/doi/10.1021/acs.jmedchem.7b01444" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9067-9089</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01395" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00933" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Hermant">Paul Hermant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damien++Bosc">Damien Bosc</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Piveteau">Catherine Piveteau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronan++Gealageas">Ronan Gealageas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=BaoVy++Lam">BaoVy Lam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cyril++Ronco">Cyril Ronco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthieu++Roignant">Matthieu Roignant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hasina++Tolojanahary">Hasina Tolojanahary</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ludovic++Jean">Ludovic Jean</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierre-Yves++Renard">Pierre-Yves Renard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed++Lemdani">Mohamed Lemdani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marilyne++Bourotte">Marilyne Bourotte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrien++Herledan">Adrien Herledan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Corentin++Bedart">Corentin Bedart</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre++Biela">Alexandre Biela</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Leroux">Florence Leroux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benoit++Deprez">Benoit Deprez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2777-4538" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca++Deprez-Poulain">Rebecca Deprez-Poulain</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-3318-5297" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Univ. Lille Nord de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000 Lille, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Normandie Université, COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA Rouen, CNRS, F-76821 Mont-Saint-Aignan Cedex, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Univ. Lille, EA 2694, Santé Publique: Épidémiologie et Qualité des Soins, F-59000 Lille, France</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Institut Universitaire de France, F-75231, Paris, France</span></div><div class="corresp-info"><strong>*</strong>Phone: +33 (0)320 964 948. E-mail: <a href="/cdn-cgi/l/email-protection#34465156515757551a50514446514e74415a5d4219585d585851061a5246"><span class="__cf_email__" data-cfemail="32405750575151531c56574240574872475c5b441f5e5b5e5e57001c5440">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01444&amp;href=/doi/10.1021%2Facs.jmedchem.7b01444" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9067–9089</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 6, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 September 2017</li><li><span class="item_label"><b>Published</b> online</span>24 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 November 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01444" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01444</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9067%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BHermant%252C%2BDamien%2BBosc%252C%2BCatherine%2BPiveteau%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D21%26contentID%3Dacs.jmedchem.7b01444%26title%3DControlling%2BPlasma%2BStability%2Bof%2BHydroxamic%2BAcids%253A%2BA%2BMedChem%2BToolbox%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9089%26publicationDate%3DNovember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01444"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3908</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01444" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Hermant&quot;},{&quot;first_name&quot;:&quot;Damien&quot;,&quot;last_name&quot;:&quot;Bosc&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Piveteau&quot;},{&quot;first_name&quot;:&quot;Ronan&quot;,&quot;last_name&quot;:&quot;Gealageas&quot;},{&quot;first_name&quot;:&quot;BaoVy&quot;,&quot;last_name&quot;:&quot;Lam&quot;},{&quot;first_name&quot;:&quot;Cyril&quot;,&quot;last_name&quot;:&quot;Ronco&quot;},{&quot;first_name&quot;:&quot;Matthieu&quot;,&quot;last_name&quot;:&quot;Roignant&quot;},{&quot;first_name&quot;:&quot;Hasina&quot;,&quot;last_name&quot;:&quot;Tolojanahary&quot;},{&quot;first_name&quot;:&quot;Ludovic&quot;,&quot;last_name&quot;:&quot;Jean&quot;},{&quot;first_name&quot;:&quot;Pierre-Yves&quot;,&quot;last_name&quot;:&quot;Renard&quot;},{&quot;first_name&quot;:&quot;Mohamed&quot;,&quot;last_name&quot;:&quot;Lemdani&quot;},{&quot;first_name&quot;:&quot;Marilyne&quot;,&quot;last_name&quot;:&quot;Bourotte&quot;},{&quot;first_name&quot;:&quot;Adrien&quot;,&quot;last_name&quot;:&quot;Herledan&quot;},{&quot;first_name&quot;:&quot;Corentin&quot;,&quot;last_name&quot;:&quot;Bedart&quot;},{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;Biela&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Leroux&quot;},{&quot;first_name&quot;:&quot;Benoit&quot;,&quot;last_name&quot;:&quot;Deprez&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;Deprez-Poulain&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9067-9089&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01444&quot;},&quot;abstract&quot;:&quot;Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas. Some hydroxamic acids display a high plasma clearance resulting in poor in vivo activity, though they may be very potent compounds in vitro. We designed a 57-member library of hydroxamic acids to explore the structure–plasma stability relationships in these series and to identify which enzyme(s) and which pharmacophores are critical for plasma stability. Arylesterases and carboxylesterases were identified as the main metabolic enzymes for hydroxamic acids. Finally, we suggest structural features to be introduced or removed to improve stability. This work thus provides the first medicinal chemistry toolbox (experimental procedures and structural guidance) to assess and control the plasma stability of hydroxamic acids and realize their full potential as in vivo pharmacological probes and therapeutic agents. This study is particularly relevant to preclinica&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01444&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01444" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01444&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01444" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01444&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01444" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01444&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01444&amp;href=/doi/10.1021/acs.jmedchem.7b01444" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01444" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01444" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01444%26sid%3Dliteratum%253Aachs%26pmid%3D28985084%26genre%3Darticle%26aulast%3DHermant%26date%3D2017%26atitle%3DControlling%2BPlasma%2BStability%2Bof%2BHydroxamic%2BAcids%253A%2BA%2BMedChem%2BToolbox%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D21%26spage%3D9067%26epage%3D9089%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/jmcmar.2017.60.issue-21/20171109/jmcmar.2017.60.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Hydroxamic acids are outstanding zinc chelating groups that can be used to design potent and selective metalloenzyme inhibitors in various therapeutic areas. Some hydroxamic acids display a high plasma clearance resulting in poor in vivo activity, though they may be very potent compounds in vitro. We designed a 57-member library of hydroxamic acids to explore the structure–plasma stability relationships in these series and to identify which enzyme(s) and which pharmacophores are critical for plasma stability. Arylesterases and carboxylesterases were identified as the main metabolic enzymes for hydroxamic acids. Finally, we suggest structural features to be introduced or removed to improve stability. This work thus provides the first medicinal chemistry toolbox (experimental procedures and structural guidance) to assess and control the plasma stability of hydroxamic acids and realize their full potential as in vivo pharmacological probes and therapeutic agents. This study is particularly relevant to preclinical development as it allows obtaining compounds equally stable in human and rodent models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The hydroxamic acid function is a strong zinc chelating group. It can be used to design potent and selective metalloenzymes inhibitors that can serve as both biological probes<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and leads. Hydroxamic acids can also be used as bioisosters of carboxylic acid because of their weak acid properties.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In the field of infectious diseases, several hydroxamic acid series have been reported as antibacterials: inhibitors of peptide deformylase (PDF),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> inhibitors of the neurotoxin A metalloprotease of bacterium <i>Clostridium botulinum</i> (BoNTA),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> or inhibitors of UDP-3-<i>O</i>-(<i>R</i>-3-hydroxymyristoyl)-<i>N</i>-acetylglucosamine deacetylase (LpxC) of Gram-negative bacteria.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Antivirals targeting HCV replication via a yet unknown mechanism,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> HIV integrase inhibitors,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> or inhibitors of metalloproteases of the <i>Plasmodium falciparum</i> parasite,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> have also been disclosed. Recently, inhibitors of the essential nematode-specific metalloprotease DPY-31 were discovered via combined in silico and experimental methods.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Several groups have explored the use of hydroxamic acids in other therapeutic areas: inhibitors of glutamate carboxypeptidase II (GCPII) in neuropathic pain,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> inhibitors of insulin-degrading enzyme in type 2 diabetes,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> inhibitors of matrix metalloprotease (MMP) in fibrinolysis control.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In osteoarthritis, matrix-metalloproteinase<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> or aggrecanase inhibitors<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> have been proposed, while inhibitors of tumor necrosis factor converting enzyme (TACE, ADAM17) were designed for autoimmune diseases such as psoriasis or Crohn’s disease.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> In the area of cancer, several hydroxamic acids have been designed to inhibit various proteases such as the sheddase of HER-2.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Importantly, with the growing interest in epigenetics, many teams explored the possibility of inhibiting other zinc hydrolases, like histone deacetylases (HDACs). Several hydroxamic acid inhibitors of these targets have already been approved: vorinostat and belinostat for T-cell lymphoma and recently panobinostat for multiple myeloma (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Many other hydroxamic acids are currently following on these first clinical successes not only in cancer but also in several other therapeutic areas.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Marketed hydroxamic acid drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The hydroxamic acid function undergoes phase I and phase II metabolism: it is mainly hydrolyzed to the corresponding carboxylic acid,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> but also it can be reduced to the corresponding amide,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> O-glucuronylated or O-sulfated.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The carboxylic acid is usually much less active on the target and possesses different physical–chemical and permeability properties compared with its hydroxamic acid analogue.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Depending on the fragility of the hydroxamic acid function and the substituents in α- or β-position,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> metabolism is driven toward the production of carboxylic acid or the production of <i>O</i>-glucuronides. For example, the main metabolite of belinostat is the glucuronide form.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">We and other groups have tried to improve the pharmacokinetics properties of hydroxamic acids by chemical modulation.<a onclick="showRef(event, 'ref8 ref26'); return false;" href="javascript:void(0);" class="ref ref8 ref26">(8, 26)</a> We have published a preliminary study of in vitro structure–plasma stability relationships (SPSRs) of such compounds.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Here, we show that susceptibility to the esterase activity in plasma is a critical driver of the stability of hydroxamic acids.</div><div class="NLM_p">Although often overlooked, esterases are worth considering in medicinal chemistry as they are involved in the metabolism of 10% of drugs.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Also, in specific situations, esterase activity can be used to release a parent drug from the ester prodrug (e.g., angiotensin-converting enzyme inhibitors, oseltamivir, tenofovir disoproxil)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> or to inactivate rapidly a compound like in the soft-drug strategy<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (ROCK inhibitors<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>). Esterases can be sorted into two main types. Type A (arylesterases) includes paraoxonase-1 (PON-1) and other arylesterase activities. Type B (serine esterases) includes acetyl- and butylcholinesterases (AchE and BuChE) as well as carboxylesterases (CES1 and -2) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Along with these main enzymes, other esterases like arylacetamide deacetylase and acylpeptide hydrolase have been described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Last but not least, albumin, which is the most abundant protein in plasma, possesses a pseudo-esterase activity resulting in acylation of several of its nucleophilic residues such as Tyr411.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Esterases Classification<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">type A esterase</th><th class="rowsep1 colsep0" colspan="3" align="center">type B esterase</th><th class="rowsep1 colsep0" align="center">other</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">paraoxonase</th><th class="colsep0 rowsep0" align="center">other aryl esterase activities</th><th class="colsep0 rowsep0" colspan="2" align="center">cholinesterase</th><th class="colsep0 rowsep0" align="center">carboxylesterase</th><th class="colsep0 rowsep0" align="center">albumin</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">acronym</td><td class="colsep0 rowsep0" align="left">PON1</td><td class="colsep0 rowsep0" align="left">ArE</td><td class="colsep0 rowsep0" align="left">AChE</td><td class="colsep0 rowsep0" align="left">BuChE</td><td class="colsep0 rowsep0" align="left">CES</td><td class="colsep0 rowsep0" align="left">SA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC no.</td><td class="colsep0 rowsep0" align="left">3.1.8.1</td><td class="colsep0 rowsep0" align="left">3.1.1.2</td><td class="colsep0 rowsep0" align="left">3.1.1.7</td><td class="colsep0 rowsep0" align="left">3.1.1.8</td><td class="colsep0 rowsep0" align="left">3.1.1.1</td><td class="colsep0 rowsep0" align="left">6.1.1.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">catalytic mechanism</td><td class="colsep0 rowsep0" align="left">catalytic dyad His/His, Ca<sup>2+</sup> activated</td><td class="colsep0 rowsep0" align="left">undefined</td><td class="colsep0 rowsep0" colspan="3" align="center">serine catalyzed catalytic triad Ser, Glu, His</td><td class="colsep0 rowsep0" align="left">irreversible acetylation of Tyr411 and other residues</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">substrate</td><td class="colsep0 rowsep0" align="left">RCOOAr, R<sub>1</sub>O (R<sub>2</sub>O)-PO-OAr</td><td class="colsep0 rowsep0" align="left">RCOOPh</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>COOR</td><td class="colsep0 rowsep0" align="left">BuCOOR, AlkCOOR</td><td class="colsep0 rowsep0" align="left">numerous prodrugs R<sub>1</sub>COOR<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>COOR</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selective inhibitor</td><td class="colsep0 rowsep0" align="left">EDTA</td><td class="colsep0 rowsep0" align="left">DTNB</td><td class="colsep0 rowsep0" align="left">PMSF, tacrine, huprine</td><td class="colsep0 rowsep0" align="left">PMSF, tacrine, profenamine</td><td class="colsep0 rowsep0" align="left">PMSF, BNPP</td><td class="colsep0 rowsep0" align="left">undefined</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EDTA, ethylenediaminetetraacetic acid; DTNB, 5,5-dithio-bis(2-nitrobenzoic acid); PMSF, phenylmethylsulfonyl fluoride; BNPP, bis-<i>p</i>-nitrophenylphosphate.</p></div></div></div><div class="NLM_p">These enzymes display different substrate specificities (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Using a histidine dyad,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> PON-1 hydrolyzes both arylesters and phosphotriesters and is inhibited by chelating agents such as EDTA. On the opposite, other plasma arylesterase activities do not have the ability to cleave the phosphotriesters<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and are inhibited by 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> BuChE displays a larger hydrophobic pocket that accounts for its less stringent substrate specificity over AChE. Both AChE and BuChE are inhibited by phenylmethylsulfonyl fluoride (PMSF), an irreversible inhibitor of serine proteases and tacrine, a prototypal cholinesterase inhibitor, or by specific noncovalent inhibitors (huprines<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and profenamine, respectively). CES1 and -2 are both inhibited by PMSF and bis(4-nitrophenyl)phosphate (BNPP), but CES1 recognizes substrates with either small or large acyl groups.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Importantly, tissue distribution of these enzymes differs among species,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> in particular in plasma.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> While CESs are the major esterases in rodent plasma, they are absent in human plasma.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> On the contrary, AChE and BuChE are present at lower concentrations in rodent plasma. The major esterase in human plasma is BuChE, while AChE is only present in trace amounts.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Along with the plasma isoform of AChE, the E isoform of AChE (also called H for hydrophobic) is found in erythrocytes.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Interestingly, PON-1, which is associated with HDL, displays a high polymorphism that impacts its expression and activity.<a onclick="showRef(event, 'ref32 ref43'); return false;" href="javascript:void(0);" class="ref ref32 ref43">(32, 43)</a> Moreover, along with a presence in the serum, some esterases can be found in both liver and intestine. Importantly, CES1 is largely expressed in liver microsomes while CES2 is expressed in intestine microsomes,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> where they participate actively in drug metabolism.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> For these enzymes also, species differences in distribution have been reported.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a></div><div class="NLM_p">Compounds that are unstable in plasma tend to display a high clearance, resulting in poor oral bioavailability and thus poor or undetectable activity, though they may be very potent compounds in vitro. The utility of such compounds as tools to probe in vivo pharmacokinetic/pharmacodynamic relationships in animal disease models in early drug-discovery is thus compromised.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">The goal of this study is to establish structure–plasma stability relationships (SPSRs), identify enzymes at play in hydrolysis, and provide structural guidance to chemists in the design of hydroxamic acids that show sufficient stability in rodents. Obtaining hydroxamates that are equally stable in rodent and human is key to engage the target in preclinical disease models at the lowest dose, generate animal proof-of-principle, and make a first assessment of the safety window. This is of particular importance as rodent plasma is much more aggressive to hydroxamic acids than human plasma, a cause of poor systemic exposure in preclinical models. A common practice in drug discovery is to optimize compounds potency on both a human target and its rodent ortholog, as well as stability on human and rodent liver microsomes to allow for a proof of concept in animal models. Optimization of rodent plasma stability is of similar importance for the particular case of hydroxamic acids, even if the lead compound is already stable in human plasma.</div><div class="NLM_p last">In order to provide medicinal chemists with tractable information for improving stability of hydroxamic acids, we report here a set of protocols and results (the toolbox) that comprise tools to assess plasma stability of hydroxamic acids, structure–plasma stability relationships, and dashboards for the identification of involved esterases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Library Design</h3><div class="NLM_p">To maximize the relevance of our study for medicinal chemists, we selected substructures found in a wide range of biologically active hydroxamic acids. The resulting 57-member library inspired from inhibitors of several classes of Zn metallohydrolases allows in turn the exploration of different esterase pockets. We study the impact of chain length and volume (<b>1</b>–<b>12</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A), nature of the linker (<b>1</b>, <b>13</b>–<b>21</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B), α-substituents (<b>13</b>, <b>20</b>, <b>22</b>–<b>51</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C), unsaturation (<b>52</b>–<b>57</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D), and cyclic constraints (<b>36</b>, <b>42</b>, <b>44</b>, <b>50</b>, <b>51</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>E) and compare compounds.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hydroxamic acid library design: <i>n</i> = 0–6; <i>m</i> = 1–3; in gray highlight, diversity within each hydroxamic acid library subset; Cy = Bz or cHx or adamantyl; Ar = Bz, <i>p</i>-fluorobenzyl, 4-pyridinyl, biphenyl, heteroaryl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Among the compounds selected, linear alkylhydroxamic acid series (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A) with various chain length and terminal cycles or linkers (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B) have been partially inspired by HDAC inhibitors and BoNTA inhibitors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Diversely α-substituted hydroxamic acids (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C) were inspired by <i>Pf</i>AM1 malonic inhibitors,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> LpxC inhibitors,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and <i>h</i>IDE inhibitors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Other compounds were selected by homology to sulfonamides or sulfone-derived inhibitors of matrix metalloproteases (MMPs).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Hydroxamic acids inspired by inhibitors of aggrecanases (AGG)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> or TACE<a onclick="showRef(event, 'ref48 ref16'); return false;" href="javascript:void(0);" class="ref ref48 ref16">(48, 16)</a> were also designed and synthesized. Series of compounds with an unsaturation in α-position of the hydroxamic acid function (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D) have been inspired by cinnamic HDAC inhibitors,<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a><i>Pf</i>AM1 inhibitors,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> or BoNTA inhibitors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Finally, a number of hydroxamic acids displaying cyclic constraints in α-position (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>E) complete the library. They were inspired by MMP,<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> LpxC,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and TACE<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> inhibitors.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis of the Library</h3><div class="NLM_p">The studied <b>1</b>–<b>57</b> compounds were obtained either as previously described<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (<b>37</b>, <b>38</b>, <b>40</b>–<b>42</b>, <b>57</b>) or via diverse synthetic approaches (<b>1</b>–<b>36</b>, <b>39</b>, <b>43</b>–<b>56</b>) summarized in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Hydroxamic acids, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, were obtained either from the corresponding carboxylic acid by coupling with <i>O</i>-tritylhydroxylamine<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> or from the corresponding ester by aminolysis with either hydroxylamine hydrochloride and KOH<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> or hydroxylamine and catalytic KCN<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (<b>12</b>, <b>15</b>–<b>17</b>, <b>19</b>, <b>20</b>, <b>30</b>–<b>37</b>, <b>39</b>, <b>43</b>–<b>45</b>, <b>50</b>, <b>51</b>). Noncommercial precursors (<b>22b</b>–<b>29b</b>, <b>46b</b>–<b>49b</b>, <b>52b</b>, <b>54b</b>–<b>56b</b>) were synthesized as described in <a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>–<a class="ref internalNav" href="#sch7" aria-label="7">7</a>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. From Carboxylic Acid or Ester Precursors to Final Hydroxamic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KCN, aq NH<sub>2</sub>OH 50 wt %, MeOH, room temp, 2 h–48 h, 4%–88%; (b) NH<sub>2</sub>OH·HCl, KOH, MeOH, room temp, 16 h, 36% yield for <b>18</b>; (c) (i) 2 M NaOH, EtOH/THF, room temp, 16 h, (ii) 1 N HCl, 52–99%; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 2 h, quantitative yield; (e) (i) <i>O</i>-tritylhydroxylamine, EDCI, HOBt, <i>N</i>-methylmorpholine, DMF, room temp, 16 h; (ii) TFA, TIS, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 15 min, 8%–99%.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Adamantane Derivative <b>12a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methylbenzenesulfonyl chloride, pyridine, room temp, 20 h, 75%; (b) KCN, DMF, 80 °C, 15 h, 84%; (c) KOH, EtOH, H<sub>2</sub>O, 90 °C, 20 h, 97%; (d) SOCl<sub>2</sub>, MeOH, 0 °C to room temp, 4 h, 21%.</p></p></figure><div class="NLM_p">Commercial 2-(adamantan-1-yl)ethan-1-ol was tosylated and the resulting sulfonate was substituted using cyanide to afford <b>58</b>. Then, the nitrile was hydrolyzed under basic conditions giving the corresponding carboxylic acid, which was converted into the methyl ester <b>12a</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">Hydroxamic acid analogs bearing a secondary amine (<b>17</b>, <b>27</b>, and <b>28)</b> or a cinnamyl moiety (<b>52</b> and <b>55</b>) were synthesized as described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The linear ester precursor <b>17a</b> was obtained via an aza-Michael reaction, whereas a reductive amination from benzaldehyde and the corresponding amino acid afforded acidic precursors <b>27b</b> and <b>28b</b>.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Benzenepropenoic acids <b>54b</b> and <b>55a</b>, analogues of HDAC inhibitors, were obtained according to the literature.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> Compound <b>52b</b>, the acid precursor of a botulinum neurotoxin A protease inhibitor,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> was synthesized by a Döbner–Knöevenagel condensation from malonic acid and 2,4-dichlorobenzaldehyde. At last, disubstituted alkene <b>56b</b> was synthesized by palladium-catalyzed Heck diarylation<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Secondary Amines <b>17a</b>, <b>27b</b>–<b>28b</b> and Cynnamyl Precursors <b>52b</b>, <b>54b</b>, <b>55a</b>, and <b>56b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzylamine, EtOH, room temp, 18 h, 84%; (b) malonic acid, pyridine, reflux, 1 h, quantitative yield; (c) MeOH, H<sub>2</sub>SO<sub>4</sub>, reflux, 16 h, 79%; (d) <i>N</i>,<i>N</i>-diethylethylenediamine, Et<sub>3</sub>N, dioxane, 90 °C, 16 h, 65%; (e) valeraldehyde, SnCl<sub>2</sub>·2H<sub>2</sub>O, AcOH, MeOH, 40 °C, 16 h, 48%; (f) (i) LiOH·H<sub>2</sub>O, MeOH, room temp, 20 min, (ii) benzaldehyde, room temp, 1 h, (iii) NaBH<sub>4</sub>, room temp, 30 min, 76–100%; (g) chlorosulfonic acid, 10–12 °C, 16 h, 30%; (h) aniline, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 16 h, 66%; (i) iodobenzene, silver acetate, palladium acetate, acetic acid, 110 °C, 6 h, 61%.</p></p></figure><div class="NLM_p">Malonic precursors were synthesized to explore the impact of substitution in α-position of the hydroxamic acid function. A one-pot Knoevenagel reduction catalyzed by <span class="smallcaps smallerCapital">l</span>-proline gave precursor <b>60</b>.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The dissymmetric opening of the Meldrum’s acids <b>59</b> and <b>60</b> with primary amines and subsequent methyl esterification afforded <b>15a</b>, <b>20a</b>, and <b>33a</b>. Precursors <b>61</b> and <b>62</b> were obtained via alkylation of commercial malonic esters. Monosaponification followed by coupling with the corresponding amine resulted in compounds <b>30a</b>–<b>32a</b>, <b>34a</b>–<b>36a</b>, <b>39a</b>, <b>43a</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Malonic Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) 2-naphthaldehyde, MeCN, room temp, 1.5 h, (ii) Hantzsch’s ester, <span class="smallcaps smallerCapital">l</span>-proline, MeOH, room temp, 16 h, 68%; (b) aniline, MeCN, 80 °C, 2 h, 48% <b>15b</b>, benzylamine, MeCN room temp, 3 h, 63% <b>20b</b>, benzylamine, MeCN, microwave 80 °C, 1.75 h, 95% <b>33b</b>; (c) SOCl<sub>2</sub>, MeOH, 0 °C to room temp, 0.5–5.25 h, 43%–89%; (d) (i) NaH, THF, 0 °C to room temp, 30 min, (ii) 4-(chloromethyl)pyridine hydrochloride, 40 °C, 5.5 h, 23%; (e) (i) sodium, abs EtOH, 0–50 °C, 1 h, (ii) bromomethylbenzene, 50 °C, 19 h, 37%; (f) KOH, EtOH, room temp, 24 h, quantitative yield; (g) amine, HBTU, DIPEA, DMF, 0 °C to room temp, 4–18 h, 41–75%.</p></p></figure><div class="NLM_p">Ester precursors <b>16a</b>, <b>22a</b>–<b>26a</b> were obtained as follows (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The 2-phenylethan-1-amine was alkylated by methyl-2-bromoacetate to give ester <b>16a</b>, while alkylation of methyl 4-phenylbutanoate with methyl iodide afforded compound <b>22a</b>. Alkylation of dimethyl malonate with (2-iodoethyl)benzene followed by hydrolysis and decarboxylation gave methyl ester <b>23a</b>. Treatment of ethyl (methylsulfonyl)acetate and ethyl (phenylsulfonyl)acetate with both sodium hydride and (2-bromoethyl)benzene afforded <b>69</b> and <b>24a</b>, respectively. Phenylsulfonyl <b>24a</b> was alkylated with methyl iodide and sodium hydride to give <b>25a</b>. In a similar manner methylsulfonyl <b>69</b> was treated with benzyl bromide, giving <b>26a</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Phenylalkyl Ester Precursors <b>16a</b>, <b>22a</b>–<b>26a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) methyl 2-bromoacetate, DIPEA, DMF, 0 °C to room temp, 4 h, 54%; (b) LDA, MeI, THF, −78 °C to room temp, 85%; (c) (i) (2-iodoethyl)benzene, NaH, DMF, 70 °C, 3.5 h, 79%, (ii) benzyl bromide, NaH, DMF, toluene, room temp, 60 h, 83%; (iii) KOH, 2-methoxyethanol/H<sub>2</sub>O (10/1 v/v), 130 °C, 1.5 h, then 6 N HCl, 83%. (d) (2-bromoethyl)benzene, NaH, DMF, 0 °C, 1 h, then room temp, 16 h, 90%; (e) methyl iodide or bromomethylbenzene, NaH, DMF, 55 °C, overnight, 71–78%.</p></p></figure><div class="NLM_p">Ester precursors <b>18a</b>, <b>29a</b>, <b>44a</b>, and <b>45a</b> were synthesized via acylation reactions (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Sulfonamides <b>46a</b>–<b>47a</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and <b>50a</b>, <b>51a</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> were synthesized by acylation with benzenesulfonyl chloride. At last, <span class="smallcaps smallerCapital">d</span>-valine and <span class="smallcaps smallerCapital">d</span>-phenylalanine underwent N-sulfonylation (<b>71</b>, <b>73</b>), followed by esterification (<b>72</b>, <b>74</b>) and N-alkylation to afford compounds <b>48a</b> and <b>49a</b>, respectively (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Amides <b>18a</b>, <b>29a</b>, <b>44a</b>, <b>45a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) phenylacetic acid, HOBt, EDCI, DIEA, DMF, room temp, 12–48 h, 70–84%; (b) benzoyl chloride, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temp, 1–2 h, 41–62%.</p></p></figure><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Sulfonylated Precursors <b>46a</b>–<b>51a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, 0 °C to room temp, 10 days, 64%; (b) benzenesulfonyl chloride, base, solvent, 0 °C to room temp, 2–18 h, 24–66%; (c) di-<i>tert</i>-butylacetal, toluene, DMF, 95 °C, 16 h, 65–71%; (d) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 days, room temp, 87–96%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Relations between Chemical Structure and Plasma Stability</h3><div class="NLM_p">Compounds <b>1</b>–<b>57</b> were evaluated for their stability in both rat plasma and human plasma. Rat was chosen as its plasma displays high hydrolytic properties,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and it is a species often used for regulatory toxicology studies to determine therapeutic window. Half-lives in rat plasma are presented in four tables (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) highlighting the influence of chain length and composition and nature of substituent at α to the hydroxamate function.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Influence of Chain Length, Aromaticity, and Volume on Plasma Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R-</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">Ph-</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">>6<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Ph-</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>6<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">Ph-</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.8<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">Ph-</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">2.0<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">Ph-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">Ph-</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Ph-</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">>6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">cHx-</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">cHx-</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">cHx-</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">adamantyl-</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">adamantyl-</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Half-life in rat plasma.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">From ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div></div></div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Linear Compounds with Saturated Aliphatic Linkers (<b>1</b>–<b>7</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>)</h4><div class="NLM_p">Several phenyl linear compounds were synthesized to explore the influence of the chain length on plasma stability of the hydroxamic acid function. Interestingly, when phenyl or benzyl substituents are directly linked to the hydroxamic acid function (<i>n</i> = 0 and 1), compounds are stable while the most unstable compounds were obtained with medium chain length (<i>n</i> = 2, 3, and 4). Then compounds with aliphatic extended linear chain (<i>n</i> = 5, 6) have long half-lives (4–6 h).</div><div class="NLM_p last">Cyclohexane (<b>8</b>, <b>9</b>, <b>10</b>) and adamantane derivatives (<b>11</b>, <b>12</b>) behave the same way as their phenyl analogues (<b>2</b>–<b>4</b>) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Indeed, linker with <i>n</i> = 2 or 3 is hydrolyzed rapidly in plasma (<i>t</i><sub>1/2</sub> < 0.5 h), while for <i>n</i> = 1, compounds are stable. Interestingly both lipophilicity and size impact the rate of hydrolysis. This is exemplified by the decreasing stabilities of adamantane <b>12</b> > cyclohexane <b>9</b> displaying cLogP of 2.2 and 2.01 and molecular volume of 161 and 120 Å<sup>3</sup>, respectively.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Linear Compounds with Heteroatom-Containing Linkers (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>)</h4><div class="NLM_p">Regardless of its size, the nature of the linear linker impacts plasmatic stabilities of hydroxamic acids. Indeed, half-lives vary from 0.6 to more than 6 h for a three-atom linker and from 0.3 to more than 6 h for a four-atom linker, respectively. Interestingly, linear alkyl compounds <b>4</b> and <b>5</b> are not the most stable hydroxamic acids in the series. Introduction of a secondary amine is either beneficial for stability (<b>13</b> vs <b>4</b> or <b>17</b> vs <b>5</b>) or deleterious (<b>16</b> vs <b>5</b>). The presence of an amide function in β- or γ-position of the hydroxamic acid is critical for stability (<b>20</b> vs <b>21</b> and <b>18</b> vs <b>19</b>). Also, hydroxamic acids <b>14</b> and <b>18</b> derived of glycine are far less stable than their retro-amide analogs <b>15</b> and <b>20</b>, respectively, which are the most stable compounds in the series (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Influence of the Nature of the Linear Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0018.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">linker</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-CH<sub>2</sub>-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">2.0<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-NH-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">-CO-NH-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">-NH-CO-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">>6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-CH<sub>2</sub>-CH<sub>2</sub>-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-CH<sub>2</sub>-NH-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-NH-CH<sub>2</sub>-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-CO-NH-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">-CO-NH-CH<sub>2</sub>-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>-NH-CO-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">>6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">-NH-CO-CH<sub>2</sub>-CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.43</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Half-life in rat plasma.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">From ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div></div></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Impact of the Substituent in α-Position to the Hydroxamate (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>)</h4><div class="NLM_p">In the series of 4-phenylbutanehydroxamic acid <b>4</b>, introduction of a substituent in α-position results in a higher plasma stability (<b>22</b>–<b>26</b>). On the contrary, in 2-(benzylamino)ethanehydroxamic acid series (<b>13</b>, <b>27</b>–<b>29</b>) and malonohydroxamic series (<b>20</b>, <b>30</b>–<b>43</b>), introduction of benzyl substituent or arylmethyl groups is deleterious for stability (<b>28</b>, <b>31</b>–<b>34</b>, <b>39</b>–<b>40</b>, <b>43</b>), in comparison with smaller substituents like methyl (<b>27</b>, <b>30</b>, <b>38</b>). Interestingly, the size and nature of the arylmethyl group in α positions impact stability: pyridine > phenyl > naphthyl (<b>31</b>–<b>33</b>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Impact of Substitution in α-Position of the Hydroxamic Acid Function</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0019.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0020.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Half-life in rat plasma.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">From ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div></div><div></div></div><div class="NLM_p">Surprisingly, groups at long distance from the hydroxamic acid can also impact stability. Indeed, pyridinyl compound <b>43</b> is much more stable (<i>t</i><sub>1/2</sub> = 3.3 h) than benzyl and <i>p</i>-fluorobenzyl analogues (<b>31</b>, <b>39</b>) (<i>t</i><sub>1/2</sub> = 0.8 h), although <b>43</b> contains a benzyl group in α-position, a substructure shown above to accelerate hydrolysis by plasma. Gem-dimethyl substitution or introduction of a cyclopropyl group allows obtention of stable compounds (<b>35</b>, <b>36</b>, <b>41</b>, <b>42</b>). Introduction of a methyl group in α-position moderately restores stability for benzyl-substituted compounds (<b>34</b> vs <b>31</b>; <b>40</b> vs <b>39</b>): t<sub>1/2</sub> of 1.5 vs 0.8 h. In the β-alanine series (<b>44</b>, <b>19</b>, <b>45</b>), introduction of a cyclic constraints protects from hydrolysis (<b>44</b>, <i>t</i><sub>1/2</sub> > 6 h) while introduction of a positive charge results in poorly stable compound (<b>45</b><i>t</i><sub>1/2</sub> = 0.4 h). In comparison with these β-alanine derivatives, serine-base compound <b>29</b> is stable. Finally, in the sulfonamide series the presence of an isopropyl group prevents hydrolysis (<b>46</b>, <b>48</b>) while a benzyl group promotes it (<b>47</b>). Interestingly, substitution of the nitrogen of the adjacent amide function by a benzyl group restores plasmatic stability (<b>49</b> vs <b>47</b>) but freezing α-position substituent with the amide substituent into a tetrahydroquinoline is deleterious for stability (<b>51</b>). As gem-substitution was tolerated in other series, it is also protective in sulfonamide series (<b>50</b>).</div><div class="NLM_p">Introduction of a double bond in α-position of the hydroxamic acid impacts stability. For example, compound <b>57</b> is stable while its saturated analogue <b>3</b> is rapidly hydrolyzed (<i>t</i><sub>1/2</sub> = 0.8 h) (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Other unsaturated compounds inspired by bioactive structures are stable in rat plasma (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Influence of Unsaturation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0021.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0022.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Half-life in rat plasma.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">From ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div></div><div></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Impact of Physical–Chemical Properties on Stability</h3><div class="NLM_p"><a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> presents the measured stability and physical chemical properties of the 57 hydroxamic acids. In an attempt to correlate these properties of compounds with plasma stability, we looked at the distribution of six continuous parameters for stable (<i>t</i><sub>1/2</sub> > 6 h) and unstable (<i>t</i><sub>1/2</sub> < 6 h) compounds: cLogP, cLogD<sub>7.4</sub>, polar surface area (PSA), aqueous solubility (cLogS), molecular weight, and volume. No difference of distribution between unstable and stable compounds was observed for cLogS, volume, or PSA. However, unstable hydroxamic acids tend to have a higher cLogP (36% of compounds with cLogP in [0;1.5[ range and 52% with cLogP in [1.5; 3[) than stable compounds (50% of compounds with cLogP in [0;1.5[ range and 28% with cLogP in [1.5;3[) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S8</a>). The same difference in distribution is observed for cLogD (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S8</a>). This is well illustrated in the malonic-derived hydroxamic acids <b>20</b>–<b>43</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) where compounds displaying short half-lives have a higher cLogP than those displaying a higher half-life. For example pyridine lowers cLogP in comparison with benzene and also impacts positively stability (<b>32</b> and <b>43</b>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Physical–Chemical Properties of Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub><b>1/2</b></sub> (h)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cLogP<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">cLogD<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">PSA<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">cLogS<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">volume<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">HBD<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HBA<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–1.41</td><td class="colsep0 rowsep0" align="left">137.1</td><td class="colsep0 rowsep0" align="left">80.9</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.88</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–1.72</td><td class="colsep0 rowsep0" align="left">151.2</td><td class="colsep0 rowsep0" align="left">99.1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">1.34</td><td class="colsep0 rowsep0" align="left">1.33</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–2.13</td><td class="colsep0 rowsep0" align="left">165.2</td><td class="colsep0 rowsep0" align="left">108.7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.79</td><td class="colsep0 rowsep0" align="left">1.79</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–2.58</td><td class="colsep0 rowsep0" align="left">179.2</td><td class="colsep0 rowsep0" align="left">122.8</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">2.25</td><td class="colsep0 rowsep0" align="left">2.25</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–3.07</td><td class="colsep0 rowsep0" align="left">193.2</td><td class="colsep0 rowsep0" align="left">131.7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">2.70</td><td class="colsep0 rowsep0" align="left">2.70</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–3.57</td><td class="colsep0 rowsep0" align="left">207.3</td><td class="colsep0 rowsep0" align="left">143.7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">3.16</td><td class="colsep0 rowsep0" align="left">3.16</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–4.09</td><td class="colsep0 rowsep0" align="left">221.3</td><td class="colsep0 rowsep0" align="left">158.1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">1.55</td><td class="colsep0 rowsep0" align="left">1.55</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–1.90</td><td class="colsep0 rowsep0" align="left">157.2</td><td class="colsep0 rowsep0" align="left">110.8</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">2.01</td><td class="colsep0 rowsep0" align="left">2.01</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–2.41</td><td class="colsep0 rowsep0" align="left">171.2</td><td class="colsep0 rowsep0" align="left">121.4</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">2.46</td><td class="colsep0 rowsep0" align="left">2.46</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–2.94</td><td class="colsep0 rowsep0" align="left">185.3</td><td class="colsep0 rowsep0" align="left">135.5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">1.77</td><td class="colsep0 rowsep0" align="left">1.77</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–2.69</td><td class="colsep0 rowsep0" align="left">209.3</td><td class="colsep0 rowsep0" align="left">145.8</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2.23</td><td class="colsep0 rowsep0" align="left">2.22</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–3.27</td><td class="colsep0 rowsep0" align="left">223.3</td><td class="colsep0 rowsep0" align="left">159.5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">–0.34</td><td class="colsep0 rowsep0" align="left">61.4</td><td class="colsep0 rowsep0" align="left">–1.89</td><td class="colsep0 rowsep0" align="left">180.2</td><td class="colsep0 rowsep0" align="left">119.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" align="left">–0.10</td><td class="colsep0 rowsep0" align="left">–0.24</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–1.81</td><td class="colsep0 rowsep0" align="left">194.2</td><td class="colsep0 rowsep0" align="left">119.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–1.83</td><td class="colsep0 rowsep0" align="left">194.2</td><td class="colsep0 rowsep0" align="left">121.8</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left">–0.01</td><td class="colsep0 rowsep0" align="left">61.4</td><td class="colsep0 rowsep0" align="left">–2.34</td><td class="colsep0 rowsep0" align="left">194.2</td><td class="colsep0 rowsep0" align="left">129.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">–1.41</td><td class="colsep0 rowsep0" align="left">61.4</td><td class="colsep0 rowsep0" align="left">–2.23</td><td class="colsep0 rowsep0" align="left">194.2</td><td class="colsep0 rowsep0" align="left">129.3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">–0.06</td><td class="colsep0 rowsep0" align="left">–0.20</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.10</td><td class="colsep0 rowsep0" align="left">208.2</td><td class="colsep0 rowsep0" align="left">131.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.00</td><td class="colsep0 rowsep0" align="left">208.2</td><td class="colsep0 rowsep0" align="left">132.1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.15</td><td class="colsep0 rowsep0" align="left">208.2</td><td class="colsep0 rowsep0" align="left">131.0</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–1.99</td><td class="colsep0 rowsep0" align="left">208.2</td><td class="colsep0 rowsep0" align="left">132.1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">2.25</td><td class="colsep0 rowsep0" align="left">2.25</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–2.95</td><td class="colsep0 rowsep0" align="left">193.2</td><td class="colsep0 rowsep0" align="left">133.8</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">3.74</td><td class="colsep0 rowsep0" align="left">3.74</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–5.00</td><td class="colsep0 rowsep0" align="left">269.3</td><td class="colsep0 rowsep0" align="left">181.4</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">2.72</td><td class="colsep0 rowsep0" align="left">2.87</td><td class="colsep0 rowsep0" align="left">91.9</td><td class="colsep0 rowsep0" align="left">–4.44</td><td class="colsep0 rowsep0" align="left">319.4</td><td class="colsep0 rowsep0" align="left">199.6</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">3.03</td><td class="colsep0 rowsep0" align="left">3.02</td><td class="colsep0 rowsep0" align="left">91.9</td><td class="colsep0 rowsep0" align="left">–4.61</td><td class="colsep0 rowsep0" align="left">333.4</td><td class="colsep0 rowsep0" align="left">212.3</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">3.01</td><td class="colsep0 rowsep0" align="left">3.00</td><td class="colsep0 rowsep0" align="left">91.9</td><td class="colsep0 rowsep0" align="left">–4.91</td><td class="colsep0 rowsep0" align="left">347.4</td><td class="colsep0 rowsep0" align="left">225.4</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">61.4</td><td class="colsep0 rowsep0" align="left">–2.31</td><td class="colsep0 rowsep0" align="left">194.2</td><td class="colsep0 rowsep0" align="left">130.0</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">2.27</td><td class="colsep0 rowsep0" align="left">2.26</td><td class="colsep0 rowsep0" align="left">61.4</td><td class="colsep0 rowsep0" align="left">–4.30</td><td class="colsep0 rowsep0" align="left">270.3</td><td class="colsep0 rowsep0" align="left">180.4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">1.02</td><td class="colsep0 rowsep0" align="left">0.99</td><td class="colsep0 rowsep0" align="left">98.7</td><td class="colsep0 rowsep0" align="left">–4.05</td><td class="colsep0 rowsep0" align="left">300.3</td><td class="colsep0 rowsep0" align="left">180.4</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.67</td><td class="colsep0 rowsep0" align="left">222.2</td><td class="colsep0 rowsep0" align="left">143.4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">2.10</td><td class="colsep0 rowsep0" align="left">2.12</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–4.50</td><td class="colsep0 rowsep0" align="left">298.3</td><td class="colsep0 rowsep0" align="left">192.8</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">91.3</td><td class="colsep0 rowsep0" align="left">–4.04</td><td class="colsep0 rowsep0" align="left">299.3</td><td class="colsep0 rowsep0" align="left">190.4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">3.01</td><td class="colsep0 rowsep0" align="left">3.03</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–6.20</td><td class="colsep0 rowsep0" align="left">348.4</td><td class="colsep0 rowsep0" align="left">226.0</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">2.52</td><td class="colsep0 rowsep0" align="left">2.52</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–4.76</td><td class="colsep0 rowsep0" align="left">312.4</td><td class="colsep0 rowsep0" align="left">204.8</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">1.03</td><td class="colsep0 rowsep0" align="left">1.03</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.95</td><td class="colsep0 rowsep0" align="left">236.3</td><td class="colsep0 rowsep0" align="left">155.0</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.49</td><td class="colsep0 rowsep0" align="left">234.3</td><td class="colsep0 rowsep0" align="left">148.2</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.45</td><td class="colsep0 rowsep0" align="left">226.2</td><td class="colsep0 rowsep0" align="left">137.9</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.98</td><td class="colsep0 rowsep0" align="left">240.2</td><td class="colsep0 rowsep0" align="left">152.6</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">0.8<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.31</td><td class="colsep0 rowsep0" align="left">2.32</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–4.77</td><td class="colsep0 rowsep0" align="left">316.3</td><td class="colsep0 rowsep0" align="left">198.9</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">1.5<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.73</td><td class="colsep0 rowsep0" align="left">2.73</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–5.01</td><td class="colsep0 rowsep0" align="left">330.4</td><td class="colsep0 rowsep0" align="left">212.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">>6<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.24</td><td class="colsep0 rowsep0" align="left">1.24</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–3.24</td><td class="colsep0 rowsep0" align="left">254.3</td><td class="colsep0 rowsep0" align="left">165.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">78.4</td><td class="colsep0 rowsep0" align="left">–2.77</td><td class="colsep0 rowsep0" align="left">252.2</td><td class="colsep0 rowsep0" align="left">154.0</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">91.3</td><td class="colsep0 rowsep0" align="left">–4.03</td><td class="colsep0 rowsep0" align="left">299.3</td><td class="colsep0 rowsep0" align="left">190.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left">69.6</td><td class="colsep0 rowsep0" align="left">–1.75</td><td class="colsep0 rowsep0" align="left">234.3</td><td class="colsep0 rowsep0" align="left">149.2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">81.7</td><td class="colsep0 rowsep0" align="left">–2.67</td><td class="colsep0 rowsep0" align="left">291.4</td><td class="colsep0 rowsep0" align="left">193.5</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">0.93</td><td class="colsep0 rowsep0" align="left">0.93</td><td class="colsep0 rowsep0" align="left">103.9</td><td class="colsep0 rowsep0" align="left">–2.87</td><td class="colsep0 rowsep0" align="left">272.3</td><td class="colsep0 rowsep0" align="left">167.7</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">1.65</td><td class="colsep0 rowsep0" align="left">1.64</td><td class="colsep0 rowsep0" align="left">103.9</td><td class="colsep0 rowsep0" align="left">–4.06</td><td class="colsep0 rowsep0" align="left">320.4</td><td class="colsep0 rowsep0" align="left">193.8</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">2.72</td><td class="colsep0 rowsep0" align="left">2.71</td><td class="colsep0 rowsep0" align="left">95.1</td><td class="colsep0 rowsep0" align="left">–4.61</td><td class="colsep0 rowsep0" align="left">362.4</td><td class="colsep0 rowsep0" align="left">236.0</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">3.44</td><td class="colsep0 rowsep0" align="left">3.43</td><td class="colsep0 rowsep0" align="left">95.1</td><td class="colsep0 rowsep0" align="left">–5.77</td><td class="colsep0 rowsep0" align="left">410.5</td><td class="colsep0 rowsep0" align="left">257.6</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">–0.48</td><td class="colsep0 rowsep0" align="left">–0.48</td><td class="colsep0 rowsep0" align="left">113.1</td><td class="colsep0 rowsep0" align="left">–2.00</td><td class="colsep0 rowsep0" align="left">300.3</td><td class="colsep0 rowsep0" align="left">182.8</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">1.61</td><td class="colsep0 rowsep0" align="left">1.61</td><td class="colsep0 rowsep0" align="left">95.1</td><td class="colsep0 rowsep0" align="left">–3.60</td><td class="colsep0 rowsep0" align="left">332.4</td><td class="colsep0 rowsep0" align="left">200.7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">2.64</td><td class="colsep0 rowsep0" align="left">2.64</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–3.96</td><td class="colsep0 rowsep0" align="left">232.1</td><td class="colsep0 rowsep0" align="left">136.5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">2.83</td><td class="colsep0 rowsep0" align="left">2.83</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–4.75</td><td class="colsep0 rowsep0" align="left">239.3</td><td class="colsep0 rowsep0" align="left">150.9</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">1.80</td><td class="colsep0 rowsep0" align="left">1.80</td><td class="colsep0 rowsep0" align="left">103.9</td><td class="colsep0 rowsep0" align="left">–4.36</td><td class="colsep0 rowsep0" align="left">318.4</td><td class="colsep0 rowsep0" align="left">192.1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">3.71</td><td class="colsep0 rowsep0" align="left">2.28</td><td class="colsep0 rowsep0" align="left">70.4</td><td class="colsep0 rowsep0" align="left">–5.80</td><td class="colsep0 rowsep0" align="left">358.5</td><td class="colsep0 rowsep0" align="left">256.6</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">2.79</td><td class="colsep0 rowsep0" align="left">2.79</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–4.30</td><td class="colsep0 rowsep0" align="left">239.3</td><td class="colsep0 rowsep0" align="left">148.9</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">>6</td><td class="colsep0 rowsep0" align="left">1.31</td><td class="colsep0 rowsep0" align="left">1.31</td><td class="colsep0 rowsep0" align="left">49.3</td><td class="colsep0 rowsep0" align="left">–2.41</td><td class="colsep0 rowsep0" align="left">163.2</td><td class="colsep0 rowsep0" align="left">99.1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Half-life in rat plasma.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">cLogP, cLogD, PSA in Å<sup>2</sup>, <i>S</i> in mol/L, volume in Å<sup>3</sup> calculated by PipelinePilot.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Hydrogen-bond donors; hydrogen-bond acceptors.</p></div></div></div><div class="NLM_p last">We then performed an analysis including the (categorical) HBD and HBA parameters. Indeed, a χ<sup>2</sup> test showed a link between stability and HBD < 3 (<i>p</i> = 0.068). This led us to perform a multivariate analysis using HBD along with the six other continuous variables. A stepwise logistic regression yielded a model with HBD, MW, and volume. It shows that HBD < 3 favors stability (OR = 4.80), along with a higher molecular weight (OR = 1.06) and lower volume (OR = 0.91).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Implication of Esterases</h3><div class="NLM_p">To find which esterase(s) was (were) responsible for the hydrolysis of the unstable compounds and attempt to rationalize SPSR with the structure of their catalytic sites, we measured and compared half-lives of unstable hydroxamic acids in the presence and absence of nonselective and selective esterase inhibitors (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Figure S1</a>). We then calculated a score <i>S</i> for each esterase activity for a given hydroxamic acid and displayed results as dashboards (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information methods</a>) to provide a visual tool to compare the behavior of compounds in the light of the structure.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibitor-based esterase profiling scheme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Involvement of esterase activities in the hydrolysis of a given hydroxamic acid: using score <i>S</i> calculated as given in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Methods</a>. <sup><i>b</i></sup>Positions of the amine or the amide (from Ph-, from -CONHOH).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">First, none of the hydroxamic acids are stabilized by the addition of EDTA to plasma, excluding paraoxonase from the set of hydroxamates hydrolyzing enzymes. Most linear analogues (A, B, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) that are unstable in plasma are usually stabilized by both DTNB (arylesterase inhibitor) and PMSF (serine esterase inhibitor), while branched hydroxamic acids (C, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) are not stabilized by DTNB.</div><div class="NLM_p">In linear series, where the linker bears methylene groups, amide groups, or secondary amines, our study reveals implication of various esterases activities. In the first series (A), shorter chain lengths (≤3) are highly hydrolyzed by arylesterases and carboxylesterases (<b>3</b>, <b>4</b>) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Longer chains (<i>n</i> = 4 or 5) are moderately hydrolyzed by these enzymes (<b>5</b>, <b>6</b>) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Compound <b>12</b> is not stabilized by DTNB addition to plasma, in strong contrast with other linear hydroxamic acids, probably due to both bulkiness and lipophilicity of adamantyl group in comparison to phenyl (<b>12</b> vs <b>3</b>). Also, cholinesterases are only moderately implicated in the instability of these series. Interestingly, while BuChE is not involved in the hydrolysis of <b>5</b> (<i>n</i> = 4), it does participate in the instability of shorter compound <b>4</b> (<i>n</i> = 3) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Noteworthy, we were unable to stabilize hydroxamic acids <b>9</b> and <b>10</b>, both bearing a cyclohexyle side chain.</div><div class="NLM_p">Introduction of a positive charge in β-position of the hydroxamic acid protects from hydrolysis by BuChE (<b>13</b> vs <b>3</b>) when chain length is 3, while it protects from hydrolysis by arylesterases (<b>16</b> vs <b>5</b>) when chain length is 4. Conversely, introduction of a positive charge in γ-position of the hydroxamic acid, though improving stability, does not change the esterase activities implicated (<b>17</b> vs <b>5</b>).</div><div class="NLM_p">In the linear series, carboxylesterases seem more implicated in the hydrolysis of amide-containing compounds. Though no clear differences could be seen between <b>14</b>, <b>18</b>, and <b>19</b>, no esterase inhibitor was able to stabilize related amide <b>21</b>, the reverse amide of <b>19</b>.</div><div class="NLM_p">Substitution in α-position (C, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) prevents hydrolysis by arylesterases while reinforcing hydrolysis by carboxylesterases. In malonic series (<b>31</b>–<b>34</b>, <b>39</b>, <b>40</b>, <b>43</b>), presence of a benzyl group, or 2-naphthylmethyl or 4-pyridinylmethyl analogues, results in similar susceptibility profiles. Interestingly, introduction of a positive charge (secondary amine) in β-position of the hydroxamic function reduces the involvement of BuChE as previously described in linear series (<b>28</b> vs <b>13</b> or <b>17</b>), while introduction of a positive charge (tertiary amine) in β-position (<b>45</b>) has no effect. This can be attributed to both steric constraints in <b>45</b> and to the absence of a benzyl substituent. At last, in sulfonamide series, generally quite stable, introduction of the benzyl group in α-position of the hydroxamic acid increased sensitivity to carboxylesterases, and AChE to a lesser extent.</div><div class="NLM_p">Our study has also identified highly unstable hydroxamates <b>9</b>, <b>10</b>, <b>21</b> (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) for which no esterase inhibitor could restore stability in plasma. Co-incubation with a mixture of highly concentrated esterase inhibitors only slightly improves their half-lives by 2-fold. We hypothesized that these hydroxamic acids were extremely affine substrates for esterases. To check this, we used them as competitors for other hydroxamic acids. For example, compound <b>4</b>, which displays an average half-life of 2 h, is highly stabilized in the presence of competitor <b>9</b>, <b>10</b>, or <b>21</b> and its half-life is increased by 10-fold at least (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a> and <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Stabilization of <b>4</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">competitor</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">none</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">20.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">30.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">22.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Half-life in rat plasma of <b>4</b> (10 μM) in the absence or presence of competitor at 80 μM.</p></div></div></div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Stabilization of <b>4</b> by highly unstable hydroxamic acids <b>9</b>, <b>10</b>, and <b>21</b>: % of <b>4</b> remaining in the absence (◆) or presence of <b>9</b> (○), <b>10</b> (□), <b>21</b> (△).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As one of the AChE isoforms (isoform E) is found anchored to erythrocytes, we checked for stability of hydroxamic acids in whole blood. No significant differences between plasma and whole blood stabilities were observed. This suggests that this isoform does not contribute significantly to the hydrolysis of hydroxamates.</div><div class="NLM_p">As well, outside the plasma compartment, two isoforms of carboxylesterases are present in liver (CES1) and intestine (CES2) microsomes. We therefore checked for stability of compound <b>3</b> on microsomes in nonoxidative conditions. <b>3</b>, which displays a half-life of 0.8 h in plasma, is also very unstable in liver microsomes (<i>t</i><sub>1/2</sub> = 0.25 h) while stable on intestine microsomes (<i>t</i><sub>1/2</sub> > 6 h). This result suggests an implication of CES1 rather than CES2 in the hydrolysis of this compound. This implication of CES1 was further confirmed by the fact that <b>3</b> is hydrolyzed by both rodent and human CES1 isolated enzymes, like several other hydroxamic acids (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Table S2</a>).</div><div class="NLM_p last">To draw general trends, we compared Box and Whisker plots for each physical–chemical parameter (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figures S9–S11</a>) for substrates and nonsubstrates of ArE, AChE, and CES. No differences were evidenced for AChE and CES substrates. On the contrary, hydroxamic acids hydrolyzed by ArE display a cLogS and lower molecular weight and volume (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S11</a>). Because arylesterase activity of plasma is not attributed to a specific enzyme, these results cannot be correlated with structural data.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> summarizes structure–plasma stability relationships of hydroxamic acids. Regarding physical–chemical properties, HBD < 3 is beneficial for plasma stability. In the malonic series cLogP > 1.5 is deleterious for stability. Regarding structural features, combination of the nature or length of the linker with the hydrophobicity of the substituents is critical for stability. The presence of a tertiary carbon in α-position, in a cycle like cyclopropyl or tetrahydropyran, stabilizes compounds. Also, bigger substituents like sulfonamides in β-position are usually beneficial for stability. Hydroxamic acids bearing a double bond in this study proved to be stable toward esterase hydrolysis. Absence of an arylmethyl substituent, either constrained or not, in α-position of the hydroxamic acid function protects from hydrolysis.</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure–plasma stability relationships of hydroxamic acids: molecular properties and structural features increasing or decreasing stability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> CES Recognizes α-Arylmethyl-Substituted Hydroxamic Acids</h3><div class="NLM_p">CES is the prominent esterase involved in the hydrolysis of all unstable compounds (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). The preference of carboxylesterases for hydroxamic acids that display an arylmethyl group in α-position was rationalized by docking of <b>33</b>, <b>47</b>, <b>51</b> in a model of rat CES1 (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Catalytic Ser221 points toward the carbonyl of the hydroxamic acid, with distances and angles compatible with the hydrolysis (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information methods</a>). Interestingly, the arylmethyl group in α-position interacts nicely with Phe304 and Phe318. Moreover, Phe318 position shifts as a function of the size and distance of the aromatic group. For example, with the naphthyl analogue <b>33</b>, Phe 318 is pushed backward, while for constrained analogue <b>51</b>, it moves closer (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Interaction with these Phe side chains helps better positioning in front of the catalytic Ser. Consistently, docking of compounds less sensitive to CES-mediated hydrolysis showed that the hydroxamic carbonyls are further away from the catalytic Ser221 due to the lack of arylmethyl group in α-position.</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Docking of <b>33</b>, <b>47</b>, <b>51</b> in rat CES1. Carbon atoms for <b>33</b>, <b>47</b>, and <b>51</b> and key residues are in orange, magenta, and cyan, respectively. Arrow points to the carbonyl group of the hydroxamic function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Shifting or Inverting an Amide Dramatically Impacts Stability</h3><div class="NLM_p last">To understand why compound <b>20</b> was stable while close amide analogues <b>18</b>, <b>19</b>, and <b>21</b> were not (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), these four compounds were docked in both mAChE and in rCES (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S6–S7</a>). For example, hydroxamic acid <b>18</b> is stabilized within mAChE pocket by hydrogen bonds between the carbonyl of the hydroxamic acid function and the oxyanion hole, a hydrogen bond with Ser125 and a H−π stacking to Tyr124. Similarly, the carbonyl of the hydroxamic function of <b>21</b> interacts with the oxyanion hole. An additional hydrogen bond between its amide function and Glu202, via a water molecule, is observed in the model. In comparison with <b>18</b> and <b>21</b>, hydroxamic acid <b>19</b> makes fewer interactions with mAChE and the hydroxamic acid function is further away from the catalytic Ser203 (2.45 Å vs 2.24 Å for <b>18</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Table S4</a>). Finally, the stable hydroxamic acid <b>20</b> does not appear to make significant interactions with the catalytic site of mAChE. As a consequence, the carbonyl of the hydroxamic acid function is too far to allow the attack by Ser203 (3.03 Å, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S6 and Table S4</a>). Similar results were obtained for rCES1 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S7</a>). Binding of unstable hydroxamic acids <b>18</b> and <b>21</b> is driven by the interaction of the amide function with a water molecule in the vicinity of the oxyanion hole on one side and π-stacking (parallel or T-shaped) with Phe304 and Phe318. Slightly more stable compound <b>19</b> is engaged in a H−π stacking with Leu255. In all these three cases, distances and angles to catalytic Ser221 are compatible with hydrolysis, in strong opposition with stable compound <b>20</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Table S4</a>). These results support the differences in stabilities for compounds <b>18</b>–<b>21</b> and corroborate the critical role of the amide position.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Plasma Esterase Activities Differ between Species</h3><div class="NLM_p">All compounds of this study were shown to be stable in human plasma (<i>t</i><sub>1/2</sub> > 6 h) with the exception of compound <b>21</b>. This compound, though far more stable in human plasma (<i>t</i><sub>1/2</sub> = 2.4 h) than in rat plasma (<i>t</i><sub>1/2</sub> = 0.43 h), is still rapidly hydrolyzed in human plasma (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The greater stability of hydroxamates in human plasma compared to rat plasma can be explained by both structural differences in the catalytic pockets (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S2–S5</a>) and relative concentrations and activities of the esterases between species.</div><div class="NLM_p">Regarding cholinesterases, hAChE and hBuChE catalytic pockets are narrower than those of rodent AChE and BuChE (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S5</a>), respectively. Importantly, there is only a low concentration of AChE in human plasma, while BuChE is the most abundant esterase in human plasma.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">We showed for a representative set of hydroxamic acids sensitive to CES hydrolysis that they are substrates of both rodent and human enzymes (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Table S2</a>), in spite of structural differences in catalytic pockets (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Figure S5 parts E and F</a>, respectively). While CESs are the main esterases involved in rat plasma hydrolysis of hydroxamic acids, the fact that CESs are the most abundant esterases in rodent plasma while they are absent in human plasma explains the difference of stabilities in rat and human plasma.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Moreover, because CESs are present in liver and intestine microsomes, in both species, reducing the susceptibility of an hydroxamic acid to this enzyme is likely to have an impact on rodent plasma stability and human first-pass metabolism.</div><div class="NLM_p">All the results obtained from this study can be used to guide the optimization of the plasma stability of hydroxamic acids. Some empirical rules are illustrated in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. For example, introduction of cyclic constraints, small α-substituents, and removal or shortening of α-arylmethyl groups improve stabilities, especially toward CES.</div><figure id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Examples of the use of the medchem toolbox to stabilize hydroxamic acids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We designed and synthesized a 57-member library of hydroxamic acids based on templates found in inhibitors of the main classes of zinc metallohydrolases. This library was used to explore the structure–plasma stability relationships in chemical series relevant to the medicinal chemistry of this important class of therapeutic targets. In addition to including various chemical templates, the library covered a fair range of physical-chemical parameters (i.e., 137 < MW < 410, −1.4 < log <i>D</i> < 3.4, 49.3 < tPSA < 113).</div><div class="NLM_p">Finding 1: With the exception of one compound, all hydroxamates were found to be very stable in human plasma. In contrast, many hydroxamates were unstable in rat plasma. This difference between species may pose a difficulty during preclinical development, as it may preclude systemic exposure and engagement of target in species used in toxicological studies.</div><div class="NLM_p">Finding 2: Thanks to a deconvolution scheme that uses a series of inhibitors of increasing selectivity, we were able to determine which enzyme was responsible for the hydrolysis. It appears that hydrolysis of unstable hydroxamates is performed by a limited number of plasma enzymes, mainly CES.</div><div class="NLM_p">Finding 3: A This limited number of enzymes has defined structural requirements, in contrast with the large variety of promiscuous metabolic enzymes such as CYP450 and phase 2 enzymes that account for the majority of transformations performed on xenobiotics. It was thus possible to identify structural features that are beneficial or deleterious for plasma stability. We identified, for example, that arylmethyl substituent in α-position of the hydroxamic acid is well recognized by CES. Also, in linear amide-bearing compounds, the position and orientation of the amide bond relative to the hydroxamate are critical to recognition and stability: a NHCO in β-position of the hydroxamic function is stable while other amides are highly recognized by AChE and CES, leading to low stability. We also show that BuChE does not hydrolyze hydroxamic acids bearing a positive charge or bulky groups.</div><div class="NLM_p">In term of molecular properties, we saw that stable hydroxamates are found in the low range of log <i>P</i>, while a systematic multivariate analysis yielded a model where HBD < 3 favors stability (OR = 4.80).</div><div class="NLM_p last">As the hydroxamic acid function is often critical for pharmacological activity, its replacement by isosters is often not possible. Also, stability in rodent plasma is essential to achieve proof-of-concept in animal to assess secondary and safety pharmacology and finally to estimate the safety window of drug candidates. Therefore, a large difference in metabolic stability between human and preclinical species, especially when it involves transformation of a key element of pharmacophore, can compromise developability of a drug candidate. Although the use of esterase inhibitors could partially restore adequate plasma concentration in animal models, these inhibitors have themselves side effects that could impede the interpretation of pharmacodynamic studies. In all, our study provides a toolbox that includes a validated protocol for hydroxamates stability testing, an esterase deconvolution procedure, and SPSR that guide structural changes during optimization on the target of interest. It can help prioritize hits and leads based on structural liabilities (templates and physical–chemical properties). This is the first comprehensive rule of thumb to obtain hydroxamic acids as stable in rodent as in human plasma, thus bridging the gap between species during preclinical development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Chemistry</h3><div class="NLM_p last">Merck Millipore aluminum-backed sheets and TLC silica gel 60 F<sub>254</sub> were used for TLC. GraceResolv cartridge columns (4–120 g) were used to purify chemicals by flash column chromatography helped by Interchim Puriflash 430 equipped with evaporative light scattering detector (ELSD). <sup>1</sup>H and <sup>13</sup>C NMR were recorded at room temperature on a Bruker DPX 300 at 300 and 75 MHz, respectively. <sup>1</sup>H NMR spectra chemical shifts are in parts per million (ppm) relative to the peak of DMSO-<i>d</i><sub>6</sub> (2.50 ppm), CD<sub>3</sub>OD (3.31 ppm), or CDCl<sub>3</sub> (7.26 ppm). <sup>13</sup>C NMR spectra chemical shifts are in parts per million (ppm) relative to the peak of DMSO-<i>d</i><sub>6</sub> (39.52 ± 0.06 ppm), CD<sub>3</sub>OD (49.00 ± 0.06 ppm), acetone-<i>d</i><sub>6</sub> (2.05 ± 0.06 ppm), or CDCl<sub>3</sub> (77.16 ± 0.06 ppm). Coupling constants (<i>J</i>) are reported in hertz (Hz), and peak multiplicities are reported as singlet (s), doublet (d), triplet (t), quadruplet (q), broad (br), and multiplet (m). Purity (%) was measured by reverse-phase chromatography HPLC using UV detection (215 nm), and all final compounds showed purities greater than 95%. Mass spectra were recorded on a LCMS system (Waters) composed of solvent manager 2695, photodiode array detector 2996, micromassZQ, and a C<sub>18</sub> Xbridge 3.5 μm particle size HPLC column, dimensions 4.6 mm × 50 mm. Analytical reverse phase HPLC gradient starting from 100% aqueous buffer, pH = 3.8 ± 0.3 (NH<sub>4</sub>OH 0.01%, HCOOH 0.02%), and reaching 100% acetonitrile buffer (NH<sub>4</sub>OH 0.01%, HCOOH 0.02%) within 3.25 min at a flow rate of 2 mL/min was used. When needed, compounds were purified by preparative HPLC on a LCMS Waters-2 system composed of solvent manager 2545, dual wavelength absorbance detector 2487, 3100 single quadrupole mass detector and using a Xbridge prep C<sub>18</sub> 5 μm OBD dimensions 50 mm × 250 mm column. Reverse phase preparative HPLC linear gradients started from 100% of aq buffer pH = 3.8 ± 0.3 (NH<sub>4</sub>OH 0.01%, HCOOH 0.02%) or aq buffer pH = 9.2 ± 0.3 (NH<sub>4</sub>OH 0.03%, HCOOH 0.01%) and reached 100% acetonitrile buffer (NH<sub>4</sub>OH 0.01%, HCOOH 0.02%) or (NH<sub>4</sub>OH 0.03%, HCOOH 0.01%) within 25 min at a flow rate of 80 mL/min. High-resolution mass spectrometry (HRMS) was performed with a quadrupole time-of-flight (TOF) Micromass Waters. Melting points were recorded on a Büchi melting point B-450. All commercial reagents and solvents were used without further purification. The synthesis of <b>37</b>–<b>38</b>, <b>40</b>–<b>42</b> has been previously described.<a onclick="showRef(event, 'cit8a ref24'); return false;" href="javascript:void(0);" class="ref cit8a ref24">(8a, 24)</a></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Highly Toxic Compound</h3><div class="NLM_p last">Potassium cyanide extracted in aqueous phase was stirred and basified with KOH 15% (pH has to be superior or equal to 14). Then sodium hypochlorite (NaClO) 2.6% active chloride was added in very large excess (compared to the amount of potassium cyanide) and stirred at room temperature for 10 min. Iodide strip was used to evaluate the oxidative potential of the mixture. A purple-blue color indicates a strong potential, allowing disposal of the treated phase in the adequate waste tank for destruction.</div></div><div id="secx" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure A for the Synthesis of Compounds <b>22b</b>, <b>24b</b>–<b>26b</b>, <b>29b</b>, <b>46b</b>, <b>47b</b>, <b>55b</b></h3><div class="NLM_p last">Ester (1.00 mmol, 1.0 equiv) was dissolved in ethanol/THF (1:2), and aqueous NaOH 2 M (13.00 mmol, 13.0 equiv) was added. The solution was stirred at room temperature for 16 h. HCl 1 N was added to bring the pH up to 2–3. The resulting mixture was extracted with dichloromethane. The organic layer was dried over MgSO<sub>4</sub> and evaporated to give the corresponding carboxylic acid.</div></div><div id="secy" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure B for the Synthesis of Compounds <b>1</b>–<b>11</b>, <b>13</b>, <b>14</b>, <b>21</b>–<b>29</b>, <b>46</b>–<b>49</b>, <b>52</b>–<b>56</b></h3><div class="NLM_p last">Commercial carboxylic acid (2.00 mmol, 1 equiv) and HOBt (2.20 mmol, 1.1 equiv) were dissolved in DMF (10 mL). A solution of EDCI·HCl (2.70 mmol, 1.5 equiv) and <i>N</i>-methylmorpholine (6.01 mmol, 3 equiv) in DMF (6.5 mL) was slowly added to the previous solution cooled to 0 °C. Then a solution of <i>O</i>-tritylhydroxylamine (2.50 mmol, 1.25 equiv) in DMF (2.5 mL) was added. The mixture was stirred at room temperature overnight. The solvent was evaporated under reduced pressure, and the residue was dissolved in DCM and washed two times with aqueous sat. NaHCO<sub>3</sub> and two times with aqueous sat. NH<sub>4</sub>Cl. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the desired <i>O</i>-tritylhydroxamic acid. The corresponding <i>O</i>-tritylhydroxamic acid (1 mmol, 1 equiv) was dissolved in DCM (9.50 mL), and liquid TFA (0.25 mL) and triethylsilane (0.25 mL) were added. The mixture was stirred at room temperature for 30 min. Solvents were removed under reduced pressure and the crude product was washed three times with pentane/diethyl ether 75:25 (v:v) affording a residue. The corresponding residue was purified by preparative HPLC using a linear acetonitrile/water (ammonium acetate/formic acid buffer, pH = 3.8) gradient (2:98 to 100:0 over 25 min) for hydroxamic acids <b>3</b>, <b>4</b>, <b>9</b>, <b>10</b>, <b>14</b>. Or the residue was washed with diethyl ether/petroleum ether (1:4) to give a crude product which was purified by flash silica gel column chromatography to give desired hydroxamic acid <b>1</b>, <b>2</b>, <b>5</b>–<b>8</b>, <b>11</b>, <b>13</b>, <b>21</b>–<b>29</b>, <b>46</b>–<b>49</b>, <b>52</b>–<b>56</b>.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure C for the Synthesis Compounds <b>30</b>–<b>32</b>, <b>34</b>–<b>36</b>, <b>39</b>, <b>43</b></h3><div class="NLM_p last">To a solution of diethyl 2-methylmalonate (3.56 mmol, 1 equiv) in ethanol absolute (5 mL, 0.7 M) was added solid KOH (5.34 mmol, 1.5 equiv). This mixture was stirred for 24 h at room temperature before EtOH was evaporated in vacuo. The residue was dissolved in aqueous sat. NaHCO<sub>3</sub> and washed with EtOAc. The aqueous phase was acidified to pH 1–2 with aqueous HCl 1 M. The desired carboxylic acid was extracted thrice with ethyl acetate, and organic phases were pooled and evaporated to give pure carboxylic acid <b>63</b>–<b>68</b>. To a solution of the appropriate carboxylic acid (2.70 mmol, 1 equiv) in anhydrous DMF (6.60 mL, 0.5 M) at 0 °C were added HBTU (2.97 mmol, 1.1 equiv) and anhydrous DIPEA (8.1 mmol, 3 equiv). This mixture was stirred 5 min before benzylamine (2.83 mmol, 1.05 equiv) was added. The mixture was stirred 10 min at 0 °C, and 4 h 30 min at room temperature. The solvent was evaporated under high vacuum, and the crude product was partitioned between aqueous sat. NaHCO<sub>3</sub> and EtOAc. The organic layer was washed 3 times with aqueous sat. NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, and evaporated under vacuum. The residue was purified by flash silica gel column chromatography (cyclohexane/EtOAc 1:0 to 1:1 (v:v)), affording the corresponding ethyl 2-(benzylcarbamoyl)-2-methylacetate <b>30a</b>–<b>32a</b>, <b>34a</b>–<b>36a</b>, <b>39a</b>, <b>43a</b>. To a solution of the latter (1.94 mmol, 1 equiv) in MeOH (4.31 mL, 0.45 M) was added a solution of aqueous hydroxylamine 50% (4.31 mL) and KCN (0.012 g, 0.019 mmol, 0.1 equiv). The mixture was stirred for 15 h 30 min at room temperature before it was concentrated under vacuum. The residue was partitioned between water and EtOAc (1:50, v:v). The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water (ammonium acetate/formic acid buffer, pH = 3.8) gradient (2:98 to 100:0 over 25 min). This afforded pure hydroxamic acids <b>30</b>–<b>32</b>, <b>34</b>–<b>36</b>, <b>39</b>, <b>43</b>.</div></div><div id="sec5_1_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Benzhydroxamic Acid (<b>1</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from benzoic acid. White solid (0.075 g, 17%). Purity: 98%. Mp: 129 °C. <i>t</i><sub>R,LCMS</sub> = 1.37 min. MS (ESI−): <i>m</i>/<i>z</i> = 136 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 138 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.19 (s, 1H), 9.02 (s, 1H), 7.74 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 7.5 Hz, 2H), 7.53–7.41 (m, 3H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 164.1, 132.8, 131.1, 128.3, 126.8. HRMS <i>m</i>/<i>z</i> calculated for C<sub>7</sub>H<sub>8</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 138.0555. Found: 138.0566.</div></div><div id="sec5_1_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Phenylethanehydroxamic Acid (<b>2</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from 2-phenylacetic acid. Light brown solid (0.063 g, 13%). Purity: 96%. Mp: 119 °C. <i>t</i><sub>R,LCMS</sub> = 1.52 min. MS (ESI−): <i>m</i>/<i>z</i> = 150 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 152 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.65 (s, 1H), 8.81 (s, 1H), 7.32–7.19 (m, 5H), 3.27 (s, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 167.0, 136.0, 129.3, 128.9, 128.1, 126.4, 39.4. HRMS <i>m</i>/<i>z</i> calculated for C<sub>8</sub>H<sub>10</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 152.0712. Found: 152.0734.</div></div><div id="sec5_1_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-Phenylpropanehydroxamic Acid (<b>3</b>)</h3><div class="NLM_p last">Obtained following the general procedure B. White solid (0.084 g, 26%). Purity 98%. Mp: 80 °C. <i>t</i><sub>R,LCMS</sub> = 1.76 min. MS (ESI−): <i>m</i>/<i>z</i> = 164 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 166 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CDCl<sub>3</sub>) δ (ppm): 10.35 (s, 1H), 8.70 (s, 1H), 7.29–7.14 (m, 5H), 2.82–2.78 (t, <i>J</i> = 7.5 Hz, 2H), 2.27–2.22 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR 75 MHz (CDCl<sub>3</sub>) δ (ppm): 171.1, 140.3, 128.8, 128.4, 126.7, 34.9, 31.5. HRMS <i>m</i>/<i>z</i> calculated for C<sub>9</sub>H<sub>12</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 166.0868. Found: 166.0882.</div></div><div id="sec5_1_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-Phenylbutanehydroxamic Acid (<b>4</b>)</h3><div class="NLM_p last">Obtained following the general procedure B. Brown oil (0.176 g, 51%). Purity 95%. <i>t</i><sub>R,LCMS</sub> = 1.94 min. MS (ESI−): <i>m</i>/<i>z</i> = 178 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 180 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.36 (s, 1H), 8.69 (br s, 1H), 7.31–7.15 (m, 5H), 2.57–2.55 (t, <i>J</i> = 7.5 Hz, 2H), 1.99–1.94 (t, <i>J</i> = 7.5 Hz, 2H), 1.83–1.73 (m, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.1, 141.9, 128.5, 126.0, 34.8, 32.0, 27.2. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>14</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 180.1025. Found: 180.1049.</div></div><div id="sec5_1_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-Phenylpentanehydroxamic Acid (<b>5</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from 5-phenylpentanoic acid. White solid (0.036 g, 10%). Purity: 90%. Mp: 74 °C. <i>t</i><sub>R,LCMS</sub> = 2.47 min. MS (ESI+): <i>m</i>/<i>z</i> = 194 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 7.27–7.12 (m, 2H), 2.61–2.57 (m, 2H), 2.15–2.10 (m, 2H), 2.08–2.03 (m, 2H), 1.70–1.59 (m, 4H). <sup>13</sup>C NMR 75 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 170.2, 142.3, 128.3, 128.2, 125.6, 35.2, 30.9, 25.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>11</sub>H<sub>16</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 194.1181. Found: 194.1180.</div></div><div id="sec5_1_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-Phenylhexanehydroxamic Acid (<b>6</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from 6-phenylhexanoic acid. White solid (0.247 g, 45%). Purity: 99%. Mp: 71 °C. <i>t</i><sub>R,LCMS</sub> = 2.72 min. MS (ESI+): <i>m</i>/<i>z</i> = 208 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.31 (br s, 1H), 10.00 (br s, 1H), 8.64 (br s, 1H), 7.28–7.13 (m, 5H), 2.57–2.49 (m, 7H), 1.92 (t, <i>J</i> = 14.4 Hz, 2H), 1.59–1.51 (m, 4H), 1.29–1.27 (m, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.5, 142.7, 128.7, 128.7, 126.1, 35.5, 32.7, 31.2, 28.7, 25.4. HRMS <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>18</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 208.1338. Found: 208.1334.</div></div><div id="sec5_1_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 7-Phenylheptanehydroxamic Acid (<b>7</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from 7-phenylheptanoic acid. White powder (0.060 g, 13%). Purity 96%. Mp: 66 °C. <i>t</i><sub>R,LCMS</sub> = 2.97 min. MS (ESI+): <i>m</i>/<i>z</i> = 222 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 7.27–7.11 (m, 5H), 2.58 (t, <i>J</i> = 7.5 Hz, 2H), 2.09 (t, <i>J</i> = 7.5 Hz, 2H), 1.62–1.55 (m, 4H), 1.34–1.29 (m, 4H). <sup>13</sup>C NMR 75 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 170.3, 142.6, 128.3, 128.2, 125.5, 35.5, 32.3, 31.3, 29.0, 25.3. HRMS <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>20</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 222.1494. Found: 222.1494.</div></div><div id="sec5_1_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Cyclohexylethanehydroxamic Acid (<b>8</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from 2-cyclohexylacetic acid. White solid (0.107g, 18%). Purity: 80%. Mp: 146 °C. <i>t</i><sub>R,LCMS</sub> = 2.20 min. MS (ESI+): <i>m</i>/<i>z</i> = 158 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.31 (br s, 1H), 8.64 (br s, 1H), 1.81 (d, <i>J</i> = 6.3 Hz, 2H), 1.62 (d, <i>J</i> = 7.5 Hz, 6H), 1.20–1.06 (m, 3H), 0.92–0.85 (m, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.6, 40.8, 34.9, 32.9, 26.3, 26.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>8</sub>H<sub>16</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 158.1181. Found: 158.1179.</div></div><div id="sec5_1_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-Cyclohexylpropanehydroxamic Acid (<b>9</b>)</h3><div class="NLM_p last">Obtained following the general procedure B. Colorless oil (0.072 g, 21%). Purity 99%. <i>t</i><sub>R,LCMS</sub> = 2.49 min. MS (ESI−): <i>m</i>/<i>z</i> = 170 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 172 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 1.96–1.91 (t, <i>J</i> = 7.5 Hz, 2H), 1.67–1.63 (m, 5H), 1.41–1.33 (m, 2H), 1.23–1.08 (m, 4H), 0.88–0.78 (q, <i>J</i> = 10.2 Hz, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.3, 36.5, 32.6, 32.5, 29.8, 26.1, 25.7. HRMS <i>m</i>/<i>z</i> calculated for C<sub>9</sub>H<sub>18</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 172.1338. Found: 172.1354.</div></div><div id="sec5_1_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-Cyclohexylbutanehydroxamic Acid (<b>10</b>)</h3><div class="NLM_p last">Obtained following the general procedure B. White solid (0.034 g, 9%). Purity 98%. Mp: 81 °C. <i>t</i><sub>R,LCMS</sub> = 2.42 min. MS (ESI−): <i>m</i>/<i>z</i> = 184 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 186 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.28 (br s, 1H), 8.63 (br s, 1H), 1.89 (t, <i>J</i> = 7.5 Hz, 2H), 1.66–1.62 (m, 5H), 1.53–1.42 (quin, <i>J</i> = 7.5 Hz, 2H), 1.24–1.06 (m, 6H), 0.88–0.77 (m, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.1, 36.8, 36.4, 32.8, 32.5, 26.2, 25.8, 22.5. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>20</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 186.1494. Found: 186.1517.</div></div><div id="sec5_1_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-(1-Adamantyl)ethanehydroxamic Acid (<b>11</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from 2-(adamantan-1-yl)acetic acid. White solid (0.120 g, 48%). Purity 99%. Mp: 173 °C. <i>t</i><sub>R,LCMS</sub> = 2.63 min. MS (ESI+): <i>m</i>/<i>z</i> = 210 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.20 (br s, 1H), 1.90 (s, 3H), 1.68–1.54 (m, 14H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 167.2, 47.1, 42.5, 36.9, 32.6, 28.5. HRMS <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>20</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 210.1494. Found: 210.1507.</div></div><div id="sec5_1_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-(1-Adamantyl)propanehydroxamic Acid (<b>12</b>)</h3><div class="NLM_p last">To a solution of 2-(1-adamantyl)ethanol (1.984 g, 11 mmol, 1 equiv) in pyridine (13.7 mL, 0.8 M) was added 4-methylbenzenesulfonyl chloride (2.098 g, 11 mmol, 1 equiv), and the resulting yellow mixture was stirred 20 h at room temperature. Pyridine was evaporated under vacuum, and the crude product was dissolved in EtOAc. The organic phase was washed twice with 1 N HCl and then twice with aqueous sat. NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, filtered, and concentrated to afford 2-(1-adamantyl)ethyl 4-methylbenzenesulfonate (3.003 g, 75%) as a colorless oil. Purity 91%. <i>t</i><sub>R,LCMS</sub> = 3.95 min. MS (ESI+): <i>m</i>/<i>z</i> = 357 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.79 (d, <i>J</i> = 8.3 Hz, 2H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 4.05 (t, <i>J</i> = 6.9 Hz, 2H), 2.42 (s, 3H), 1.85 (s, 3H), 1.63–1.49 (m, 8H), 1.37–1.33 (m, 8H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 144.8, 132.4, 130.1, 127.6, 67.4, 41.8, 41.5, 36.3, 31.2, 27.8, 21.0. To a solution of this tosylate (2.342 g, 7.00 mmol, 1 equiv) in DMF (8.75 mL, 0.8 M) was added KCN (0.911 g, 14.00 mmol, 2 equiv). The resulting suspension was stirred at 80 °C for 15 h. It was diluted with water and extracted with Et<sub>2</sub>O. The combined organic phases were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give 1.126 g of a yellow oil. This crude product was purified by flash silica gel column chromatography (cyclohexane/ethyl acetate, 90:10 to 70:30). Pure 3-(1-adamantyl)propanenitrile <b>58</b> (1.126 g, 84%) was obtained as yellow needle crystals. No signal by LCMS. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 2.40 (t, <i>J</i> = 8.0 Hz, 2H), 1.92 (br s, 3H), 1.62 (br q, <i>J</i> = 12.3 Hz, 6H), 1.44 (d, <i>J</i> = 2.5 Hz, 6H), 1.36 (t, <i>J</i> = 8.0 Hz, 3H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 121.6, 40.9, 36.6, 31.7, 27.8, 10.2. To a solution of <b>58</b> (0.869 g, 4.59 mmol, 1 equiv) in EtOH (9.20 mL, 0.5 M) was added a solution of KOH (0.901 g, 16.07 mmol, 3.5 equiv) in H<sub>2</sub>O (9.20 mL, 1.75 M). The mixture was heated to 90 °C for 20 h. Solvents were evaporated in vacuo and then the residue was dissolved in aqueous HCl 1 M and EtOAc. The organic phase was washed three times with HCl 1 M, once with brine and dried over MgSO<sub>4</sub>. EtOAc was evaporated in vacuo affording 3-(1-adamantyl)propanoic acid (0.942 g, 97%) as white crystals. TLC cyclohexane/EtOAc 70:30 (v:v) <i>R</i><sub><i>f</i></sub> = 0.5. To a solution of this acid (0.309 g, 1.48 mmol, 1 equiv) in anhydrous methanol (5 mL, 0.33 M) cooled to 0 °C was added dropwise thionyl chloride (0.323 mL, 4.45 mmol, 3 equiv). The reaction was stirred at room temperature for 4 h 30 min before solvents were evaporated under vacuum. White crystals were obtained which were dissolved in EtOAc (a white precipitate appear) and washed with aqueous NaHCO<sub>3</sub> 5%. (The white precipitate disappeared when aqueous phase was added.) The crude product methyl 3-(1-adamantyl)propanoate <b>12a</b> was obtained as a white powder (0.071 g, 21%) by evaporating the solvent and was used in the next step without further purification. TLC cyclohexane/EtOAc 70:30 (v:v) <i>R</i><sub><i>f</i></sub> = 0.90. To a solution of <b>12a</b> (0.071 g, 0.31 mmol, 1 equiv) in MeOH (0.700 mL, 0.45 M) was added a solution of aqueous hydroxylamine 50% (0.700 mL) before KCN (0.02 g, 0.028 mmol, 0.1 equiv). The mixture was stirred for 12 h 30 min at room temperature. It was concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water (ammonium acetate/formic acid buffer, pH = 9.2) gradient (2:98 to 100:0 over 25 min) affording 3-(1-adamantyl)propanehydroxamic acid <b>12</b> as a white powder (0.026 g, 36%). Purity 99%. Mp: 153 °C. TLC cyclohexane/EtOAc 70:30 (v:v) <i>R</i><sub><i>f</i></sub> = 0.50. <i>t</i><sub>R,LCMS</sub> = 2.57 min. MS (ESI−): <i>m</i>/<i>z</i> = 222 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 224 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 10.31 (s, 1H), 8.62 (d, <i>J</i> = 1.2 Hz, 1H), 1.91–1.85 (m, 5H), 1.61 (q, <i>J</i> = 12.1 Hz, 6H), 1.41 (d, <i>J</i> = 2.1 Hz, 6H), 1.25 (td, <i>J</i> = 5.4 Hz, <i>J</i> = 2.8 Hz, 2H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 169.8, 41.5, 36.5, 31.6, 27.9, 26.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>22</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 224.1651. Found: 224.1664.</div></div><div id="sec5_1_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(Benzylamino)ethanehydroxamic Acid (<b>13</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <i>N</i>-benzylglycine hydrochloride. White powder (0.070 g, 25%). Purity 99%. Mp: 169 °C. <i>t</i><sub>R,LCMS</sub> = 1.47 min. MS (ESI+): <i>m</i>/<i>z</i> = 181 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.94 (br s, 1H), 9.31 (br s, 1H), 9.26 (br s, 1H), 7.45–7.42 (m, 5H), 4.16 (s, 2H), 3.55 (s, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 162.2, 131.9, 130.5, 129.5, 129.2, 50.4, 45.2. HRMS <i>m</i>/<i>z</i> calculated for C<sub>9</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 181.0972. Found: 181.0977.</div></div><div id="sec5_1_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-[2-(Hydroxyamino)-2-oxoethyl]benzamide (<b>14</b>)</h3><div class="NLM_p last">Obtained following the general procedure B. White solid (0.008 g, 5%). Purity 97%. Mp: 149 °C. <i>t</i><sub>R,LCMS</sub> = 1.43 min. MS (ESI−): <i>m</i>/<i>z</i> = 193 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 195 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 7.88–7.85 (dd, <i>J</i> = 0.9 Hz, <i>J</i> = 8.1 Hz, 2H), 7.54 (tt, <i>J</i> = 0.9 Hz, <i>J</i> = 7.5 Hz, 1H), 7.46 (td, <i>J</i> = 7.5 Hz, <i>J</i> = 8.1 Hz, 2H), 3.99 (s, 2H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 170.7, 169.1, 135.2, 133.1, 129.8, 128.7, 42.1. HRMS <i>m</i>/<i>z</i> calculated for C<sub>9</sub>H<sub>11</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 195.0770. Found: 195.0799.</div></div><div id="sec5_1_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-(Hydroxyamino)-3-oxo-<i>N</i>-phenylpropanamide (<b>15</b>)</h3><div class="NLM_p last">A solution of commercial Meldrum’s acid (0.332 g, 2.30 mmol, 1 equiv) and aniline (0.631 mL, 6.91 mmol, 3 equiv) in MeCN (1.85 mL, 1.25 M) was stirred for 2 h at 80 °C. The mixture was evaporated under vacuum and the residue was partitioned between aqueous sat. NaHCO<sub>3</sub> and EtOAc. The aqueous phase was acidified to pH 1–2 with HCl 1 M and extracted with ethyl acetate. Solvents were evaporated under reduced pressure to afford 3-anilino-3-oxopropanoic acid <b>15b</b> (0.202 g, 48%) as white crystals. <i>t</i><sub>R,LCMS</sub> = 1.60 min. MS (ESI−): <i>m</i>/<i>z</i> = 178 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 180 [M + H]<sup>+</sup>. Caution: A 40% rate of degradation was observed after 3 days at room temperature (brown color appears on crystals). Impure carboxylic acid <b>15b</b> (0.202 g, 1.12 mmol, 1 equiv) was solubilized in anhydrous MeOH (3.5 mL, 0.32 M) at 0 °C. SOCl<sub>2</sub> (0.246 mL, 3.38 mmol, 3 equiv) was added dropwise, and the mixture was stirred for 1 h at room temperature. The mixture was dissolved in EtOAc (10 mL) and water (20 mL). The aqueous phase was extracted twice with EtOAc, organic phases were pooled, dried over MgSO<sub>4</sub>, and evaporated under vacuum, affording methyl 3-anilino-3-oxopropanoate <b>15a</b> as a white powder (0.189 g, 43%) with a purity of only 50%. <b>15a</b> was anyway used in the final step without further purification. <i>t</i><sub>R,LCMS</sub> = 2.02 min. MS (ESI−): <i>m</i>/<i>z</i> = 192 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 194 [M + H]<sup>+</sup>. To a solution of <b>15a</b> (0.189 g, 0.98 mmol, 1 equiv) in MeOH (4 mL, 0.25 M) was added a solution of aqueous hydroxylamine 50% (4 mL,) and KCN (0.032 g, 0.49 mmol, 0.5 equiv). The solution was stirred overnight at room temperature. It was concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water (ammonium acetate/formic acid buffer, pH = 3.8) gradient (2:98 to 100:0 over 25 min), affording the hydroxamic acid <b>15</b> as a white powder (0.015 g, 8%). Purity 96%. Mp: 149 °C. <i>t</i><sub>R,LCMS</sub> = 1.55 min. MS (ESI−): <i>m</i>/<i>z</i> = 193 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 195 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.10 (s, 1H), 7.59–7.56 (m, 2H), 7.30 (t, <i>J</i> = 7.4 Hz, 2H), 7.04 (t, <i>J</i> = 7.4 Hz, 1H), 3.11 (s, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 165.5, 163.6, 138.9, 128.7, 123.4, 119.0, 42.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>9</sub>H<sub>11</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 195.0770. Found: 195.0801.</div></div><div id="sec5_1_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-(2-Phenylethylamino)ethanehydroxamic Acid (<b>16</b>)</h3><div class="NLM_p last">To a solution of 2-phenylethanamine (0.162 g, 1.33 mmol, 1 equiv) and anhydrous DIPEA (0.244 mL, 1.40 mmol, 1.05 equiv) in anhydrous DMF (2.40 mL, 0.55 M) at 0 °C was added dropwise methyl 2-bromoacetate (0.123 mL, 1.33 mmol, 1 equiv). The mixture was stirred for 1 h at 0 °C and 3 h at room temperature. Solvents were evaporated in vacuo and the brown crude product was purified by flash silica gel column chromatography (cyclohexane/EtOAc, 100:0 to 30:70) affording methyl 2-(2-phenylethylamino)acetate (<b>16a</b>) as a colorless oil (0.146 g, 54%). <i>t</i><sub>R,LCMS</sub> = 1.65 min. MS (ESI+): <i>m</i>/<i>z</i> = 194 [M + H]<sup>+</sup>. To a solution of <b>16a</b> (0.086 g, 0.44 mmol, 1 equiv) in MeOH (0.490 mL, 0.45 M) was added a solution of aqueous hydroxylamine 50% (4.90 mL) and KCN (0.003 g, 0.05 mmol, 0.1 equiv). The mixture was stirred for 3 h 30 min at room temperature. It was concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water (ammonium acetate/formic acid buffer, pH = 9.2) gradient (2:98 to 100:0 over 25 min), affording the hydroxamic acid <b>16</b> as a white powder (0.032 g, 36%). Purity 98%. Mp: 146 °C. <i>t</i><sub>R,LCMS</sub> = 1.47 min. MS (ESI−): <i>m</i>/<i>z</i> = 193 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 195 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.30–7.14 (m, 5H), 3.03 (s, 2H), 2.68 (s, 4H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 167.8, 140.2, 128.5, 128.2, 125.8, 50.5, 49.8, 35.7. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 195.1134. Found: 195.1140.</div></div><div id="sec5_1_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-(Benzylamino)propanehydroxamic Acid (<b>17</b>)</h3><div class="NLM_p last">To a solution of methyl prop-2-enoate (0.316 mL, 3.48 mmol, 1 equiv) in ethanol (1.70 mL, 2 M) was added benzylamine (0.381 mL, 3.48 mmol, 1 equiv), and the mixture was stirred for 18 h at room temperature. The crude product was purified by flash silica gel column chromatography (DCM/MeOH, 100:0 to 90:10) affording methyl 3-(benzylamino)propanoate <b>17a</b> (0.603 g, 84%) as a colorless oil. Purity 94%. <i>t</i><sub>R,LCMS</sub> = 1.47 min. MS (ESI+): <i>m</i>/<i>z</i> = 194 [M + H]<sup>+</sup>. To a solution of <b>17a</b> (0.603 g, 3.12 mmol, 1 equiv) in methanol (6.80 mL, 0.45 M) was added a solution of aqueous hydroxylamine 50% (6.80 mL) and KCN (0.02 g, 0.28 mmol, 0.1 equiv). The mixture was stirred for 3 h 30 min at room temperature. It was then concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). The organic layer was evaporated under vacuum and purified by flash column chromatography (DCM/MeOH, 100:0 to 85:15) affording the hydroxamic acid <b>17</b> as white crystals (0.097 g, 15%). Purity 99%. Mp: 118 °C. <i>t</i><sub>R,LCMS</sub> = 1.17 min. MS (ESI−): <i>m</i>/<i>z</i> = 193 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 195 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.30 (m, 4H), 7.22 (m, 1H), 3.66 (s, 2H), 2.67 (t, <i>J</i> = 6.9 Hz, 2H), 2.12 (t, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.3, 140.8, 128.1, 127.9, 126.5, 52.7, 45.0, 33.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 195.1134. Found: 195.1140.</div></div><div id="sec5_1_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-Hydroxycarbamoylmethyl-2-phenylacetamide (<b>18</b>)</h3><div class="NLM_p last">To a solution of hydroxylamine hydrochloride (2.12 g, 30.57 mmol, 7 equiv) in MeOH (35 mL) was added KOH (2.70 g, 48.0 mmol, 11 equiv). The mixture was stirred for 30 min at room temperature. This solution was then filtered and added to a solution of methyl 2-(2-phenylacetamido)acetate <b>18a</b> (0.905 g, 4.37 mmol, 1 equiv) in MeOH (25 mL). The mixture was stirred at room temperature for 16 h. Solvent was removed under reduced pressure. The residue was dissolved in H<sub>2</sub>O, acidified to pH = 5 with 6 N HCl, and neutralized with aqueous sat. NaHCO<sub>3</sub>. Precipitate was collected by filtration to give compound <b>18</b> as a pasty amorphous solid. Purity 99%. <i>t</i><sub>R,LCMS</sub> = 1.53 min. MS (ESI−): <i>m</i>/<i>z</i> = 207 [M – H]<sup>−</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 7.31–7.23 (m, 5H), 3.74 (s, 2H), 3.55 (s, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 170.3, 165.3, 138.5, 129.6, 128.4, 126.2, 44.4, 40.3. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub> [M + H] <sup>+</sup>: 209.0926. Found: 209.0917.</div></div><div id="sec5_1_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-[3-(Hydroxyamino)-3-oxopropyl]benzamide (<b>19</b>)</h3><div class="NLM_p last">To a solution of methyl 3-benzamidopropanoate (0.123 g, 0.59 mmol, 1 equiv) in MeOH (1.60 mL, 0.45 M) was added a solution of aqueous hydroxylamine 50% (1.30 mL) and KCN (0.004 g, 0.05 mmol, 0.1 equiv). The mixture was stirred for 2 h 15 min at room temperature. It was then concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water (ammonium acetate/formic acid buffer, pH = 9.2) gradient (2:98 to 100:0 over 25 min), affording the hydroxamic acid <b>19</b> as a white powder (0.077 g, 88%). Purity 99%. Mp: 156 °C. <i>t</i><sub>R,LCMS</sub> = 1.48 min. MS (ESI−): <i>m</i>/<i>z</i> = 207 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 209 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.52 (t, <i>J</i> = 5.5 Hz, 1H), 7.85–7.81 (m, 2H), 7.54–7.41 (m, 3H), 3.44 (td, <i>J</i> = 7.1 Hz, <i>J</i> = 5.5 Hz, 2H), 2.26 (t, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 167.2, 166.1, 134.4, 131.1, 128.2, 127.1, 36.0, 32.4. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 209.0926. Found: 209.0926.</div></div><div id="sec5_1_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-Benzyl-3-(hydroxyamino)-3-oxopropanamide (<b>20</b>)</h3><div class="NLM_p last">A solution of Meldrum’s acid (0.445 g, 3.08 mmol, 1 equiv) and benzylamine (0.800 mL, 7.33 mmol, 2.37 equiv) in MeCN (2.50 mL, 1.2 M) was stirred at room temperature for 3 h. A light yellow color appeared, and white crystals quickly formed. They were filtered and washed with diethyl ether affording the carboxylic acid <b>20b</b> as white crystals (0.374 g, 63%). Mp: 176 °C. <i>t</i><sub>R,LCMS</sub> = 1.68 min. MS (ESI−): <i>m</i>/<i>z</i> = 192 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 194 [M + H]<sup>+</sup>. To a solution of <b>20b</b> (0.340 g, 1.76 mmol, 1 equiv) in MeOH (5.90 mL, 0.3 M) at 0 °C was added dropwise thionyl chloride (0.383 μL, 5.28 mmol, 3 equiv). The reaction mixture was stirred at room temperature for 30 min, then solvents were evaporated in vacuo. White crystals were obtained. These crystals were dissolved in EtOAc and washed with aqueous 5% NaHCO<sub>3</sub>. EtOAc was evaporated in vacuo, and methyl ester <b>20a</b> was crystallized from methanol affording colorless crystals (0.168 g, 46%). Mp: 108 °C. <i>t</i><sub>R,LCMS</sub> = 1.98 min. MS (ESI−): <i>m</i>/<i>z</i> = 206 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 208 [M + H]<sup>+</sup>. To a solution of <b>20a</b> (0.159 g, 0.76 mmol, 1 equiv) in MeOH (1.60 mL, 0.45 M) was added a solution of aqueous hydroxylamine 50% (1.60 mL) and KCN (0.005 g, 0.06 mmol, 0.1 equiv). The mixture was stirred for 17 h at room temperature. It was concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). Solvents in the organic layer were evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water gradient, containing ammonium acetate/formic acid buffer (pH = 9.2), starting with H<sub>2</sub>O 98% to reach acetonitrile 100% in 25 min. Pure hydroxamic acid <b>20</b> was obtained as white crystals (0.069 g, 42%). Purity 98%. Mp: 135 °C. <i>t</i><sub>R,LCMS</sub> = 1.55 min. MS (ESI−): <i>m</i>/<i>z</i> = 207 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 209 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.84 (s, 1H), 8.91 (s, 1H), 8.46 (t, <i>J</i> = 5.8 Hz, 1H), 7.34–7.20 (m, 5H), 4.28 (d, <i>J</i> = 5.8 Hz, 2H), 2.96 (s, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 166.3, 163.7, 139.1, 128.2, 127.2, 126.7, 42.2, 40.8. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 209.0926. Found: 209.0935.</div></div><div id="sec5_1_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-Hydroxy-<i>N</i>′-phenylsuccinamide (<b>21</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from 3-(phenylcarbamoyl)propanoic acid. White powder (0.040 g, 12%). Purity 99%. Mp: 122 °C. <i>t</i><sub>R,LCMS</sub> = 2.20 min. MS (ESI+): <i>m</i>/<i>z</i> = 209 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 7.63 (d, <i>J</i> = 6.9 Hz, 2H), 7.26 (t, <i>J</i> = 6.9 Hz, 2H), 7.02 (t, <i>J</i> = 6.9 Hz, 1H), 2.65 (br s, 2H), 2.46 (br s, 2H). <sup>13</sup>C NMR 75 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 170.0, 169.4, 139.4, 128.6, 123.1, 119.0, 31.8, 27.5. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 209.0926. Found: 209.0923.</div></div><div id="secw" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-Hydroxy-2-methyl-4-phenylbutyramide (<b>22</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>22b</b>. White powder (0.160 g, 25%). Purity 99%. Mp: 134 °C. <i>t</i><sub>R,LCMS</sub> = 2.57 min. MS (ESI+): <i>m</i>/<i>z</i> = 194 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.42 (br s, 1H), 8.72 (br s, 1H), 7.29–7.14 (m, 5H), 2.49–2.45 (m, 2H), 2.13–2.10 (m, 1H), 1.80–1.74 (m, 1H), 1.56–1.54 (m, 1H), 1.02 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 172.7, 142.3, 128.8, 128.6, 126.2, 36.9, 35.8, 33.5, 18.4. HRMS <i>m</i>/<i>z</i> calculated for C<sub>11</sub>H<sub>16</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 194.1181. Found: 194.1182.</div></div><div id="sec5_1_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-Benzyl-4-phenylbutanehydroxamic Acid (<b>23</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>23b</b>. White amorphous solid (0.037 g, 13%). Purity: 95%. Mp: 131 °C. <i>t</i><sub>R,LCMS</sub> = 2.58 min. MS (ESI+): <i>m</i>/<i>z</i> = 270 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.45 (br s, 1H), 8.78 (br s, 1H), 7.28–7.11 (m, 10H), 2.84 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 13.5 Hz, 1H), 2.63 (dd, <i>J</i> = 6.9 Hz, <i>J</i> = 13.5 Hz, 1H), 2.50–2.31 (m, 3H), 1.83–1.73 (m, 1H), 1.64–1.53 (m, 1H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 171.1, 142.2, 140.2, 129.3, 128.8, 128.6, 128.5, 126.5, 126.2, 44.8, 38.6, 34.4, 33.5. HRMS <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>20</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 270.1494. Found: 270.1503.</div></div><div id="sec5_1_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Benzenesulfonyl-<i>N</i>-hydroxy-4-phenylbutyramide (<b>24</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>24b</b>. White powder (0.07 g, 63%). Purity 99%. Mp: 176 °C. <i>t</i><sub>R,LCMS</sub> = 2.70 min. MS (ESI+): <i>m</i>/<i>z</i> = 320 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.94 (br s, 1H), 9.32 (br s, 1H), 7.79–7.73 (m, 3H), 7.65–7.60 (m, 2H), 7.25–7.18 (m, 3H), 7.09–7.06 (m, 2H), 3.76 (s, 1H), 2.50–2.37 (m, 2H), 1.99 (br s, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 160.7, 140.4, 137.4, 134.7, 129.6, 128.9, 128.6, 126.7, 67.1, 32.2, 28.7. HRMS <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>18</sub>NO<sub>4</sub>S [M + H]<sup>+</sup>: 320.0957. Found: 320.0956.</div></div><div id="sec5_1_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Benzenesulfonyl-<i>N</i>-hydroxy-2-methyl-4-phenylbutyramide (<b>25</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>25a</b>. White powder (0.020 g, 12%). Purity 99%. Mp: 159 °C. <i>t</i><sub>R,LCMS</sub> = 2.82 min. MS (ESI+): <i>m</i>/<i>z</i> = 334 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CDCl<sub>3</sub>) δ (ppm): 7.82 (d, <i>J</i> = 7.5 Hz, 2H), 7.73–7.68 (m, 1H), 7.60–7.55 (m, 2H), 7.32–7.14 (m, 5H), 2.69–2.55 (m, 3H), 2.24–2.14 (m, 1H), 1.58 (s, 3H). <sup>13</sup>C NMR 75 MHz (CDCl<sub>3</sub>) δ (ppm): 165.1, 140.0, 134.7, 134.5, 130.1, 129.3, 128.6, 128.3, 126.5, 71.0, 35.1, 30.3, 16.7. HRMS <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>20</sub>NO<sub>4</sub>S [M + H]<sup>+</sup>: 334.1113. Found: 334.1113.</div></div><div id="sec5_1_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-Benzyl-<i>N</i>-hydroxy-2-methanesulfonyl-4-phenylbutyramide (<b>26</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>26a</b>. White solid (0.047g, 10%). Purity 99%. Mp: 105 °C. <i>t</i><sub>R,LCMS</sub> = 2.90 min. MS (ESI+): <i>m</i>/<i>z</i> = 348 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 7.40–7.32 (m, 5H), 7.30–7.13 (m, 3H), 7.10 (d, <i>J</i> = 6.9 Hz, 2H), 3.85 (d, <i>J</i> = 13.8 Hz, 1H), 3.40 (d, <i>J</i> = 13.8 Hz, 1H), 3.06 (s, 3H), 2.85–2.80 (m, 2H), 2.36–2.26 (m, 1H), 2.11–2.00 (m, 1H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 165.4, 141.4, 134.7, 130.2, 128.7, 128.2, 127.9, 127.1, 125.7, 73.9, 38.2, 36.6, 35.7, 29.9. HRMS <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>22</sub>NO<sub>4</sub>S [M + H]<sup>+</sup>: 348.1270. Found: 348.1288.</div></div><div id="sec5_1_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>S</i>)-2-Benzylamino-<i>N</i>-hydroxypropionamide (<b>27</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>27b</b>. White powder (0.030 g, 8%). Purity 87%. Mp: 154 °C. <i>t</i><sub>R,LCMS</sub> = 1.22 min. MS (ESI+): <i>m</i>/<i>z</i> = 195 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.81 (br s, 1H), 7.31–7.20 (m, 5H), 3.66 (d, <i>J</i> = 13.2 Hz, 1H), 3.49 (d, <i>J</i> = 13.2 Hz, 1H), 2.99 (q, <i>J</i> = 6.9 Hz, 1H), 1.11 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 171.7, 140.9, 128.6, 128.3, 127.1, 54.4, 51.1, 19.9. HRMS <i>m</i>/<i>z</i> calculated for C<sub>10</sub>H<sub>15</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>: 195.1134. Found: 195.1124.</div></div><div id="sec5_1_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>S</i>)-2-Benzylamino-<i>N</i>-hydroxy-3-phenylpropionamide (<b>28</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>28b</b>. White solid (0.095 g, 13%). Purity: 99%. Mp: 163 °C. <i>t</i><sub>R,LCMS</sub> = 2.25 min. MS (ESI+): <i>m</i>/<i>z</i> = 271 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.00 (br s, 1H), 9.56 (br s, 1H), 9.34 (br s, 1H), 7.46–7.42 (m, 5H), 7.32–7.27 (m, 3H), 7.17 (d, <i>J</i> = 6.9 Hz, 2H), 4.03 (s, 2H), 3.77–3.72 (m, 2H), 3.20–3.00 (m, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 163.3, 135.2, 132.0, 130.5, 129.8, 129.5, 129.2, 129.0, 127.7, 59.0, 49.4, 36.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 271.1447. Found: 271.1438.</div></div><div id="sec5_1_2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-[(1<i>S</i>)-2-(Hydroxyamino)-1-(hydroxymethyl)-2-oxoethyl]-4-phenylbenzamide (<b>29</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>29b</b>. White solid (0.046 g, 8%). Purity 90%. Mp: 179 °C. <i>t</i><sub>R,LCMS</sub> = 2.53 min. MS (ESI+): <i>m</i>/<i>z</i> = 301 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 7.97 (d, <i>J</i> = 8.1 Hz, 2H), 7.73 (d, <i>J</i> = 8.1 Hz, 2H), 7.67 (d, <i>J</i> = 7.5 Hz, 2H) 7.46 (t, <i>J</i> = 7.5 Hz, 2H), 7.38 (d, <i>J</i> = 7.5 Hz, 1H), 4.63 (t, <i>J</i> = 5.7 Hz, 2H), 3.89 (d, <i>J</i> = 5.7 Hz, 1H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD–<i>d</i><sub>4</sub>) δ (ppm): 168.4, 168.2, 144.6, 139.8, 132.3, 128.6, 127.8, 126.7, 126.6, 61.5, 53.9. HRMS <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 301.1188. Found: 301.1198.</div></div><div id="sec5_1_2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-Benzyl-3-(hydroxyamino)-2-methyl-3-oxopropanamide (<b>30</b>)</h3><div class="NLM_p last">Obtained following the general procedure C from commercial 1,3-diethyl 2-methylpropanedioate. White powder (0.025 g, 4%). Purity 99%. Mp: 138 °C. <i>t</i><sub>R,LCMS</sub> = 1.65 min. MS (ESI−): <i>m</i>/<i>z</i> = 221 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 223 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.38 (br s, 1H), 8.90 (s, 1H), 8.17 (t, <i>J</i> = 5.7 Hz, 1H), 7.33–7.22 (m, 5H), 4.26 (d, <i>J</i> = 5.7 Hz, 2H), 3.07 (q, <i>J</i> = 7.1 Hz, 1H), 1.22 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.6, 167.4, 139.3, 128.2, 127.1, 126.7, 44.3, 42.2, 14.6. HRMS <i>m</i>/<i>z</i> calculated for C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 223.1083. Found: 223.1086.</div></div><div id="sec5_1_2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>,2-Dibenzyl-3-(hydroxyamino)-3-oxopropanamide (<b>31</b>)</h3><div class="NLM_p last">Obtained following the general procedure C from commercial 1,3-diethyl 2-benzylpropanedioate. White crystals (0.201 g, 27%). Purity 99%. TLC dichloromethane/methanol 95:05 (v:v) <i>R</i><sub><i>f</i></sub> = 0.55. Mp: 179 °C. <i>t</i><sub>R,LCMS</sub> = 2.22 min. MS (ESI−): <i>m</i>/<i>z</i> = 297 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 299 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.43 (s, 1H), 8.92 (s, 1H), 8.19 (t, <i>J</i> = 5.7 Hz, 1H), 7.28–7.09 (m, 10H), 4.29 (dd, <i>J</i> = 6.1 Hz, <i>J</i> = 15.2 Hz, 1H), 4.18 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 15.2 Hz, 1H), 3.30 (t, <i>J</i> = 7.5 Hz, 1H), 3.04 (t, <i>J</i> = 5.7 Hz, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.1, 165.7, 139.1, 138.9, 128.8, 128.1, 127.0, 126.6, 126.1, 52.3, 42.2, 34.6. HRMS <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 299.1396. Found: 299.1399.</div></div><div id="sec5_1_2_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-Benzyl-3-(hydroxyamino)-3-oxo-2-(4-pyridylmethyl)propanamide (<b>32</b>)</h3><div class="NLM_p last">To a solution of commercial dimethyl malonate (1.068 g, 8.08 mmol, 1 equiv) in THF (15 mL, 0.5 M) at 0 °C was carefully added NaH 60% dispersion in mineral oil (0.679 g, 17 mmol, 2.1 equiv), and the mixture was allowed to come back to room temperature and stirred for 30 min before 4-(chloromethyl)pyridine hydrochloride (1.193 g, 7.27 mmol, 0.9 equiv) was added. The mixture was stirred at 40 °C for 5 h. Solvents were evaporated in vacuo and the residue was purified by flash silica gel column chromatography (cyclohexane/EtOAc, 100:0 to 50:50) affording <b>61</b> as a colorless oil. <i>t</i><sub>R,LCMS</sub> = 1.62 min. MS (ESI+): <i>m</i>/<i>z</i> = 224 [M + H]<sup>+</sup>. Degradation occurs very quickly, the oil turning rapidly reddish, then blackish, and solids then start to form. A degradation rate of 55% was calculated based on UV–LCMS. This intermediate (0.870 g, 23%) was engaged in the next step, following general procedure C without further purification. <b>32</b> was thus obtained as a white solid (0.02 g, 7%). Purity 99%. Mp: 87 °C. <i>t</i><sub>R,LCMS</sub> = 1.52 min. MS (ESI−): <i>m</i>/<i>z</i> = 298 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 300 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.46 (s, 1H), 8.97 (s, 1H), 8.44 (d, <i>J</i> = 1.4 Hz, 2H), 8.26 (t, <i>J</i> = 5.8 Hz, 1H), 7.30–7.11 (m, 7H), 4.29 (dd, <i>J</i> = 15.1 Hz, <i>J</i> = 6.0 Hz, 1H), 4.19 (dd, <i>J</i> = 15.1 Hz, <i>J</i> = 5.7 Hz, 1H), 3.35 (t, <i>J</i> = 7.6 Hz, 1H), 3.06 (dd, <i>J</i> = 7.6 Hz, <i>J</i> = 2.6 Hz, 1H), 3.08 (dd, <i>J</i> = 7.6 Hz, <i>J</i> = 3.5 Hz, 1H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 167.7, 165.3, 149.3, 147.8, 139.0, 128.2, 127.0, 126.7, 124.2, 51.0, 42.2, 33.6. HRMS <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 300.1348. Found: 300.1376.</div></div><div id="sec5_1_2_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-Benzyl-3-(hydroxyamino)-2-(2-naphthylmethyl)-3-oxopropanamide (<b>33</b>)</h3><div class="NLM_p last">Meldrum’s acid (0.500 g, 3.47 mmol, 1 equiv) and 2-naphthaldehyde (0.542 g, 3.47 mmol, 1 equiv) were dissolved in acetonitrile (4 mL, 1 M) and stirred at room temperature for 1 h 30 min. A solution of Hantzsch’s ester (0.879 g, 3.47 mmol, 1 equiv) in methanol (3 mL) was added to the mixture, followed by <span class="smallcaps smallerCapital">l</span>-proline (0.080 g, 0.69 mmol, 0.2 equiv). The resulting mixture was stirred overnight at room temperature. A precipitate was formed and dissolved when the mixture was diluted with acetonitrile. Solvents were evaporated in vacuo and the residue was triturated in methanol, affording 2,2-dimethyl-5-(2-naphthylmethyl)-1,3-dioxane-4,6-dione <b>60</b> as a white solid (0.676 g, 68%). Purity 99%. <i>t</i><sub>R,LCMS</sub> = 1.17 min. MS (ESI+): <i>m</i>/<i>z</i> = 285 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CDCl<sub>3</sub>) δ (ppm): 7.82–7.76 (m, 4H), 7.50–7.42 (m, 3H), 3.84 (t, <i>J</i> = 4.9 Hz, 1H), 3.65 (d, <i>J</i> = 4.9 Hz, 2H), 1.73 (s, 3H), 1.50 (s, 3H). <sup>13</sup>C NMR 75 MHz (CDCl<sub>3</sub>) δ (ppm): 165.4, 134.9, 133.5, 132.6, 128.7, 128.4, 128.0, 127.9, 127.7, 126.3, 126.0, 105.3, 48.4, 32.3, 28.6, 27.3. A solution of <b>60</b> (0.097 g, 0.34 mmol, 1 equiv) and benzylamine (0.037 mL, 0.34 mmol, 1 equiv) in acetonitrile (0.480 mL, 0.7 M) was heated under microwave irradiation at 80 °C for 1 h 45 min. The product spontaneously crystallized from the light yellow reaction mixture at room temperature. It was filtered off and washed with diethyl ether, affording 3-(benzylamino)-2-(2-naphthylmethyl)-3-oxopropanoic acid <b>33b</b> (0.112 g, 95%) as light-yellow crystals. <i>t</i><sub>R,LCMS</sub> = 2.62 min. MS (ESI−): <i>m</i>/<i>z</i> = 332 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 334 [M + H]<sup>+</sup>. To a solution of carboxylic acid <b>33b</b> (0.112 g, 0.33 mmol, 1 equiv) in methanol (1 mL, 0.3 M) at 0 °C was added dropwise thionyl chloride (0.073 mL, 1.00 mmol, 3 equiv). The reaction mixture was stirred at room temperature for 5 h before methanol was evaporated in vacuo. A white powder was obtained and dissolved in ethyl acetate, washed with sat. aqueous NaHCO<sub>3</sub> twice. Organic fractions were pooled and evaporated under vacuum, affording methyl 3-(benzylamino)-2-(2-naphthylmethyl)-3-oxopropanoate <b>33a</b> as a white powder (0.105 g, 89%). <i>t</i><sub>R,LCMS</sub> = 2.98 min. MS (ESI−): <i>m</i>/<i>z</i> = 346 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 348 [M + H]<sup>+</sup>. To a solution of <b>33a</b> (0.105 g, 0.30 mmol, 1 equiv) in MeOH (0.660 mL, 0.45 M) was added a solution of aqueous hydroxylamine 50% (0.660 mL) and KCN (0.02 g, 0.028 mmol, 0.1 equiv). The mixture was stirred for 4 h at room temperature. It was concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). Solvents in the organic layer were evaporated under vacuum and the residue was purified by preparative HPLC using a linear acetonitrile/water gradient, containing ammonium acetate/formic acid buffer (pH = 9.2), starting with H<sub>2</sub>O 98% to reach acetonitrile 100% in 25 min. Pure hydroxamic acid <b>33</b> was obtained as a white powder (0.039 g, 36%). Purity 99%. <i>t</i><sub>R,LCMS</sub> = 2.52 min. MS (ESI−): <i>m</i>/<i>z</i> = 347 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 349 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.43 (s, 1H), 8.93 (s, 1H), 8.25 (t, <i>J</i> = 5.9 Hz, 1H), 7.88–7.78 (m, 3H), 7.69 (s, 1H), 7.51–7.36 (m, 3H), 7.15–7.01 (m, 5H), 4.31 (dd, <i>J</i> = 6.2 Hz, <i>J</i> = 15.3 Hz, 1H), 4.17 (dd, <i>J</i> = 5.4 Hz, <i>J</i> = 15.3 Hz, 1H), 3.43 (t, <i>J</i> = 7.5 Hz, 1H), 3.22 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 168.1, 165.7, 139.0, 136.6, 133.0, 131.8, 128.0, 127.7, 127.6, 127.5, 127.4, 127.0, 126.9, 125.9, 125.4, 52.3, 42.2, 34.9. HRMS <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 349.1552. Found: 349.1545.</div></div><div id="sec5_1_2_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>,2-Dibenzyl-3-(hydroxyamino)-2-methyl-3-oxopropanamide (<b>34</b>)</h3><div class="NLM_p last">To a solution of alcoholate ethoxysodium (3.8 mL, 13.33 mmol, 1.2 equiv) cooled to 0 °C with an ice bath was added commercial diethyl 2-methylpropanedioate (1 mL, 8.61 mmol, 1 equiv). Then the mixture was heated to 50 °C for 1 h and bromomethylbenzene (0.927 mL, 7.75 mmol, 0.9 equiv) was added. The mixture was heated again to 50 °C during 19 h, and solvent was evaporated under vacuum. The crude product was dissolved in EtOAc and aqueous sat. NaHCO<sub>3</sub>, and then the organic layer was washed three time with aqueous sat. NaHCO<sub>3</sub> and one time with aqueous NaOH 10% and then dried with MgSO<sub>4</sub> and evaporated under vacuum to give not pure diethyl 2-benzyl-2-methylpropanedioate <b>62</b> (1.409 g, 37%) as an orange oil. Purity 60%. <i>t</i><sub>R,LCMS</sub> = 3.28 min. MS (ESI+): <i>m</i>/<i>z</i> = 265 [M + H]<sup>+</sup>. This synthesis intermediate was used for general procedure C without further purification. <b>34</b> was obtained as a white solid (0.089 g, 12%). Purity 99%. Mp: 66 °C. <i>t</i><sub>R,LCMS</sub> = 2.33 min. MS (ESI−): <i>m</i>/<i>z</i> = 311 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 313 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.23 (t, <i>J</i> = 5.5 Hz, 1H), 7.32–7.08 (m, 10H), 4.28 (t, <i>J</i> = 5.5 Hz, 2H), 3.17 (d, <i>J</i> = 13.2 Hz, 1H), 3.08 (d, <i>J</i> = 13.2 Hz, 1H), 1.16 (s, 1H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 171.4, 169.1, 139.4, 137.1, 130.1, 128.1, 127.8, 127.1, 126.6, 126.3, 52.9, 42.5, 41.7, 18.8. HRMS <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 313.1552. Found: 313.1560.</div></div><div id="sec5_1_2_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-Benzyl-3-(hydroxyamino)-2,2-dimethyl-3-oxopropanamide (<b>35</b>)</h3><div class="NLM_p last">Obtained following the general procedure C from commercial 1,3-diethyl 2,2-dimethylpropanedioate. White solid (0.02 g, 7%). Purity 99%. Mp: 133 °C. <i>t</i><sub>R,LCMS</sub> = 1.73 min. MS (ESI−): <i>m</i>/<i>z</i> = 235 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 237 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.33 (s, 1H), 8.07 (t, <i>J</i> = 5.8 Hz, 1H), 7.36–7.18 (m, 5H), 4.26 (d, <i>J</i> = 5.8 Hz, 2H), 1.31 (s, 6H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 172.5, 170.1, 139.6, 128.1, 126.8, 126.5, 52.3, 48.2, 23.2. HRMS <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 237.1239. Found: 237.1247.</div></div><div id="sec5_1_2_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-Benzyl-1-(hydroxycarbamoyl)cyclopropanecarboxamide (<b>36</b>)</h3><div class="NLM_p last">Obtained following the general procedure C from commercial 1,1-diethyl cyclopropane-1,1-dicarboxylate. Colorless oil (0.02 g, 4%). Purity 99%. <i>t</i><sub>R,LCMS</sub> = 1.73 min. MS (ESI−): <i>m</i>/<i>z</i> = 233 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 235 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 8.54 (s, 1H), 7.34–7.21 (m, 5H), 4.40 (s, 2H), 1.40–1.28 (ddd, <i>J</i> = 5.9 Hz, <i>J</i> = 8.7 Hz, <i>J</i> = 19.4 Hz, 4H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 172.0, 170.0, 139.8, 129.4, 128.4, 128.2, 44.4, 28.4, 15.5. HRMS <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 235.1083. Found: 235.1092.</div></div><div id="sec5_1_2_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 2-Benzyl-<i>N</i>-[(4-fluorophenyl)methyl]-3-(hydroxyamino)-3-oxopropanamide (<b>39</b>)</h3><div class="NLM_p last">Obtained following the general procedure C from commercial 1,3-diethyl 2-benzylpropanedioate. Light yellow crystals (0.046 g, 4%). Purity 97%. Mp: 185 °C. <i>t</i><sub>R,LCMS</sub> = 2.63 min. MS (ESI−): <i>m</i>/<i>z</i> = 315 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 317 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 7.25–7.19 (m, 5H), 7.13–7.09 (m, 2H), 7.00–6.94 (m, 2H), 4.36 (d, <i>J</i> = 15.0 Hz, 1H), 4.23 (d, <i>J</i> = 15.0 Hz, 1H), 3.33 (t, <i>J</i> = 7.8 Hz, 1H), 3.15 (d, <i>J</i> = 7.8 Hz, 2H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 168.7, 165.0, 161.7 (d, <i>J</i><sub><i>CF</i></sub> = 22.4 Hz), 139.3, 135.6 (d, <i>J</i><sub><i>CF</i></sub> = 2.3 Hz), 130.3 (d, <i>J</i><sub><i>CF</i></sub> = 8.4 Hz), 130.0, 129.5, 127.7, 116.2 (d, <i>J</i><sub><i>CF</i></sub> = 22.4 Hz), 54.7, 43.4, 37.2. HRMS <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>18</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 317.1301. Found: 317.1303.</div></div><div id="sec5_1_2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-Benzyl-3-(hydroxyamino)-3-oxo-<i>N</i>-(4-pyridylmethyl)propanamide (<b>43</b>)</h3><div class="NLM_p last">Obtained following the general procedure C from commercial 1,3-diethyl 2-benzylpropanedioate. White powder (0.080 g, 22%). Purity 98%. Mp: 204 °C. <i>t</i><sub>R,LCMS</sub> = 1.37 min. MS (ESI−): <i>m</i>/<i>z</i> = 298 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 300 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 8.37 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 2H), 7.28–7.23 (m, 5H), 7.11 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 2H), 4.46 (d, <i>J</i> = 16.5 Hz, 1H), 4.31 (d, <i>J</i> = 16.5 Hz, 1H), 3.40 (t, <i>J</i> = 7.8 Hz, 1H), 3.19 (d, <i>J</i> = 7.8 Hz, 2H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 171.3, 168.6, 150.5, 149.9, 139.3, 130.1, 129.6, 127.8, 123.6, 54.7, 42.9, 36.9. HRMS <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 300.1348. Found: 300.1361.</div></div><div id="sec5_1_2_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1-Benzoylpyrrolidine-3-carbohydroxamic Acid (<b>44</b>)</h3><div class="NLM_p last">To a solution of commercial <i>O</i>-1-<i>tert</i>-butyl <i>O</i>-3-methylpyrrolidine-1,3-dicarboxylate (0.200 g, 0.87 mmol, 1 equiv) in anhydrous DCM (2 mL, 0.43 M) was added dropwise TFA (0.513 mL, 6.97 mmol, 8 equiv) at 0 °C. The cooling bath was removed, and the mixture was stirred 1 h at room temperature. Then DCM was evaporated in vacuo, the residue was dissolved in DCM and evaporated again under vacuum (5 cycles) to eliminate TFA. Methyl pyrrolidine-3-carboxylate <b>70</b> (0.112 g, 99%) was obtained as yellow oil. To a solution of amine <b>70</b> (0.112 g, 0.86 mmol, 1 equiv) and DIPEA (0.161 mL, 0.95 mmol, 1.1 equiv) in anhydrous DCM (2 mL, 0.43 M) at 0 °C was added dropwise benzoyl chloride (0.101 mL, 0.87 mmol, 1 equiv). The ice bath was removed, and the solution was stirred for 2 h to rt. Solvent was evaporated under vacuum, and the residue was partitioned between aqueous HCl (1M) and EtOAc. The aqueous phase was extracted two times with EtOAc and the three organic layers were pooled, dried over MgSO<sub>4</sub>, and evaporated to give a yellow crude product which was purified by flash column chromatography cyclohexane/EtOAc. Pure methyl 1-benzoylpyrrolidine-3-carboxylate <b>44a</b> (0.167 g, 62%) was obtained as colorless oil. <i>t</i><sub>R,LCMS</sub> = 2.45 min. MS (ESI+): <i>m</i>/<i>z</i> = 234 [M + H]<sup>+</sup>. To a solution of <b>44a</b> (0.167 g, 0.71 mmol, 1 equiv) in MeOH (2.97 mL, 0.24 M) was added a solution of aqueous hydroxylamine 50% (2.97 mL, aq NH<sub>2</sub>OH/MeOH 1:1 (v:v)) and KCN (0.023 g, 0.35 mmol, 0.5 equiv). The solution was stirred overnight at room temperature (convenience). Crude product was concentrated under vacuum and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)), and then the aqueous layer was dissolved in a mixture of aqueous 15% KOH/NaClO 75:25 (v:v) and discarded in an appropriate waste tank. The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water gradient, containing ammonium acetate/formic acid buffer (pH = 3.8), starting with H<sub>2</sub>O 98% to reach acetonitrile 100% in 25 min. Pure hydroxamic acid <b>44</b> was obtained as colorless oil (0.027 g, 16%). Purity 97%. <i>t</i><sub>R,LCMS</sub> = 1.37 min. MS (ESI−): <i>m</i>/<i>z</i> = 233 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 235 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 8.52 (s, 1H), 7.54–7.50 (m, 2H), 7.49–7.43 (m, 3H), 3.85–3.37 (m, 2H), 3.69–3.50 (m, 2H), 2.94 (t, <i>J</i> = 7.6 Hz, 1H), 2.23–2.17 (m, 1H), 2.11 (dd, <i>J</i> = 6.8 Hz, <i>J</i> = 13.8 Hz, 1H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 172.3, 171.6, 137.7, 131.4, 129.6, 128.1, 42.7, 41.1, 31.0, 29.2. HRMS <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 235.1083. Found: 235.1114.</div></div><div id="sec5_1_2_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-[3-(Hydroxyamino)-3-oxo-2-(1-piperidyl)propyl]benzamide (<b>45</b>)</h3><div class="NLM_p last">To a solution of commercial methyl 3-amino-2-(1-piperidyl)propanoate <b>74</b> (0.437 g, 2.34 mmol, 1.1 equiv) and DIPEA (0.396 mL, 2.32 mmol, 1.1 equiv) in anhydrous DCM at 0 °C was added benzoyl chloride (0.248 mL, 2.13 mmol, 1 equiv). The solution was allowed to warm at room temperature and stirred 1 h. Then DCM was evaporated under pressure, and the residue was partitioned between aqueous HCl 1 M and EtOAc. The aqueous layer was washed twice by EtOAc and basified with K<sub>2</sub>CO<sub>3</sub>. Then the desired product was extracted by EtOAc. Solvent was evaporated in vacuo to afford methyl 3-benzamido-2-(1-piperidyl)propanoate <b>45a</b> as yellow oil (0.257 g, 41%). <i>t</i><sub>R,LCMS</sub> = 1.86 min. MS (ESI+): <i>m</i>/<i>z</i> = 291 [M + H]<sup>+</sup>. To a solution of <b>45a</b> (0.100 g, 0.35 mmol, 1 equiv) in MeOH (1.43 mL, 0.25 M) was added a solution of aqueous hydroxylamine 50% (1.43 mL, aq NH<sub>2</sub>OH/MeOH 1:1 (v:v)) and KCN (0.011 g, 0.17 mmol, 0.5 equiv). The mixture was stirred overnight at room temperature (convenience). Crude product was concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). Then the aqueous layer was dissolved in a mixture of aqueous 15% KOH/NaClO 75:25 (v:v) and discarded in an appropriate waste tank. The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water gradient, containing ammonium acetate/formic acid buffer (pH = 9.2), starting with H<sub>2</sub>O 98% to reach acetonitrile 100% in 25 min. Pure hydroxamic acid <b>45</b> was obtained as brown solid (0.029 g, 29%). Purity 98%. Mp: 93 °C. <i>t</i><sub>R,LCMS</sub> = 1.48 min. MS (ESI−): <i>m</i>/<i>z</i> = 290 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 292 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 8.42 (br s, 1H), 7.88–7.78 (d, <i>J</i> = 7.2 Hz, 2H), 7.56–7.42 (m, 3H), 3.80 (dd, <i>J</i> = 6.2 Hz, <i>J</i> = 13.2 Hz, 1H), 3.62 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 13.2 Hz, 1H), 2.72–2.67 (q, <i>J</i> = 5.4 Hz, <i>J</i> = 9.2 Hz, 4H), 1.62 (m, 4H), 1.46–1.51 (q, <i>J</i> = 5.4 Hz, <i>J</i> = 11.1 Hz, 2H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm):170.4, 168.9, 135.6, 132.8, 129.6, 128.3, 66.3, 42.5, 39.5, 27.0, 25.3. HRMS <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>: 292.1661. Found: 292.1693.</div></div><div id="sec5_1_2_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (<i>S</i>)-2-Benzenesulfonylamino-<i>N</i>-hydroxy-3-methylbutyramide (<b>46</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>46b</b>. Pink solid (0.080 g, 12%). Purity 99%. Mp: 160 °C. <i>t</i><sub>R,LCMS</sub> = 1.80 min. MS (ESI+): <i>m</i>/<i>z</i> = 273 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.49 (br s, 1H), 8.77 (br s, 1H), 7.92 (d, <i>J</i> = 9.0 Hz, 1H), 7.78–7.74 (m, 2H), 7.62–7.51 (m, 3H), 3.28 (t, <i>J</i> = 8.4 Hz, 1H), 1.78–1.71 (m, 1H), 0.73 (d, <i>J</i> = 6.6 Hz, 3H), 0.70 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 167.1, 142.0, 132.6, 129.3, 126.8, 60.2, 31.2, 19.4, 19.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>11</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 273.0909. Found: 273.0898.</div></div><div id="sec5_1_2_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (<i>S</i>)-2-Benzenesulfonylamino-<i>N</i>-hydroxy-3-phenylpropionamide (<b>47</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>47b</b>. White powder (0.020 g, 11%). Purity 97%. Mp: 97 °C. <i>t</i><sub>R,LCMS</sub> = 2.47 min. MS (ESI+): <i>m</i>/<i>z</i> = 321 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 7.71–7.54 (m, 5H), 7.48–7.10 (m, 5H), 3.96–3.90 (m, 1H), 2.75 (dd, <i>J</i> = 7.5 Hz, <i>J</i> = 13.5 Hz, 2H). <sup>13</sup>C NMR 75 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 166.9, 141.2, 136.6, 132.3, 129.3, 128.9, 128.2, 126.7, 126.6, 55.9, 38.9. HRMS <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 321.0909. Found: 321.0916.</div></div><div id="sec5_1_2_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (<i>R</i>)-2-(Benzenesulfonylbenzylamino)-<i>N</i>-hydroxy-3-methylbutyramide (<b>48</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>48a</b>. Colorless oil (0.02 g, 4%). Purity 99%. <i>t</i><sub>R,LCMS</sub> = 2.92 min. MS (ESI+): <i>m</i>/<i>z</i> = 363 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 7.71–7.68 (m, 2H), 7.58–7.52 (m, 1H), 7.46–7.40 (m, 4H), 7.21–7.19 (m, 3H), 4.77 (s, 2H), 3.94 (d, <i>J</i> = 10.8 Hz, 1H), 2.05 (m, 1H), 0.79 (d, <i>J</i> = 6.6 Hz, 3H), 0.79 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR 75 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 166.2, 141.1, 137.9, 132.3, 129.2, 128.7, 127.8, 127.1, 127.0, 63.8, 48.1, 26.6, 18.9, 18.6. HRMS <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 363.1379. Found: 363.1372.</div></div><div id="sec5_1_2_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (<i>R</i>)-2-(Benzenesulfonylbenzylamino)-3-phenyl-<i>N</i>-hydroxypropionamide (<b>49</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>49b</b>. Colorless oil (0.020 g, 4%). Purity 98%. <i>t</i><sub>R,LCMS</sub> = 3.07 min. MS (ESI+): <i>m</i>/<i>z</i> = 411 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 7.82–7.79 (m, 2H), 7.61 (t, <i>J</i> = 7.5 Hz, 1H), 7.52 (t, <i>J</i> = 7.5 Hz, 2H), 7.39 (d, <i>J</i> = 6.6 Hz, 2H), 7.27–7.15 (m, 6H), 7.03–7.01 (m, 2H), 4.81 (s, 2H), 4.56 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 10.2 Hz, 1H), 3.14 (dd, <i>J</i> = 10.2 Hz, <i>J</i> = 13.2 Hz, 1H), 2.60 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 13.2 Hz, 1H). <sup>13</sup>C NMR 75 MHz (acetone-<i>d</i><sub>6</sub>) δ (ppm): 165.5, 140.5, 138.7, 136.7, 132.7, 129.2, 129.0, 128.3, 128.2, 127.9, 127.2, 126.9, 126.6, 58.8, 48.3, 37.1. HRMS <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 411.1379. Found: 411.1395.</div></div><div id="sec5_1_2_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 4-(Benzenesulfonamido)tetrahydropyran-4-carbohydroxamic Acid (<b>50</b>)</h3><div class="NLM_p last">To a solution of commercial methyl 4-aminooxane-4-carboxylate (0.105 g, 0.66 mmol, 1 equiv) in pyridine (0.942 mL, 0.7 M) was added dropwise liquid benzenesulfonyl chloride (0.101 mL, 0.79 mmol, 1.2 equiv). This solution was stirred 2 h at room temperature (starts light yellow and then becomes dark red). The mixture was partitioned between EtOAc and aq HCl 1 M, and the organic phase was washed once again with aq HCl 1 M. Celite was added to the organic phase and EtOAc was evaporated under vacuum affording a solid deposit purified by flash column chromatography cyclohexane 100% to cyclohexane/EtOAc 1:1 (v:v). Colorless oil (0.179 g, 66%). Purity 98%. TLC cyclohexane 100% <i>R</i><sub><i>f</i></sub> = 0.05. TLC cyclohexane/EtOAc 1:1 (v:v) <i>R</i><sub><i>f</i></sub> = 0.75. <i>t</i><sub>R,LCMS</sub> = 2.12 min. MS (ESI+): <i>m</i>/<i>z</i> = 298 [M + H]<sup>+</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 300 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CDCl<sub>3</sub>) δ (ppm): 7.87–7.84 (m, 2H), 7.57–7.47 (m, 3H), 3.60–3.56 (m, 4H), 3.47 (s, 3H), 2.11–2.03 (m, 2H), 1.91–1.85 (m, 2H). <sup>13</sup>C NMR 75 MHz (CDCl<sub>3</sub>) δ (ppm): 172.8, 141.1, 132.9, 129.2, 127.3, 63.0, 59.1, 52.6, 33.2. To a solution of methyl ester <b>50a</b> (0.018 g, 0.06 mmol, 1 equiv) in MeOH (0.133 mL, 0.45 M) were added aqueous hydroxylamine 50% (0.133 mL, 1.98 mmol, 33 equiv) and solid KCN (0.001 g, 0.06 mmol, 0.1 equiv). The mixture was stirred for 48 h (convenience) at room temperature. The crude product was concentrated under vacuum and the residue was dissolved in acetonitrile with some drops of acidic water (0.1% formic acid) under the fume hood and filtered, and the solution was purified by preparative HPLC using a linear acetonitrile/water gradient, containing ammonium acetate/formic acid buffer (pH = 3.8), starting with H<sub>2</sub>O 98% to reach acetonitrile 100% in 25 min. CH<sub>3</sub>CN was evaporated under vacuum (37 °C under 148 mbar) and aqueous solution was sublimated affording <b>50</b> as a white powder (0.011 g, 57%). Purity 95%. Mp: 61 °C. <i>t</i><sub>R,LCMS</sub> = 1.57 min. MS (ESI−): <i>m</i>/<i>z</i> = 299 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 301 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.40 (s, 1H), 8.71 (s, 1H), 7.81–7.78 (m, 2H), 7.61–7.52 (m, 3H), 3.40–3.24 (m, 4H), 1.87–1.76 (m, 4H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 169.4, 143.1, 132.1, 128.9, 126.2, 62.4, 58.1, 32.8. HRMS <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>17</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup>: 301.0858. Found: 301.0860.</div></div><div id="sec5_1_2_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 2-(Benzenesulfonyl)-3,4-dihydro-1<i>H</i>-isoquinoline-3-carbohydroxamic Acid (<b>51</b>)</h3><div class="NLM_p last">To a solution of commercial 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (0.200 g, 0.94 mmol, 1 equiv) in anhydrous methanol (3.12 mL, 0.3 M) under argon at 0 °C was added dropwise SOCl<sub>2</sub> (0.204 mL, 2.80 mmol, 3 equiv). The mixture was stirred at room temperature for 10 days, and then the mixture was dissolved in EtOAc (10 mL) and washed with water. The aqueous phase was extracted 2 times with EtOAc. Organic phases were pooled, dried over MgSO<sub>4</sub>, and evaporated under vacuum. Methyl ester product <b>79</b> was obtained as white powder (0.120 g, 64%). <i>t</i><sub>R,LCMS</sub> = 1.53 min. MS (ESI+): <i>m</i>/<i>z</i> = 192 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.25 (s, 4H), 4.50 (m, 1H), 4.30 (s, 2H), 3.79 (s, 3H), 3.28 (dd, <i>J</i> = 3.8 Hz, <i>J</i> = 16.8 Hz, 1H), 3.17 (m, 1H). To a solution of secondary amine <b>79</b> (0.120 g, 0.62 mmol, 1 equiv) in anhydrous DCM (2 mL, 0.3 M) at 0 °C was added liquid TEA (0.254 mL, 1.88 mmol, 3 equiv) and benzenesulfonyl chloride (0.096 mL, 0.75 mmol, 1.2 equiv), and then the cooling bath was removed and the solution was stirred 3 h at rt. Solvent was evaporated under reduced pressure, and the residue was dissolved in aqueous sat. NaHCO<sub>3</sub> and EtOAc. The product was extracted 2 times with EtOAc, dried over MgSO<sub>4</sub>, and evaporated in vacuo. The residue was purified by flash column chromatography cyclohexane/ethyl acetate to afford the desired sulfonamide <b>51a</b> as colorless oil (0.048 g, 23%). <i>t</i><sub>R,LCMS</sub> = 2.97 min. MS (ESI+): <i>m</i>/<i>z</i> = 332 [M + H]<sup>+</sup>. To a solution of methyl ester (0.023 g, 0.07 mmol, 1 equiv) in MeOH (0.298 mL, 0.23 M) was added a solution of aqueous hydroxylamine 50% (0.298 mL, aq NH<sub>2</sub>OH/MeOH 1:1 (v:v)) and KCN (0.002 g, 0.03 mmol, 0.5 equiv). The solution was stirred overnight at room temperature (convenience). Crude product was concentrated under vacuum, and an aqueous workup was performed using H<sub>2</sub>O/EtOAc (1:50 (v:v)). Then the aqueous layer was dissolved in a mixture of aqueous 15% KOH/NaClO 75:25 (v:v) and discarded in an appropriate waste tank. The organic layer was evaporated under vacuum and purified by preparative HPLC using a linear acetonitrile/water gradient, containing ammonium acetate/formic acid buffer (pH = 3.8), starting with H<sub>2</sub>O 98% to reach acetonitrile 100% in 25 min. Pure hydroxamic acid <b>51</b> was obtained as white powder (0.009 g, 41%). Purity 99%. Mp: 116 °C. <i>t</i><sub>R,LCMS</sub> = 2.27 min. MS (ESI−): <i>m</i>/<i>z</i> = 331 [M – H]<sup>−</sup>. MS (ESI+): <i>m</i>/<i>z</i> = 333 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 7.79 (m, 2H), 7.61 (tt, <i>J</i> = 1.4 Hz, <i>J</i> = 7.5 Hz, 1H), 7.46 (tt, <i>J</i> = 1.4 Hz, <i>J</i> = 7.5 Hz, 2H), 7.11–7.00 (m, 4H), 4.55 (d, <i>J</i> = 4.7 Hz, 2H), 4.47 (t, <i>J</i> = 5.8 Hz, 1H), 3.01 (dd, <i>J</i> = 5.6 Hz, <i>J</i> = 15.5 Hz, 1H), 2.78 (dd, <i>J</i> = 6.4 Hz, <i>J</i> = 15.5 Hz, 1H). <sup>13</sup>C NMR 75 MHz (CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ (ppm): 170.2, 139.3, 134.2, 134.1, 133.8, 130.3, 128.8, 128.6, 128.5, 127.8, 127.2, 56.1, 47.0, 32.1. HRMS <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 333.0909. Found: 333.0928.</div></div><div id="sec5_1_2_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (<i>E</i>)-3-(2,4-Dichlorophenyl)-<i>N</i>-hydroxyacrylamide (<b>52</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>52b</b>. White powder (0.030 g, 6%). Purity 99%. Mp: 175 °C. <i>t</i><sub>R,LCMS</sub> = 2.63 min. MS (ESI+): <i>m</i>/<i>z</i> = 232 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.89 (br s, 1H), 9.16 (br s, 1H), 7.73–7.64 (m, 3H), 7.48 (d, <i>J</i> = 15.9 Hz, 1H), 6.53 (d, <i>J</i> = 15.9 Hz, 1H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 162.3, 134.9, 134.5, 132.9, 132.2, 129.9, 129.3, 128.5, 123.5. HRMS <i>m</i>/<i>z</i> calculated for C<sub>9</sub>H<sub>8</sub>NO<sub>2</sub>Cl<sub>2</sub> [M + H]<sup>+</sup>: 231.9932. Found: 231.9935.</div></div><div id="sec5_1_2_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (<i>E</i>)-3-Biphenyl-4-yl-<i>N</i>-hydroxyacrylamide (<b>53</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from commercial (2<i>E</i>)-3-{[1,1′-biphenyl]-4-yl}prop-2-enoic acid. White powder (0.110 g, 38%). Purity 99%. Mp: 168 °C. <i>t</i><sub>R,LCMS</sub> = 2.73 min. MS (ESI+): <i>m</i>/<i>z</i> = 240 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.78 (s, 1H), 9.05 (br s, 1H), 7.73–7.63 (m, 6H), 7.53–7.35 (m, 4H), 6.50 (d, <i>J</i> = 14.4 Hz, 1H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 163.2, 141.4, 139.8, 138.3, 134.4, 129.5, 128.6, 128.3, 127.6, 127.1, 119.6. HRMS <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>14</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 240.1025. Found: 240.1007.</div></div><div id="sec5_1_2_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (<i>E</i>)-<i>N</i>-Hydroxy-3-{4-[(phenylamino)sulfonyl]phenyl}prop-2-enamide (<b>54</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>54b</b>. Pink solid (0.080 g, 18%). Purity 99%. Mp: 171 °C. <i>t</i><sub>R,LCMS</sub> = 2.47 min. MS (ESI+): <i>m</i>/<i>z</i> = 319 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.85 (br s, 1H), 10.32 (br s, 1H), 9.12 (br s, 1H), 7.76–7.68 (m, 4H), 7.43 (d, <i>J</i> = 15.9 Hz, 1H), 7.24 (t, <i>J</i> = 7.5 Hz, 2H), 7.08 (d, <i>J</i> = 7.5 Hz, 1H), 7.00 (t, <i>J</i> = 7.5 Hz, 2H), 6.52 (d, <i>J</i> = 15.9 Hz, 1H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 162.5, 140.1, 139.5, 138.0, 136.9, 129.6, 128.5, 127.7, 124.7, 122.8, 120.6. HRMS <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>15</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 319.0753. Found: 319.0764.</div></div><div id="sec5_1_2_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (<i>E</i>)-3-[2-Butyl-1-(2-diethylaminoethyl)-1<i>H</i>-benzoimidazol-5-yl]-<i>N</i>-hydroxyacrylamide (<b>55</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>55b</b>. Yellow oil (0.22 g, 57%). Purity 97%. <i>t</i><sub>R,LCMS</sub> = 2.19 min. MS (ESI+): <i>m</i>/<i>z</i> = 357 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 9.50 (br s, 2H), 7.76 (s, 1H), 7.60 (d, <i>J</i> = 15.9 Hz, 1H), 7.47–7.44 (m, 2H), 6.45 (d, <i>J</i> = 15.9 Hz, 1H), 3.35–3.30 (m, 10H), 3.12–3.05 (m, 4H), 2.89 (t, <i>J</i> = 7.8 Hz, 2H), 1.82 (m, 2H), 1.48 (m, 2H), 1.18 (t, <i>J</i> = 7.8 Hz, 3H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 163.7, 156.8, 143.1, 139.9, 136.7, 136.3, 129.3, 121.7, 119.6, 115.7, 110.7, 47.0, 46.1, 40.2, 29.2, 26.4, 22.4, 14.2, 9.0. HRMS <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 359.2447. Found: 359.2447.</div></div><div id="sec5_1_2_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>N</i>-Hydroxy-3,3-diphenylacrylamide (<b>56</b>)</h3><div class="NLM_p last">Obtained following the general procedure B from <b>56b</b>. White solid (0.44 g, 46%). Purity: 99%. Mp: 134 °C. <i>t</i><sub>R,LCMS</sub> = 2.63 min. MS (ESI+): <i>m</i>/<i>z</i> = 240 [M + H]<sup>+</sup>. <sup>1</sup>H NMR 300 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 10.60 (br s, 1H), 8.80 (br s, 1H), 7.34–7.13 (m, 11H), 6.27 (s, 1H). <sup>13</sup>C NMR 75 MHz (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 163.2, 150.1, 141.9, 139.3, 129.1, 128.9, 128.1, 128.1. HRMS <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>14</sub>NO<sub>2</sub> [M + H]<sup>+</sup>: 240.1025. Found: 240.1029.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> General Biology</h3><div class="NLM_p last">Ethylenediaminetetraacetic acid (EDTA), 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), phenylmethanesulfonyl fluoride (PMSF), bis(4-nitrophenyl)phosphate (BNPP), ethopropazine hydrochloride (profenamine), enalapril maleate salt, eucatropine hydrochloride, and prasugrel were obtained from Sigma-Aldrich. Tacrine hydrochloride was obtained from Tocris. Huprine 2 was obtained as previously described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Trandolapril was obtained from Sequoia Research Products. Solvents were from common sources and of LC–MS grade. Stock solutions of all compounds were prepared in methanol at a concentration of 1 mM. Rat plasma and human plasma, mixed gender, were purchased from Seralab. Rat whole blood male and female were purchased from Charles River, France (SANOFAHEL005) and pooled upon reception. Rat and human liver microsomes and rat intestinal microsomes were purchased from Tebu-bio. Solvents were from common sources and of LC–MS grade.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Plasma/Whole Blood Stabilities</h3><div class="NLM_p last">Plasma or whole blood incubations were performed in duplicate, at 37 °C, in Eppendorf tubes. The incubation contained 10 μM test compound (1% methanol) in rat or human plasma in a final volume of 0.5 mL. Sampling points were taken at 0, 15, 30, 60, 120, 240, 360 min, and reactions were terminated by adding ice-cold methanol containing 500 nM internal standard (9 volumes). The samples were centrifuged for 10 min at 10 000<i>g</i>, 4 °C, to pellet precipitated protein, and the supernatant was transferred in Matrix tubes for LC–MS/MS analysis. Incubations with specific esterases inhibitors were performed in duplicate, at 37 °C, in Eppendorf tubes. The incubation contained 10 μM test compound (1% methanol) in rat or human plasma and the appropriate esterase inhibitor (1.25 mM PMSF, 0.25 mM BNPP, 1 mM DTNB, 0.05 mM profenamine, 0.5 mM EDTA, or 0.5 mM huprine2) in a final volume of 0.5 mL. Sampling points were taken at 0, 15, 30, 60, 120, 240, 360 min, and reactions were terminated by adding ice-cold methanol containing 500 nM internal standard (9 volumes). The samples were centrifuged for 10 min at 10 000<i>g</i>, 4 °C, to pellet precipitated protein, and the supernatant was transferred in Matrix tubes for LC–MS/MS analysis. Control incubations were performed in duplicate with methanol instead of the inhibitor compound. Each experiment included a reference compound tested in the same conditions and allowing the validation of the experiment: eucatropine (10 μM, <i>t</i><sub>1/2</sub> = 9 min, human plasma or whole blood) and enalapril (10 μM, <i>t</i><sub>1/2</sub> = 13 min, rat plasma or whole blood).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Microsomal Stability</h3><div class="NLM_p last">Microsomal incubations were performed in duplicate, at 37 °C, in glass tubes. The incubation contained 1 μM test compound (1% methanol) in rat liver microsomes, human liver microsomes, or rat intestinal microsomes (1 mg of microsomal protein/mL) in a final volume of 0.25 mL. Sampling points were taken at 0, 15, 30, 60, 120 min, and reactions were terminated by adding ice-cold methanol or acetonitrile containing 200 nM internal standard (4 volumes). The samples were centrifuged for 10 min at 10 000<i>g</i>, 4 °C, to pellet precipitated microsomal protein, and the supernatant was transferred in Matrix tubes for LC–MS/MS analysis. Control incubations were performed in triplicate with denaturated microsomes with acetonitrile containing 200 nM internal standard, and sampling points were taken at 0 and 120 min (to evaluate the compound chemical stability in the experimental conditions). Each experiment included a reference compound tested in the same conditions and allowed the validation of the experiment: trandolapril (<i>t</i><sub>1/2</sub>(human) = 20 min, <i>t</i><sub>1/2</sub>(rat) = 7 min, 1 μM, CES1 substrate) for liver microsomes and prasugrel (<i>t</i><sub>1/2</sub>(rat) = 1 min, 1 μM, CES2 substrate) for intestinal microsomes.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> LC–MS/MS Analysis</h3><div class="NLM_p">Samples analysis were performed on a liquid chromatography coupled to a triple quadrupole mass spectrometer (Aquity I class, Xevo TQD, Waters, Les Ulis, France) with an electrospray ionization source. Chromatographic separations were carried out using an Acquity BEH C18, 1.7 μm, 50 mm × 2.1 mm column (Waters) maintained at 40 °C. Mobile phase solvent A was 10 mM ammonium acetate in water, and solvent B was acetonitrile with 0.1% of formic acid. The following gradient was applied: 2% B during 10 s, 2–98% B in 1 min 50 s; hold at 98% B for 30 s; 98–2% B in 5 s; 2% B hold for 1 min 30 s. The injection volume was 1 μL, and the flow rate was 600 μL/min. The desolvation and cone gas flow were respectively 1200 and 50 L/h; the source temperature was 600 °C. The capillary and cone voltages, the collision energy, and the observed MRM transitions were automatically optimized for each compound.</div><div class="NLM_p last">Quantitation of each compound was achieved by conversion of the corresponding analyte/internal standard peak area ratios to percentage drug remaining, using the <i>T</i><sub>0</sub> ratio values as 100%. The slope of the linear regression from log percentage remaining versus incubation time relationships (−<i>k</i>) was used in the conversion to in vitro <i>t</i><sub>1/2</sub> values by in vitro <i>t</i><sub>1/2</sub> = −0.693/<i>k</i>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Statistical Analysis</h3><div class="NLM_p last">Half-lives were calculated using Xlfit (IDBS Ltd.). Data for Box–Whisker plots were calculated using Microsoft Excel. Univariate and multivariate statistical analysis was performed using SPSS version 19 (IBM, Armonk, NY).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01444">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01444" class="ext-link">10.1021/acs.jmedchem.7b01444</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplementary figures, supplementary tables, synthesis of intermediates, and molecular docking and scoring methods (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf">jm7b01444_si_001.pdf (1.36 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_002.csv">jm7b01444_si_002.csv (1.9 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01444" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca Deprez-Poulain</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span>; 
    <span class="hlFld-Affiliation affiliation">Institut
Universitaire de France, F-75231, Paris, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3318-5297" title="Orcid link">http://orcid.org/0000-0002-3318-5297</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c9bbacabacaaaaa8e7adacb9bbacb389bca7a0bfe4a5a0a5a5acfbe7afbb"><span class="__cf_email__" data-cfemail="dcaeb9beb9bfbfbdf2b8b9acaeb9a69ca9b2b5aaf1b0b5b0b0b9eef2baae">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Hermant</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damien Bosc</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Piveteau</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronan Gealageas</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">BaoVy Lam</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cyril Ronco</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthieu Roignant</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hasina Tolojanahary</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ludovic Jean</span> - <span class="hlFld-Affiliation affiliation">Normandie Université,
COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA Rouen,
CNRS, F-76821 Mont-Saint-Aignan Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre-Yves Renard</span> - <span class="hlFld-Affiliation affiliation">Normandie Université,
COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA Rouen,
CNRS, F-76821 Mont-Saint-Aignan Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed Lemdani</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille, EA
2694, Santé Publique: Épidémiologie et Qualité
des Soins, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marilyne Bourotte</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrien Herledan</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Corentin Bedart</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre Biela</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Leroux</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoit Deprez</span> - <span class="hlFld-Affiliation affiliation">Univ. Lille Nord
de France, INSERM, Institut Pasteur de Lille, U1177, Drugs and Molecules
for Living Systems, F-59000 Lille, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2777-4538" title="Orcid link">http://orcid.org/0000-0002-2777-4538</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.H., D.B., and C.P. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e10208-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the institutions that support our laboratory: INSERM, Université de Lille, Institut Pasteur de Lille. The authors thank Agathe Urban, Matthias Borms, and Thomas Bosio for technical assistance. Foundation pour la Recherche Médicale (Grant DCM20111223046) and Agence Nationale de la Recherche (Grant ANR-11-JS07-015-01) are thanked for funding. P.H. is recipient of a doctoral fellowship of Conseil Régional Nord-Pas de Calais and INSERM. NMR acquisitions were done at the Laboratoire d’Application de Résonance Magnétique Nucléaire (LARMN), Lille, France. R.D.-P. is a member of the Institut Universitaire de France.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i95" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i95"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> Abbreviations Used</h2><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AGG</td><td class="NLM_def"><p class="first last">aggrecanase</p></td></tr><tr><td class="NLM_term">aq</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">ArE</td><td class="NLM_def"><p class="first last">arylesterase</p></td></tr><tr><td class="NLM_term">BNPP</td><td class="NLM_def"><p class="first last">bis(4-nitrophenyl)phosphate</p></td></tr><tr><td class="NLM_term">BoNTA</td><td class="NLM_def"><p class="first last">neurotoxin A metalloprotease of bacterium <i>Clostridium botulinum</i></p></td></tr><tr><td class="NLM_term">BuChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">CES1</td><td class="NLM_def"><p class="first last">carboxylesterase-1</p></td></tr><tr><td class="NLM_term">CES2</td><td class="NLM_def"><p class="first last">carboxylesterase-2</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DTNB</td><td class="NLM_def"><p class="first last">5,5′-dithiobis(2-nitrobenzoic acid)</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">GCPII</td><td class="NLM_def"><p class="first last">glutamate carboxypeptidase II</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HER-2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">IDE</td><td class="NLM_def"><p class="first last">insulin-degrading enzyme</p></td></tr><tr><td class="NLM_term">LDA</td><td class="NLM_def"><p class="first last">lithium diisopropylamide</p></td></tr><tr><td class="NLM_term">LpxC</td><td class="NLM_def"><p class="first last">UDP-3-<i>O</i>-(<i>R</i>-3-hydroxymyristoyl)-<i>N</i>-acetylglucosamine deacetylase</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloprotease</p></td></tr><tr><td class="NLM_term">OR</td><td class="NLM_def"><p class="first last">odd ratio</p></td></tr><tr><td class="NLM_term">PDF</td><td class="NLM_def"><p class="first last">peptide deformylase</p></td></tr><tr><td class="NLM_term"><i>Pf</i>AM1</td><td class="NLM_def"><p class="first last"><i>Plasmodium</i><i>falciparum</i> aminopeptide 1</p></td></tr><tr><td class="NLM_term">PMSF</td><td class="NLM_def"><p class="first last">phenylmethanesulfonyl fluoride</p></td></tr><tr><td class="NLM_term">PON-1</td><td class="NLM_def"><p class="first last">paraoxonase-1</p></td></tr><tr><td class="NLM_term">profenamine</td><td class="NLM_def"><p class="first last">ethopropazine hydrochloride</p></td></tr><tr><td class="NLM_term">ROCK</td><td class="NLM_def"><p class="first last">rho kinase</p></td></tr><tr><td class="NLM_term">SA</td><td class="NLM_def"><p class="first last">serum albumin</p></td></tr><tr><td class="NLM_term">TACE</td><td class="NLM_def"><p class="first last">tumor necrosis factor α converting enzyme</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TIS</td><td class="NLM_def"><p class="first last">triisopropylsilane</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sieber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Proteomic Profiling of Metalloprotease Activities with Cocktails of Active-Site Probes</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/nchembio781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fnchembio781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16565715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFSqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=274-281&author=S.+A.+Sieberauthor=S.+Niessenauthor=H.+S.+Hooverauthor=B.+F.+Cravatt&title=Proteomic+Profiling+of+Metalloprotease+Activities+with+Cocktails+of+Active-Site+Probes&doi=10.1038%2Fnchembio781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic profiling of metalloprotease activities with cocktails of active-site probes</span></div><div class="casAuthors">Sieber, Stephan A.; Niessen, Sherry; Hoover, Heather S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">274-281</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metalloproteases are a large, diverse class of enzymes involved in many physiol. and disease processes.  Metalloproteases are regulated by post-translational mechanisms that diminish the effectiveness of conventional genomic and proteomic methods for their functional characterization.  Chem. probes directed at active sites offer a potential way to measure metalloprotease activities in biol. systems; however, large variations in structure limit the scope of any single small-mol. probe aimed at profiling this enzyme class.  Here, we address this problem by creating a library of metalloprotease-directed probes that show complementary target selectivity.  These probes were applied as a 'cocktail' to proteomes and their labeling profiles were analyzed collectively using an advanced liq. chromatog.-mass spectrometry platform.  More than 20 metalloproteases were identified, including members from nearly all of the major branches of this enzyme class.  These findings suggest that chem. proteomic methods can serve as a universal strategy to profile the activity of the metalloprotease superfamily in complex biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNE0SB8T8albVg90H21EOLACvtfcHk0lhQfjmMqTXP1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFSqtrg%253D&md5=520ffbbd133cba468cc679d300896a6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnchembio781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio781%26sid%3Dliteratum%253Aachs%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DH.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteomic%2520Profiling%2520of%2520Metalloprotease%2520Activities%2520with%2520Cocktails%2520of%2520Active-Site%2520Probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D274%26epage%3D281%26doi%3D10.1038%2Fnchembio781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Marmion, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, K. B.</span><span> </span><span class="NLM_article-title">Hydroxamic Acids - an Intriguing Family of Enzyme Inhibitors and Biomedical Ligands</span> <span class="citation_source-journal">Eur. J. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">3003</span><span class="NLM_x">–</span> <span class="NLM_lpage">3016</span><span class="refDoi"> DOI: 10.1002/ejic.200400221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fejic.200400221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2004&publication_year=2004&pages=3003-3016&author=C.+J.+Marmionauthor=D.+Griffithauthor=K.+B.+Nolan&title=Hydroxamic+Acids+-+an+Intriguing+Family+of+Enzyme+Inhibitors+and+Biomedical+Ligands&doi=10.1002%2Fejic.200400221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fejic.200400221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200400221%26sid%3Dliteratum%253Aachs%26aulast%3DMarmion%26aufirst%3DC.%2BJ.%26aulast%3DGriffith%26aufirst%3DD.%26aulast%3DNolan%26aufirst%3DK.%2BB.%26atitle%3DHydroxamic%2520Acids%2520-%2520an%2520Intriguing%2520Family%2520of%2520Enzyme%2520Inhibitors%2520and%2520Biomedical%2520Ligands%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2004%26volume%3D2004%26spage%3D3003%26epage%3D3016%26doi%3D10.1002%2Fejic.200400221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Boularot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglione, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duroc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves de Sousa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larue, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresteil, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artaud, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinnel, T.</span><span> </span><span class="NLM_article-title">Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1021/jm060910c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060910c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=10-20&author=A.+Boularotauthor=C.+Giglioneauthor=S.+Petitauthor=Y.+Durocauthor=R.+Alves+de+Sousaauthor=V.+Larueauthor=T.+Cresteilauthor=F.+Dardelauthor=I.+Artaudauthor=T.+Meinnel&title=Discovery+and+Refinement+of+a+New+Structural+Class+of+Potent+Peptide+Deformylase+Inhibitors&doi=10.1021%2Fjm060910c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm060910c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060910c%26sid%3Dliteratum%253Aachs%26aulast%3DBoularot%26aufirst%3DA.%26aulast%3DGiglione%26aufirst%3DC.%26aulast%3DPetit%26aufirst%3DS.%26aulast%3DDuroc%26aufirst%3DY.%26aulast%3DAlves%2Bde%2BSousa%26aufirst%3DR.%26aulast%3DLarue%26aufirst%3DV.%26aulast%3DCresteil%26aufirst%3DT.%26aulast%3DDardel%26aufirst%3DF.%26aulast%3DArtaud%26aufirst%3DI.%26aulast%3DMeinnel%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520Refinement%2520of%2520a%2520New%2520Structural%2520Class%2520of%2520Potent%2520Peptide%2520Deformylase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D10%26epage%3D20%26doi%3D10.1021%2Fjm060910c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Seki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Šilhár, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowe, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lardy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K. D.</span><span> </span><span class="NLM_article-title">Synthesis/Biological Evaluation of Hydroxamic Acids and Their Prodrugs as Inhibitors for Botulinum Neurotoxin a Light Chain</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1208</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmc.2013.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=24360826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1208-1217&author=H.+Sekiauthor=S.+Pellettauthor=P.+%C5%A0ilh%C3%A1rauthor=G.+N.+Stoweauthor=B.+Blancoauthor=M.+A.+Lardyauthor=E.+A.+Johnsonauthor=K.+D.+Janda&title=Synthesis%2FBiological+Evaluation+of+Hydroxamic+Acids+and+Their+Prodrugs+as+Inhibitors+for+Botulinum+Neurotoxin+a+Light+Chain&doi=10.1016%2Fj.bmc.2013.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain</span></div><div class="casAuthors">Seki, Hajime; Pellett, Sabine; Silhar, Peter; Stowe, G. Neil; Blanco, Beatriz; Lardy, Matthew A.; Johnson, Eric A.; Janda, Kim D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1208-1217</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Botulinum neurotoxin A (BoNT/A) is the most potent toxin known.  Unfortunately, it is also a potential bioweapon in terrorism, which is without an approved therapeutic treatment once cellular intoxication takes place.  Previously, we reported how hydroxamic acid prodrug carbamates increased cellular uptake, which translated to successful inhibition of this neurotoxin.  Building upon this research, we detail BoNT/A protease mol. modeling studies accompanied by the construction of small library of hydroxamic acids based on 2,4-dichlorocinnamic hydroxamic acid scaffold and their carbamate prodrug derivatization along with the evaluation of these mols. in both enzymic and cellular models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRmI6_3n4afLVg90H21EOLACvtfcHk0lhaRrrcW5JI_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtLrP&md5=374545a7527db243f7dfd00f4157753c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DSeki%26aufirst%3DH.%26aulast%3DPellett%26aufirst%3DS.%26aulast%3D%25C5%25A0ilh%25C3%25A1r%26aufirst%3DP.%26aulast%3DStowe%26aufirst%3DG.%2BN.%26aulast%3DBlanco%26aufirst%3DB.%26aulast%3DLardy%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DE.%2BA.%26aulast%3DJanda%26aufirst%3DK.%2BD.%26atitle%3DSynthesis%252FBiological%2520Evaluation%2520of%2520Hydroxamic%2520Acids%2520and%2520Their%2520Prodrugs%2520as%2520Inhibitors%2520for%2520Botulinum%2520Neurotoxin%2520a%2520Light%2520Chain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1208%26epage%3D1217%26doi%3D10.1016%2Fj.bmc.2013.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">McAllister, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramite, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barham, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitton-Fry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R. M.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzien, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanmugasundaram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaras, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uccello, D. P.</span><span> </span><span class="NLM_article-title">Heterocyclic Methylsulfone Hydroxamic Acid Lpxc Inhibitors as Gram-Negative Antibacterial Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6832</span><span class="NLM_x">–</span> <span class="NLM_lpage">6838</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.09.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2012.09.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=23046961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVykur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6832-6838&author=L.+A.+McAllisterauthor=J.+I.+Montgomeryauthor=J.+A.+Abramiteauthor=U.+Reillyauthor=M.+F.+Brownauthor=J.+M.+Chenauthor=R.+A.+Barhamauthor=Y.+Cheauthor=S.+W.+Chungauthor=C.+A.+Menardauthor=M.+Mitton-Fryauthor=L.+M.+Mullinsauthor=M.+C.+Noeauthor=J.+P.+O%E2%80%99Donnellauthor=R.+M.+Oliverauthor=J.+B.+Penzienauthor=M.+Plummerauthor=L.+M.+Priceauthor=V.+Shanmugasundaramauthor=A.+P.+Tomarasauthor=D.+P.+Uccello&title=Heterocyclic+Methylsulfone+Hydroxamic+Acid+Lpxc+Inhibitors+as+Gram-Negative+Antibacterial+Agents&doi=10.1016%2Fj.bmcl.2012.09.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents</span></div><div class="casAuthors">McAllister, Laura A.; Montgomery, Justin I.; Abramite, Joseph A.; Reilly, Usa; Brown, Matthew F.; Chen, Jinshan M.; Barham, Rose A.; Che, Ye; Chung, Seung Won; Menard, Carol A.; Mitton-Fry, Mark; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Oliver, Robert M.; Penzien, Joseph B.; Plummer, Mark; Price, Loren M.; Shanmugasundaram, Veerabahu; Tomaras, Andrew P.; Uccello, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6832-6838</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and antibacterial activity of heterocyclic methylsulfone hydroxamates is presented.  Compds. in this series are potent inhibitors of the LpxC enzyme, a key enzyme involved in the prodn. of lipopolysaccharide (LPS) found in the outer membrane of Gram-neg. bacteria.  SAR evaluation of compds. in this series revealed analogs, e.g., I, with potent antibacterial activity against challenging Gram-neg. species such as Pseudomonas aeruginosa and Klebsiella pneumoniae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5_EQM-fls8LVg90H21EOLACvtfcHk0liy9BIVs5MLAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVykur7P&md5=93dbfffc47f4eab6b67111ef7e67fa2e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.09.058%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DBarham%26aufirst%3DR.%2BA.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DS.%2BW.%26aulast%3DMenard%26aufirst%3DC.%2BA.%26aulast%3DMitton-Fry%26aufirst%3DM.%26aulast%3DMullins%26aufirst%3DL.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DOliver%26aufirst%3DR.%2BM.%26aulast%3DPenzien%26aufirst%3DJ.%2BB.%26aulast%3DPlummer%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DL.%2BM.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26atitle%3DHeterocyclic%2520Methylsulfone%2520Hydroxamic%2520Acid%2520Lpxc%2520Inhibitors%2520as%2520Gram-Negative%2520Antibacterial%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6832%26epage%3D6838%26doi%3D10.1016%2Fj.bmcl.2012.09.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraghty, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Hydroxamic Acids Block Replication of Hepatitis C Virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1021/jm501330g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501330g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=785-800&author=T.+Aiauthor=Y.+Xuauthor=L.+Qiuauthor=R.+J.+Geraghtyauthor=L.+Chen&title=Hydroxamic+Acids+Block+Replication+of+Hepatitis+C+Virus&doi=10.1021%2Fjm501330g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamic Acids Block Replication of Hepatitis C Virus</span></div><div class="casAuthors">Ai, Teng; Xu, Yanli; Qiu, Li; Geraghty, Robert J.; Chen, Liqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">785-800</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Intrigued by the role of protein acetylation in hepatitis C virus (HCV) replication, we tested known histone deacetylase (HDAC) inhibitors and a focused library of structurally simple hydroxamic acids for inhibition of a HCV subgenomic replicon.  While known HDAC inhibitors with varied inhibitory profiles proved to be either relatively toxic or ineffective, structure-activity relationship (SAR) studies on cinnamic hydroxamic acid and benzo[b]thiophen-2-hydroxamic acid gave rise to compds. 22 and 53, which showed potent and selective anti-HCV activity and therefore are promising starting points for further structural optimization and mechanistic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmTtnDAbQUBbVg90H21EOLACvtfcHk0liy9BIVs5MLAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbbK&md5=9e28da98b4b9083f4c185d7390efbdfe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm501330g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501330g%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DGeraghty%26aufirst%3DR.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DHydroxamic%2520Acids%2520Block%2520Replication%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D785%26epage%3D800%26doi%3D10.1021%2Fjm501330g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Azaindole Hydroxamic Acids Are Potent HIV-1 Integrase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7211</span><span class="NLM_x">–</span> <span class="NLM_lpage">7219</span><span class="refDoi"> DOI: 10.1021/jm900862n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900862n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7211-7219&author=M.+B.+Pleweauthor=S.+L.+Butlerauthor=K.+R.+Dressauthor=Q.+Huauthor=T.+W.+Johnsonauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=H.+Lamauthor=W.+Liuauthor=D.+Nowlinauthor=Q.+Pengauthor=S.+V.+Rahavendranauthor=S.+P.+Tanisauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=J.+Zhang&title=Azaindole+Hydroxamic+Acids+Are+Potent+HIV-1+Integrase+Inhibitors&doi=10.1021%2Fjm900862n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900862n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900862n%26sid%3Dliteratum%253Aachs%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DNowlin%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAzaindole%2520Hydroxamic%2520Acids%2520Are%2520Potent%2520HIV-1%2520Integrase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7211%26epage%3D7219%26doi%3D10.1021%2Fjm900862n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piveteau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10909</span><span class="NLM_x">–</span> <span class="NLM_lpage">10917</span><span class="refDoi"> DOI: 10.1021/jm301506h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301506h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10909-10917&author=R.+Deprez-Poulainauthor=M.+Flipoauthor=C.+Piveteauauthor=F.+Lerouxauthor=S.+Dassonnevilleauthor=I.+Florentauthor=L.+Maesauthor=P.+Cosauthor=B.+Deprez&title=Structure-Activity+Relationships+and+Blood+Distribution+of+Antiplasmodial+Aminopeptidase-1+Inhibitors&doi=10.1021%2Fjm301506h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors</span></div><div class="casAuthors">Deprez-Poulain, Rebecca; Flipo, Marion; Piveteau, Catherine; Leroux, Florence; Dassonneville, Sandrine; Florent, Isabelle; Maes, Louis; Cos, Paul; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10909-10917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria is a severe infectious disease that causes between 655 000 and 1.2 million deaths annually.  To overcome the resistance to current drugs, new biol. targets are needed for drug development.  Aminopeptidase M1 (PfAM1), a zinc metalloprotease, has been proposed as a new drug target to fight malaria.  Herein, we disclosed the structure-activity relationships of a selective family of hydroxamate PfAM1 inhibitors based on the malonic template.  In particular, we performed a fluoro-scanning around hit 1 that enlightened the key positions of the halogen for activity.  The docking of the best inhibitor 2 is consistent with in vitro results.  The stability of 2 was evaluated in microsomes, in plasma, and toward glutathione.  The in vivo distribution study performed with the nanomolar hydroxamate inhibitor BDM14471 revealed that it reaches its site of action.  However, it fails to kill the parasite at concns. relevant to the enzymic inhibitory potency, suggesting that killing the parasite remains a challenge for potent and drug-like catalytic-site binding PfAM1 inhibitors.  In all, this study provides important insights for the design of inhibitors of PfAM1 and the validity of this target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy63Ha4C-69LVg90H21EOLACvtfcHk0liRunzz4RU2zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL&md5=79f58a63feb789266e494450a5950390</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm301506h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301506h%26sid%3Dliteratum%253Aachs%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DFlorent%26aufirst%3DI.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DStructure-Activity%2520Relationships%2520and%2520Blood%2520Distribution%2520of%2520Antiplasmodial%2520Aminopeptidase-1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10909%26epage%3D10917%26doi%3D10.1021%2Fjm301506h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkwater, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaraman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiardini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, S.</span><span> </span><span class="NLM_article-title">Two-Pronged Attack: Dual Inhibition of Plasmodium Falciparum M1 and M17 Metalloaminopeptidases by a Novel Series of Hydroxamic Acid-Based Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9168</span><span class="NLM_x">–</span> <span class="NLM_lpage">9183</span><span class="refDoi"> DOI: 10.1021/jm501323a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501323a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9168-9183&author=S.+N.+Mistryauthor=N.+Drinkwaterauthor=C.+Ruggeriauthor=K.+K.+Sivaramanauthor=S.+Loganathanauthor=S.+Fletcherauthor=M.+Dragauthor=A.+Paiardiniauthor=V.+M.+Averyauthor=P.+J.+Scammellsauthor=S.+McGowan&title=Two-Pronged+Attack%3A+Dual+Inhibition+of+Plasmodium+Falciparum+M1+and+M17+Metalloaminopeptidases+by+a+Novel+Series+of+Hydroxamic+Acid-Based+Inhibitors&doi=10.1021%2Fjm501323a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Two-Pronged Attack: Dual Inhibition of Plasmodium falciparum M1 and M17 Metalloaminopeptidases by a Novel Series of Hydroxamic Acid-Based Inhibitors</span></div><div class="casAuthors">Mistry, Shailesh N.; Drinkwater, Nyssa; Ruggeri, Chiara; Sivaraman, Komagal Kannan; Loganathan, Sasdekumar; Fletcher, Sabine; Drag, Marcin; Paiardini, Alessandro; Avery, Vicky M.; Scammells, Peter J.; McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9168-9183</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasmodium parasites, the causative agents of malaria, have developed resistance to most of the current antimalarial therapies, including artemisinin combination therapies which are widely described as the last line of defense.  Antimalarial agents with a novel mode of action are urgently required.  Two Plasmodium falciparum aminopeptidases, PfA-M1 and PfA-M17, play crucial roles in the erythrocytic stage of infection and have been validated as potential antimalarial targets.  Using compd.-bound crystal structures of both enzymes, the authors have used a structure-guided approach to develop a novel series of inhibitors capable of potent inhibition of both PfA-M1 and PfA-M17 activity and parasite growth in culture.  Herein the authors describe the design, synthesis, and evaluation of a series of hydroxamic acid-based inhibitors I [R1 = PhCO, 2-FC6H4CO, 3-H2NC6H4CO, etc.; R2 = HO, HONH] and demonstrate the compds. to be exciting new leads for the development of novel antimalarial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTJUvJd2YOGLVg90H21EOLACvtfcHk0liRunzz4RU2zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E&md5=6b6fe308bc3b434d686268e65014d9c1</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm501323a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501323a%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DLoganathan%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DTwo-Pronged%2520Attack%253A%2520Dual%2520Inhibition%2520of%2520Plasmodium%2520Falciparum%2520M1%2520and%2520M17%2520Metalloaminopeptidases%2520by%2520a%2520Novel%2520Series%2520of%2520Hydroxamic%2520Acid-Based%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9168%26epage%3D9183%26doi%3D10.1021%2Fjm501323a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">France, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, A. P.</span><span> </span><span class="NLM_article-title">Identification and Activity of Inhibitors of the Essential Nematode-Specific Metalloprotease Dpy-31</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5752</span><span class="NLM_x">–</span> <span class="NLM_lpage">5755</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2015.10.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5752-5755&author=D.+J.+Franceauthor=G.+Stepekauthor=D.+R.+Houstonauthor=L.+Williamsauthor=G.+McCormackauthor=M.+D.+Walkinshawauthor=A.+P.+Page&title=Identification+and+Activity+of+Inhibitors+of+the+Essential+Nematode-Specific+Metalloprotease+Dpy-31&doi=10.1016%2Fj.bmcl.2015.10.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.077%26sid%3Dliteratum%253Aachs%26aulast%3DFrance%26aufirst%3DD.%2BJ.%26aulast%3DStepek%26aufirst%3DG.%26aulast%3DHouston%26aufirst%3DD.%2BR.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DMcCormack%26aufirst%3DG.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DPage%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520and%2520Activity%2520of%2520Inhibitors%2520of%2520the%2520Essential%2520Nematode-Specific%2520Metalloprotease%2520Dpy-31%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5752%26epage%3D5755%26doi%3D10.1016%2Fj.bmcl.2015.10.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Novakova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jancarik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlicek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlinova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barinka, C.</span><span> </span><span class="NLM_article-title">Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase Ii: Structural Characterization and Biological Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4539</span><span class="NLM_x">–</span> <span class="NLM_lpage">4550</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01806</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4539-4550&author=Z.+Novakovaauthor=K.+Wozniakauthor=A.+Jancarikauthor=R.+Raisauthor=Y.+Wuauthor=J.+Pavlicekauthor=D.+Ferrarisauthor=B.+Havlinovaauthor=J.+Ptacekauthor=J.+Vavraauthor=N.+Hinauthor=C.+Rojasauthor=P.+Majerauthor=B.+S.+Slusherauthor=T.+Tsukamotoauthor=C.+Barinka&title=Unprecedented+Binding+Mode+of+Hydroxamate-Based+Inhibitors+of+Glutamate+Carboxypeptidase+Ii%3A+Structural+Characterization+and+Biological+Activity&doi=10.1021%2Facs.jmedchem.5b01806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity</span></div><div class="casAuthors">Novakova, Zora; Wozniak, Krystyna; Jancarik, Andrej; Rais, Rana; Wu, Ying; Pavlicek, Jiri; Ferraris, Dana; Havlinova, Barbora; Ptacek, Jakub; Vavra, Jan; Hin, Niyada; Rojas, Camilo; Majer, Pavel; Slusher, Barbara S.; Tsukamoto, Takashi; Barinka, Cyril</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4539-4550</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of glutamate carboxypeptidase II (GCPII) is effective in preclin. models of neurol. disorders assocd. with excessive activation of glutamatergic systems.  Here we report synthesis, structural characterization, and biol. activity of new hydroxamic acid-based inhibitors with nanomolar affinity for human GCPII.  Crystal structures of GCPII/hydroxamate complexes revealed an unprecedented binding mode in which the putative P1' glutarate occupies the spacious entrance funnel rather than the conserved glutamate-binding S1' pocket.  This unique binding mode provides a mechanistic explanation for the structure-activity relationship data, most notably the lack of enantiospecificity and the tolerance for bulky/hydrophobic functions as substituents of a canonical glutarate moiety.  The in vivo pharmacokinetics profile of one of the inhibitors will be presented along with analgesic efficacy data from the rat chronic constrictive injury model of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC9E-sr57YkbVg90H21EOLACvtfcHk0liRunzz4RU2zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL0%253D&md5=8ebdd56cda221edd563f22b6b268a7aa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01806%26sid%3Dliteratum%253Aachs%26aulast%3DNovakova%26aufirst%3DZ.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPavlicek%26aufirst%3DJ.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DHavlinova%26aufirst%3DB.%26aulast%3DPtacek%26aufirst%3DJ.%26aulast%3DVavra%26aufirst%3DJ.%26aulast%3DHin%26aufirst%3DN.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DBarinka%26aufirst%3DC.%26atitle%3DUnprecedented%2520Binding%2520Mode%2520of%2520Hydroxamate-Based%2520Inhibitors%2520of%2520Glutamate%2520Carboxypeptidase%2520Ii%253A%2520Structural%2520Characterization%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4539%26epage%3D4550%26doi%3D10.1021%2Facs.jmedchem.5b01806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enée, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totobenazara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahklal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdelet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woitrain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauriot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrelle, F.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herledan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piveteau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Endert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Catalytic Site Inhibition of Insulin-Degrading Enzyme by a Small Molecule Induces Glucose Intolerance in Mice</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8250</span><span class="refDoi"> DOI: 10.1038/ncomms9250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fncomms9250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=26394692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGks7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8250&author=R.+Deprez-Poulainauthor=N.+Hennuyerauthor=D.+Boscauthor=W.+G.+Liangauthor=E.+En%C3%A9eauthor=X.+Marechalauthor=J.+Chartonauthor=J.+Totobenazaraauthor=G.+Berteauthor=J.+Jahklalauthor=T.+Verdeletauthor=J.+Dumontauthor=S.+Dassonnevilleauthor=E.+Woitrainauthor=M.+Gauriotauthor=C.+Paquetauthor=I.+Duplanauthor=P.+Hermantauthor=F.-X.+Cantrelleauthor=E.+Sevinauthor=M.+Culotauthor=V.+Landryauthor=A.+Herledanauthor=C.+Piveteauauthor=G.+Lippensauthor=F.+Lerouxauthor=W.-J.+Tangauthor=P.+van+Endertauthor=B.+Staelsauthor=B.+Deprez&title=Catalytic+Site+Inhibition+of+Insulin-Degrading+Enzyme+by+a+Small+Molecule+Induces+Glucose+Intolerance+in+Mice&doi=10.1038%2Fncomms9250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice</span></div><div class="casAuthors">Deprez-Poulain, Rebecca; Hennuyer, Nathalie; Bosc, Damien; Liang, Wenguang G.; Enee, Emmanuelle; Marechal, Xavier; Charton, Julie; Totobenazara, Jane; Berte, Gonzague; Jahklal, Jouda; Verdelet, Tristan; Dumont, Julie; Dassonneville, Sandrine; Woitrain, Eloise; Gauriot, Marion; Paquet, Charlotte; Duplan, Isabelle; Hermant, Paul; Cantrelle, Francois- Xavier; Sevin, Emmanuel; Culot, Maxime; Landry, Valerie; Herledan, Adrien; Piveteau, Catherine; Lippens, Guy; Leroux, Florence; Tang, Wei-Jen; van Endert, Peter; Staels, Bart; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8250</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Insulin-degrading enzyme (IDE) is a protease that cleaves insulin and other bioactive peptides such as amyloid-β.  Knockout and genetic studies have linked IDE to Alzheimer's disease and type-2 diabetes.  As the major insulin-degrading protease, IDE is a candidate drug target in diabetes.  Here we have used kinetic target-guided synthesis to design the first catalytic site inhibitor of IDE suitable for in vivo studies (BDM44768).  Crystallog. and small angle X-ray scattering analyses show that it locks IDE in a closed conformation.  Among a panel of metalloproteases, BDM44768 selectively inhibits IDE.  Acute treatment of mice with BDM44768 increases insulin signalling and surprisingly impairs glucose tolerance in an IDE-dependent manner.  These results confirm that IDE is involved in pathways that modulate short-term glucose homeostasis, but casts doubt on the general usefulness of the inhibition of IDE catalytic activity to treat diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodV3LKS8InMbVg90H21EOLACvtfcHk0lhcbndG2ulY7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGks7%252FN&md5=b04d4adc8373a451e8f9a0c82a827462</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncomms9250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9250%26sid%3Dliteratum%253Aachs%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DBosc%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DW.%2BG.%26aulast%3DEn%25C3%25A9e%26aufirst%3DE.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DTotobenazara%26aufirst%3DJ.%26aulast%3DBerte%26aufirst%3DG.%26aulast%3DJahklal%26aufirst%3DJ.%26aulast%3DVerdelet%26aufirst%3DT.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DWoitrain%26aufirst%3DE.%26aulast%3DGauriot%26aufirst%3DM.%26aulast%3DPaquet%26aufirst%3DC.%26aulast%3DDuplan%26aufirst%3DI.%26aulast%3DHermant%26aufirst%3DP.%26aulast%3DCantrelle%26aufirst%3DF.-X.%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DLandry%26aufirst%3DV.%26aulast%3DHerledan%26aufirst%3DA.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DLippens%26aufirst%3DG.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DW.-J.%26aulast%3Dvan%2BEndert%26aufirst%3DP.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DCatalytic%2520Site%2520Inhibition%2520of%2520Insulin-Degrading%2520Enzyme%2520by%2520a%2520Small%2520Molecule%2520Induces%2520Glucose%2520Intolerance%2520in%2520Mice%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8250%26doi%3D10.1038%2Fncomms9250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Orbe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arias, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugarte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belzunce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Páramo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel Matrix Metalloproteinase Inhibitors as Potent Antihemorrhagic Agents: From Hit Identification to an Optimized Lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2465</span><span class="NLM_x">–</span> <span class="NLM_lpage">2488</span><span class="refDoi"> DOI: 10.1021/jm501940y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501940y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2465-2488&author=J.+Orbeauthor=J.+A.+S%C3%A1nchez-Ariasauthor=O.+Rabalauthor=J.+A.+Rodr%C3%ADguezauthor=A.+Salicioauthor=A.+Ugarteauthor=M.+Belzunceauthor=M.+Xuauthor=W.+Wuauthor=H.+Tanauthor=H.+Maauthor=J.+A.+P%C3%A1ramoauthor=J.+Oyarzabal&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+Matrix+Metalloproteinase+Inhibitors+as+Potent+Antihemorrhagic+Agents%3A+From+Hit+Identification+to+an+Optimized+Lead&doi=10.1021%2Fjm501940y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Matrix Metalloproteinase Inhibitors As Potent Antihemorrhagic Agents: From Hit Identification to an Optimized Lead</span></div><div class="casAuthors">Orbe, Josune; Sanchez-Arias, Juan A.; Rabal, Obdulia; Rodriguez, Jose A.; Salicio, Agustina; Ugarte, Ana; Belzunce, Miriam; Xu, Musheng; Wu, Wei; Tan, Haizhong; Ma, Hongyu; Paramo, Jose A.; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2465-2488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Growing evidence suggests that matrix metalloproteinases (MMP) are involved in thrombus dissoln.; then, considering that new therapeutic strategies are required for controlling hemorrhage, we hypothesized that MMP inhibition may reduce bleeding by delaying fibrinolysis.  Thus, we designed and synthesized a novel series of MMP inhibitors to identify potential candidates for acute treatment of bleeding.  Structure-based and knowledge-based strategies were utilized to design this novel chem. series, α-spiropiperidine hydroxamates, of potent and sol. (>75 μg/mL) pan-MMP inhibitors.  The initial hit was progressed to an optimal lead I.  Racemic I showed a remarkable in vitro phenotypic response and outstanding in vivo efficacy; in fact, the mouse bleeding time at 1 mg/kg was 0.85 min compared to 29.28 min using saline.  In addn., I displayed an optimal ADME and safety profile (e.g., no thrombus formation).  Its corresponding enantiomers were sepd., leading to the preclin. candidate (R)-I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGretnPXVi3YibVg90H21EOLACvtfcHk0lhcbndG2ulY7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGiurk%253D&md5=1d56002442eae50c83de14d1f217701b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm501940y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501940y%26sid%3Dliteratum%253Aachs%26aulast%3DOrbe%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%2BA.%26aulast%3DSalicio%26aufirst%3DA.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DBelzunce%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DP%25C3%25A1ramo%26aufirst%3DJ.%2BA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520as%2520Potent%2520Antihemorrhagic%2520Agents%253A%2520From%2520Hit%2520Identification%2520to%2520an%2520Optimized%2520Lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2465%26epage%3D2488%26doi%3D10.1021%2Fjm501940y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Noe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti-Morrow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocum, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardink, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokar, C.</span><span> </span><span class="NLM_article-title">Discovery of 3,3-Dimethyl-5-Hydroxypipecolic Hydroxamate-Based Inhibitors of Aggrecanase and Mmp-13</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2808</span><span class="NLM_x">–</span> <span class="NLM_lpage">2811</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2005.03.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=15911259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2808-2811&author=M.+C.+Noeauthor=V.+Natarajanauthor=S.+L.+Snowauthor=P.+G.+Mitchellauthor=L.+Lopresti-Morrowauthor=L.+M.+Reevesauthor=S.+A.+Yocumauthor=T.+J.+Cartyauthor=J.+A.+Barberiaauthor=F.+J.+Sweeneyauthor=J.+L.+Lirasauthor=M.+Vaughnauthor=J.+R.+Hardinkauthor=J.+M.+Hawkinsauthor=C.+Tokar&title=Discovery+of+3%2C3-Dimethyl-5-Hydroxypipecolic+Hydroxamate-Based+Inhibitors+of+Aggrecanase+and+Mmp-13&doi=10.1016%2Fj.bmcl.2005.03.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13</span></div><div class="casAuthors">Noe, Mark C.; Natarajan, Vijayalakshmi; Snow, Sheri L.; Mitchell, Peter G.; Lopresti-Morrow, Lori; Reeves, Lisa M.; Yocum, Sue A.; Carty, Thomas J.; Barberia, John A.; Sweeney, Francis J.; Liras, Jennifer L.; Vaughn, Marcie; Hardink, Joel R.; Hawkins, Joel M.; Tokar, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2808-2811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of pipecolic hydroxamate inhibitors of MMP-13 and aggrecanase was discovered based on screening known inhibitors of TNF-α converting enzyme (TACE).  Thus, a diastereoselective Strecker reaction of H2C:CHCH2CMe2CHO with (R)-H2NCH(Me)Ph gave the α-aminonitrile I which was subsequently asym. dihydroxylated, cyclized, hydrogenated, and sulfonylated to give the desired pipecolic acid hydroxamates II (R = 2-MeC6H4, 2,4-Cl2C6H3, 4-quinolinyl, etc.).  Potency vs. aggrecanase was optimized by modification of the benzyloxyarylsulfonamide group.  Incorporation of geminal alkyl substitution at the 3-position of the piperidine ring improved metabolic stability, presumably by increasing steric hindrance around the metabolically labile hydroxamic acid.  This modification also resulted in dramatic improvement of aggrecanase activity with a slight redn. in selectivity vs. MMP-1.  Synthesis, structure activity relationships, and strategies to reduce metabolic clearance are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIkZAvxWGTLVg90H21EOLACvtfcHk0ljJTOKJ0BaNxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wju7k%253D&md5=80844b9e116bc4bf5fbd2e9d245bb250</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.105%26sid%3Dliteratum%253Aachs%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DSnow%26aufirst%3DS.%2BL.%26aulast%3DMitchell%26aufirst%3DP.%2BG.%26aulast%3DLopresti-Morrow%26aufirst%3DL.%26aulast%3DReeves%26aufirst%3DL.%2BM.%26aulast%3DYocum%26aufirst%3DS.%2BA.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DBarberia%26aufirst%3DJ.%2BA.%26aulast%3DSweeney%26aufirst%3DF.%2BJ.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DVaughn%26aufirst%3DM.%26aulast%3DHardink%26aufirst%3DJ.%2BR.%26aulast%3DHawkins%26aufirst%3DJ.%2BM.%26aulast%3DTokar%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25203%252C3-Dimethyl-5-Hydroxypipecolic%2520Hydroxamate-Based%2520Inhibitors%2520of%2520Aggrecanase%2520and%2520Mmp-13%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2808%26epage%3D2811%26doi%3D10.1016%2Fj.bmcl.2005.03.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">El Bakali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras-Masse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maingot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Inhibition of Aggrecanase as a Therapeutic Strategy in Osteoarthritis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.4155/fmc.14.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.4155%2Ffmc.14.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25329196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1399-1412&author=J.+El+Bakaliauthor=H.+Gras-Masseauthor=L.+Maingotauthor=B.+Deprezauthor=J.+Dumontauthor=F.+Lerouxauthor=R.+Deprez-Poulain&title=Inhibition+of+Aggrecanase+as+a+Therapeutic+Strategy+in+Osteoarthritis&doi=10.4155%2Ffmc.14.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis</span></div><div class="casAuthors">El Bakali Jamal; Gras-Masse Helene; Maingot Lucie; Deprez Benoit; Dumont Julie; Leroux Florence; Deprez-Poulain Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Future medicinal chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1399-412</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the last decade, there has been a large effort to target aggrecanases, which are responsible for the degradation of the aggrecan in the extracellular matrix of joints, in order to hopefully lead to new treatments for osteoarthritis.  Only a few inhibitors have been effective in explants or rodent models and thus only a few have reached the clinic, none of which have proven to be effective.  In this article, a survey of chemical series is described, covering historical and recent inhibitors and highlighting how some of their problems were resolved, with a critical overview of the challenges encountered.  A large effort should be undertaken in designing smaller compounds with higher residence times, defining new interaction sites on the aggrecanases and exploiting target flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc6YFS0apR4JZoeNcnHOQ9fW6udTcc2eYT9C8h1T4xwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D&md5=85f4d7d300cf08249358f9db09cf3e69</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.84%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BBakali%26aufirst%3DJ.%26aulast%3DGras-Masse%26aufirst%3DH.%26aulast%3DMaingot%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Aggrecanase%2520as%2520a%2520Therapeutic%2520Strategy%2520in%2520Osteoarthritis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1399%26epage%3D1412%26doi%3D10.4155%2Ffmc.14.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinning, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span> </span><span class="NLM_article-title">Discovery of Novel Hydroxamates as Highly Potent Tumor Necrosis Factor-Converting Enzyme Inhibitors: Part I:Discovery of Two Binding Modes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1021/jm070376o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070376o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=725-736&author=Z.+Zhuauthor=R.+Mazzolaauthor=L.+Sinningauthor=B.+McKittrickauthor=X.+Niuauthor=D.+Lundellauthor=J.+Sunauthor=P.+Orthauthor=Z.+Guoauthor=V.+Madisonauthor=R.+Ingramauthor=B.+M.+Beyer&title=Discovery+of+Novel+Hydroxamates+as+Highly+Potent+Tumor+Necrosis+Factor-Converting+Enzyme+Inhibitors%3A+Part+I%3ADiscovery+of+Two+Binding+Modes&doi=10.1021%2Fjm070376o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm070376o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070376o%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DSinning%26aufirst%3DL.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26atitle%3DDiscovery%2520of%2520Novel%2520Hydroxamates%2520as%2520Highly%2520Potent%2520Tumor%2520Necrosis%2520Factor-Converting%2520Enzyme%2520Inhibitors%253A%2520Part%2520I%253ADiscovery%2520of%2520Two%2520Binding%2520Modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D725%26epage%3D736%26doi%3D10.1021%2Fjm070376o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ouvry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berton, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhurruth-Alcor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnary, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouix-Peter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouquet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourotte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacini-Rachinel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzy, A.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reversé, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosignoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taquet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span> </span><span class="NLM_article-title">Identification of Novel Tace Inhibitors Compatible with Topical Application</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1848</span><span class="NLM_x">–</span> <span class="NLM_lpage">1853</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2017.02.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1848-1853&author=G.+Ouvryauthor=Y.+Bertonauthor=Y.+Bhurruth-Alcorauthor=L.+Bonnaryauthor=C.+Bouix-Peterauthor=K.+Bouquetauthor=M.+Bourotteauthor=S.+Chambonauthor=C.+Cominoauthor=B.+Deprezauthor=D.+Duvertauthor=G.+Duvertauthor=F.+Hacini-Rachinelauthor=C.+S.+Harrisauthor=A.-P.+Luzyauthor=A.+Mathieuauthor=C.+Milloisauthor=J.+Pascauauthor=A.+Pintoauthor=G.+Polgeauthor=A.+Reitzauthor=K.+Revers%C3%A9author=C.+Rosignoliauthor=N.+Taquetauthor=L.+F.+Hennequin&title=Identification+of+Novel+Tace+Inhibitors+Compatible+with+Topical+Application&doi=10.1016%2Fj.bmcl.2017.02.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DBerton%26aufirst%3DY.%26aulast%3DBhurruth-Alcor%26aufirst%3DY.%26aulast%3DBonnary%26aufirst%3DL.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DBouquet%26aufirst%3DK.%26aulast%3DBourotte%26aufirst%3DM.%26aulast%3DChambon%26aufirst%3DS.%26aulast%3DComino%26aufirst%3DC.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DDuvert%26aufirst%3DG.%26aulast%3DHacini-Rachinel%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DLuzy%26aufirst%3DA.-P.%26aulast%3DMathieu%26aufirst%3DA.%26aulast%3DMillois%26aufirst%3DC.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DPolge%26aufirst%3DG.%26aulast%3DReitz%26aufirst%3DA.%26aulast%3DRevers%25C3%25A9%26aufirst%3DK.%26aulast%3DRosignoli%26aufirst%3DC.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DIdentification%2520of%2520Novel%2520Tace%2520Inhibitors%2520Compatible%2520with%2520Topical%2520Application%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1848%26epage%3D1853%26doi%3D10.1016%2Fj.bmcl.2017.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Boiteau, J.-G.; Ouvry, G.; Arlabosse, J.-M.; Astri, S.; Beillard, A.; Bhurruth-Alcor, Y.; Bonnary, L.; Bouix-Peter, C.; Bouquet, K.; Bourotte, M.; Cardinaud, I.; Comino, C.; Deprez, B.; Duvert, D.; Féret, A.; Hacini-Rachinel, F.; Harris, C. S.; Luzy, A.-P.; Mathieu, A.; Millois, C.; Orsini, N.; Pascau, J.; Pinto, A.; Piwnica, D.; Polge, G.; Reitz, A.; Reversé, K.; Rodeville, N.; Rossio, P.; Spiesse, D.; Tabet, S.; Taquet, N.; Tomas, L.; Vial, E.; Hennequin, L. F.</span><span> </span><span class="NLM_article-title">Discovery and Process Development of a Novel Tace Inhibitor for the Topical Treatment of Psoriasis</span>.  <span class="citation_source-journal">Bioorg. Med. Chem.</span>. Published Online: August 2,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1016/j.bmc.2017.07.054</span> ; <a href="http://www.sciencedirect.com/science/article/pii/S0968089617310647" class="extLink">http://www.sciencedirect.com/science/article/pii/S0968089617310647</a> (accessed October 5, 2017).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmc.2017.07.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.-G.+Boiteau&author=G.+Ouvry&author=J.-M.+Arlabosse&author=S.+Astri&author=A.+Beillard&author=Y.+Bhurruth-Alcor&author=L.+Bonnary&author=C.+Bouix-Peter&author=K.+Bouquet&author=M.+Bourotte&author=I.+Cardinaud&author=C.+Comino&author=B.+Deprez&author=D.+Duvert&author=A.+F%C3%A9ret&author=F.+Hacini-Rachinel&author=C.+S.+Harris&author=A.-P.+Luzy&author=A.+Mathieu&author=C.+Millois&author=N.+Orsini&author=J.+Pascau&author=A.+Pinto&author=D.+Piwnica&author=G.+Polge&author=A.+Reitz&author=K.+Revers%C3%A9&author=N.+Rodeville&author=P.+Rossio&author=D.+Spiesse&author=S.+Tabet&author=N.+Taquet&author=L.+Tomas&author=E.+Vial&author=L.+F.+Hennequin&title=Discovery+and+Process+Development+of+a+Novel+Tace+Inhibitor+for+the+Topical+Treatment+of+Psoriasis&doi=10.1016%2Fj.bmc.2017.07.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.054%26sid%3Dliteratum%253Aachs%26aulast%3DBoiteau%26aufirst%3DJ.-G.%26atitle%3DDiscovery%2520and%2520Process%2520Development%2520of%2520a%2520Novel%2520Tace%2520Inhibitor%2520for%2520the%2520Topical%2520Treatment%2520of%2520Psoriasis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26doi%3D10.1016%2Fj.bmc.2017.07.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katiyar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marando, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeleswaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalluri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B.</span><span> </span><span class="NLM_article-title">Discovery of a Potent, Selective, and Orally Active Human Epidermal Growth Factor Receptor-2 Sheddase Inhibitor for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span><span class="refDoi"> DOI: 10.1021/jm061344o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061344o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=603-606&author=W.+Yaoauthor=J.+Zhuoauthor=D.+M.+Burnsauthor=M.+Xuauthor=C.+Zhangauthor=Y.+L.+Liauthor=D.+Q.+Qianauthor=C.+Heauthor=L.+Wengauthor=E.+Shiauthor=Q.+Linauthor=C.+Agriosauthor=T.+C.+Burnauthor=E.+Caulderauthor=M.+B.+Covingtonauthor=J.+S.+Fridmanauthor=S.+Friedmanauthor=K.+Katiyarauthor=G.+Hollisauthor=Y.+Liauthor=C.+Liuauthor=X.+Liuauthor=C.+A.+Marandoauthor=R.+Newtonauthor=M.+Panauthor=P.+Scherleauthor=N.+Taylorauthor=K.+Vaddiauthor=Z.+R.+Wassermanauthor=R.+Wynnauthor=S.+Yeleswaramauthor=R.+Jalluriauthor=M.+Bowerauthor=B.+B.+Zhouauthor=B.+Metcalf&title=Discovery+of+a+Potent%2C+Selective%2C+and+Orally+Active+Human+Epidermal+Growth+Factor+Receptor-2+Sheddase+Inhibitor+for+the+Treatment+of+Cancer&doi=10.1021%2Fjm061344o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm061344o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061344o%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DBurns%26aufirst%3DD.%2BM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%2BL.%26aulast%3DQian%26aufirst%3DD.%2BQ.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWeng%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DAgrios%26aufirst%3DC.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DCovington%26aufirst%3DM.%2BB.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DFriedman%26aufirst%3DS.%26aulast%3DKatiyar%26aufirst%3DK.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMarando%26aufirst%3DC.%2BA.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DWasserman%26aufirst%3DZ.%2BR.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DJalluri%26aufirst%3DR.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DB.%2BB.%26aulast%3DMetcalf%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Active%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520Sheddase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D603%26epage%3D606%26doi%3D10.1021%2Fjm061344o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Falkenberg, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Histone Deacetylases and Their Inhibitors in Cancer, Neurological Diseases and Immune Disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1038/nrd4360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fnrd4360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25131830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKrtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=673-691&author=K.+J.+Falkenbergauthor=R.+W.+Johnstone&title=Histone+Deacetylases+and+Their+Inhibitors+in+Cancer%2C+Neurological+Diseases+and+Immune+Disorders&doi=10.1038%2Fnrd4360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders</span></div><div class="casAuthors">Falkenberg, Katrina J.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">673-691</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epigenetic aberrations, which are recognized as key drivers of several human diseases, are often caused by genetic defects that result in functional deregulation of epigenetic proteins, their altered expression and/or their atypical recruitment to certain gene promoters.  Importantly, epigenetic changes are reversible, and epigenetic enzymes and regulatory proteins can be targeted using small mols.  This Review discusses the role of altered expression and/or function of one class of epigenetic regulators - histone deacetylases (HDACs) - and their role in cancer, neurol. diseases and immune disorders.  We highlight the development of small-mol. HDAC inhibitors and their use in the lab., in preclin. models and in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXiWEG49LhebVg90H21EOLACvtfcHk0lit82dFMCxgog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKrtLjI&md5=ccfb68fa3fd4685e2305cdf8a6a9c81a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd4360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4360%26sid%3Dliteratum%253Aachs%26aulast%3DFalkenberg%26aufirst%3DK.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DHistone%2520Deacetylases%2520and%2520Their%2520Inhibitors%2520in%2520Cancer%252C%2520Neurological%2520Diseases%2520and%2520Immune%2520Disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D673%26epage%3D691%26doi%3D10.1038%2Fnrd4360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, W. V.</span><span> </span><span class="NLM_article-title">B-N-Biaryl Ether Sulfonamide Hydroxamates as Potent Gelatinase Inhibitors: Part 2. Optimization of A-Amino Substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2007.11.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1140-1145&author=S.-M.+Yangauthor=R.+H.+Scannevinauthor=B.+Wangauthor=S.+L.+Burkeauthor=Z.+Huangauthor=P.+Karnachiauthor=L.+J.+Wilsonauthor=K.+J.+Rhodesauthor=B.+Laguauthor=W.+V.+Murray&title=B-N-Biaryl+Ether+Sulfonamide+Hydroxamates+as+Potent+Gelatinase+Inhibitors%3A+Part+2.+Optimization+of+A-Amino+Substituents&doi=10.1016%2Fj.bmcl.2007.11.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.129%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-M.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DS.%2BL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DKarnachi%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26atitle%3DB-N-Biaryl%2520Ether%2520Sulfonamide%2520Hydroxamates%2520as%2520Potent%2520Gelatinase%2520Inhibitors%253A%2520Part%25202.%2520Optimization%2520of%2520A-Amino%2520Substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1140%26epage%3D1145%26doi%3D10.1016%2Fj.bmcl.2007.11.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. Q.</span><span> </span><span class="NLM_article-title">Stability Studies of Vorinostat and Its Two Metabolites in Human Plasma, Serum and Urine</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/j.jpba.2006.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.jpba.2006.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16824724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFers7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=556-564&author=L.+Duauthor=D.+G.+Mussonauthor=A.+Q.+Wang&title=Stability+Studies+of+Vorinostat+and+Its+Two+Metabolites+in+Human+Plasma%2C+Serum+and+Urine&doi=10.1016%2Fj.jpba.2006.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Stability studies of vorinostat and its two metabolites in human plasma, serum and urine</span></div><div class="casAuthors">Du, Lihong; Musson, Donald G.; Wang, Amy Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">556-564</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Effects of storage time and freeze-thaw procedure on the stability of vorinostat (suberoylanilide hydroxamic acid) and its two metabolites, vorinostat O-glucuronide (M1) and 4-anilino-4-oxobutanoic acid (M2), in human plasma, serum and urine have been examd. using high turbulence liq. chromatog. (HTLC) online extn. and tandem mass spectrometry (MS/MS) [L. Du, D.G. Musson, A.Q. Wang, Rapid Commun. Mass Spectrom. 19 (2005) 1779-1787].  Vorinostat was demonstrated not to be stable in human plasma during the process of sample processing and storage.  Acidifying the plasma sample to prevent possible enzymic hydrolysis and using plasma with different anticoagulants were evaluated to increase the stability of vorinostat, but neither of these approaches improved stability.  Human serum was then used as an alternative to plasma to monitor drug concn., and vorinostat and its two metabolites maintained consistent concns. in human serum after 3 freeze-thaw cycles and more than 1 yr storage at -70 °C.  By comparing the stability results of serum, EDTA plasma and heparin plasma, it was deduced that clotting proteins of plasma might be a major cause of vorinostat degrdn.  The stability of the three analytes during the process of serum sample collection was verified indicating that prolonged sample collection (up to 180 min) has no effect on the integrity of these analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj49Hq1PWdqLVg90H21EOLACvtfcHk0lit82dFMCxgog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFers7vI&md5=9317771ea638d773bd38fcd7d9ea7a0c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2006.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2006.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DMusson%26aufirst%3DD.%2BG.%26aulast%3DWang%26aufirst%3DA.%2BQ.%26atitle%3DStability%2520Studies%2520of%2520Vorinostat%2520and%2520Its%2520Two%2520Metabolites%2520in%2520Human%2520Plasma%252C%2520Serum%2520and%2520Urine%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D42%26spage%3D556%26epage%3D564%26doi%3D10.1016%2Fj.jpba.2006.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, K.</span><span> </span><span class="NLM_article-title">Reductase Activity of Aldehyde Oxidase toward the Carcinogen N-Hydroxy-2-Acetylaminofluorene and the Related Hydroxamic Acids</span> <span class="citation_source-journal">Biochem. Mol. Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1197-1203&author=S.+Kitamuraauthor=K.+Sugiharaauthor=K.+Tatsumi&title=Reductase+Activity+of+Aldehyde+Oxidase+toward+the+Carcinogen+N-Hydroxy-2-Acetylaminofluorene+and+the+Related+Hydroxamic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DReductase%2520Activity%2520of%2520Aldehyde%2520Oxidase%2520toward%2520the%2520Carcinogen%2520N-Hydroxy-2-Acetylaminofluorene%2520and%2520the%2520Related%2520Hydroxamic%2520Acids%26jtitle%3DBiochem.%2520Mol.%2520Biol.%2520Int.%26date%3D1994%26volume%3D34%26spage%3D1197%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mulder, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerman, J. H.</span><span> </span><span class="NLM_article-title">Sulfation and Glucuronidation as Competing Pathways in the Metabolism of Hydroxamic Acids: The Role of N,O-Sulfonation in Chemical Carcinogenesis of Aromatic Amines</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1289/ehp.834927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1289%2Fehp.834927" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1983&pages=27-32&author=G.+J.+Mulderauthor=J.+H.+Meerman&title=Sulfation+and+Glucuronidation+as+Competing+Pathways+in+the+Metabolism+of+Hydroxamic+Acids%3A+The+Role+of+N%2CO-Sulfonation+in+Chemical+Carcinogenesis+of+Aromatic+Amines&doi=10.1289%2Fehp.834927"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1289%2Fehp.834927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.834927%26sid%3Dliteratum%253Aachs%26aulast%3DMulder%26aufirst%3DG.%2BJ.%26aulast%3DMeerman%26aufirst%3DJ.%2BH.%26atitle%3DSulfation%2520and%2520Glucuronidation%2520as%2520Competing%2520Pathways%2520in%2520the%2520Metabolism%2520of%2520Hydroxamic%2520Acids%253A%2520The%2520Role%2520of%2520N%252CO-Sulfonation%2520in%2520Chemical%2520Carcinogenesis%2520of%2520Aromatic%2520Amines%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D1983%26volume%3D49%26spage%3D27%26epage%3D32%26doi%3D10.1289%2Fehp.834927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kook, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G.</span><span> </span><span class="NLM_article-title">Improving Potency and Metabolic Stability by Introducing an Alkenyl Linker to Pyridine-Based Histone Deacetylase Inhibitors for Orally Available Runx3 Modulators</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.ejmech.2016.11.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=997-1010&author=D.+Songauthor=C.+Leeauthor=Y.+J.+Kookauthor=S.+J.+Ohauthor=J.+S.+Kangauthor=H.-J.+Kimauthor=G.+Han&title=Improving+Potency+and+Metabolic+Stability+by+Introducing+an+Alkenyl+Linker+to+Pyridine-Based+Histone+Deacetylase+Inhibitors+for+Orally+Available+Runx3+Modulators&doi=10.1016%2Fj.ejmech.2016.11.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DKook%26aufirst%3DY.%2BJ.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DH.-J.%26aulast%3DHan%26aufirst%3DG.%26atitle%3DImproving%2520Potency%2520and%2520Metabolic%2520Stability%2520by%2520Introducing%2520an%2520Alkenyl%2520Linker%2520to%2520Pyridine-Based%2520Histone%2520Deacetylase%2520Inhibitors%2520for%2520Orally%2520Available%2520Runx3%2520Modulators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D997%26epage%3D1010%26doi%3D10.1016%2Fj.ejmech.2016.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lassalas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasfargeas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayendran, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span> </span><span class="NLM_article-title">Structure Property Relationships of Carboxylic Acid Isosteres</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3183</span><span class="NLM_x">–</span> <span class="NLM_lpage">3203</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3183-3203&author=P.+Lassalasauthor=B.+Gayauthor=C.+Lasfargeasauthor=M.+J.+Jamesauthor=V.+Tranauthor=K.+G.+Vijayendranauthor=K.+R.+Brundenauthor=M.+C.+Kozlowskiauthor=C.+J.+Thomasauthor=A.+B.+Smithauthor=D.+M.+Hurynauthor=C.+Ballatore&title=Structure+Property+Relationships+of+Carboxylic+Acid+Isosteres&doi=10.1021%2Facs.jmedchem.5b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Property Relationships of Carboxylic Acid Isosteres</span></div><div class="casAuthors">Lassalas, Pierrik; Gay, Bryant; Lasfargeas, Caroline; James, Michael J.; Tran, Van; Vijayendran, Krishna G.; Brunden, Kurt R.; Kozlowski, Marisa C.; Thomas, Craig J.; Smith, Amos B.; Huryn, Donna M.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3183-3203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of a carboxylic acid with a surrogate structure, or (bio)-isostere, is a classical strategy in medicinal chem.  The general underlying principle is that by maintaining the features of the carboxylic acid crit. for biol. activity, but appropriately modifying the physicochem. properties, improved analogs may result.  In this context, a systematic assessment of the physicochem. properties of carboxylic acid isosteres would be desirable to enable more informed decisions of potential replacements to be used for analog design.  Herein we report the structure-property relationships (SPR) of 35 phenylpropionic acid derivs., in which the carboxylic acid moiety is replaced with a series of known isosteres.  The data set generated provides an assessment of the relative impact on the physicochem. properties that these replacements may have compared to the carboxylic acid analog.  As such, this study presents a framework for how to rationally apply isosteric replacements of the carboxylic acid functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIF98i2ITNrLVg90H21EOLACvtfcHk0ljAh4uEEu9l_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D&md5=34490fc72fdb321d8c9751bef1bf79c5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01963%26sid%3Dliteratum%253Aachs%26aulast%3DLassalas%26aufirst%3DP.%26aulast%3DGay%26aufirst%3DB.%26aulast%3DLasfargeas%26aufirst%3DC.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DTran%26aufirst%3DV.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DKozlowski%26aufirst%3DM.%2BC.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DStructure%2520Property%2520Relationships%2520of%2520Carboxylic%2520Acid%2520Isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3183%26epage%3D3203%26doi%3D10.1021%2Facs.jmedchem.5b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Hydroxamates: Relationships between Structure and Plasma Stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6790</span><span class="NLM_x">–</span> <span class="NLM_lpage">6802</span><span class="refDoi"> DOI: 10.1021/jm900648x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900648x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6790-6802&author=M.+Flipoauthor=J.+Chartonauthor=A.+Hocineauthor=S.+Dassonnevilleauthor=B.+Deprezauthor=R.+Deprez-Poulain&title=Hydroxamates%3A+Relationships+between+Structure+and+Plasma+Stability&doi=10.1021%2Fjm900648x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamates: Relationships between Structure and Plasma Stability</span></div><div class="casAuthors">Flipo, Marion; Charton, Julie; Hocine, Akila; Dassonneville, Sandrine; Deprez, Benoit; Deprez-Poulain, Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6790-6802</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxamates are valuable tools for chem. biol. as well as interesting leads for medicinal chem.  Although many hydroxamates display nanomolar activities against metalloproteases, only three hydroxamates have reached the market, among which is the HDAC inhibitor vorinostat.  Failures in development are generally attributed to lack of selectivity, toxicity, or poor stability.  To help medicinal chemists with respect to plasma stability, the authors have performed the first and preliminary study on structure-plasma stability for hydroxamates.  The authors define some structural rules to predict or improve the plasma stability in the preclin. stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk66ooWU1NhbVg90H21EOLACvtfcHk0ljAh4uEEu9l_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ&md5=069a87988fbeb68a248d006c7f6307a0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm900648x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900648x%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DHocine%26aufirst%3DA.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DHydroxamates%253A%2520Relationships%2520between%2520Structure%2520and%2520Plasma%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6790%26epage%3D6802%26doi%3D10.1021%2Fjm900648x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Calvo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Canamaque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjornelund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, L. F.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Metabolism, and Excretion of (14)C-Labeled Belinostat in Patients with Recurrent or Progressive Malignancies</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1007/s10637-015-0321-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1007%2Fs10637-015-0321-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=193-201&author=E.+Calvoauthor=G.+Reddyauthor=V.+Boniauthor=L.+Garcia-Canamaqueauthor=T.+Songauthor=J.+Tjornelundauthor=M.+R.+Choiauthor=L.+F.+Allen&title=Pharmacokinetics%2C+Metabolism%2C+and+Excretion+of+%2814%29C-Labeled+Belinostat+in+Patients+with+Recurrent+or+Progressive+Malignancies&doi=10.1007%2Fs10637-015-0321-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10637-015-0321-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-015-0321-8%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo%26aufirst%3DE.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DBoni%26aufirst%3DV.%26aulast%3DGarcia-Canamaque%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DTjornelund%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DM.%2BR.%26aulast%3DAllen%26aufirst%3DL.%2BF.%26atitle%3DPharmacokinetics%252C%2520Metabolism%252C%2520and%2520Excretion%2520of%2520%252814%2529C-Labeled%2520Belinostat%2520in%2520Patients%2520with%2520Recurrent%2520or%2520Progressive%2520Malignancies%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2016%26volume%3D34%26spage%3D193%26epage%3D201%26doi%3D10.1007%2Fs10637-015-0321-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuker, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Nmr-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5628</span><span class="NLM_x">–</span> <span class="NLM_lpage">5639</span><span class="refDoi"> DOI: 10.1021/jm020160g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020160g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5628-5639&author=P.+J.+Hajdukauthor=S.+B.+Shukerauthor=D.+G.+Nettesheimauthor=R.+Craigauthor=D.+J.+Augeriauthor=D.+Betebennerauthor=D.+H.+Albertauthor=Y.+Guoauthor=R.+P.+Meadowsauthor=L.+Xuauthor=M.+Michaelidesauthor=S.+K.+Davidsenauthor=S.+W.+Fesik&title=Nmr-Based+Modification+of+Matrix+Metalloproteinase+Inhibitors+with+Improved+Bioavailability&doi=10.1021%2Fjm020160g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm020160g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020160g%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBetebenner%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMichaelides%26aufirst%3DM.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DNmr-Based%2520Modification%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520with%2520Improved%2520Bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5628%26epage%3D5639%26doi%3D10.1021%2Fjm020160g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, T.</span><span> </span><span class="NLM_article-title">The Emerging Role of Human Esterases</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.2133/dmpk.DMPK-12-RV-042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.2133%2Fdmpk.DMPK-12-RV-042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22813719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVykurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=466-477&author=T.+Fukamiauthor=T.+Yokoi&title=The+Emerging+Role+of+Human+Esterases&doi=10.2133%2Fdmpk.DMPK-12-RV-042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of human esterases</span></div><div class="casAuthors">Fukami, Tatsuki; Yokoi, Tsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-477</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">In this review, novel aspects of the role of esterases, which contribute to the metab. of 10% of therapeutic drugs, are described.  Esterases hydrolyze the compds. that contain ester, amide, and thioester bonds, which cause prodrug activation or detoxification.  Among esterases, carboxylesterases are well known to be involved in the hydrolysis of a variety of drugs.  Addnl., other esterases have recently received attention for their pharmacol. and toxicol. roles.  Arylacetamide deacetylase (AADAC) is involved in the hydrolysis of flutamide, phenacetin, and rifamycins.  AADAC is assocd. with adverse drug reactions because the hydrolytic metabolites of flutamide and phenacetin appear to be assocd. with hepatotoxicity and nephrotoxicity/hematotoxicity, resp.  Paraoxonase and butyrylcholinesterase hydrolyze pirocarpine/simvastatin and succinylcholine/bambuterol, resp.  Although the esterases that hydrolyze the acyl-glucuronides of drugs have largely been unknown, we recently found that α/β hydrolase domain contg. 10 (ABHD10) is responsible for the hydrolysis of mycophenolic acid acyl-glucuronide in human liver.  Because acyl-glucuronides are assocd. with toxicity, ABHD10 might function as a detoxification enzyme.  Thus, various esterases, which include enzymes that have not been known to hydrolyze drugs, are involved in drug metab. with different substrate specificity.  Further esterase studies should be conducted to promote our understanding in clin. pharmacotherapy and drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDhsUJ4NrYQbVg90H21EOLACvtfcHk0liiGANfWoFSTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVykurzE&md5=d760b8a6a3217a4ab9716190800012b0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.DMPK-12-RV-042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.DMPK-12-RV-042%26sid%3Dliteratum%253Aachs%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYokoi%26aufirst%3DT.%26atitle%3DThe%2520Emerging%2520Role%2520of%2520Human%2520Esterases%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2012%26volume%3D27%26spage%3D466%26epage%3D477%26doi%3D10.2133%2Fdmpk.DMPK-12-RV-042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Casey Laizure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witbrodt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. B.</span><span> </span><span class="NLM_article-title">The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1002/phar.1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fphar.1194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=23386599" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=210-222&author=S.+Casey+Laizureauthor=V.+Herringauthor=Z.+Huauthor=K.+Witbrodtauthor=R.+B.+Parker&title=The+Role+of+Human+Carboxylesterases+in+Drug+Metabolism%3A+Have+We+Overlooked+Their+Importance%3F&doi=10.1002%2Fphar.1194"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fphar.1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.1194%26sid%3Dliteratum%253Aachs%26aulast%3DCasey%2BLaizure%26aufirst%3DS.%26aulast%3DHerring%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWitbrodt%26aufirst%3DK.%26aulast%3DParker%26aufirst%3DR.%2BB.%26atitle%3DThe%2520Role%2520of%2520Human%2520Carboxylesterases%2520in%2520Drug%2520Metabolism%253A%2520Have%2520We%2520Overlooked%2520Their%2520Importance%253F%26jtitle%3DPharmacotherapy%26date%3D2013%26volume%3D33%26spage%3D210%26epage%3D222%26doi%3D10.1002%2Fphar.1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hwang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juhasz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodor, N.</span><span> </span><span class="NLM_article-title">Soft Drugs. 12. Design, Synthesis, and Evaluation of Soft Bufuralol Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span><span class="refDoi"> DOI: 10.1021/jm9904654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9904654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1525-1532&author=S.-K.+Hwangauthor=A.+Juhaszauthor=S.-H.+Yoonauthor=N.+Bodor&title=Soft+Drugs.+12.+Design%2C+Synthesis%2C+and+Evaluation+of+Soft+Bufuralol+Analogues&doi=10.1021%2Fjm9904654"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm9904654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904654%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.-K.%26aulast%3DJuhasz%26aufirst%3DA.%26aulast%3DYoon%26aufirst%3DS.-H.%26aulast%3DBodor%26aufirst%3DN.%26atitle%3DSoft%2520Drugs.%252012.%2520Design%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Soft%2520Bufuralol%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1525%26epage%3D1532%26doi%3D10.1021%2Fjm9904654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Boland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraets, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeders, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castermans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanormelingen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stassen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defert, O.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft Rock Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4309</span><span class="NLM_x">–</span> <span class="NLM_lpage">4324</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00308</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00308" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4309-4324&author=S.+Bolandauthor=A.+Bourinauthor=J.+Alenauthor=J.+Geraetsauthor=P.+Schroedersauthor=K.+Castermansauthor=N.+Kindtauthor=N.+Boumansauthor=L.+Panittiauthor=S.+Fransenauthor=J.+Vanormelingenauthor=J.+M.+Stassenauthor=D.+Leysenauthor=O.+Defert&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel%2C+Highly+Active+Soft+Rock+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors</span></div><div class="casAuthors">Boland, Sandro; Bourin, Arnaud; Alen, Jo; Geraets, Jacques; Schroeders, Pieter; Castermans, Karolien; Kindt, Nele; Boumans, Nicki; Panitti, Laura; Fransen, Silke; Vanormelingen, Jessica; Stassen, Jean Marie; Leysen, Dirk; Defert, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4309-4324</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ROCK1 and ROCK2 play important roles in numerous cellular functions, including smooth muscle cell contraction, cell proliferation, adhesion, and migration.  Consequently, ROCK inhibitors are of interest for treating multiple indications including cardiovascular diseases, inflammatory and autoimmune diseases, lung diseases, and eye diseases.  However, systemic inhibition of ROCK is expected to result in significant side effects.  Strategies allowing reduced systemic exposure are therefore of interest.  In a continuing effort toward identification of ROCK inhibitors, we here report the design, synthesis, and evaluation of novel soft ROCK inhibitors displaying an ester function allowing their rapid inactivation in the systemic circulation.  Those compds., e.g. I, display subnanomolar activity against ROCK and strong differences of functional activity between parent compds. and expected metabolites.  The binding mode of a representative compd. was detd. exptl. in a single-crystal X-ray diffraction study.  Enzymes responsible for inactivation of these compds. once they enter systemic circulation are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWI5LwOkT64rVg90H21EOLACvtfcHk0liiGANfWoFSTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D&md5=320e6fbb1cf87ba8c03fc17795f6802f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00308%26sid%3Dliteratum%253Aachs%26aulast%3DBoland%26aufirst%3DS.%26aulast%3DBourin%26aufirst%3DA.%26aulast%3DAlen%26aufirst%3DJ.%26aulast%3DGeraets%26aufirst%3DJ.%26aulast%3DSchroeders%26aufirst%3DP.%26aulast%3DCastermans%26aufirst%3DK.%26aulast%3DKindt%26aufirst%3DN.%26aulast%3DBoumans%26aufirst%3DN.%26aulast%3DPanitti%26aufirst%3DL.%26aulast%3DFransen%26aufirst%3DS.%26aulast%3DVanormelingen%26aufirst%3DJ.%26aulast%3DStassen%26aufirst%3DJ.%2BM.%26aulast%3DLeysen%26aufirst%3DD.%26aulast%3DDefert%26aufirst%3DO.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%252C%2520Highly%2520Active%2520Soft%2520Rock%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4309%26epage%3D4324%26doi%3D10.1021%2Facs.jmedchem.5b00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lockridge, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydess, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoryan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopfer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichs, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, P.</span><span> </span><span class="NLM_article-title">Pseudo-Esterase Activity of Human Albumin: Slow Turnover on Tyrosine 411 and Stable Acetylation of 82 Residues Including 59 Lysines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">22582</span><span class="NLM_x">–</span> <span class="NLM_lpage">22590</span><span class="refDoi"> DOI: 10.1074/jbc.M802555200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1074%2Fjbc.M802555200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=18577514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVKmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22582-22590&author=O.+Lockridgeauthor=W.+Xueauthor=A.+Gaydessauthor=H.+Grigoryanauthor=S.+J.+Dingauthor=L.+M.+Schopferauthor=S.+H.+Hinrichsauthor=P.+Masson&title=Pseudo-Esterase+Activity+of+Human+Albumin%3A+Slow+Turnover+on+Tyrosine+411+and+Stable+Acetylation+of+82+Residues+Including+59+Lysines&doi=10.1074%2Fjbc.M802555200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudo-esterase Activity of Human Albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines</span></div><div class="casAuthors">Lockridge, Oksana; Xue, Weihua; Gaydess, Andrea; Grigoryan, Hasmik; Ding, Shi-Jian; Schopfer, Lawrence M.; Hinrichs, Steven H.; Masson, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">22582-22590</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human albumin is thought to hydrolyze esters because multiple equiv. of product are formed for each equiv. of albumin.  Esterase activity with p-nitrophenyl acetate has been attributed to turnover at tyrosine 411.  However, p-nitrophenyl acetate creates multiple, stable, acetylated adducts, a property contrary to turnover.  Our goal was to identify residues that become acetylated by p-nitrophenyl acetate and det. the relationship between stable adduct formation and turnover.  Fatty acid-free human albumin was treated with 0.5 mM p-nitrophenyl acetate for 5 min to 2 wk, or with 10 mM p-nitrophenyl acetate for 48 h to 2 wk.  Aliquots were digested with pepsin, trypsin, or GluC and analyzed by mass spectrometry to identify labeled residues.  Only Tyr-411 was acetylated within the first 5 min of reaction with 0.5 mM p-nitrophenyl acetate.  After 0.5-6 h there was partial acetylation of 16-17 residues including Asp-1, Lys-4, Lys-12, Tyr-411, Lys-413, and Lys-414.  Treatment with 10 mM p-nitrophenyl acetate resulted in acetylation of 59 lysines, 10 serines, 8 threonines, 4 tyrosines, and Asp-1.  When Tyr-411 was blocked with diisopropylfluorophosphate or chlorpyrifos oxon, albumin had normal esterase activity with β-naphthyl acetate as visualized on a nondenaturing gel.  However, after 82 residues had been acetylated, esterase activity was almost completely inhibited.  The half-life for deacetylation of Tyr-411 at pH 8.0, 22 °C was 61 ± 4 h.  Acetylated lysines formed adducts that were even more stable.  In conclusion, the pseudo-esterase activity of albumin is the result of irreversible acetylation of 82 residues and is not the result of turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpopadUHptJXLVg90H21EOLACvtfcHk0lj-xFLCZJ2hfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVKmsLc%253D&md5=97593568c831b73aebcadd75c7f7ca61</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802555200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802555200%26sid%3Dliteratum%253Aachs%26aulast%3DLockridge%26aufirst%3DO.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DGaydess%26aufirst%3DA.%26aulast%3DGrigoryan%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DS.%2BJ.%26aulast%3DSchopfer%26aufirst%3DL.%2BM.%26aulast%3DHinrichs%26aufirst%3DS.%2BH.%26aulast%3DMasson%26aufirst%3DP.%26atitle%3DPseudo-Esterase%2520Activity%2520of%2520Human%2520Albumin%253A%2520Slow%2520Turnover%2520on%2520Tyrosine%2520411%2520and%2520Stable%2520Acetylation%2520of%252082%2520Residues%2520Including%252059%2520Lysines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D22582%26epage%3D22590%26doi%3D10.1074%2Fjbc.M802555200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidukov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumshtein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khersonsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meged, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfik, D. S.</span><span> </span><span class="NLM_article-title">Structure and Evolution of the Serum Paraoxonase Family of Detoxifying and Anti-Atherosclerotic Enzymes</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1038/nsmb767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fnsmb767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=15098021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=412-419&author=M.+Harelauthor=A.+Aharoniauthor=L.+Gaidukovauthor=B.+Brumshteinauthor=O.+Khersonskyauthor=R.+Megedauthor=H.+Dvirauthor=R.+B.+Ravelliauthor=A.+McCarthyauthor=L.+Tokerauthor=I.+Silmanauthor=J.+L.+Sussmanauthor=D.+S.+Tawfik&title=Structure+and+Evolution+of+the+Serum+Paraoxonase+Family+of+Detoxifying+and+Anti-Atherosclerotic+Enzymes&doi=10.1038%2Fnsmb767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes</span></div><div class="casAuthors">Harel, Michal; Aharoni, Amir; Gaidukov, Leonid; Brumshtein, Boris; Khersonsky, Olga; Meged, Ran; Dvir, Hay; Ravelli, Raimond B. G.; McCarthy, Andrew; Toker, Lilly; Silman, Israel; Sussman, Joel L.; Tawfik, Dan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the serum paraoxonase (PON) family have been identified in mammals and other vertebrates, and in invertebrates.  PONs exhibit a wide range of physiol. important hydrolytic activities, including drug metab. and detoxification of nerve agents.  PON1 and PON3 reside on high-d. lipoprotein (HDL; 'good cholesterol') and are involved in the prevention of atherosclerosis.  Here, the authors describe the 1st crystal structure of a PON family member, a variant of PON1 obtained by directed evolution, at a resoln. of 2.2 Å.  Recombinant PON1 variant G2E6 was found to be a 6-bladed β-propeller with a unique active site lid that was also involved in HDL binding.  The 3-dimensional structure and directed evolution studies permitted a detailed description of PON1's active site and catalytic mechanism, which were reminiscent of secreted phospholipase A2, and of the routes by which PON family members diverged toward different substrate and reaction selectivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI851cIlyl0rVg90H21EOLACvtfcHk0lj-xFLCZJ2hfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsLg%253D&md5=778fdefc4c131aea944aca577d7bf159</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnsmb767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb767%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DAharoni%26aufirst%3DA.%26aulast%3DGaidukov%26aufirst%3DL.%26aulast%3DBrumshtein%26aufirst%3DB.%26aulast%3DKhersonsky%26aufirst%3DO.%26aulast%3DMeged%26aufirst%3DR.%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DToker%26aufirst%3DL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DTawfik%26aufirst%3DD.%2BS.%26atitle%3DStructure%2520and%2520Evolution%2520of%2520the%2520Serum%2520Paraoxonase%2520Family%2520of%2520Detoxifying%2520and%2520Anti-Atherosclerotic%2520Enzymes%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D412%26epage%3D419%26doi%3D10.1038%2Fnsmb767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Montella, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valle, D.</span><span> </span><span class="NLM_article-title">The Classification of Esterases: An Important Gene Family Involved in Insecticide Resistance--a Review</span> <span class="citation_source-journal">Mem. Inst. Oswaldo Cruz</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1590/S0074-02762012000400001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1590%2FS0074-02762012000400001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22666852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=437-449&author=I.+R.+Montellaauthor=R.+Schamaauthor=D.+Valle&title=The+Classification+of+Esterases%3A+An+Important+Gene+Family+Involved+in+Insecticide+Resistance%2D%2Da+Review&doi=10.1590%2FS0074-02762012000400001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The classification of esterases: an important gene family involved in insecticide resistance - a review</span></div><div class="casAuthors">Montella, Isabela Reis; Schama, Renata; Valle, Denise</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">437-449</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">0074-0276</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">A review.  The use of chem. insecticides continues to play a major role in the control of disease vector populations, which is leading to the global dissemination of insecticide resistance.  A greater capacity to detoxify insecticides, due to an increase in the expression or activity of three major enzyme families, also known as metabolic resistance, is one major resistance mechanisms.  The esterase family of enzymes hydrolyze ester bonds, which are present in a wide range of insecticides; therefore, these enzymes may be involved in resistance to the main chems. employed in control programs.  Historically, insecticide resistance has driven research on insect esterases and schemes for their classification.  Currently, several different nomenclatures are used to describe the esterases of distinct species and a universal std. classification does not exist.  The esterase gene family appears to be rapidly evolving and each insect species has a unique complement of detoxification genes with only a few orthologues across species.  The examples listed in this review cover different aspects of their biochem. nature.  However, they do not appear to contribute to reliably distinguish among the different resistance mechanisms.  Presently, the phylogenetic criterion appears to be the best one for esterase classification.  Joint genomic, biochem. and microarray studies will help unravel the classification of this complex gene family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhxRPi8xpbrVg90H21EOLACvtfcHk0lj-xFLCZJ2hfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtb8%253D&md5=b6dafff05a03c35318ede9c9aec48652</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1590%2FS0074-02762012000400001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0074-02762012000400001%26sid%3Dliteratum%253Aachs%26aulast%3DMontella%26aufirst%3DI.%2BR.%26aulast%3DSchama%26aufirst%3DR.%26aulast%3DValle%26aufirst%3DD.%26atitle%3DThe%2520Classification%2520of%2520Esterases%253A%2520An%2520Important%2520Gene%2520Family%2520Involved%2520in%2520Insecticide%2520Resistance--a%2520Review%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2012%26volume%3D107%26spage%3D437%26epage%3D449%26doi%3D10.1590%2FS0074-02762012000400001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Yamaori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isobe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span> </span><span class="NLM_article-title">Involvement of Human Blood Arylesterases and Liver Microsomal Carboxylesterases in Nafamostat Hydrolysis</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.2133/dmpk.21.147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.2133%2Fdmpk.21.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16702735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1aku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=147-155&author=S.+Yamaoriauthor=N.+Fujiyamaauthor=M.+Kushiharaauthor=T.+Funahashiauthor=T.+Kimuraauthor=I.+Yamamotoauthor=T.+Soneauthor=M.+Isobeauthor=T.+Ohshimaauthor=K.+Matsumuraauthor=M.+Odaauthor=K.+Watanabe&title=Involvement+of+Human+Blood+Arylesterases+and+Liver+Microsomal+Carboxylesterases+in+Nafamostat+Hydrolysis&doi=10.2133%2Fdmpk.21.147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis</span></div><div class="casAuthors">Yamaori, Satoshi; Fujiyama, Nobuhiro; Kushihara, Mika; Funahashi, Tatsuya; Kimura, Toshiyuki; Yamamoto, Ikuo; Sone, Tomomichi; Isobe, Masakazu; Ohshima, Tohru; Matsumura, Kenji; Oda, Minoru; Watanabe, Kazuhito</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">Metab. of nafamostat, a clin. used serine protease inhibitor, was investigated with human blood and liver enzyme sources.  All the enzyme sources examd. (whole blood, erythrocytes, plasma and liver microsomes) showed nafamostat hydrolytic activity.  Vmax and Km values for the nafamostat hydrolysis in erythrocytes were 278 nmol/min/mL blood fraction and 628 μM; those in plasma were 160 nmol/min/mL blood fraction and 8890 μM, resp.  Human liver microsomes exhibited a Vmax value of 26.9 nmol/min/mg protein and a Km value of 1790 μM.  Hydrolytic activity of the erythrocytes and plasma was inhibited by 5, 5'-dithiobis(2-nitrobenzoic acid), an arylesterase inhibitor, in a concn.-dependent manner.  In contrast, little or no suppression of these activities was seen with phenylmethylsulfonyl fluoride (PMSF), diisopropyl fluorophosphate (DFP), bis(p-nitrophenyl)phosphate (BNPP), BW284C51 and ethopropazine.  The liver microsomal activity was markedly inhibited by PMSF, DFP and BNPP, indicating that carboxylesterase was involved in the nafamostat hydrolysis.  Human carboxylesterase 2 expressed in COS-1 cells was capable of hydrolyzing nafamostat at 10 and 100 μM, whereas recombinant carboxylesterase 1 showed significant activity only at a higher substrate concn. (100 μM).  The nafamostat hydrolysis in 18 human liver microsomes correlated with aspirin hydrolytic activity specific for carboxylesterase 2 (r = 0.815, p < 0.01) but not with imidapril hydrolysis catalyzed by carboxylesterase 1 (r = 0.156, p = 0.54).  These results suggest that human arylesterases and carboxylesterase 2 may be predominantly responsible for the metab. of nafamostat in the blood and liver, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeRbZxBkGzbrVg90H21EOLACvtfcHk0ljx9_N_3GtplA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1aku7g%253D&md5=92bfd97d95143f7631cb2719264bfcf5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.147%26sid%3Dliteratum%253Aachs%26aulast%3DYamaori%26aufirst%3DS.%26aulast%3DFujiyama%26aufirst%3DN.%26aulast%3DKushihara%26aufirst%3DM.%26aulast%3DFunahashi%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DI.%26aulast%3DSone%26aufirst%3DT.%26aulast%3DIsobe%26aufirst%3DM.%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520Human%2520Blood%2520Arylesterases%2520and%2520Liver%2520Microsomal%2520Carboxylesterases%2520in%2520Nafamostat%2520Hydrolysis%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D147%26epage%3D155%26doi%3D10.2133%2Fdmpk.21.147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ronco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foucault, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.-Y.</span><span> </span><span class="NLM_article-title">New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span><span class="refDoi"> DOI: 10.1002/cmdc.201000523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fcmdc.201000523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=21344648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=876-888&author=C.+Roncoauthor=R.+Foucaultauthor=E.+Gillonauthor=P.+Bohnauthor=F.+Nachonauthor=L.+Jeanauthor=P.-Y.+Renard&title=New+Huprine+Derivatives+Functionalized+at+Position+9+as+Highly+Potent+Acetylcholinesterase+Inhibitors&doi=10.1002%2Fcmdc.201000523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors</span></div><div class="casAuthors">Ronco, Cyril; Foucault, Richard; Gillon, Emilie; Bohn, Pierre; Nachon, Florian; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">876-888</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of 24 huprine derivs. diversely functionalized at position 9 have been synthesized and evaluated for their inhibitory activity against human recombinant acetylcholinesterase (AChE).  These derivs. were prepd. in one to five steps from huprine 1 bearing an ester function at position 9.  Ten analogs (1, 2, 6-9, 13-15, and 23) are active in the low nanomolar range (IC50 <5 nM), very close to the parent compd. huprine X.  Compds. 2, 6, and 7 show a very good selectivity for AChE, with AChE inhibitory activities 700-1160-fold higher than those for butyrylcholinesterase (BChE).  The inhibitory potency of these compds. decreases with the steric bulk of the substituents at position 9.  According to docking simulations, small substituents fit into the acyl-binding pocket, whereas the larger ones stick out of the active site gorge of AChE.  Detn. of the kinetic parameters of three of the most potent huprines (2, 6, and 7) showed that most of the difference in KD is accounted by a decrease in kon, which is correlated to the increase of the substituent size.  A first in vivo evaluation has been performed in mice for the most active compd. 2 (I, IC50=1.1 nM) and showed a rather weak toxicity (LD50=40 mg kg-1) and an ability to cross the blood-brain barrier with doses above 15 mg kg-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJUII0bHstbVg90H21EOLACvtfcHk0ljx9_N_3GtplA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D&md5=bea8949ab5693c5698a106965160688f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000523%26sid%3Dliteratum%253Aachs%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DFoucault%26aufirst%3DR.%26aulast%3DGillon%26aufirst%3DE.%26aulast%3DBohn%26aufirst%3DP.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DNew%2520Huprine%2520Derivatives%2520Functionalized%2520at%2520Position%25209%2520as%2520Highly%2520Potent%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D876%26epage%3D888%26doi%3D10.1002%2Fcmdc.201000523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Imai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span> </span><span class="NLM_article-title">Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1734</span><span class="NLM_x">–</span> <span class="NLM_lpage">1741</span><span class="refDoi"> DOI: 10.1124/dmd.106.009381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1124%2Fdmd.106.009381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16837570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1734-1741&author=T.+Imaiauthor=M.+Taketaniauthor=M.+Shiiauthor=M.+Hosokawaauthor=K.+Chiba&title=Substrate+Specificity+of+Carboxylesterase+Isozymes+and+Their+Contribution+to+Hydrolase+Activity+in+Human+Liver+and+Small+Intestine&doi=10.1124%2Fdmd.106.009381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine</span></div><div class="casAuthors">Imai, Teruko; Taketani, Megumi; Shii, Mayumi; Hosokawa, Masakiyo; Chiba, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1734-1741</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Hydrolase activity from human liver and small intestine microsomes was compared with that of recombinant human carboxylesterases, hCE-1 and hCE-2.  Although both hCE-1 and hCE-2 are present in human liver, the dominant component was found to be hCE-1, whereas the hydrolase activity of the human small intestine was found to be predominantly hCE-2.  HCE-2 has a limited ability to hydrolyze large acyl compd. substrates.  Interestingly, propranolol derivs., good substrates for hCE-2, were easily hydrolyzed by substitution of the Me group on the 2-position of the acyl moiety, but were barely hydrolyzed when the Me group was substituted on the 3-position.  These findings suggest that hCE-2 does not easily form acylated intermediates because of conformational interference in its active site.  In contrast, hCE-1 could hydrolyze a variety of substrates.  The hydrolytic activity of hCE-2 increased with increasing alc. chain length in benzoic acid deriv. substrates, whereas hCE-1 preferentially catalyzed the hydrolysis of substrates with short alc. chains.  Kinetic data showed that the detg. factor for the rate of hydrolysis of p-aminobenzoic acid esters was Vmax for hCE-1 and Km for hCE-2.  Furthermore, the addn. of hydrophobic alcs. to the reaction mixt. with p-aminobenzoic acid Pr ester induced high and low levels of transesterification by hCE-1 and hCE-2, resp.  When considering the substrate specificities of hCE-1, it is necessary to consider the transesterification ability of hCE-1, in addn. to the binding structure of the substrate in the active site of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_5Qby7_S88LVg90H21EOLACvtfcHk0ljx9_N_3GtplA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI&md5=b2d3c1d2aee89b647e1c8030daee8c3a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.009381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.009381%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26aulast%3DTaketani%26aufirst%3DM.%26aulast%3DShii%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26atitle%3DSubstrate%2520Specificity%2520of%2520Carboxylesterase%2520Isozymes%2520and%2520Their%2520Contribution%2520to%2520Hydrolase%2520Activity%2520in%2520Human%2520Liver%2520and%2520Small%2520Intestine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1734%26epage%3D1741%26doi%3D10.1124%2Fdmd.106.009381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Minagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, A.</span><span> </span><span class="NLM_article-title">Species Differences in Hydrolysis of Isocarbacyclin Methyl Ester (Tei-9090) by Blood Esterases</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.1016/0006-2952(95)00071-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2F0006-2952%2895%2900071-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=1361-1365&author=T.+Minagawaauthor=Y.+Kohnoauthor=T.+Suwaauthor=A.+Tsuji&title=Species+Differences+in+Hydrolysis+of+Isocarbacyclin+Methyl+Ester+%28Tei-9090%29+by+Blood+Esterases&doi=10.1016%2F0006-2952%2895%2900071-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2900071-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252900071-7%26sid%3Dliteratum%253Aachs%26aulast%3DMinagawa%26aufirst%3DT.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DSuwa%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DA.%26atitle%3DSpecies%2520Differences%2520in%2520Hydrolysis%2520of%2520Isocarbacyclin%2520Methyl%2520Ester%2520%2528Tei-9090%2529%2520by%2520Blood%2520Esterases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26spage%3D1361%26epage%3D1365%26doi%3D10.1016%2F0006-2952%2895%2900071-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Rudakova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boltneva, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhaeva, G. F.</span><span> </span><span class="NLM_article-title">Comparative Analysis of Esterase Activities of Human, Mouse, and Rat Blood</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1007/s10517-011-1457-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1007%2Fs10517-011-1457-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22803044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=73-75&author=E.+V.+Rudakovaauthor=N.+P.+Boltnevaauthor=G.+F.+Makhaeva&title=Comparative+Analysis+of+Esterase+Activities+of+Human%2C+Mouse%2C+and+Rat+Blood&doi=10.1007%2Fs10517-011-1457-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Analysis of Esterase Activities of Human, Mouse, and Rat Blood</span></div><div class="casAuthors">Rudakova, E. V.; Boltneva, N. P.; Makhaeva, G. F.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-75</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acetylcholinesterase, butyrylcholinesterase, carboxylesterase, and paraoxonase activities in human, mouse, and rat blood were measured.  The proportions of these enzymes activities differed significantly.  In humans, the most significant were cholinesterase activities, while in rats and mice the contribution of carboxylesterase activity was the greatest.  High arylesterase activity of paraoxonase was obsd. in all cases.  Species-specific differences should be taken into consideration when carrying out preclin. trials on rodents for optimization of the pharmacokinetic characteristics of drugs contg. complex ester groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomojhlePQlNbVg90H21EOLACvtfcHk0lhxDhzTXnA2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylu7vJ&md5=9cf56c1d6ef8aab2ce15ae47f30f30b0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10517-011-1457-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10517-011-1457-y%26sid%3Dliteratum%253Aachs%26aulast%3DRudakova%26aufirst%3DE.%2BV.%26aulast%3DBoltneva%26aufirst%3DN.%2BP.%26aulast%3DMakhaeva%26aufirst%3DG.%2BF.%26atitle%3DComparative%2520Analysis%2520of%2520Esterase%2520Activities%2520of%2520Human%252C%2520Mouse%252C%2520and%2520Rat%2520Blood%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2011%26volume%3D152%26spage%3D73%26epage%3D75%26doi%3D10.1007%2Fs10517-011-1457-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Bahar, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, T.</span><span> </span><span class="NLM_article-title">Species Difference of Esterase Expression and Hydrolase Activity in Plasma</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">3979</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span><span class="refDoi"> DOI: 10.1002/jps.23258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fjps.23258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22833171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=3979-3988&author=F.+G.+Baharauthor=K.+Ohuraauthor=T.+Ogiharaauthor=T.+Imai&title=Species+Difference+of+Esterase+Expression+and+Hydrolase+Activity+in+Plasma&doi=10.1002%2Fjps.23258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Species difference of esterase expression and hydrolase activity in plasma</span></div><div class="casAuthors">Bahar, Fatma Goksin; Ohura, Kayoko; Ogihara, Takuo; Imai, Teruko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3979-3988</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Differences in esterase expression among human, rhesus monkey, cynomolgus monkey, dog, minipig, rabbit, rat, and mouse plasma were identified using native polyacrylamide gel electrophoresis.  Paraoxonase (PON) and butyrylcholinesterase (BChE) were ubiquitous in all species, but were highly expressed in primates and dogs, whereas carboxylesterase (CES) was only abundant in rabbits, mice, and rats.  Several unknown esterases were obsd. in minipig and mouse plasma.  These differences in plasma esterases and their expression levels result in species differences with respect to hydrolase activity.  These differences were characterized using several different substrates.  In contrast to the high hydrolase activity found for p-nitrophenylacetate (PNPA), a substrate of several hydrolase enzymes, irinotecan, a carbamate compd., was resistant to all plasma esterases.  Oseltamivir, temocapril, and propranolol (PL) derivs. were rapidly hydrolyzed in mouse and rat plasma by their highly active CES enzyme, but rabbit plasma CES hydrolyzed only the PL derivs.  Interestingly, PL derivs. were highly hydrolyzed by monkey plasma BChE, whereas BChE from human, dog, and minipig plasma showed negligible activity.  In conclusion, the esterase expression and hydrolyzing pattern of dog plasma were found to be closest to that of human plasma.  These differences should be considered when selecting model animals for preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIjepKzp5aYLVg90H21EOLACvtfcHk0lhxDhzTXnA2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L&md5=6ec3b10b30a3ab7071a426eadb993a11</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjps.23258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23258%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DF.%2BG.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DSpecies%2520Difference%2520of%2520Esterase%2520Expression%2520and%2520Hydrolase%2520Activity%2520in%2520Plasma%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D3979%26epage%3D3988%26doi%3D10.1002%2Fjps.23258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hosokawa, M.</span><span> </span><span class="NLM_article-title">Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.3390/molecules13020412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.3390%2Fmolecules13020412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=18305428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=412-431&author=M.+Hosokawa&title=Structure+and+Catalytic+Properties+of+Carboxylesterase+Isozymes+Involved+in+Metabolic+Activation+of+Prodrugs&doi=10.3390%2Fmolecules13020412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs</span></div><div class="casAuthors">Hosokawa, Masakiyo</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">412-431</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Mammalian carboxylesterases (CESs) comprise a multigene family whose gene products play important roles in biotransformation of ester- or amide-type prodrugs.  They are members of an α,β-hydrolase-fold family and are found in various mammals.  It has been suggested that CESs can be classified into 5 major groups denominated CES1-CES5, according to the homol. of the amino acid sequence, and the majority of CESs that have been identified belong to the CES1 or CES2 family.  The substrate specificities of CES1 and CES2 are significantly different.  The CES1 isoenzyme mainly hydrolyzes a substrate with a small alc. group and large acyl group, but its wide active site pocket sometimes allows it to act on structurally distinct compds. of either a large or small alc. moiety.  In contrast, the CES2 isoenzyme recognizes a substrate with a large alc. group and small acyl group, and its substrate specificity may be restricted by the capability of acyl-enzyme conjugate formation due to the presence of conformational interference in the active pocket.  Since pharmacokinetic and pharmacol. data for prodrugs obtained from preclin. expts. using various animals are generally used as refs. for human studies, it is important to clarify the biochem. properties of CES isoenzymes.  Further experimentation for an understanding of detailed substrate specificity of prodrugs for CES isoenzymes and its hydrolyzates will help researchers to design the ideal prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouTX8xLu6R1rVg90H21EOLACvtfcHk0lhxDhzTXnA2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D&md5=2737ed528ff2b616b7d256ad01b5c1d1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13020412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13020412%26sid%3Dliteratum%253Aachs%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DStructure%2520and%2520Catalytic%2520Properties%2520of%2520Carboxylesterase%2520Isozymes%2520Involved%2520in%2520Metabolic%2520Activation%2520of%2520Prodrugs%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D412%26epage%3D431%26doi%3D10.3390%2Fmolecules13020412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlacek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoharan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boopathy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duysen, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockridge, O.</span><span> </span><span class="NLM_article-title">Butyrylcholinesterase, Paraoxonase, and Albumin Esterase, but Not Carboxylesterase, Are Present in Human Plasma</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span><span class="refDoi"> DOI: 10.1016/j.bcp.2005.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bcp.2005.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16213467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=1673-1684&author=B.+Liauthor=M.+Sedlacekauthor=I.+Manoharanauthor=R.+Boopathyauthor=E.+G.+Duysenauthor=P.+Massonauthor=O.+Lockridge&title=Butyrylcholinesterase%2C+Paraoxonase%2C+and+Albumin+Esterase%2C+but+Not+Carboxylesterase%2C+Are+Present+in+Human+Plasma&doi=10.1016%2Fj.bcp.2005.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma</span></div><div class="casAuthors">Li, Bin; Sedlacek, Meghan; Manoharan, Indumathi; Boopathy, Rathnam; Duysen, Ellen G.; Masson, Patrick; Lockridge, Oksana</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1673-1684</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The goal of this work was to identify the esterases in human plasma and to clarify common misconceptions.  The method for identifying esterases was nondenaturing gradient gel electrophoresis stained for esterase activity.  We report that human plasma contains four esterases: butyrylcholinesterase (E.C. 3.1.1.8), paraoxonase (E.C. 3.1.8.1), acetylcholinesterase (E.C. 3.1.1.7), and albumin.  Butyrylcholinesterase (BChE), paraoxonase (PON1), and albumin are in high enough concns. to contribute significantly to ester hydrolysis.  However, only trace amts. of acetylcholinesterase (AChE) are present.  Monomeric AChE is seen in wild-type as well as in silent BChE plasma.  Albumin has esterase activity with alpha- and beta-naphthylacetate as well as with p-nitrophenyl acetate.  Misconception #1 is that human plasma contains carboxylesterase.  We demonstrate that human plasma contains no carboxylesterase (E.C. 3.1.1.1), in contrast to mouse, rat, rabbit, horse, cat, and tiger that have high amts. of plasma carboxylesterase.  Misconception #2 is that lab. animals have BChE but no AChE in their plasma.  We demonstrate that mice, unlike humans, have substantial amts. of sol. AChE as well as BChE in their plasma.  Plasma from AChE and BChE knockout mice allowed identification of AChE and BChE bands without the use of inhibitors.  Human BChE is irreversibly inhibited by diisopropylfluorophosphate, echothiophate, and paraoxon, but mouse BChE spontaneously reactivates.  Since human plasma contains no carboxylesterase, only BChE, PON1, and albumin esterases need to be considered when evaluating hydrolysis of an ester drug in human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobFY6T-ENpA7Vg90H21EOLACvtfcHk0lh7sJYuY7nq8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLzJ&md5=d9d557d16e4e43d82f1c2d391dc3ac89</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DSedlacek%26aufirst%3DM.%26aulast%3DManoharan%26aufirst%3DI.%26aulast%3DBoopathy%26aufirst%3DR.%26aulast%3DDuysen%26aufirst%3DE.%2BG.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DLockridge%26aufirst%3DO.%26atitle%3DButyrylcholinesterase%252C%2520Paraoxonase%252C%2520and%2520Albumin%2520Esterase%252C%2520but%2520Not%2520Carboxylesterase%252C%2520Are%2520Present%2520in%2520Human%2520Plasma%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D1673%26epage%3D1684%26doi%3D10.1016%2Fj.bcp.2005.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Meshorer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soreq, H.</span><span> </span><span class="NLM_article-title">Virtues and Woes of Ache Alternative Splicing in Stress-Related Neuropathologies</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1016/j.tins.2006.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.tins.2006.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=216-224&author=E.+Meshorerauthor=H.+Soreq&title=Virtues+and+Woes+of+Ache+Alternative+Splicing+in+Stress-Related+Neuropathologies&doi=10.1016%2Fj.tins.2006.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2006.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2006.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DMeshorer%26aufirst%3DE.%26aulast%3DSoreq%26aufirst%3DH.%26atitle%3DVirtues%2520and%2520Woes%2520of%2520Ache%2520Alternative%2520Splicing%2520in%2520Stress-Related%2520Neuropathologies%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D216%26epage%3D224%26doi%3D10.1016%2Fj.tins.2006.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Polasek, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doogue, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miners, J. O.</span><span> </span><span class="NLM_article-title">Metabolic Activation of Clopidogrel: In Vitro Data Provide Conflicting Evidence for the Contributions of Cyp2c19 and Pon1</span> <span class="citation_source-journal">Ther. Adv. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1177/2042098611422559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1177%2F2042098611422559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25083217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A280%3ADC%252BC2cbotVGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=253-261&author=T.+M.+Polasekauthor=M.+P.+Doogueauthor=J.+O.+Miners&title=Metabolic+Activation+of+Clopidogrel%3A+In+Vitro+Data+Provide+Conflicting+Evidence+for+the+Contributions+of+Cyp2c19+and+Pon1&doi=10.1177%2F2042098611422559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1</span></div><div class="casAuthors">Polasek Thomas M; Doogue Matthew P; Miners John O</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic advances in drug safety</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">253-61</span>
        ISSN:<span class="NLM_cas:issn">2042-0986</span>.
    </div><div class="casAbstract">The recent report that clopidogrel efficacy may be more dependent on paraoxonase-1 (PON1) than on cytochrome P450 2C19 (CYP2C19) activity raises questions about the roles of these and other enzymes in clopidogrel activation.  To provide insight into the emerging PON1 versus CYP2C19 debate, this commentary summarizes the clinical evidence on the pharmacokinetic determinants of clopidogrel efficacy.  We then review the in vitro studies investigating the enzymes involved in clopidogrel activation, and comment on their strengths and limitations.  There is agreement amongst in vitro studies regarding the involvement of CYP1A2 and CYP2B6 in the metabolism of clopidogrel to 2-oxo-clopidogrel.  However, the evidence for other CYP enzymes in the first activation step (e.g.  CYP2C19 and CYP3A4) is inconsistent and dependent on the in vitro test system and laboratory.  All major drug metabolizing CYP enzymes are capable of converting 2-oxo-clopidogrel to sulfenic acid intermediates that subsequently form the active thiol metabolite.  However, the extent of CYP involvement in this second step has been challenged, and new evidence suggests that CYP-independent hydrolytic cleavage of the thioester bond may be more important than oxidative metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaXk-rgHeYvQWRJ3OJdH_qfW6udTcc2eZldixewSlnsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbotVGktQ%253D%253D&md5=c060df10c5002350d5a7b6867d04241a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1177%2F2042098611422559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2042098611422559%26sid%3Dliteratum%253Aachs%26aulast%3DPolasek%26aufirst%3DT.%2BM.%26aulast%3DDoogue%26aufirst%3DM.%2BP.%26aulast%3DMiners%26aufirst%3DJ.%2BO.%26atitle%3DMetabolic%2520Activation%2520of%2520Clopidogrel%253A%2520In%2520Vitro%2520Data%2520Provide%2520Conflicting%2520Evidence%2520for%2520the%2520Contributions%2520of%2520Cyp2c19%2520and%2520Pon1%26jtitle%3DTher.%2520Adv.%2520Drug%2520Saf.%26date%3D2011%26volume%3D2%26spage%3D253%26epage%3D261%26doi%3D10.1177%2F2042098611422559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Eng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niosi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simila, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Utility of the Carboxylesterase Inhibitor Bis-Para-Nitrophenylphosphate (Bnpp) in the Plasma Unbound Fraction Determination for a Hydrolytically Unstable Amide Derivative and Agonist of the Tgr5 Receptor</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span><span class="refDoi"> DOI: 10.3109/00498251003706598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.3109%2F00498251003706598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=20297923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVGksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=369-380&author=H.+Engauthor=M.+Niosiauthor=T.+S.+McDonaldauthor=A.+Wolfordauthor=Y.+Chenauthor=S.+T.+Similaauthor=J.+N.+Baumanauthor=J.+Warmusauthor=A.+S.+Kalgutkar&title=Utility+of+the+Carboxylesterase+Inhibitor+Bis-Para-Nitrophenylphosphate+%28Bnpp%29+in+the+Plasma+Unbound+Fraction+Determination+for+a+Hydrolytically+Unstable+Amide+Derivative+and+Agonist+of+the+Tgr5+Receptor&doi=10.3109%2F00498251003706598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor</span></div><div class="casAuthors">Eng, H.; Niosi, M.; McDonald, T. S.; Wolford, A.; Chen, Y.; Simila, S. T. M.; Bauman, J. N.; Warmus, J.; Kalgutkar, A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">369-380</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A novel system has been devised to measure for a plasma-labile compd.  The bis-para-nitrophenylphosphate (BNPP) methodol. can be potentially applied to stabilize hydrolytic cleavage of structurally diverse carboxylesterase substrates in the plasma (and other tissue), thereby allowing the characterization of pharmacol. studies on plasma-labile compds. if and when they emerge as hits in exploratory drug-discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeCqPjMIO6lrVg90H21EOLACvtfcHk0lh7sJYuY7nq8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVGksLk%253D&md5=e91e6ea616181fe2095d5fa876de37d5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3109%2F00498251003706598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498251003706598%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DH.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DWolford%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSimila%26aufirst%3DS.%2BT.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DWarmus%26aufirst%3DJ.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DUtility%2520of%2520the%2520Carboxylesterase%2520Inhibitor%2520Bis-Para-Nitrophenylphosphate%2520%2528Bnpp%2529%2520in%2520the%2520Plasma%2520Unbound%2520Fraction%2520Determination%2520for%2520a%2520Hydrolytically%2520Unstable%2520Amide%2520Derivative%2520and%2520Agonist%2520of%2520the%2520Tgr5%2520Receptor%26jtitle%3DXenobiotica%26date%3D2010%26volume%3D40%26spage%3D369%26epage%3D380%26doi%3D10.3109%2F00498251003706598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Warmus, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limberakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podoll, T.</span><span> </span><span class="NLM_article-title">Structure-Based Design of an <i>in vivo</i> Active Hydroxamic Acid Inhibitor of <i>P. aeruginosa</i> LpxC</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2536</span><span class="NLM_x">–</span> <span class="NLM_lpage">2543</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2012.01.140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2536-2543&author=J.+S.+Warmusauthor=C.+L.+Quinnauthor=C.+Taylorauthor=S.+T.+Murphyauthor=T.+A.+Johnsonauthor=C.+Limberakisauthor=D.+Ortwineauthor=J.+Bronsteinauthor=P.+Paganoauthor=J.+D.+Knafelsauthor=S.+Lightleauthor=I.+Mochalkinauthor=R.+Brideauauthor=T.+Podoll&title=Structure-Based+Design+of+an+in+vivo+Active+Hydroxamic+Acid+Inhibitor+of+P.+aeruginosa+LpxC&doi=10.1016%2Fj.bmcl.2012.01.140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.140%26sid%3Dliteratum%253Aachs%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DQuinn%26aufirst%3DC.%2BL.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DJohnson%26aufirst%3DT.%2BA.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DOrtwine%26aufirst%3DD.%26aulast%3DBronstein%26aufirst%3DJ.%26aulast%3DPagano%26aufirst%3DP.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLightle%26aufirst%3DS.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DBrideau%26aufirst%3DR.%26aulast%3DPodoll%26aufirst%3DT.%26atitle%3DStructure-Based%2520Design%2520of%2520an%2520in%2520vivo%2520Active%2520Hydroxamic%2520Acid%2520Inhibitor%2520of%2520P.%2520aeruginosa%2520LpxC%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2536%26epage%3D2543%26doi%3D10.1016%2Fj.bmcl.2012.01.140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, X.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.-R.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Novel Metalloproteinase Inhibitors Based on L-Tyrosine Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5738</span><span class="NLM_x">–</span> <span class="NLM_lpage">5744</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmc.2012.08.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5738-5744&author=X.-C.+Chengauthor=R.-L.+Wangauthor=Z.-K.+Dongauthor=J.+Liauthor=Y.-Y.+Liauthor=R.-R.+Li&title=Design%2C+Synthesis+and+Evaluation+of+Novel+Metalloproteinase+Inhibitors+Based+on+L-Tyrosine+Scaffold&doi=10.1016%2Fj.bmc.2012.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.-C.%26aulast%3DWang%26aufirst%3DR.-L.%26aulast%3DDong%26aufirst%3DZ.-K.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-Y.%26aulast%3DLi%26aufirst%3DR.-R.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Novel%2520Metalloproteinase%2520Inhibitors%2520Based%2520on%2520L-Tyrosine%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5738%26epage%3D5744%26doi%3D10.1016%2Fj.bmc.2012.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komurasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, M.</span><span> </span><span class="NLM_article-title">Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span><span class="refDoi"> DOI: 10.1021/jm9707582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9707582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=640-649&author=Y.+Tamuraauthor=F.+Watanabeauthor=T.+Nakataniauthor=K.+Yasuiauthor=M.+Fujiauthor=T.+Komurasakiauthor=H.+Tsuzukiauthor=R.+Maekawaauthor=T.+Yoshiokaauthor=K.+Kawadaauthor=K.+Sugitaauthor=M.+Ohtani&title=Highly+Selective+and+Orally+Active+Inhibitors+of+Type+IV+Collagenase+%28MMP-9+and+MMP-2%29%3A+N-Sulfonylamino+Acid+Derivatives&doi=10.1021%2Fjm9707582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=10.1021%2Fjm9707582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707582%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DNakatani%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DK.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DKomurasaki%26aufirst%3DT.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DR.%26aulast%3DYoshioka%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DK.%26aulast%3DSugita%26aufirst%3DK.%26aulast%3DOhtani%26aufirst%3DM.%26atitle%3DHighly%2520Selective%2520and%2520Orally%2520Active%2520Inhibitors%2520of%2520Type%2520IV%2520Collagenase%2520%2528MMP-9%2520and%2520MMP-2%2529%253A%2520N-Sulfonylamino%2520Acid%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D640%26epage%3D649%26doi%3D10.1021%2Fjm9707582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">Protease inhibitors. Part 7: Inhibition of <i>Clostridium histolyticum</i> Collagenase with Sulfonylated Derivatives of L-Valine Hydroxamate</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/S0928-0987(99)00090-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2FS0928-0987%2899%2900090-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10699384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVans7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=67-76&author=C.+T.+Supuranauthor=A.+Scozzafava&title=Protease+inhibitors.+Part+7%3A+Inhibition+of+Clostridium+histolyticum+Collagenase+with+Sulfonylated+Derivatives+of+L-Valine+Hydroxamate&doi=10.1016%2FS0928-0987%2899%2900090-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46cR"><div class="casContent"><span class="casTitleNuber">46c</span><div class="casTitle"><span class="NLM_cas:atitle">Protease inhibitors. Part 7 Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of l-valine hydroxamate</span></div><div class="casAuthors">Supuran, C. T.; Scozzafava, A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Sulfonylated L-valine hydroxamate derivs. were obtained by reaction of alkyl/arylsulfonyl halides with the title amino acid, followed by treatment with benzyl chloride, and conversion of the COOH moiety to the CONHOH group.  Other derivs. were obtained by reaction of N-benzyl-L-valine with arylisocyanates, arylsulfonylisocyanates or benzoylisothiocyanate, followed by the similar conversion of the COOH into the CONHOH moiety, with hydroxylamine in the presence of carbodiimides.  The obtained compds. were assayed as inhibitors of the Clostridium histolyticum collagenase, ChC (EC 3.4.24.3), a zinc enzyme which degrades triple helical collagen.  The hydroxamate derivs. were generally 100-500 times more active than the corresponding carboxylates.  In the series of synthesized derivs., substitution patterns leading to best ChC inhibitors were those involving perfluoroalkylsulfonyl- and substituted-arylsulfonyl moieties, such as pentafluorophenylsulfonyl; 3- and 4-protected-aminophenylsulfonyl-; 3- and 4-carboxyphenylsulfonyl-; 3-trifluoromethylphenylsulfonyl; or 1- and 2-naphthyl among others.  Similarly to the matrix metalloproteinase hydroxamate inhibitors, ChC inhibitors of the type reported here must incorporate hydrophobic moieties at the P2' and P3' subsites, in order to achieve tight binding to the enzyme.  Such compds. might lead to drugs useful in the treatment of corneal bacterial keratitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtl2jRweK_vrVg90H21EOLACvtfcHk0liTKCmojN2BFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVans7w%253D&md5=2ec6e3410afec24734ac14a2f779c7ab</span></div><a href="/servlet/linkout?suffix=cit46c&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2899%2900090-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252899%252900090-1%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DProtease%2520inhibitors.%2520Part%25207%253A%2520Inhibition%2520of%2520Clostridium%2520histolyticum%2520Collagenase%2520with%2520Sulfonylated%2520Derivatives%2520of%2520L-Valine%2520Hydroxamate%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D10%26spage%3D67%26epage%3D76%26doi%3D10.1016%2FS0928-0987%2899%2900090-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">MacPherson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayburt, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capparelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doughty, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spirito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blancuzzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Byrne, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D. T.</span><span> </span><span class="NLM_article-title">Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">–</span> <span class="NLM_lpage">2532</span><span class="refDoi"> DOI: 10.1021/jm960871c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960871c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1yntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2525-2532&author=L.+J.+MacPhersonauthor=E.+K.+Bayburtauthor=M.+P.+Capparelliauthor=B.+J.+Carrollauthor=R.+Goldsteinauthor=M.+R.+Justiceauthor=L.+Zhuauthor=S.+Huauthor=R.+A.+Meltonauthor=L.+Fryerauthor=R.+L.+Goldbergauthor=J.+R.+Doughtyauthor=S.+Spiritoauthor=V.+Blancuzziauthor=D.+Wilsonauthor=E.+M.+O%E2%80%99Byrneauthor=V.+Ganuauthor=D.+T.+Parker&title=Discovery+of+CGS+27023A%2C+a+Non-Peptidic%2C+Potent%2C+and+Orally+Active+Stromelysin+Inhibitor+That+Blocks+Cartilage+Degradation+in+Rabbits&doi=10.1021%2Fjm960871c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46dR"><div class="casContent"><span class="casTitleNuber">46d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor that Blocks Cartilage Degradation in Rabbits</span></div><div class="casAuthors">MacPherson, Lawrence J.; Bayburt, Erol K.; Capparelli, Michael P.; Carroll, Brian J.; Goldstein, Robert; Justice, Michael R.; Zhu, Lijuan; Hu, Shou-Ih; Melton, Richard A.; Fryer, Lynn; Goldberg, Ron L.; Doughty, John R.; Spirito, Salvatore; Blancuzzi, Vincent; Wilson, Doug; O'Byrne, Elizabeth M.; Ganu, Vishwas; Parker, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2525-2532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationships of a lead hydroxamic acid inhibitor of recombinant human stromelysin were systematically defined by taking advantage of a concise synthesis that allowed diverse functionality to be explored at each position in a template.  An ex vivo rat model and an in vivo rabbit model of stromelysin-induced cartilage degrdn. were used to further optimize these analogs for oral activity and duration of action.  The culmination of these modifications resulted in CGS 27023A, a potent, orally active stromelysin inhibitor that blocks the erosion of cartilage matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMDtjlFldPALVg90H21EOLACvtfcHk0lgunxo6gKqSJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1yntbY%253D&md5=219c31bebd8b709c32f00958cb6ea7c1</span></div><a href="/servlet/linkout?suffix=cit46d&amp;dbid=16384&amp;doi=10.1021%2Fjm960871c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960871c%26sid%3Dliteratum%253Aachs%26aulast%3DMacPherson%26aufirst%3DL.%2BJ.%26aulast%3DBayburt%26aufirst%3DE.%2BK.%26aulast%3DCapparelli%26aufirst%3DM.%2BP.%26aulast%3DCarroll%26aufirst%3DB.%2BJ.%26aulast%3DGoldstein%26aufirst%3DR.%26aulast%3DJustice%26aufirst%3DM.%2BR.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DMelton%26aufirst%3DR.%2BA.%26aulast%3DFryer%26aufirst%3DL.%26aulast%3DGoldberg%26aufirst%3DR.%2BL.%26aulast%3DDoughty%26aufirst%3DJ.%2BR.%26aulast%3DSpirito%26aufirst%3DS.%26aulast%3DBlancuzzi%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Byrne%26aufirst%3DE.%2BM.%26aulast%3DGanu%26aufirst%3DV.%26aulast%3DParker%26aufirst%3DD.%2BT.%26atitle%3DDiscovery%2520of%2520CGS%252027023A%252C%2520a%2520Non-Peptidic%252C%2520Potent%252C%2520and%2520Orally%2520Active%2520Stromelysin%2520Inhibitor%2520That%2520Blocks%2520Cartilage%2520Degradation%2520in%2520Rabbits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2525%26epage%3D2532%26doi%3D10.1021%2Fjm960871c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Dankwardt, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbot, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wart, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, K. A. M.</span><span> </span><span class="NLM_article-title">Amino Acid Derived Sulfonamide Hydroxamates as Inhibitors of Procollagen C-Proteinase. Part 2: Solid-Phase Optimization of Side Chains</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00117-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2FS0960-894X%2802%2900117-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1233-1235&author=S.+M.+Dankwardtauthor=S.+C.+Abbotauthor=C.+A.+Brokaauthor=R.+L.+Martinauthor=C.+S.+Chanauthor=E.+B.+Springmanauthor=H.+E.+Van+Wartauthor=K.+A.+M.+Walker&title=Amino+Acid+Derived+Sulfonamide+Hydroxamates+as+Inhibitors+of+Procollagen+C-Proteinase.+Part+2%3A+Solid-Phase+Optimization+of+Side+Chains&doi=10.1016%2FS0960-894X%2802%2900117-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46e&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900117-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900117-8%26sid%3Dliteratum%253Aachs%26aulast%3DDankwardt%26aufirst%3DS.%2BM.%26aulast%3DAbbot%26aufirst%3DS.%2BC.%26aulast%3DBroka%26aufirst%3DC.%2BA.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DChan%26aufirst%3DC.%2BS.%26aulast%3DSpringman%26aufirst%3DE.%2BB.%26aulast%3DVan%2BWart%26aufirst%3DH.%2BE.%26aulast%3DWalker%26aufirst%3DK.%2BA.%2BM.%26atitle%3DAmino%2520Acid%2520Derived%2520Sulfonamide%2520Hydroxamates%2520as%2520Inhibitors%2520of%2520Procollagen%2520C-Proteinase.%2520Part%25202%253A%2520Solid-Phase%2520Optimization%2520of%2520Side%2520Chains%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1233%26epage%3D1235%26doi%3D10.1016%2FS0960-894X%2802%2900117-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">El Bakali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras-Masse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maingot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Inhibition of Aggrecanase as a Therapeutic Strategy in Osteoarthritis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.4155/fmc.14.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.4155%2Ffmc.14.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25329196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1399-1412&author=J.+El+Bakaliauthor=H.+Gras-Masseauthor=L.+Maingotauthor=B.+Deprezauthor=J.+Dumontauthor=F.+Lerouxauthor=R.+Deprez-Poulain&title=Inhibition+of+Aggrecanase+as+a+Therapeutic+Strategy+in+Osteoarthritis&doi=10.4155%2Ffmc.14.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis</span></div><div class="casAuthors">El Bakali Jamal; Gras-Masse Helene; Maingot Lucie; Deprez Benoit; Dumont Julie; Leroux Florence; Deprez-Poulain Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Future medicinal chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1399-412</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the last decade, there has been a large effort to target aggrecanases, which are responsible for the degradation of the aggrecan in the extracellular matrix of joints, in order to hopefully lead to new treatments for osteoarthritis.  Only a few inhibitors have been effective in explants or rodent models and thus only a few have reached the clinic, none of which have proven to be effective.  In this article, a survey of chemical series is described, covering historical and recent inhibitors and highlighting how some of their problems were resolved, with a critical overview of the challenges encountered.  A large effort should be undertaken in designing smaller compounds with higher residence times, defining new interaction sites on the aggrecanases and exploiting target flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc6YFS0apR4JZoeNcnHOQ9fW6udTcc2eaq-R01o4vx6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D&md5=85f4d7d300cf08249358f9db09cf3e69</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.84%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BBakali%26aufirst%3DJ.%26aulast%3DGras-Masse%26aufirst%3DH.%26aulast%3DMaingot%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Aggrecanase%2520as%2520a%2520Therapeutic%2520Strategy%2520in%2520Osteoarthritis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1399%26epage%3D1412%26doi%3D10.4155%2Ffmc.14.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Clary, L.; Pascal, J.-C.</span><span> </span><span class="NLM_article-title">4-Alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide Compounds as Selective Tace-Inhibitors for the Treatment of Inflammatory Diseases</span>. WO2011033010 A1 March 24,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.+Clary&author=J.-C.+Pascal&title=4-Alkoxy-N-%282-hydroxycarbamoyl-2-piperidinyl-ethyl%29-benzamide+Compounds+as+Selective+Tace-Inhibitors+for+the+Treatment+of+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClary%26aufirst%3DL.%26atitle%3D4-Alkoxy-N-%25282-hydroxycarbamoyl-2-piperidinyl-ethyl%2529-benzamide%2520Compounds%2520as%2520Selective%2520Tace-Inhibitors%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Finn, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollinshead, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrianov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokaldere, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikovska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailite, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piskunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starchenkov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vorona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalvinsh, I.</span><span> </span><span class="NLM_article-title">Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1002/hlca.200590129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fhlca.200590129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=1630-1657&author=P.+W.+Finnauthor=M.+Bandaraauthor=C.+Butcherauthor=A.+Finnauthor=R.+Hollinsheadauthor=N.+Khanauthor=N.+Lawauthor=S.+Murthyauthor=R.+Romeroauthor=C.+Watkinsauthor=V.+Andrianovauthor=R.+M.+Bokaldereauthor=K.+Dikovskaauthor=V.+Gailiteauthor=E.+Lozaauthor=I.+Piskunovaauthor=I.+Starchenkovauthor=M.+Voronaauthor=I.+Kalvinsh&title=Novel+Sulfonamide+Derivatives+as+Inhibitors+of+Histone+Deacetylase&doi=10.1002%2Fhlca.200590129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200590129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200590129%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DP.%2BW.%26aulast%3DBandara%26aufirst%3DM.%26aulast%3DButcher%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DA.%26aulast%3DHollinshead%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DN.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DR.%26aulast%3DWatkins%26aufirst%3DC.%26aulast%3DAndrianov%26aufirst%3DV.%26aulast%3DBokaldere%26aufirst%3DR.%2BM.%26aulast%3DDikovska%26aufirst%3DK.%26aulast%3DGailite%26aufirst%3DV.%26aulast%3DLoza%26aufirst%3DE.%26aulast%3DPiskunova%26aufirst%3DI.%26aulast%3DStarchenkov%26aufirst%3DI.%26aulast%3DVorona%26aufirst%3DM.%26aulast%3DKalvinsh%26aufirst%3DI.%26atitle%3DNovel%2520Sulfonamide%2520Derivatives%2520as%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2005%26volume%3D88%26spage%3D1630%26epage%3D1657%26doi%3D10.1002%2Fhlca.200590129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lye, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoo, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangthongpitag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khng, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonday, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantharaj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span> </span><span class="NLM_article-title">Discovery of (2e)-3-{2-Butyl-1-[2-(Diethylamino)Ethyl]-1h-Benzimidazol-5-Yl}-N-Hydroxyacrylamide (Sb939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4694</span><span class="NLM_x">–</span> <span class="NLM_lpage">4720</span><span class="refDoi"> DOI: 10.1021/jm2003552</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2003552" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1emsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4694-4720&author=H.+Wangauthor=N.+Yuauthor=D.+Chenauthor=K.+C.+L.+Leeauthor=P.+L.+Lyeauthor=J.+W.+W.+Changauthor=W.+Dengauthor=M.+C.+Y.+Ngauthor=T.+Luauthor=M.+L.+Khooauthor=A.+Poulsenauthor=K.+Sangthongpitagauthor=X.+Wuauthor=C.+Huauthor=K.+C.+Gohauthor=X.+Wangauthor=L.+Fangauthor=K.+L.+Gohauthor=H.+H.+Khngauthor=S.+K.+Gohauthor=P.+Yeoauthor=X.+Liuauthor=Z.+Bondayauthor=J.+M.+Woodauthor=B.+W.+Dymockauthor=E.+Kantharajauthor=E.+T.+Sun&title=Discovery+of+%282e%29-3-%7B2-Butyl-1-%5B2-%28Diethylamino%29Ethyl%5D-1h-Benzimidazol-5-Yl%7D-N-Hydroxyacrylamide+%28Sb939%29%2C+an+Orally+Active+Histone+Deacetylase+Inhibitor+with+a+Superior+Preclinical+Profile&doi=10.1021%2Fjm2003552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile</span></div><div class="casAuthors">Wang, Haishan; Yu, Niefang; Chen, Dizhong; Lee, Ken Chi Lik; Lye, Pek Ling; Chang, Joyce Wei Wei; Deng, Weiping; Ng, Melvin Chi Yeh; Lu, Ting; Khoo, Mui Ling; Poulsen, Anders; Sangthongpitag, Kanda; Wu, Xiaofeng; Hu, Changyong; Goh, Kee Chuan; Wang, Xukun; Fang, Lijuan; Goh, Kay Lin; Khng, Hwee Hoon; Goh, Siok Kun; Yeo, Pauline; Liu, Xin; Bonday, Zahid; Wood, Jeanette M.; Dymock, Brian W.; Kantharaj, Ethirajulu; Sun, Eric T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4694-4720</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3-(1,2-disubstituted-1H-benzimidazol-5-yl)-N-hydroxyacrylamides was designed and synthesized as HDAC inhibitors.  Extensive SARs have been established for in vitro potency (HDAC1 enzyme and COLO 205 cellular IC50), liver microsomal stability (t1/2), cytochrome P 450 inhibition (3A4 IC50), and clogP, among others.  These parameters were fine-tuned by carefully adjusting the substituents at positions 1 and 2 of the benzimidazole ring.  After comprehensive in vitro and in vivo profiling of the selected compds., SB939 (I) was identified as a preclin. development candidate.  I is a potent pan-HDAC inhibitor with excellent druglike properties, is highly efficacious in in vivo tumor models (HCT-116, PC-3, A2780, MV4-11, Ramos), and has high and dose-proportional oral exposures and very good ADME, safety, and pharmaceutical properties.  When orally dosed to tumor-bearing mice, I is enriched in tumor tissue which may contribute to its potent antitumor activity and prolonged duration of action.  I is currently being tested in phase I and phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd9r-fRIzdS7Vg90H21EOLACvtfcHk0lgXrSVF7CWTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1emsr8%253D&md5=a69bf922fb86c47ddee9c9fc112cc9a2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm2003552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003552%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DK.%2BC.%2BL.%26aulast%3DLye%26aufirst%3DP.%2BL.%26aulast%3DChang%26aufirst%3DJ.%2BW.%2BW.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DNg%26aufirst%3DM.%2BC.%2BY.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DKhoo%26aufirst%3DM.%2BL.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DGoh%26aufirst%3DK.%2BL.%26aulast%3DKhng%26aufirst%3DH.%2BH.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DYeo%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBonday%26aufirst%3DZ.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DKantharaj%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DE.%2BT.%26atitle%3DDiscovery%2520of%2520%25282e%2529-3-%257B2-Butyl-1-%255B2-%2528Diethylamino%2529Ethyl%255D-1h-Benzimidazol-5-Yl%257D-N-Hydroxyacrylamide%2520%2528Sb939%2529%252C%2520an%2520Orally%2520Active%2520Histone%2520Deacetylase%2520Inhibitor%2520with%2520a%2520Superior%2520Preclinical%2520Profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4694%26epage%3D4720%26doi%3D10.1021%2Fjm2003552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterness, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliven, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskra, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lame, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Anaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGahee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocum, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti-Morrow, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobiassen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn-Bowser, M. L.</span><span> </span><span class="NLM_article-title">Pyran-Containing Sulfonamide Hydroxamic Acids: Potent Mmp Inhibitors That Spare Mmp-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3395</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2004.04.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=15177439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1GntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3389-3395&author=L.+A.+Reiterauthor=R.+P.+Robinsonauthor=K.+F.+McClureauthor=C.+S.+Jonesauthor=M.+R.+Reeseauthor=P.+G.+Mitchellauthor=I.+G.+Otternessauthor=M.+L.+Blivenauthor=J.+Lirasauthor=S.+R.+Cortinaauthor=K.+M.+Donahueauthor=J.+D.+Eskraauthor=R.+J.+Griffithsauthor=M.+E.+Lameauthor=A.+Lopez-Anayaauthor=G.+J.+Martinelliauthor=S.+M.+McGaheeauthor=S.+A.+Yocumauthor=L.+L.+Lopresti-Morrowauthor=L.+M.+Tobiassenauthor=M.+L.+Vaughn-Bowser&title=Pyran-Containing+Sulfonamide+Hydroxamic+Acids%3A+Potent+Mmp+Inhibitors+That+Spare+Mmp-1&doi=10.1016%2Fj.bmcl.2004.04.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1</span></div><div class="casAuthors">Reiter, Lawrence A.; Robinson, Ralph P.; McClure, Kim F.; Jones, Christopher S.; Reese, Matthew R.; Mitchell, Peter G.; Otterness, Ivan G.; Bliven, Marcia L.; Liras, Jennifer; Cortina, Santo R.; Donahue, Kathleen M.; Eskra, James D.; Griffiths, Richard J.; Lame, Mary E.; Lopez-Anaya, Arturo; Martinelli, Gary J.; McGahee, Shunda M.; Yocum, Sue A.; Lopresti-Morrow, Lori L.; Tobiassen, Lisa M.; Vaughn-Bowser, Marcie L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3389-3395</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The SAR of a series of sterically hindered sulfonamide hydroxamic acids with relatively large P1' groups is described.  The compds. typically spare MMP-1 while being potent inhibitors of MMP-13.  The metabolically more stable compds. in the series contain either a monocyclic or bicyclic pyran ring adjacent to the hydroxamate group.  Despite the sparing of MMP-1, pre-clin. and clin. studies revealed that fibrosis in rats and MSS in humans is still produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34-Ar8ooZhLVg90H21EOLACvtfcHk0lgXrSVF7CWTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1GntbY%253D&md5=f980b0e20c45d16605a60791876346f7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.083%26sid%3Dliteratum%253Aachs%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DMitchell%26aufirst%3DP.%2BG.%26aulast%3DOtterness%26aufirst%3DI.%2BG.%26aulast%3DBliven%26aufirst%3DM.%2BL.%26aulast%3DLiras%26aufirst%3DJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DEskra%26aufirst%3DJ.%2BD.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DLame%26aufirst%3DM.%2BE.%26aulast%3DLopez-Anaya%26aufirst%3DA.%26aulast%3DMartinelli%26aufirst%3DG.%2BJ.%26aulast%3DMcGahee%26aufirst%3DS.%2BM.%26aulast%3DYocum%26aufirst%3DS.%2BA.%26aulast%3DLopresti-Morrow%26aufirst%3DL.%2BL.%26aulast%3DTobiassen%26aufirst%3DL.%2BM.%26aulast%3DVaughn-Bowser%26aufirst%3DM.%2BL.%26atitle%3DPyran-Containing%2520Sulfonamide%2520Hydroxamic%2520Acids%253A%2520Potent%2520Mmp%2520Inhibitors%2520That%2520Spare%2520Mmp-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3389%26epage%3D3395%26doi%3D10.1016%2Fj.bmcl.2004.04.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schudok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorwart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haase, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neises, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weithmann, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmann, T.</span><span> </span><span class="NLM_article-title">Tetrahydroisoquinoline-3-Carboxylate Based Matrix-Metalloproteinase Inhibitors: Design, Synthesis and Structure–Activity Relationship</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3529</span><span class="NLM_x">–</span> <span class="NLM_lpage">3544</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00215-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2FS0968-0896%2802%2900215-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3529-3544&author=H.+Matterauthor=M.+Schudokauthor=W.+Schwabauthor=W.+Thorwartauthor=D.+Barbierauthor=G.+Billenauthor=B.+Haaseauthor=B.+Neisesauthor=K.-U.+Weithmannauthor=T.+Wollmann&title=Tetrahydroisoquinoline-3-Carboxylate+Based+Matrix-Metalloproteinase+Inhibitors%3A+Design%2C+Synthesis+and+Structure%E2%80%93Activity+Relationship&doi=10.1016%2FS0968-0896%2802%2900215-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900215-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900215-8%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DSchudok%26aufirst%3DM.%26aulast%3DSchwab%26aufirst%3DW.%26aulast%3DThorwart%26aufirst%3DW.%26aulast%3DBarbier%26aufirst%3DD.%26aulast%3DBillen%26aufirst%3DG.%26aulast%3DHaase%26aufirst%3DB.%26aulast%3DNeises%26aufirst%3DB.%26aulast%3DWeithmann%26aufirst%3DK.-U.%26aulast%3DWollmann%26aufirst%3DT.%26atitle%3DTetrahydroisoquinoline-3-Carboxylate%2520Based%2520Matrix-Metalloproteinase%2520Inhibitors%253A%2520Design%252C%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3529%26epage%3D3544%26doi%3D10.1016%2FS0968-0896%2802%2900215-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Murphy-Benenato, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thresher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span> </span><span class="NLM_article-title">Synthesis, Structure, and Sar of Tetrahydropyran-Based Lpxc Inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span><span class="refDoi"> DOI: 10.1021/ml500210x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500210x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1213-1218&author=K.+E.+Murphy-Benenatoauthor=N.+Olivierauthor=A.+Choyauthor=P.+L.+Rossauthor=M.+D.+Millerauthor=J.+Thresherauthor=N.+Gaoauthor=M.+R.+Hale&title=Synthesis%2C+Structure%2C+and+Sar+of+Tetrahydropyran-Based+Lpxc+Inhibitors&doi=10.1021%2Fml500210x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fml500210x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500210x%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy-Benenato%26aufirst%3DK.%2BE.%26aulast%3DOlivier%26aufirst%3DN.%26aulast%3DChoy%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DP.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DThresher%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DHale%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%252C%2520Structure%252C%2520and%2520Sar%2520of%2520Tetrahydropyran-Based%2520Lpxc%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1213%26epage%3D1218%26doi%3D10.1021%2Fml500210x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traskos, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J. J. W.</span><span> </span><span class="NLM_article-title">A,B-Cyclic-B-Benzamido Hydroxamic Acids: Novel Templates for the Design, Synthesis, and Evaluation of Selective Inhibitors of Tnf-A Converting Enzyme (Tace)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2007.11.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=694-699&author=G.+R.+Ottauthor=N.+Asakawaauthor=Z.+Luauthor=R.-Q.+Liuauthor=M.+B.+Covingtonauthor=K.+Vaddiauthor=M.+Qianauthor=R.+C.+Newtonauthor=D.+D.+Christauthor=J.+M.+Traskosauthor=C.+P.+Deciccoauthor=J.+J.+W.+Duan&title=A%2CB-Cyclic-B-Benzamido+Hydroxamic+Acids%3A+Novel+Templates+for+the+Design%2C+Synthesis%2C+and+Evaluation+of+Selective+Inhibitors+of+Tnf-A+Converting+Enzyme+%28Tace%29&doi=10.1016%2Fj.bmcl.2007.11.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DAsakawa%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DR.-Q.%26aulast%3DCovington%26aufirst%3DM.%2BB.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DTraskos%26aufirst%3DJ.%2BM.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%2BW.%26atitle%3DA%252CB-Cyclic-B-Benzamido%2520Hydroxamic%2520Acids%253A%2520Novel%2520Templates%2520for%2520the%2520Design%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Selective%2520Inhibitors%2520of%2520Tnf-A%2520Converting%2520Enzyme%2520%2528Tace%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D694%26epage%3D699%26doi%3D10.1016%2Fj.bmcl.2007.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Yang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Mild and Efficient Lewis Acid-Promoted Detritylation in the Synthesis of N-Hydroxy Amides: A Concise Synthesis of (−)-Cobactin T</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">8123</span><span class="NLM_x">–</span> <span class="NLM_lpage">8126</span><span class="refDoi"> DOI: 10.1021/jo701411d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701411d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=8123-8126&author=S.-M.+Yangauthor=B.+Laguauthor=L.+J.+Wilson&title=Mild+and+Efficient+Lewis+Acid-Promoted+Detritylation+in+the+Synthesis+of+N-Hydroxy+Amides%3A+A+Concise+Synthesis+of+%28%E2%88%92%29-Cobactin+T&doi=10.1021%2Fjo701411d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjo701411d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701411d%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-M.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DMild%2520and%2520Efficient%2520Lewis%2520Acid-Promoted%2520Detritylation%2520in%2520the%2520Synthesis%2520of%2520N-Hydroxy%2520Amides%253A%2520A%2520Concise%2520Synthesis%2520of%2520%2528%25E2%2588%2592%2529-Cobactin%2520T%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D8123%26epage%3D8126%26doi%3D10.1021%2Fjo701411d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Levy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobelny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casabonne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadzan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galardy, R. E.</span><span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors: A Structure–Activity Study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1021/jm970494j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970494j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=199-223&author=D.+E.+Levyauthor=F.+Lapierreauthor=W.+Liangauthor=W.+Yeauthor=C.+W.+Langeauthor=X.+Liauthor=D.+Grobelnyauthor=M.+Casabonneauthor=D.+Tyrrellauthor=K.+Holmeauthor=A.+Nadzanauthor=R.+E.+Galardy&title=Matrix+Metalloproteinase+Inhibitors%3A+A+Structure%E2%80%93Activity+Study&doi=10.1021%2Fjm970494j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm970494j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970494j%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DLapierre%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DLange%26aufirst%3DC.%2BW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGrobelny%26aufirst%3DD.%26aulast%3DCasabonne%26aufirst%3DM.%26aulast%3DTyrrell%26aufirst%3DD.%26aulast%3DHolme%26aufirst%3DK.%26aulast%3DNadzan%26aufirst%3DA.%26aulast%3DGalardy%26aufirst%3DR.%2BE.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%253A%2520A%2520Structure%25E2%2580%2593Activity%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D199%26epage%3D223%26doi%3D10.1021%2Fjm970494j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Ho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strobel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralbovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.</span><span> </span><span class="NLM_article-title">Improved Solution- and Solid-Phase Preparation of Hydroxamic Acids from Esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">4873</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1021/jo050036f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050036f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFKjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=4873-4875&author=C.+Y.+Hoauthor=E.+Strobelauthor=J.+Ralbovskyauthor=R.+A.+Galemmo&title=Improved+Solution-+and+Solid-Phase+Preparation+of+Hydroxamic+Acids+from+Esters&doi=10.1021%2Fjo050036f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Improved solution- and solid-phase preparation of hydroxamic acids from esters</span></div><div class="casAuthors">Ho, Chih Y.; Strobel, Eric; Ralbovsky, Janet; Galemmo, Robert A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4873-4875</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The addn. of small amts. of solid KCN to carboxylic esters, either solid-supported or in soln., in THF/MeOH/NH2OH increased the efficiency of their transformation to the corresponding hydroxamic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoyGOhJrr627Vg90H21EOLACvtfcHk0lgH4ONO6cYd4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFKjurs%253D&md5=14fe68273034da24eba2441319a706a4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjo050036f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050036f%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DC.%2BY.%26aulast%3DStrobel%26aufirst%3DE.%26aulast%3DRalbovsky%26aufirst%3DJ.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26atitle%3DImproved%2520Solution-%2520and%2520Solid-Phase%2520Preparation%2520of%2520Hydroxamic%2520Acids%2520from%2520Esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D4873%26epage%3D4875%26doi%3D10.1021%2Fjo050036f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Harris, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthington, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melander, C.</span><span> </span><span class="NLM_article-title">A Facile Synthesis of 1,5-Disubstituted-2-Aminoimidazoles: Antibiotic Activity of a First Generation Library</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4516</span><span class="NLM_x">–</span> <span class="NLM_lpage">4519</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2011.05.123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4516-4519&author=T.+L.+Harrisauthor=R.+J.+Worthingtonauthor=C.+Melander&title=A+Facile+Synthesis+of+1%2C5-Disubstituted-2-Aminoimidazoles%3A+Antibiotic+Activity+of+a+First+Generation+Library&doi=10.1016%2Fj.bmcl.2011.05.123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.123%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DT.%2BL.%26aulast%3DWorthington%26aufirst%3DR.%2BJ.%26aulast%3DMelander%26aufirst%3DC.%26atitle%3DA%2520Facile%2520Synthesis%2520of%25201%252C5-Disubstituted-2-Aminoimidazoles%253A%2520Antibiotic%2520Activity%2520of%2520a%2520First%2520Generation%2520Library%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4516%26epage%3D4519%26doi%3D10.1016%2Fj.bmcl.2011.05.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Boldt, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K. D.</span><span> </span><span class="NLM_article-title">Identification of a Potent Botulinum Neurotoxin a Protease Inhibitor Using in Situ Lead Identification Chemistry</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">–</span> <span class="NLM_lpage">1732</span><span class="refDoi"> DOI: 10.1021/ol0603211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0603211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitl2hsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1729-1732&author=G.+E.+Boldtauthor=J.+P.+Kennedyauthor=K.+D.+Janda&title=Identification+of+a+Potent+Botulinum+Neurotoxin+a+Protease+Inhibitor+Using+in+Situ+Lead+Identification+Chemistry&doi=10.1021%2Fol0603211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Potent Botulinum Neurotoxin A Protease Inhibitor Using in Situ Lead Identification Chemistry</span></div><div class="casAuthors">Boldt, Grant E.; Kennedy, Jack P.; Janda, Kim D.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1729-1732</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Botulinum neurotoxins (BoNTs), etiol. agents of the deadly food poisoning disease botulism, are the most toxic proteins currently known.  By using in situ lead identification chem., we have uncovered the first class of inhibitors that displays nanomolar potency.  From a 15 μM lead compd., structure-activity relationship studies were performed granting the most potent BoNT/A inhibitor reported to date that displays an inhibition const. of 300 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVP2ivVFRqrVg90H21EOLACvtfcHk0lgH4ONO6cYd4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitl2hsrc%253D&md5=e0c3bbc633653ad724a956b98672c29b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fol0603211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0603211%26sid%3Dliteratum%253Aachs%26aulast%3DBoldt%26aufirst%3DG.%2BE.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DJanda%26aufirst%3DK.%2BD.%26atitle%3DIdentification%2520of%2520a%2520Potent%2520Botulinum%2520Neurotoxin%2520a%2520Protease%2520Inhibitor%2520Using%2520in%2520Situ%2520Lead%2520Identification%2520Chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D1729%26epage%3D1732%26doi%3D10.1021%2Fol0603211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Double Arylations of Terminal Olefins in Acetic Acid</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1466</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span><span class="refDoi"> DOI: 10.1016/j.tet.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.tet.2011.12.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=1466-1474&author=D.+Xuauthor=C.+Luauthor=W.+Chen&title=Palladium-Catalyzed+Double+Arylations+of+Terminal+Olefins+in+Acetic+Acid&doi=10.1016%2Fj.tet.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DPalladium-Catalyzed%2520Double%2520Arylations%2520of%2520Terminal%2520Olefins%2520in%2520Acetic%2520Acid%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D1466%26epage%3D1474%26doi%3D10.1016%2Fj.tet.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Ramachary, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkaiah, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishor, M.</span><span> </span><span class="NLM_article-title">Multi-Catalysis Cascade Reactions Based on the Methoxycarbonylketene Platform: Diversity-Oriented Synthesis of Functionalized Non-Symmetrical Malonates for Agrochemicals and Pharmaceuticals</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2053</span><span class="NLM_x">–</span> <span class="NLM_lpage">2062</span><span class="refDoi"> DOI: 10.1039/b901652j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1039%2Fb901652j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=2053-2062&author=D.+B.+Ramacharyauthor=C.+Venkaiahauthor=Y.+V.+Reddyauthor=M.+Kishor&title=Multi-Catalysis+Cascade+Reactions+Based+on+the+Methoxycarbonylketene+Platform%3A+Diversity-Oriented+Synthesis+of+Functionalized+Non-Symmetrical+Malonates+for+Agrochemicals+and+Pharmaceuticals&doi=10.1039%2Fb901652j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2Fb901652j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb901652j%26sid%3Dliteratum%253Aachs%26aulast%3DRamachary%26aufirst%3DD.%2BB.%26aulast%3DVenkaiah%26aufirst%3DC.%26aulast%3DReddy%26aufirst%3DY.%2BV.%26aulast%3DKishor%26aufirst%3DM.%26atitle%3DMulti-Catalysis%2520Cascade%2520Reactions%2520Based%2520on%2520the%2520Methoxycarbonylketene%2520Platform%253A%2520Diversity-Oriented%2520Synthesis%2520of%2520Functionalized%2520Non-Symmetrical%2520Malonates%2520for%2520Agrochemicals%2520and%2520Pharmaceuticals%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D2053%26epage%3D2062%26doi%3D10.1039%2Fb901652j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollenberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">Esterase Activities in the Blood, Liver and Intestine of Several Preclinical Species and Humans</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.2174/187231209788654081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.2174%2F187231209788654081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=19601867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=70-77&author=L.+M.+Berryauthor=L.+Wollenbergauthor=Z.+Zhao&title=Esterase+Activities+in+the+Blood%2C+Liver+and+Intestine+of+Several+Preclinical+Species+and+Humans&doi=10.2174%2F187231209788654081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Esterase activities in the blood, liver and intestine of several preclinical species and humans</span></div><div class="casAuthors">Berry, Loren M.; Wollenberg, Lance; Zhao, Zhiyang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">70-77</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Species and tissue differences in the activity of three major classes of esterases, carboxylesterase (CE), butyrylcholinesterase (BChE) and paraoxonase (PON), were studied.  Substantial species differences in activity of these esterases were obsd. between the mouse, rat, dog monkey and human.  Such species differences must be considered when using these preclin. species to optimize the pharmacokinetic properties of ester compds. intended for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDFldzEQtQKLVg90H21EOLACvtfcHk0lh227eb-BbLcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGju70%253D&md5=f480d5a0b9f54e7a34eadac588521caa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F187231209788654081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231209788654081%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DWollenberg%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DEsterase%2520Activities%2520in%2520the%2520Blood%252C%2520Liver%2520and%2520Intestine%2520of%2520Several%2520Preclinical%2520Species%2520and%2520Humans%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2009%26volume%3D3%26spage%3D70%26epage%3D77%26doi%3D10.2174%2F187231209788654081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46a','cit46b','cit46c','cit46d','cit46e'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samo Guzelj, Sanja Nabergoj, Martina Gobec, Stane Pajk, Veronika Klančič, Bram Slütter, Ruža Frkanec, Adela Štimac, Primož Šket, Janez Plavec, Irena Mlinarič-Raščan, <span class="NLM_string-name hlFld-ContribAuthor">Žiga Jakopin</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7809-7838. <a href="https://doi.org/10.1021/acs.jmedchem.1c00644" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00644%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BFine-Tuning%252Bof%252BDesmuramylpeptide%252BNOD2%252BAgonists%252BDefines%252BTheir%252BIn%252BVivo%252BAdjuvant%252BActivity%26aulast%3DGuzelj%26aufirst%3DSamo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08042021%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7809%26epage%3D7838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Olasunkanmi O. Olaoye, Paris R. Watson, Nabanita Nawar, Mulu Geletu, Abootaleb Sedighi, Shazreh Bukhari, Yasir S. Raouf, Pimyupa Manaswiyoungkul, Fettah Erdogan, Ayah Abdeldayem, Aaron D. Cabral, Muhammad Murtaza Hassan, Krimo Toutah, Andrew E. Shouksmith, Justyna M. Gawel, Johan Israelian, Tudor B. Radu, Niyati Kachhiyapatel, Elvin D. de Araujo, David W. Christianson, <span class="NLM_string-name hlFld-ContribAuthor">Patrick T. Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2691-2704. <a href="https://doi.org/10.1021/acs.jmedchem.0c01922" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01922%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnique%252BMolecular%252BInteraction%252Bwith%252Bthe%252BHistone%252BDeacetylase%252B6%252BCatalytic%252BTunnel%25253A%252BCrystallographic%252Band%252BBiological%252BCharacterization%252Bof%252Ba%252BModel%252BChemotype%26aulast%3DOlaoye%26aufirst%3DOlasunkanmi%2BO.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D06112020%26date%3D12022021%26volume%3D64%26issue%3D5%26spage%3D2691%26epage%3D2704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew J. Stott, Michel C. Maillard, Vahri Beaumont, David Allcock, Omar Aziz, Alexander H. Borchers, Wesley Blackaby, Perla Breccia, Gillian Creighton-Gutteridge, Alan F. Haughan, Rebecca E. Jarvis, Christopher A. Luckhurst, Kim L. Matthews, George McAllister, Scott Pollack, Elizabeth Saville-Stones, Amanda J. Van de Poël, Huw D. Vater, Julie Vann, Rachel Williams, Dawn Yates, Ignacio Muñoz-Sanjuán, <span class="NLM_string-name hlFld-ContribAuthor">Celia Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 380-388. <a href="https://doi.org/10.1021/acsmedchemlett.0c00532" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00532%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvaluation%252Bof%252B5-%252528Trifluoromethyl%252529-1%25252C2%25252C4-oxadiazole-Based%252BClass%252BIIa%252BHDAC%252BInhibitors%252Bfor%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DStott%26aufirst%3DAndrew%2BJ.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12102020%26date%3D03022021%26date%3D11022021%26volume%3D12%26issue%3D3%26spage%3D380%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tetsuro Tago, Jun Toyohara, <span class="NLM_string-name hlFld-ContribAuthor">Kenji Ishii</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 746-755. <a href="https://doi.org/10.1021/acschemneuro.0c00774" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00774%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DPreclinical%252BEvaluation%252Bof%252Ban%252B18F-Labeled%252BSW-100%252BDerivative%252Bfor%252BPET%252BImaging%252Bof%252BHistone%252BDeacetylase%252B6%252Bin%252Bthe%252BBrain%26aulast%3DTago%26aufirst%3DTetsuro%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D02122020%26date%3D19012021%26date%3D27012021%26volume%3D12%26issue%3D4%26spage%3D746%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Damien Bosc, Virgyl Camberlein, Ronan Gealageas, Omar Castillo-Aguilera, Benoit Deprez, <span class="NLM_string-name hlFld-ContribAuthor">Rebecca Deprez-Poulain</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetic Target-Guided Synthesis: Reaching the Age of Maturity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 3817-3833. <a href="https://doi.org/10.1021/acs.jmedchem.9b01183" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01183%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinetic%252BTarget-Guided%252BSynthesis%25253A%252BReaching%252Bthe%252BAge%252Bof%252BMaturity%26aulast%3DBosc%26aufirst%3DDamien%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D22072019%26date%3D24122019%26date%3D10122019%26volume%3D63%26issue%3D8%26spage%3D3817%26epage%3D3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lucas G. Viviani, Erika Piccirillo, Henning Ulrich, <span class="NLM_string-name hlFld-ContribAuthor">Antonia T.-do Amaral</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5′-Nucleotidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (2)
                                     , 621-630. <a href="https://doi.org/10.1021/acs.jcim.9b00884" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00884%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DVirtual%252BScreening%252BApproach%252Bfor%252Bthe%252BIdentification%252Bof%252BHydroxamic%252BAcids%252Bas%252BNovel%252BHuman%252BEcto-5%2525E2%252580%2525B2-Nucleotidase%252BInhibitors%26aulast%3DViviani%26aufirst%3DLucas%2BG.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D30092019%26date%3D26112019%26date%3D12112019%26volume%3D60%26issue%3D2%26spage%3D621%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel Bouchet, Camille Linot, Dusan Ruzic, Danica Agbaba, Benoit Fouchaq, Joëlle Roche, Katarina Nikolic, Christophe Blanquart, <span class="NLM_string-name hlFld-ContribAuthor">Philippe Bertrand</span>. </span><span class="cited-content_cbyCitation_article-title">Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 863-868. <a href="https://doi.org/10.1021/acsmedchemlett.8b00440" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00440%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DExtending%252BCross%252BMetathesis%252BTo%252BIdentify%252BSelective%252BHDAC%252BInhibitors%25253A%252BSynthesis%25252C%252BBiological%252BActivities%25252C%252Band%252BModeling%26aulast%3DBouchet%26aufirst%3DSamuel%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D24092018%26date%3D09052019%26date%3D17052019%26date%3D09052019%26volume%3D10%26issue%3D6%26spage%3D863%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie Zang, Xuewu Liang, Yongxue Huang, Yuping Jia, Xiaoyang Li, Wenfang Xu, C. James Chou, <span class="NLM_string-name hlFld-ContribAuthor">Yingjie Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5304-5322. <a href="https://doi.org/10.1021/acs.jmedchem.8b00384" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00384%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPazopanib-Based%252BHDAC%252Band%252BVEGFR%252BDual%252BInhibitors%252BTargeting%252BCancer%252BEpigenetics%252Band%252BAngiogenesis%252BSimultaneously%26aulast%3DZang%26aufirst%3DJie%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09032018%26date%3D07062018%26date%3D22052018%26volume%3D61%26issue%3D12%26spage%3D5304%26epage%3D5322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel Ramsbeck, Antje Hamann, Georg Richter, Dagmar Schlenzig, Stefanie Geissler, Vera Nykiel, Holger Cynis, Stephan Schilling, <span class="NLM_string-name hlFld-ContribAuthor">Mirko Buchholz</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4578-4592. <a href="https://doi.org/10.1021/acs.jmedchem.8b00330" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00330%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252BNext-Generation%252BMeprin%252B%2525CE%2525B2%252BInhibitors%26aulast%3DRamsbeck%26aufirst%3DDaniel%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28022018%26date%3D07052018%26date%3D25042018%26volume%3D61%26issue%3D10%26spage%3D4578%26epage%3D4592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Dongxiao  Li</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhong</span>, <span class="hlFld-ContribAuthor ">Ge  Liu</span>, <span class="hlFld-ContribAuthor ">Xueqin  Wang</span>, <span class="hlFld-ContribAuthor ">Yuanxiang  Lu</span>, <span class="hlFld-ContribAuthor ">Fangyuan  Qin</span>, <span class="hlFld-ContribAuthor ">Yuqi  Guo</span>, <span class="hlFld-ContribAuthor ">Shaofeng  Duan</span>, <span class="hlFld-ContribAuthor ">Deyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of HDAC6 selective inhibitors: pharmacophore based virtual screening, molecular docking and molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (6)
                                     , 1928-1939. <a href="https://doi.org/10.1080/07391102.2020.1743760" title="DOI URL">https://doi.org/10.1080/07391102.2020.1743760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1743760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1743760%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentification%252Bof%252BHDAC6%252Bselective%252Binhibitors%25253A%252Bpharmacophore%252Bbased%252Bvirtual%252Bscreening%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DYan%26aufirst%3DGuoyi%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D6%26spage%3D1928%26epage%3D1939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharyu  Kesharwani</span>, <span class="hlFld-ContribAuthor ">Sandeep  Sundriyal</span>. </span><span class="cited-content_cbyCitation_article-title">Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113055. <a href="https://doi.org/10.1016/j.ejmech.2020.113055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNon-hydroxamate%252Binhibitors%252Bof%252B1-deoxy-d-xylulose%252B5-phosphate%252Breductoisomerase%252B%252528DXR%252529%25253A%252BA%252Bcritical%252Breview%252Band%252Bfuture%252Bperspective%26aulast%3DKesharwani%26aufirst%3DSharyu%26date%3D2021%26volume%3D213%26spage%3D113055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucy  Lin</span>, <span class="hlFld-ContribAuthor ">Lewis D.  Turner</span>, <span class="hlFld-ContribAuthor ">Peter  Šilhár</span>, <span class="hlFld-ContribAuthor ">Sabine  Pellett</span>, <span class="hlFld-ContribAuthor ">Eric A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Kim D.  Janda</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 3-hydroxy-1,2-dimethylpyridine-4(1
              H
              )-thione as a metal-binding motif for the inhibition of botulinum neurotoxin A. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 137-143. <a href="https://doi.org/10.1039/D0MD00320D" title="DOI URL">https://doi.org/10.1039/D0MD00320D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00320D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00320D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252B3-hydroxy-1%25252C2-dimethylpyridine-4%2525281%252BH%252B%252529-thione%252Bas%252Ba%252Bmetal-binding%252Bmotif%252Bfor%252Bthe%252Binhibition%252Bof%252Bbotulinum%252Bneurotoxin%252BA%26aulast%3DLin%26aufirst%3DLucy%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D137%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santanu  Ghosh</span>, <span class="hlFld-ContribAuthor ">Anisha  Purkait</span>, <span class="hlFld-ContribAuthor ">Chandan K.  Jana</span>. </span><span class="cited-content_cbyCitation_article-title">Environmentally benign decarboxylative
              N
              -,
              O
              -, and
              S
              -acetylations and acylations. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (24)
                                     , 8721-8727. <a href="https://doi.org/10.1039/D0GC03731A" title="DOI URL">https://doi.org/10.1039/D0GC03731A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC03731A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC03731A%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DEnvironmentally%252Bbenign%252Bdecarboxylative%252BN%252B-%25252C%252BO%252B-%25252C%252Band%252BS%252B-acetylations%252Band%252Bacylations%26aulast%3DGhosh%26aufirst%3DSantanu%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D24%26spage%3D8721%26epage%3D8727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leandro A.  Alves Avelar</span>, <span class="hlFld-ContribAuthor ">Dusan  Ruzic</span>, <span class="hlFld-ContribAuthor ">Nemanja  Djokovic</span>, <span class="hlFld-ContribAuthor ">Thomas  Kurz</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of selective histone deacetylase 6 zinc binding groups. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (11)
                                     , 3166-3177. <a href="https://doi.org/10.1080/07391102.2019.1652687" title="DOI URL">https://doi.org/10.1080/07391102.2019.1652687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1652687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1652687%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DStructure-based%252Bdesign%252Bof%252Bselective%252Bhistone%252Bdeacetylase%252B6%252Bzinc%252Bbinding%252Bgroups%26aulast%3DAlves%2BAvelar%26aufirst%3DLeandro%2BA.%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D11%26spage%3D3166%26epage%3D3177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. V.  Danilov</span>, <span class="hlFld-ContribAuthor ">V. V.  Burmistrov</span>, <span class="hlFld-ContribAuthor ">G. M.  Butov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Properties of N,N′-Disubstituted Ureas and Their
Isosteric Analogs Containing Polycyclic Fragments: III. Synthesis and Properties ofN-[2-(Adamantan-1-yl)ethyl]-N′-R-ureas. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>56 </em>
                                    (7)
                                     , 1132-1139. <a href="https://doi.org/10.1134/S1070428020070027" title="DOI URL">https://doi.org/10.1134/S1070428020070027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428020070027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428020070027%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BProperties%252Bof%252BN%25252CN%2525E2%252580%2525B2-Disubstituted%252BUreas%252Band%252BTheir%252BIsosteric%252BAnalogs%252BContaining%252BPolycyclic%252BFragments%25253A%252BIII.%252BSynthesis%252Band%252BProperties%252BofN-%25255B2-%252528Adamantan-1-yl%252529ethyl%25255D-N%2525E2%252580%2525B2-R-ureas%26aulast%3DDanilov%26aufirst%3DD.%2BV.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D7%26spage%3D1132%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Máté  Kozsup</span>, <span class="hlFld-ContribAuthor ">Donal M.  Keogan</span>, <span class="hlFld-ContribAuthor ">Deirdre  Fitzgerald-Hughes</span>, <span class="hlFld-ContribAuthor ">Éva A.  Enyedy</span>, <span class="hlFld-ContribAuthor ">Brendan  Twamley</span>, <span class="hlFld-ContribAuthor ">Péter  Buglyó</span>, <span class="hlFld-ContribAuthor ">Darren M.  Griffith</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterisation of Co(
              iii
              ) complexes of
              N
              -formyl hydroxylamines and antibacterial activity of a Co(
              iii
              ) peptide deformylase inhibitor complex. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (21)
                                     , 6980-6988. <a href="https://doi.org/10.1039/D0DT01123A" title="DOI URL">https://doi.org/10.1039/D0DT01123A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT01123A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT01123A%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DSynthesis%252Band%252Bcharacterisation%252Bof%252BCo%252528%252Biii%252B%252529%252Bcomplexes%252Bof%252BN%252B-formyl%252Bhydroxylamines%252Band%252Bantibacterial%252Bactivity%252Bof%252Ba%252BCo%252528%252Biii%252B%252529%252Bpeptide%252Bdeformylase%252Binhibitor%252Bcomplex%26aulast%3DKozsup%26aufirst%3DM%25C3%25A1t%25C3%25A9%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D21%26spage%3D6980%26epage%3D6988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarek S.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Taghreed A.  Sheha</span>, <span class="hlFld-ContribAuthor ">Nader E.  Abo-Dya</span>, <span class="hlFld-ContribAuthor ">Mohammed A.  AlAwadh</span>, <span class="hlFld-ContribAuthor ">Nabil A.  Alhakamy</span>, <span class="hlFld-ContribAuthor ">Zakaria K.  Abdel-Samii</span>, <span class="hlFld-ContribAuthor ">Siva S.  Panda</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>, <span class="hlFld-ContribAuthor ">Mamdouh F.A.  Mohamed</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103797. <a href="https://doi.org/10.1016/j.bioorg.2020.103797" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103797%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252Bvalproic%252Bacid%252Bconjugates%252Bwith%252Bimproved%252Bhistone%252Bdeacetylase%252B%252528HDAC%252529%252Binhibitory%252Bactivity%26aulast%3DIbrahim%26aufirst%3DTarek%2BS.%26date%3D2020%26volume%3D99%26spage%3D103797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan R.  Hughes</span>, <span class="hlFld-ContribAuthor ">Khaled A.  Shaaban</span>, <span class="hlFld-ContribAuthor ">Larissa V.  Ponomareva</span>, <span class="hlFld-ContribAuthor ">Jamie  Horn</span>, <span class="hlFld-ContribAuthor ">Chunhui  Zhang</span>, <span class="hlFld-ContribAuthor ">Chang‐Guo  Zhan</span>, <span class="hlFld-ContribAuthor ">S. Randal  Voss</span>, <span class="hlFld-ContribAuthor ">Markos  Leggas</span>, <span class="hlFld-ContribAuthor ">Jon S.  Thorson</span>. </span><span class="cited-content_cbyCitation_article-title">OleD Loki as a Catalyst for Hydroxamate Glycosylation. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (7)
                                     , 952-957. <a href="https://doi.org/10.1002/cbic.201900601" title="DOI URL">https://doi.org/10.1002/cbic.201900601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201900601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201900601%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DOleD%252BLoki%252Bas%252Ba%252BCatalyst%252Bfor%252BHydroxamate%252BGlycosylation%26aulast%3DHughes%26aufirst%3DRyan%2BR.%26date%3D2020%26date%3D2019%26volume%3D21%26issue%3D7%26spage%3D952%26epage%3D957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sida  Shen</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 121-136. <a href="https://doi.org/10.1080/13543776.2019.1708901" title="DOI URL">https://doi.org/10.1080/13543776.2019.1708901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1708901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1708901%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bhistone%252Bdeacetylase%252B6%252Binhibitors%252Bin%252Bneurodegenerative%252Bdiseases%252B%2525282014-2019%252529%26aulast%3DShen%26aufirst%3DSida%26date%3D2020%26date%3D2019%26volume%3D30%26issue%3D2%26spage%3D121%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supriya  Sasmal</span>, <span class="hlFld-ContribAuthor ">Debasish  Podder</span>, <span class="hlFld-ContribAuthor ">Mintu  Debnath</span>, <span class="hlFld-ContribAuthor ">Sujay Kumar  Nandi</span>, <span class="hlFld-ContribAuthor ">Debasish  Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Assembly‐Induced Diverse Optical Property of 4‐Biphenylcarboxy‐Protected Serine and Tyrosine. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (35)
                                     , 10302-10306. <a href="https://doi.org/10.1002/slct.201902353" title="DOI URL">https://doi.org/10.1002/slct.201902353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902353%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAssembly%2525E2%252580%252590Induced%252BDiverse%252BOptical%252BProperty%252Bof%252B4%2525E2%252580%252590Biphenylcarboxy%2525E2%252580%252590Protected%252BSerine%252Band%252BTyrosine%26aulast%3DSasmal%26aufirst%3DSupriya%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D35%26spage%3D10302%26epage%3D10306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregg B.  Fields</span>. </span><span class="cited-content_cbyCitation_article-title">The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2019,</strong> <em>8 </em>
                                    (9)
                                     , 984. <a href="https://doi.org/10.3390/cells8090984" title="DOI URL">https://doi.org/10.3390/cells8090984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells8090984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells8090984%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DThe%252BRebirth%252Bof%252BMatrix%252BMetalloproteinase%252BInhibitors%25253A%252BMoving%252BBeyond%252Bthe%252BDogma%26aulast%3DFields%26aufirst%3DGregg%2BB.%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D9%26spage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte  Courtens</span>, <span class="hlFld-ContribAuthor ">Martijn  Risseeuw</span>, <span class="hlFld-ContribAuthor ">Guy  Caljon</span>, <span class="hlFld-ContribAuthor ">Louis  Maes</span>, <span class="hlFld-ContribAuthor ">Paul  Cos</span>, <span class="hlFld-ContribAuthor ">Anandi  Martin</span>, <span class="hlFld-ContribAuthor ">Serge  Van Calenbergh</span>. </span><span class="cited-content_cbyCitation_article-title">Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (10)
                                     , 1232-1235. <a href="https://doi.org/10.1016/j.bmcl.2019.03.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDouble%252Bprodrugs%252Bof%252Ba%252Bfosmidomycin%252Bsurrogate%252Bas%252Bantimalarial%252Band%252Bantitubercular%252Bagents%26aulast%3DCourtens%26aufirst%3DCharlotte%26date%3D2019%26volume%3D29%26issue%3D10%26spage%3D1232%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rainy  Agrawal</span>, <span class="hlFld-ContribAuthor ">Yamini  Thakur</span>, <span class="hlFld-ContribAuthor ">Mamta  Tripathi</span>, <span class="hlFld-ContribAuthor ">Mohammad Khursheed  Siddiqi</span>, <span class="hlFld-ContribAuthor ">Rizwan Hasan  Khan</span>, <span class="hlFld-ContribAuthor ">Rama  Pande</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidating the binding propensity of naphthyl hydroxamic acid to human serum albumin (HSA): Multi-spectroscopic and molecular modeling approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1184 </em>, 1-11. <a href="https://doi.org/10.1016/j.molstruc.2019.01.067" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.01.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.01.067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DElucidating%252Bthe%252Bbinding%252Bpropensity%252Bof%252Bnaphthyl%252Bhydroxamic%252Bacid%252Bto%252Bhuman%252Bserum%252Balbumin%252B%252528HSA%252529%25253A%252BMulti-spectroscopic%252Band%252Bmolecular%252Bmodeling%252Bapproach%26aulast%3DAgrawal%26aufirst%3DRainy%26date%3D2019%26volume%3D1184%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Robertson</span>, <span class="hlFld-ContribAuthor ">Y.  Harcus</span>, <span class="hlFld-ContribAuthor ">C. J. C.  Johnston</span>, <span class="hlFld-ContribAuthor ">A. P.  Page</span>, <span class="hlFld-ContribAuthor ">M. D.  Walkinshaw</span>, <span class="hlFld-ContribAuthor ">R. M.  Maizels</span>, <span class="hlFld-ContribAuthor ">D. R.  Houston</span>. </span><span class="cited-content_cbyCitation_article-title">Demonstration of the Anthelmintic Potency of Marimastat in the
              Heligmosomoides polygyrus
              Rodent Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Parasitology</span><span> <strong>2018,</strong> <em>104 </em>
                                    (6)
                                     , 705-709. <a href="https://doi.org/10.1645/18-33" title="DOI URL">https://doi.org/10.1645/18-33</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1645/18-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1645%2F18-33%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Parasitology%26atitle%3DDemonstration%252Bof%252Bthe%252BAnthelmintic%252BPotency%252Bof%252BMarimastat%252Bin%252Bthe%252BHeligmosomoides%252Bpolygyrus%252BRodent%252BModel%26aulast%3DRobertson%26aufirst%3DE.%26date%3D2018%26volume%3D104%26issue%3D6%26spage%3D705%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Micaela  Faria Freitas</span>, <span class="hlFld-ContribAuthor ">Muriel  Cuendet</span>, <span class="hlFld-ContribAuthor ">Philippe  Bertrand</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC inhibitors: a 2013–2017 patent survey. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (5)
                                     , 365-381. <a href="https://doi.org/10.1080/13543776.2018.1459568" title="DOI URL">https://doi.org/10.1080/13543776.2018.1459568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1459568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1459568%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DHDAC%252Binhibitors%25253A%252Ba%252B2013%2525E2%252580%2525932017%252Bpatent%252Bsurvey%26aulast%3DFaria%2BFreitas%26aufirst%3DMicaela%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D5%26spage%3D365%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayman B.  Farag</span>, <span class="hlFld-ContribAuthor ">Heba A.  Ewida</span>, <span class="hlFld-ContribAuthor ">Mahmoud Salama  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel amide and hydrazide based thioether analogs targeting Histone deacteylase (HDAC) enzymes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>148 </em>, 73-85. <a href="https://doi.org/10.1016/j.ejmech.2018.02.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bamide%252Band%252Bhydrazide%252Bbased%252Bthioether%252Banalogs%252Btargeting%252BHistone%252Bdeacteylase%252B%252528HDAC%252529%252Benzymes%26aulast%3DFarag%26aufirst%3DAyman%2BB.%26date%3D2018%26volume%3D148%26spage%3D73%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Marketed hydroxamic acid drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hydroxamic acid library design: <i>n</i> = 0–6; <i>m</i> = 1–3; in gray highlight, diversity within each hydroxamic acid library subset; Cy = Bz or cHx or adamantyl; Ar = Bz, <i>p</i>-fluorobenzyl, 4-pyridinyl, biphenyl, heteroaryl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. From Carboxylic Acid or Ester Precursors to Final Hydroxamic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KCN, aq NH<sub>2</sub>OH 50 wt %, MeOH, room temp, 2 h–48 h, 4%–88%; (b) NH<sub>2</sub>OH·HCl, KOH, MeOH, room temp, 16 h, 36% yield for <b>18</b>; (c) (i) 2 M NaOH, EtOH/THF, room temp, 16 h, (ii) 1 N HCl, 52–99%; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 2 h, quantitative yield; (e) (i) <i>O</i>-tritylhydroxylamine, EDCI, HOBt, <i>N</i>-methylmorpholine, DMF, room temp, 16 h; (ii) TFA, TIS, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 15 min, 8%–99%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Adamantane Derivative <b>12a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methylbenzenesulfonyl chloride, pyridine, room temp, 20 h, 75%; (b) KCN, DMF, 80 °C, 15 h, 84%; (c) KOH, EtOH, H<sub>2</sub>O, 90 °C, 20 h, 97%; (d) SOCl<sub>2</sub>, MeOH, 0 °C to room temp, 4 h, 21%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Secondary Amines <b>17a</b>, <b>27b</b>–<b>28b</b> and Cynnamyl Precursors <b>52b</b>, <b>54b</b>, <b>55a</b>, and <b>56b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) benzylamine, EtOH, room temp, 18 h, 84%; (b) malonic acid, pyridine, reflux, 1 h, quantitative yield; (c) MeOH, H<sub>2</sub>SO<sub>4</sub>, reflux, 16 h, 79%; (d) <i>N</i>,<i>N</i>-diethylethylenediamine, Et<sub>3</sub>N, dioxane, 90 °C, 16 h, 65%; (e) valeraldehyde, SnCl<sub>2</sub>·2H<sub>2</sub>O, AcOH, MeOH, 40 °C, 16 h, 48%; (f) (i) LiOH·H<sub>2</sub>O, MeOH, room temp, 20 min, (ii) benzaldehyde, room temp, 1 h, (iii) NaBH<sub>4</sub>, room temp, 30 min, 76–100%; (g) chlorosulfonic acid, 10–12 °C, 16 h, 30%; (h) aniline, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 16 h, 66%; (i) iodobenzene, silver acetate, palladium acetate, acetic acid, 110 °C, 6 h, 61%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Malonic Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) 2-naphthaldehyde, MeCN, room temp, 1.5 h, (ii) Hantzsch’s ester, <span class="smallcaps smallerCapital">l</span>-proline, MeOH, room temp, 16 h, 68%; (b) aniline, MeCN, 80 °C, 2 h, 48% <b>15b</b>, benzylamine, MeCN room temp, 3 h, 63% <b>20b</b>, benzylamine, MeCN, microwave 80 °C, 1.75 h, 95% <b>33b</b>; (c) SOCl<sub>2</sub>, MeOH, 0 °C to room temp, 0.5–5.25 h, 43%–89%; (d) (i) NaH, THF, 0 °C to room temp, 30 min, (ii) 4-(chloromethyl)pyridine hydrochloride, 40 °C, 5.5 h, 23%; (e) (i) sodium, abs EtOH, 0–50 °C, 1 h, (ii) bromomethylbenzene, 50 °C, 19 h, 37%; (f) KOH, EtOH, room temp, 24 h, quantitative yield; (g) amine, HBTU, DIPEA, DMF, 0 °C to room temp, 4–18 h, 41–75%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Phenylalkyl Ester Precursors <b>16a</b>, <b>22a</b>–<b>26a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) methyl 2-bromoacetate, DIPEA, DMF, 0 °C to room temp, 4 h, 54%; (b) LDA, MeI, THF, −78 °C to room temp, 85%; (c) (i) (2-iodoethyl)benzene, NaH, DMF, 70 °C, 3.5 h, 79%, (ii) benzyl bromide, NaH, DMF, toluene, room temp, 60 h, 83%; (iii) KOH, 2-methoxyethanol/H<sub>2</sub>O (10/1 v/v), 130 °C, 1.5 h, then 6 N HCl, 83%. (d) (2-bromoethyl)benzene, NaH, DMF, 0 °C, 1 h, then room temp, 16 h, 90%; (e) methyl iodide or bromomethylbenzene, NaH, DMF, 55 °C, overnight, 71–78%.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Amides <b>18a</b>, <b>29a</b>, <b>44a</b>, <b>45a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) phenylacetic acid, HOBt, EDCI, DIEA, DMF, room temp, 12–48 h, 70–84%; (b) benzoyl chloride, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temp, 1–2 h, 41–62%.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Sulfonylated Precursors <b>46a</b>–<b>51a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, 0 °C to room temp, 10 days, 64%; (b) benzenesulfonyl chloride, base, solvent, 0 °C to room temp, 2–18 h, 24–66%; (c) di-<i>tert</i>-butylacetal, toluene, DMF, 95 °C, 16 h, 65–71%; (d) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, 2 days, room temp, 87–96%.</p></p></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibitor-based esterase profiling scheme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Involvement of esterase activities in the hydrolysis of a given hydroxamic acid: using score <i>S</i> calculated as given in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf" class="ext-link">Supporting Information Methods</a>. <sup><i>b</i></sup>Positions of the amine or the amide (from Ph-, from -CONHOH).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Stabilization of <b>4</b> by highly unstable hydroxamic acids <b>9</b>, <b>10</b>, and <b>21</b>: % of <b>4</b> remaining in the absence (◆) or presence of <b>9</b> (○), <b>10</b> (□), <b>21</b> (△).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure–plasma stability relationships of hydroxamic acids: molecular properties and structural features increasing or decreasing stability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Docking of <b>33</b>, <b>47</b>, <b>51</b> in rat CES1. Carbon atoms for <b>33</b>, <b>47</b>, and <b>51</b> and key residues are in orange, magenta, and cyan, respectively. Arrow points to the carbonyl group of the hydroxamic function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/medium/jm-2017-014449_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Examples of the use of the medchem toolbox to stabilize hydroxamic acids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01444/20171103/images/large/jm-2017-014449_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01444&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sieber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Proteomic Profiling of Metalloprotease Activities with Cocktails of Active-Site Probes</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/nchembio781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fnchembio781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16565715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFSqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=274-281&author=S.+A.+Sieberauthor=S.+Niessenauthor=H.+S.+Hooverauthor=B.+F.+Cravatt&title=Proteomic+Profiling+of+Metalloprotease+Activities+with+Cocktails+of+Active-Site+Probes&doi=10.1038%2Fnchembio781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic profiling of metalloprotease activities with cocktails of active-site probes</span></div><div class="casAuthors">Sieber, Stephan A.; Niessen, Sherry; Hoover, Heather S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">274-281</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metalloproteases are a large, diverse class of enzymes involved in many physiol. and disease processes.  Metalloproteases are regulated by post-translational mechanisms that diminish the effectiveness of conventional genomic and proteomic methods for their functional characterization.  Chem. probes directed at active sites offer a potential way to measure metalloprotease activities in biol. systems; however, large variations in structure limit the scope of any single small-mol. probe aimed at profiling this enzyme class.  Here, we address this problem by creating a library of metalloprotease-directed probes that show complementary target selectivity.  These probes were applied as a 'cocktail' to proteomes and their labeling profiles were analyzed collectively using an advanced liq. chromatog.-mass spectrometry platform.  More than 20 metalloproteases were identified, including members from nearly all of the major branches of this enzyme class.  These findings suggest that chem. proteomic methods can serve as a universal strategy to profile the activity of the metalloprotease superfamily in complex biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNE0SB8T8albVg90H21EOLACvtfcHk0lhLCDbi-eUukQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFSqtrg%253D&md5=520ffbbd133cba468cc679d300896a6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnchembio781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio781%26sid%3Dliteratum%253Aachs%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DHoover%26aufirst%3DH.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteomic%2520Profiling%2520of%2520Metalloprotease%2520Activities%2520with%2520Cocktails%2520of%2520Active-Site%2520Probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D274%26epage%3D281%26doi%3D10.1038%2Fnchembio781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Marmion, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, K. B.</span><span> </span><span class="NLM_article-title">Hydroxamic Acids - an Intriguing Family of Enzyme Inhibitors and Biomedical Ligands</span> <span class="citation_source-journal">Eur. J. Inorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">3003</span><span class="NLM_x">–</span> <span class="NLM_lpage">3016</span><span class="refDoi"> DOI: 10.1002/ejic.200400221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fejic.200400221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2004&publication_year=2004&pages=3003-3016&author=C.+J.+Marmionauthor=D.+Griffithauthor=K.+B.+Nolan&title=Hydroxamic+Acids+-+an+Intriguing+Family+of+Enzyme+Inhibitors+and+Biomedical+Ligands&doi=10.1002%2Fejic.200400221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fejic.200400221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200400221%26sid%3Dliteratum%253Aachs%26aulast%3DMarmion%26aufirst%3DC.%2BJ.%26aulast%3DGriffith%26aufirst%3DD.%26aulast%3DNolan%26aufirst%3DK.%2BB.%26atitle%3DHydroxamic%2520Acids%2520-%2520an%2520Intriguing%2520Family%2520of%2520Enzyme%2520Inhibitors%2520and%2520Biomedical%2520Ligands%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2004%26volume%3D2004%26spage%3D3003%26epage%3D3016%26doi%3D10.1002%2Fejic.200400221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Boularot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglione, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duroc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves de Sousa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larue, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresteil, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artaud, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinnel, T.</span><span> </span><span class="NLM_article-title">Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1021/jm060910c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060910c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=10-20&author=A.+Boularotauthor=C.+Giglioneauthor=S.+Petitauthor=Y.+Durocauthor=R.+Alves+de+Sousaauthor=V.+Larueauthor=T.+Cresteilauthor=F.+Dardelauthor=I.+Artaudauthor=T.+Meinnel&title=Discovery+and+Refinement+of+a+New+Structural+Class+of+Potent+Peptide+Deformylase+Inhibitors&doi=10.1021%2Fjm060910c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm060910c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060910c%26sid%3Dliteratum%253Aachs%26aulast%3DBoularot%26aufirst%3DA.%26aulast%3DGiglione%26aufirst%3DC.%26aulast%3DPetit%26aufirst%3DS.%26aulast%3DDuroc%26aufirst%3DY.%26aulast%3DAlves%2Bde%2BSousa%26aufirst%3DR.%26aulast%3DLarue%26aufirst%3DV.%26aulast%3DCresteil%26aufirst%3DT.%26aulast%3DDardel%26aufirst%3DF.%26aulast%3DArtaud%26aufirst%3DI.%26aulast%3DMeinnel%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520Refinement%2520of%2520a%2520New%2520Structural%2520Class%2520of%2520Potent%2520Peptide%2520Deformylase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D10%26epage%3D20%26doi%3D10.1021%2Fjm060910c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Seki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Šilhár, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stowe, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lardy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K. D.</span><span> </span><span class="NLM_article-title">Synthesis/Biological Evaluation of Hydroxamic Acids and Their Prodrugs as Inhibitors for Botulinum Neurotoxin a Light Chain</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1208</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmc.2013.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=24360826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1208-1217&author=H.+Sekiauthor=S.+Pellettauthor=P.+%C5%A0ilh%C3%A1rauthor=G.+N.+Stoweauthor=B.+Blancoauthor=M.+A.+Lardyauthor=E.+A.+Johnsonauthor=K.+D.+Janda&title=Synthesis%2FBiological+Evaluation+of+Hydroxamic+Acids+and+Their+Prodrugs+as+Inhibitors+for+Botulinum+Neurotoxin+a+Light+Chain&doi=10.1016%2Fj.bmc.2013.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain</span></div><div class="casAuthors">Seki, Hajime; Pellett, Sabine; Silhar, Peter; Stowe, G. Neil; Blanco, Beatriz; Lardy, Matthew A.; Johnson, Eric A.; Janda, Kim D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1208-1217</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Botulinum neurotoxin A (BoNT/A) is the most potent toxin known.  Unfortunately, it is also a potential bioweapon in terrorism, which is without an approved therapeutic treatment once cellular intoxication takes place.  Previously, we reported how hydroxamic acid prodrug carbamates increased cellular uptake, which translated to successful inhibition of this neurotoxin.  Building upon this research, we detail BoNT/A protease mol. modeling studies accompanied by the construction of small library of hydroxamic acids based on 2,4-dichlorocinnamic hydroxamic acid scaffold and their carbamate prodrug derivatization along with the evaluation of these mols. in both enzymic and cellular models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRmI6_3n4afLVg90H21EOLACvtfcHk0lhLCDbi-eUukQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtLrP&md5=374545a7527db243f7dfd00f4157753c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DSeki%26aufirst%3DH.%26aulast%3DPellett%26aufirst%3DS.%26aulast%3D%25C5%25A0ilh%25C3%25A1r%26aufirst%3DP.%26aulast%3DStowe%26aufirst%3DG.%2BN.%26aulast%3DBlanco%26aufirst%3DB.%26aulast%3DLardy%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DE.%2BA.%26aulast%3DJanda%26aufirst%3DK.%2BD.%26atitle%3DSynthesis%252FBiological%2520Evaluation%2520of%2520Hydroxamic%2520Acids%2520and%2520Their%2520Prodrugs%2520as%2520Inhibitors%2520for%2520Botulinum%2520Neurotoxin%2520a%2520Light%2520Chain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1208%26epage%3D1217%26doi%3D10.1016%2Fj.bmc.2013.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">McAllister, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramite, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barham, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitton-Fry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R. M.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzien, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanmugasundaram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaras, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uccello, D. P.</span><span> </span><span class="NLM_article-title">Heterocyclic Methylsulfone Hydroxamic Acid Lpxc Inhibitors as Gram-Negative Antibacterial Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6832</span><span class="NLM_x">–</span> <span class="NLM_lpage">6838</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.09.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2012.09.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=23046961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVykur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6832-6838&author=L.+A.+McAllisterauthor=J.+I.+Montgomeryauthor=J.+A.+Abramiteauthor=U.+Reillyauthor=M.+F.+Brownauthor=J.+M.+Chenauthor=R.+A.+Barhamauthor=Y.+Cheauthor=S.+W.+Chungauthor=C.+A.+Menardauthor=M.+Mitton-Fryauthor=L.+M.+Mullinsauthor=M.+C.+Noeauthor=J.+P.+O%E2%80%99Donnellauthor=R.+M.+Oliverauthor=J.+B.+Penzienauthor=M.+Plummerauthor=L.+M.+Priceauthor=V.+Shanmugasundaramauthor=A.+P.+Tomarasauthor=D.+P.+Uccello&title=Heterocyclic+Methylsulfone+Hydroxamic+Acid+Lpxc+Inhibitors+as+Gram-Negative+Antibacterial+Agents&doi=10.1016%2Fj.bmcl.2012.09.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents</span></div><div class="casAuthors">McAllister, Laura A.; Montgomery, Justin I.; Abramite, Joseph A.; Reilly, Usa; Brown, Matthew F.; Chen, Jinshan M.; Barham, Rose A.; Che, Ye; Chung, Seung Won; Menard, Carol A.; Mitton-Fry, Mark; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Oliver, Robert M.; Penzien, Joseph B.; Plummer, Mark; Price, Loren M.; Shanmugasundaram, Veerabahu; Tomaras, Andrew P.; Uccello, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6832-6838</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and antibacterial activity of heterocyclic methylsulfone hydroxamates is presented.  Compds. in this series are potent inhibitors of the LpxC enzyme, a key enzyme involved in the prodn. of lipopolysaccharide (LPS) found in the outer membrane of Gram-neg. bacteria.  SAR evaluation of compds. in this series revealed analogs, e.g., I, with potent antibacterial activity against challenging Gram-neg. species such as Pseudomonas aeruginosa and Klebsiella pneumoniae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5_EQM-fls8LVg90H21EOLACvtfcHk0lhsLXoeRQK3qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVykur7P&md5=93dbfffc47f4eab6b67111ef7e67fa2e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.09.058%26sid%3Dliteratum%253Aachs%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DMontgomery%26aufirst%3DJ.%2BI.%26aulast%3DAbramite%26aufirst%3DJ.%2BA.%26aulast%3DReilly%26aufirst%3DU.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DBarham%26aufirst%3DR.%2BA.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DS.%2BW.%26aulast%3DMenard%26aufirst%3DC.%2BA.%26aulast%3DMitton-Fry%26aufirst%3DM.%26aulast%3DMullins%26aufirst%3DL.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DOliver%26aufirst%3DR.%2BM.%26aulast%3DPenzien%26aufirst%3DJ.%2BB.%26aulast%3DPlummer%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DL.%2BM.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26atitle%3DHeterocyclic%2520Methylsulfone%2520Hydroxamic%2520Acid%2520Lpxc%2520Inhibitors%2520as%2520Gram-Negative%2520Antibacterial%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6832%26epage%3D6838%26doi%3D10.1016%2Fj.bmcl.2012.09.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraghty, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Hydroxamic Acids Block Replication of Hepatitis C Virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1021/jm501330g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501330g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=785-800&author=T.+Aiauthor=Y.+Xuauthor=L.+Qiuauthor=R.+J.+Geraghtyauthor=L.+Chen&title=Hydroxamic+Acids+Block+Replication+of+Hepatitis+C+Virus&doi=10.1021%2Fjm501330g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamic Acids Block Replication of Hepatitis C Virus</span></div><div class="casAuthors">Ai, Teng; Xu, Yanli; Qiu, Li; Geraghty, Robert J.; Chen, Liqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">785-800</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Intrigued by the role of protein acetylation in hepatitis C virus (HCV) replication, we tested known histone deacetylase (HDAC) inhibitors and a focused library of structurally simple hydroxamic acids for inhibition of a HCV subgenomic replicon.  While known HDAC inhibitors with varied inhibitory profiles proved to be either relatively toxic or ineffective, structure-activity relationship (SAR) studies on cinnamic hydroxamic acid and benzo[b]thiophen-2-hydroxamic acid gave rise to compds. 22 and 53, which showed potent and selective anti-HCV activity and therefore are promising starting points for further structural optimization and mechanistic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmTtnDAbQUBbVg90H21EOLACvtfcHk0lhsLXoeRQK3qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGmsbbK&md5=9e28da98b4b9083f4c185d7390efbdfe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm501330g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501330g%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DGeraghty%26aufirst%3DR.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DHydroxamic%2520Acids%2520Block%2520Replication%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D785%26epage%3D800%26doi%3D10.1021%2Fjm501330g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Azaindole Hydroxamic Acids Are Potent HIV-1 Integrase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7211</span><span class="NLM_x">–</span> <span class="NLM_lpage">7219</span><span class="refDoi"> DOI: 10.1021/jm900862n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900862n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7211-7219&author=M.+B.+Pleweauthor=S.+L.+Butlerauthor=K.+R.+Dressauthor=Q.+Huauthor=T.+W.+Johnsonauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=H.+Lamauthor=W.+Liuauthor=D.+Nowlinauthor=Q.+Pengauthor=S.+V.+Rahavendranauthor=S.+P.+Tanisauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=J.+Zhang&title=Azaindole+Hydroxamic+Acids+Are+Potent+HIV-1+Integrase+Inhibitors&doi=10.1021%2Fjm900862n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900862n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900862n%26sid%3Dliteratum%253Aachs%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DNowlin%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAzaindole%2520Hydroxamic%2520Acids%2520Are%2520Potent%2520HIV-1%2520Integrase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7211%26epage%3D7219%26doi%3D10.1021%2Fjm900862n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piveteau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10909</span><span class="NLM_x">–</span> <span class="NLM_lpage">10917</span><span class="refDoi"> DOI: 10.1021/jm301506h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301506h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10909-10917&author=R.+Deprez-Poulainauthor=M.+Flipoauthor=C.+Piveteauauthor=F.+Lerouxauthor=S.+Dassonnevilleauthor=I.+Florentauthor=L.+Maesauthor=P.+Cosauthor=B.+Deprez&title=Structure-Activity+Relationships+and+Blood+Distribution+of+Antiplasmodial+Aminopeptidase-1+Inhibitors&doi=10.1021%2Fjm301506h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors</span></div><div class="casAuthors">Deprez-Poulain, Rebecca; Flipo, Marion; Piveteau, Catherine; Leroux, Florence; Dassonneville, Sandrine; Florent, Isabelle; Maes, Louis; Cos, Paul; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10909-10917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria is a severe infectious disease that causes between 655 000 and 1.2 million deaths annually.  To overcome the resistance to current drugs, new biol. targets are needed for drug development.  Aminopeptidase M1 (PfAM1), a zinc metalloprotease, has been proposed as a new drug target to fight malaria.  Herein, we disclosed the structure-activity relationships of a selective family of hydroxamate PfAM1 inhibitors based on the malonic template.  In particular, we performed a fluoro-scanning around hit 1 that enlightened the key positions of the halogen for activity.  The docking of the best inhibitor 2 is consistent with in vitro results.  The stability of 2 was evaluated in microsomes, in plasma, and toward glutathione.  The in vivo distribution study performed with the nanomolar hydroxamate inhibitor BDM14471 revealed that it reaches its site of action.  However, it fails to kill the parasite at concns. relevant to the enzymic inhibitory potency, suggesting that killing the parasite remains a challenge for potent and drug-like catalytic-site binding PfAM1 inhibitors.  In all, this study provides important insights for the design of inhibitors of PfAM1 and the validity of this target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy63Ha4C-69LVg90H21EOLACvtfcHk0lhQOdeLNmmlsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslaks7%252FL&md5=79f58a63feb789266e494450a5950390</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm301506h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301506h%26sid%3Dliteratum%253Aachs%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DFlorent%26aufirst%3DI.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DStructure-Activity%2520Relationships%2520and%2520Blood%2520Distribution%2520of%2520Antiplasmodial%2520Aminopeptidase-1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10909%26epage%3D10917%26doi%3D10.1021%2Fjm301506h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkwater, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaraman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiardini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, S.</span><span> </span><span class="NLM_article-title">Two-Pronged Attack: Dual Inhibition of Plasmodium Falciparum M1 and M17 Metalloaminopeptidases by a Novel Series of Hydroxamic Acid-Based Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9168</span><span class="NLM_x">–</span> <span class="NLM_lpage">9183</span><span class="refDoi"> DOI: 10.1021/jm501323a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501323a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9168-9183&author=S.+N.+Mistryauthor=N.+Drinkwaterauthor=C.+Ruggeriauthor=K.+K.+Sivaramanauthor=S.+Loganathanauthor=S.+Fletcherauthor=M.+Dragauthor=A.+Paiardiniauthor=V.+M.+Averyauthor=P.+J.+Scammellsauthor=S.+McGowan&title=Two-Pronged+Attack%3A+Dual+Inhibition+of+Plasmodium+Falciparum+M1+and+M17+Metalloaminopeptidases+by+a+Novel+Series+of+Hydroxamic+Acid-Based+Inhibitors&doi=10.1021%2Fjm501323a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Two-Pronged Attack: Dual Inhibition of Plasmodium falciparum M1 and M17 Metalloaminopeptidases by a Novel Series of Hydroxamic Acid-Based Inhibitors</span></div><div class="casAuthors">Mistry, Shailesh N.; Drinkwater, Nyssa; Ruggeri, Chiara; Sivaraman, Komagal Kannan; Loganathan, Sasdekumar; Fletcher, Sabine; Drag, Marcin; Paiardini, Alessandro; Avery, Vicky M.; Scammells, Peter J.; McGowan, Sheena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9168-9183</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasmodium parasites, the causative agents of malaria, have developed resistance to most of the current antimalarial therapies, including artemisinin combination therapies which are widely described as the last line of defense.  Antimalarial agents with a novel mode of action are urgently required.  Two Plasmodium falciparum aminopeptidases, PfA-M1 and PfA-M17, play crucial roles in the erythrocytic stage of infection and have been validated as potential antimalarial targets.  Using compd.-bound crystal structures of both enzymes, the authors have used a structure-guided approach to develop a novel series of inhibitors capable of potent inhibition of both PfA-M1 and PfA-M17 activity and parasite growth in culture.  Herein the authors describe the design, synthesis, and evaluation of a series of hydroxamic acid-based inhibitors I [R1 = PhCO, 2-FC6H4CO, 3-H2NC6H4CO, etc.; R2 = HO, HONH] and demonstrate the compds. to be exciting new leads for the development of novel antimalarial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTJUvJd2YOGLVg90H21EOLACvtfcHk0lhQOdeLNmmlsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahs77E&md5=6b6fe308bc3b434d686268e65014d9c1</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm501323a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501323a%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DDrinkwater%26aufirst%3DN.%26aulast%3DRuggeri%26aufirst%3DC.%26aulast%3DSivaraman%26aufirst%3DK.%2BK.%26aulast%3DLoganathan%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DDrag%26aufirst%3DM.%26aulast%3DPaiardini%26aufirst%3DA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMcGowan%26aufirst%3DS.%26atitle%3DTwo-Pronged%2520Attack%253A%2520Dual%2520Inhibition%2520of%2520Plasmodium%2520Falciparum%2520M1%2520and%2520M17%2520Metalloaminopeptidases%2520by%2520a%2520Novel%2520Series%2520of%2520Hydroxamic%2520Acid-Based%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9168%26epage%3D9183%26doi%3D10.1021%2Fjm501323a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">France, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, A. P.</span><span> </span><span class="NLM_article-title">Identification and Activity of Inhibitors of the Essential Nematode-Specific Metalloprotease Dpy-31</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5752</span><span class="NLM_x">–</span> <span class="NLM_lpage">5755</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2015.10.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5752-5755&author=D.+J.+Franceauthor=G.+Stepekauthor=D.+R.+Houstonauthor=L.+Williamsauthor=G.+McCormackauthor=M.+D.+Walkinshawauthor=A.+P.+Page&title=Identification+and+Activity+of+Inhibitors+of+the+Essential+Nematode-Specific+Metalloprotease+Dpy-31&doi=10.1016%2Fj.bmcl.2015.10.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.077%26sid%3Dliteratum%253Aachs%26aulast%3DFrance%26aufirst%3DD.%2BJ.%26aulast%3DStepek%26aufirst%3DG.%26aulast%3DHouston%26aufirst%3DD.%2BR.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DMcCormack%26aufirst%3DG.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DPage%26aufirst%3DA.%2BP.%26atitle%3DIdentification%2520and%2520Activity%2520of%2520Inhibitors%2520of%2520the%2520Essential%2520Nematode-Specific%2520Metalloprotease%2520Dpy-31%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5752%26epage%3D5755%26doi%3D10.1016%2Fj.bmcl.2015.10.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Novakova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jancarik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlicek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlinova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barinka, C.</span><span> </span><span class="NLM_article-title">Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase Ii: Structural Characterization and Biological Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4539</span><span class="NLM_x">–</span> <span class="NLM_lpage">4550</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01806</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4539-4550&author=Z.+Novakovaauthor=K.+Wozniakauthor=A.+Jancarikauthor=R.+Raisauthor=Y.+Wuauthor=J.+Pavlicekauthor=D.+Ferrarisauthor=B.+Havlinovaauthor=J.+Ptacekauthor=J.+Vavraauthor=N.+Hinauthor=C.+Rojasauthor=P.+Majerauthor=B.+S.+Slusherauthor=T.+Tsukamotoauthor=C.+Barinka&title=Unprecedented+Binding+Mode+of+Hydroxamate-Based+Inhibitors+of+Glutamate+Carboxypeptidase+Ii%3A+Structural+Characterization+and+Biological+Activity&doi=10.1021%2Facs.jmedchem.5b01806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity</span></div><div class="casAuthors">Novakova, Zora; Wozniak, Krystyna; Jancarik, Andrej; Rais, Rana; Wu, Ying; Pavlicek, Jiri; Ferraris, Dana; Havlinova, Barbora; Ptacek, Jakub; Vavra, Jan; Hin, Niyada; Rojas, Camilo; Majer, Pavel; Slusher, Barbara S.; Tsukamoto, Takashi; Barinka, Cyril</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4539-4550</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of glutamate carboxypeptidase II (GCPII) is effective in preclin. models of neurol. disorders assocd. with excessive activation of glutamatergic systems.  Here we report synthesis, structural characterization, and biol. activity of new hydroxamic acid-based inhibitors with nanomolar affinity for human GCPII.  Crystal structures of GCPII/hydroxamate complexes revealed an unprecedented binding mode in which the putative P1' glutarate occupies the spacious entrance funnel rather than the conserved glutamate-binding S1' pocket.  This unique binding mode provides a mechanistic explanation for the structure-activity relationship data, most notably the lack of enantiospecificity and the tolerance for bulky/hydrophobic functions as substituents of a canonical glutarate moiety.  The in vivo pharmacokinetics profile of one of the inhibitors will be presented along with analgesic efficacy data from the rat chronic constrictive injury model of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC9E-sr57YkbVg90H21EOLACvtfcHk0lhQOdeLNmmlsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsL0%253D&md5=8ebdd56cda221edd563f22b6b268a7aa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01806%26sid%3Dliteratum%253Aachs%26aulast%3DNovakova%26aufirst%3DZ.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPavlicek%26aufirst%3DJ.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DHavlinova%26aufirst%3DB.%26aulast%3DPtacek%26aufirst%3DJ.%26aulast%3DVavra%26aufirst%3DJ.%26aulast%3DHin%26aufirst%3DN.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DBarinka%26aufirst%3DC.%26atitle%3DUnprecedented%2520Binding%2520Mode%2520of%2520Hydroxamate-Based%2520Inhibitors%2520of%2520Glutamate%2520Carboxypeptidase%2520Ii%253A%2520Structural%2520Characterization%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4539%26epage%3D4550%26doi%3D10.1021%2Facs.jmedchem.5b01806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enée, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totobenazara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahklal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdelet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woitrain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauriot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrelle, F.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herledan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piveteau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Endert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Catalytic Site Inhibition of Insulin-Degrading Enzyme by a Small Molecule Induces Glucose Intolerance in Mice</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8250</span><span class="refDoi"> DOI: 10.1038/ncomms9250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fncomms9250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=26394692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGks7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8250&author=R.+Deprez-Poulainauthor=N.+Hennuyerauthor=D.+Boscauthor=W.+G.+Liangauthor=E.+En%C3%A9eauthor=X.+Marechalauthor=J.+Chartonauthor=J.+Totobenazaraauthor=G.+Berteauthor=J.+Jahklalauthor=T.+Verdeletauthor=J.+Dumontauthor=S.+Dassonnevilleauthor=E.+Woitrainauthor=M.+Gauriotauthor=C.+Paquetauthor=I.+Duplanauthor=P.+Hermantauthor=F.-X.+Cantrelleauthor=E.+Sevinauthor=M.+Culotauthor=V.+Landryauthor=A.+Herledanauthor=C.+Piveteauauthor=G.+Lippensauthor=F.+Lerouxauthor=W.-J.+Tangauthor=P.+van+Endertauthor=B.+Staelsauthor=B.+Deprez&title=Catalytic+Site+Inhibition+of+Insulin-Degrading+Enzyme+by+a+Small+Molecule+Induces+Glucose+Intolerance+in+Mice&doi=10.1038%2Fncomms9250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice</span></div><div class="casAuthors">Deprez-Poulain, Rebecca; Hennuyer, Nathalie; Bosc, Damien; Liang, Wenguang G.; Enee, Emmanuelle; Marechal, Xavier; Charton, Julie; Totobenazara, Jane; Berte, Gonzague; Jahklal, Jouda; Verdelet, Tristan; Dumont, Julie; Dassonneville, Sandrine; Woitrain, Eloise; Gauriot, Marion; Paquet, Charlotte; Duplan, Isabelle; Hermant, Paul; Cantrelle, Francois- Xavier; Sevin, Emmanuel; Culot, Maxime; Landry, Valerie; Herledan, Adrien; Piveteau, Catherine; Lippens, Guy; Leroux, Florence; Tang, Wei-Jen; van Endert, Peter; Staels, Bart; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8250</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Insulin-degrading enzyme (IDE) is a protease that cleaves insulin and other bioactive peptides such as amyloid-β.  Knockout and genetic studies have linked IDE to Alzheimer's disease and type-2 diabetes.  As the major insulin-degrading protease, IDE is a candidate drug target in diabetes.  Here we have used kinetic target-guided synthesis to design the first catalytic site inhibitor of IDE suitable for in vivo studies (BDM44768).  Crystallog. and small angle X-ray scattering analyses show that it locks IDE in a closed conformation.  Among a panel of metalloproteases, BDM44768 selectively inhibits IDE.  Acute treatment of mice with BDM44768 increases insulin signalling and surprisingly impairs glucose tolerance in an IDE-dependent manner.  These results confirm that IDE is involved in pathways that modulate short-term glucose homeostasis, but casts doubt on the general usefulness of the inhibition of IDE catalytic activity to treat diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodV3LKS8InMbVg90H21EOLACvtfcHk0lht28yaxJAJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGks7%252FN&md5=b04d4adc8373a451e8f9a0c82a827462</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fncomms9250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9250%26sid%3Dliteratum%253Aachs%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DBosc%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DW.%2BG.%26aulast%3DEn%25C3%25A9e%26aufirst%3DE.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DTotobenazara%26aufirst%3DJ.%26aulast%3DBerte%26aufirst%3DG.%26aulast%3DJahklal%26aufirst%3DJ.%26aulast%3DVerdelet%26aufirst%3DT.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DWoitrain%26aufirst%3DE.%26aulast%3DGauriot%26aufirst%3DM.%26aulast%3DPaquet%26aufirst%3DC.%26aulast%3DDuplan%26aufirst%3DI.%26aulast%3DHermant%26aufirst%3DP.%26aulast%3DCantrelle%26aufirst%3DF.-X.%26aulast%3DSevin%26aufirst%3DE.%26aulast%3DCulot%26aufirst%3DM.%26aulast%3DLandry%26aufirst%3DV.%26aulast%3DHerledan%26aufirst%3DA.%26aulast%3DPiveteau%26aufirst%3DC.%26aulast%3DLippens%26aufirst%3DG.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DW.-J.%26aulast%3Dvan%2BEndert%26aufirst%3DP.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DCatalytic%2520Site%2520Inhibition%2520of%2520Insulin-Degrading%2520Enzyme%2520by%2520a%2520Small%2520Molecule%2520Induces%2520Glucose%2520Intolerance%2520in%2520Mice%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8250%26doi%3D10.1038%2Fncomms9250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Orbe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Arias, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugarte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belzunce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Páramo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel Matrix Metalloproteinase Inhibitors as Potent Antihemorrhagic Agents: From Hit Identification to an Optimized Lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2465</span><span class="NLM_x">–</span> <span class="NLM_lpage">2488</span><span class="refDoi"> DOI: 10.1021/jm501940y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501940y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2465-2488&author=J.+Orbeauthor=J.+A.+S%C3%A1nchez-Ariasauthor=O.+Rabalauthor=J.+A.+Rodr%C3%ADguezauthor=A.+Salicioauthor=A.+Ugarteauthor=M.+Belzunceauthor=M.+Xuauthor=W.+Wuauthor=H.+Tanauthor=H.+Maauthor=J.+A.+P%C3%A1ramoauthor=J.+Oyarzabal&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+Matrix+Metalloproteinase+Inhibitors+as+Potent+Antihemorrhagic+Agents%3A+From+Hit+Identification+to+an+Optimized+Lead&doi=10.1021%2Fjm501940y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Matrix Metalloproteinase Inhibitors As Potent Antihemorrhagic Agents: From Hit Identification to an Optimized Lead</span></div><div class="casAuthors">Orbe, Josune; Sanchez-Arias, Juan A.; Rabal, Obdulia; Rodriguez, Jose A.; Salicio, Agustina; Ugarte, Ana; Belzunce, Miriam; Xu, Musheng; Wu, Wei; Tan, Haizhong; Ma, Hongyu; Paramo, Jose A.; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2465-2488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Growing evidence suggests that matrix metalloproteinases (MMP) are involved in thrombus dissoln.; then, considering that new therapeutic strategies are required for controlling hemorrhage, we hypothesized that MMP inhibition may reduce bleeding by delaying fibrinolysis.  Thus, we designed and synthesized a novel series of MMP inhibitors to identify potential candidates for acute treatment of bleeding.  Structure-based and knowledge-based strategies were utilized to design this novel chem. series, α-spiropiperidine hydroxamates, of potent and sol. (>75 μg/mL) pan-MMP inhibitors.  The initial hit was progressed to an optimal lead I.  Racemic I showed a remarkable in vitro phenotypic response and outstanding in vivo efficacy; in fact, the mouse bleeding time at 1 mg/kg was 0.85 min compared to 29.28 min using saline.  In addn., I displayed an optimal ADME and safety profile (e.g., no thrombus formation).  Its corresponding enantiomers were sepd., leading to the preclin. candidate (R)-I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGretnPXVi3YibVg90H21EOLACvtfcHk0lht28yaxJAJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGiurk%253D&md5=1d56002442eae50c83de14d1f217701b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm501940y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501940y%26sid%3Dliteratum%253Aachs%26aulast%3DOrbe%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%2BA.%26aulast%3DSalicio%26aufirst%3DA.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DBelzunce%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DP%25C3%25A1ramo%26aufirst%3DJ.%2BA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520as%2520Potent%2520Antihemorrhagic%2520Agents%253A%2520From%2520Hit%2520Identification%2520to%2520an%2520Optimized%2520Lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2465%26epage%3D2488%26doi%3D10.1021%2Fjm501940y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Noe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti-Morrow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocum, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardink, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokar, C.</span><span> </span><span class="NLM_article-title">Discovery of 3,3-Dimethyl-5-Hydroxypipecolic Hydroxamate-Based Inhibitors of Aggrecanase and Mmp-13</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2808</span><span class="NLM_x">–</span> <span class="NLM_lpage">2811</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2005.03.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=15911259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2808-2811&author=M.+C.+Noeauthor=V.+Natarajanauthor=S.+L.+Snowauthor=P.+G.+Mitchellauthor=L.+Lopresti-Morrowauthor=L.+M.+Reevesauthor=S.+A.+Yocumauthor=T.+J.+Cartyauthor=J.+A.+Barberiaauthor=F.+J.+Sweeneyauthor=J.+L.+Lirasauthor=M.+Vaughnauthor=J.+R.+Hardinkauthor=J.+M.+Hawkinsauthor=C.+Tokar&title=Discovery+of+3%2C3-Dimethyl-5-Hydroxypipecolic+Hydroxamate-Based+Inhibitors+of+Aggrecanase+and+Mmp-13&doi=10.1016%2Fj.bmcl.2005.03.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13</span></div><div class="casAuthors">Noe, Mark C.; Natarajan, Vijayalakshmi; Snow, Sheri L.; Mitchell, Peter G.; Lopresti-Morrow, Lori; Reeves, Lisa M.; Yocum, Sue A.; Carty, Thomas J.; Barberia, John A.; Sweeney, Francis J.; Liras, Jennifer L.; Vaughn, Marcie; Hardink, Joel R.; Hawkins, Joel M.; Tokar, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2808-2811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of pipecolic hydroxamate inhibitors of MMP-13 and aggrecanase was discovered based on screening known inhibitors of TNF-α converting enzyme (TACE).  Thus, a diastereoselective Strecker reaction of H2C:CHCH2CMe2CHO with (R)-H2NCH(Me)Ph gave the α-aminonitrile I which was subsequently asym. dihydroxylated, cyclized, hydrogenated, and sulfonylated to give the desired pipecolic acid hydroxamates II (R = 2-MeC6H4, 2,4-Cl2C6H3, 4-quinolinyl, etc.).  Potency vs. aggrecanase was optimized by modification of the benzyloxyarylsulfonamide group.  Incorporation of geminal alkyl substitution at the 3-position of the piperidine ring improved metabolic stability, presumably by increasing steric hindrance around the metabolically labile hydroxamic acid.  This modification also resulted in dramatic improvement of aggrecanase activity with a slight redn. in selectivity vs. MMP-1.  Synthesis, structure activity relationships, and strategies to reduce metabolic clearance are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIkZAvxWGTLVg90H21EOLACvtfcHk0lgW0G0TOiQ0Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wju7k%253D&md5=80844b9e116bc4bf5fbd2e9d245bb250</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.105%26sid%3Dliteratum%253Aachs%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DNatarajan%26aufirst%3DV.%26aulast%3DSnow%26aufirst%3DS.%2BL.%26aulast%3DMitchell%26aufirst%3DP.%2BG.%26aulast%3DLopresti-Morrow%26aufirst%3DL.%26aulast%3DReeves%26aufirst%3DL.%2BM.%26aulast%3DYocum%26aufirst%3DS.%2BA.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DBarberia%26aufirst%3DJ.%2BA.%26aulast%3DSweeney%26aufirst%3DF.%2BJ.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DVaughn%26aufirst%3DM.%26aulast%3DHardink%26aufirst%3DJ.%2BR.%26aulast%3DHawkins%26aufirst%3DJ.%2BM.%26aulast%3DTokar%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25203%252C3-Dimethyl-5-Hydroxypipecolic%2520Hydroxamate-Based%2520Inhibitors%2520of%2520Aggrecanase%2520and%2520Mmp-13%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2808%26epage%3D2811%26doi%3D10.1016%2Fj.bmcl.2005.03.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">El Bakali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras-Masse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maingot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Inhibition of Aggrecanase as a Therapeutic Strategy in Osteoarthritis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.4155/fmc.14.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.4155%2Ffmc.14.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25329196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1399-1412&author=J.+El+Bakaliauthor=H.+Gras-Masseauthor=L.+Maingotauthor=B.+Deprezauthor=J.+Dumontauthor=F.+Lerouxauthor=R.+Deprez-Poulain&title=Inhibition+of+Aggrecanase+as+a+Therapeutic+Strategy+in+Osteoarthritis&doi=10.4155%2Ffmc.14.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis</span></div><div class="casAuthors">El Bakali Jamal; Gras-Masse Helene; Maingot Lucie; Deprez Benoit; Dumont Julie; Leroux Florence; Deprez-Poulain Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Future medicinal chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1399-412</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the last decade, there has been a large effort to target aggrecanases, which are responsible for the degradation of the aggrecan in the extracellular matrix of joints, in order to hopefully lead to new treatments for osteoarthritis.  Only a few inhibitors have been effective in explants or rodent models and thus only a few have reached the clinic, none of which have proven to be effective.  In this article, a survey of chemical series is described, covering historical and recent inhibitors and highlighting how some of their problems were resolved, with a critical overview of the challenges encountered.  A large effort should be undertaken in designing smaller compounds with higher residence times, defining new interaction sites on the aggrecanases and exploiting target flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc6YFS0apR4JZoeNcnHOQ9fW6udTcc2ebelGHY0RWYM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D&md5=85f4d7d300cf08249358f9db09cf3e69</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.84%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BBakali%26aufirst%3DJ.%26aulast%3DGras-Masse%26aufirst%3DH.%26aulast%3DMaingot%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Aggrecanase%2520as%2520a%2520Therapeutic%2520Strategy%2520in%2520Osteoarthritis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1399%26epage%3D1412%26doi%3D10.4155%2Ffmc.14.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinning, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span> </span><span class="NLM_article-title">Discovery of Novel Hydroxamates as Highly Potent Tumor Necrosis Factor-Converting Enzyme Inhibitors: Part I:Discovery of Two Binding Modes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1021/jm070376o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070376o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=725-736&author=Z.+Zhuauthor=R.+Mazzolaauthor=L.+Sinningauthor=B.+McKittrickauthor=X.+Niuauthor=D.+Lundellauthor=J.+Sunauthor=P.+Orthauthor=Z.+Guoauthor=V.+Madisonauthor=R.+Ingramauthor=B.+M.+Beyer&title=Discovery+of+Novel+Hydroxamates+as+Highly+Potent+Tumor+Necrosis+Factor-Converting+Enzyme+Inhibitors%3A+Part+I%3ADiscovery+of+Two+Binding+Modes&doi=10.1021%2Fjm070376o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm070376o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070376o%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DSinning%26aufirst%3DL.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26atitle%3DDiscovery%2520of%2520Novel%2520Hydroxamates%2520as%2520Highly%2520Potent%2520Tumor%2520Necrosis%2520Factor-Converting%2520Enzyme%2520Inhibitors%253A%2520Part%2520I%253ADiscovery%2520of%2520Two%2520Binding%2520Modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D725%26epage%3D736%26doi%3D10.1021%2Fjm070376o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ouvry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berton, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhurruth-Alcor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnary, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouix-Peter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouquet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourotte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacini-Rachinel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzy, A.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reversé, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosignoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taquet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span> </span><span class="NLM_article-title">Identification of Novel Tace Inhibitors Compatible with Topical Application</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1848</span><span class="NLM_x">–</span> <span class="NLM_lpage">1853</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2017.02.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1848-1853&author=G.+Ouvryauthor=Y.+Bertonauthor=Y.+Bhurruth-Alcorauthor=L.+Bonnaryauthor=C.+Bouix-Peterauthor=K.+Bouquetauthor=M.+Bourotteauthor=S.+Chambonauthor=C.+Cominoauthor=B.+Deprezauthor=D.+Duvertauthor=G.+Duvertauthor=F.+Hacini-Rachinelauthor=C.+S.+Harrisauthor=A.-P.+Luzyauthor=A.+Mathieuauthor=C.+Milloisauthor=J.+Pascauauthor=A.+Pintoauthor=G.+Polgeauthor=A.+Reitzauthor=K.+Revers%C3%A9author=C.+Rosignoliauthor=N.+Taquetauthor=L.+F.+Hennequin&title=Identification+of+Novel+Tace+Inhibitors+Compatible+with+Topical+Application&doi=10.1016%2Fj.bmcl.2017.02.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DBerton%26aufirst%3DY.%26aulast%3DBhurruth-Alcor%26aufirst%3DY.%26aulast%3DBonnary%26aufirst%3DL.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DBouquet%26aufirst%3DK.%26aulast%3DBourotte%26aufirst%3DM.%26aulast%3DChambon%26aufirst%3DS.%26aulast%3DComino%26aufirst%3DC.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DDuvert%26aufirst%3DG.%26aulast%3DHacini-Rachinel%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DLuzy%26aufirst%3DA.-P.%26aulast%3DMathieu%26aufirst%3DA.%26aulast%3DMillois%26aufirst%3DC.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DPolge%26aufirst%3DG.%26aulast%3DReitz%26aufirst%3DA.%26aulast%3DRevers%25C3%25A9%26aufirst%3DK.%26aulast%3DRosignoli%26aufirst%3DC.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DIdentification%2520of%2520Novel%2520Tace%2520Inhibitors%2520Compatible%2520with%2520Topical%2520Application%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1848%26epage%3D1853%26doi%3D10.1016%2Fj.bmcl.2017.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Boiteau, J.-G.; Ouvry, G.; Arlabosse, J.-M.; Astri, S.; Beillard, A.; Bhurruth-Alcor, Y.; Bonnary, L.; Bouix-Peter, C.; Bouquet, K.; Bourotte, M.; Cardinaud, I.; Comino, C.; Deprez, B.; Duvert, D.; Féret, A.; Hacini-Rachinel, F.; Harris, C. S.; Luzy, A.-P.; Mathieu, A.; Millois, C.; Orsini, N.; Pascau, J.; Pinto, A.; Piwnica, D.; Polge, G.; Reitz, A.; Reversé, K.; Rodeville, N.; Rossio, P.; Spiesse, D.; Tabet, S.; Taquet, N.; Tomas, L.; Vial, E.; Hennequin, L. F.</span><span> </span><span class="NLM_article-title">Discovery and Process Development of a Novel Tace Inhibitor for the Topical Treatment of Psoriasis</span>.  <span class="citation_source-journal">Bioorg. Med. Chem.</span>. Published Online: August 2,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1016/j.bmc.2017.07.054</span> ; <a href="http://www.sciencedirect.com/science/article/pii/S0968089617310647" class="extLink">http://www.sciencedirect.com/science/article/pii/S0968089617310647</a> (accessed October 5, 2017).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmc.2017.07.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.-G.+Boiteau&author=G.+Ouvry&author=J.-M.+Arlabosse&author=S.+Astri&author=A.+Beillard&author=Y.+Bhurruth-Alcor&author=L.+Bonnary&author=C.+Bouix-Peter&author=K.+Bouquet&author=M.+Bourotte&author=I.+Cardinaud&author=C.+Comino&author=B.+Deprez&author=D.+Duvert&author=A.+F%C3%A9ret&author=F.+Hacini-Rachinel&author=C.+S.+Harris&author=A.-P.+Luzy&author=A.+Mathieu&author=C.+Millois&author=N.+Orsini&author=J.+Pascau&author=A.+Pinto&author=D.+Piwnica&author=G.+Polge&author=A.+Reitz&author=K.+Revers%C3%A9&author=N.+Rodeville&author=P.+Rossio&author=D.+Spiesse&author=S.+Tabet&author=N.+Taquet&author=L.+Tomas&author=E.+Vial&author=L.+F.+Hennequin&title=Discovery+and+Process+Development+of+a+Novel+Tace+Inhibitor+for+the+Topical+Treatment+of+Psoriasis&doi=10.1016%2Fj.bmc.2017.07.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.054%26sid%3Dliteratum%253Aachs%26aulast%3DBoiteau%26aufirst%3DJ.-G.%26atitle%3DDiscovery%2520and%2520Process%2520Development%2520of%2520a%2520Novel%2520Tace%2520Inhibitor%2520for%2520the%2520Topical%2520Treatment%2520of%2520Psoriasis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26doi%3D10.1016%2Fj.bmc.2017.07.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katiyar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marando, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeleswaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalluri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B.</span><span> </span><span class="NLM_article-title">Discovery of a Potent, Selective, and Orally Active Human Epidermal Growth Factor Receptor-2 Sheddase Inhibitor for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span><span class="refDoi"> DOI: 10.1021/jm061344o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061344o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=603-606&author=W.+Yaoauthor=J.+Zhuoauthor=D.+M.+Burnsauthor=M.+Xuauthor=C.+Zhangauthor=Y.+L.+Liauthor=D.+Q.+Qianauthor=C.+Heauthor=L.+Wengauthor=E.+Shiauthor=Q.+Linauthor=C.+Agriosauthor=T.+C.+Burnauthor=E.+Caulderauthor=M.+B.+Covingtonauthor=J.+S.+Fridmanauthor=S.+Friedmanauthor=K.+Katiyarauthor=G.+Hollisauthor=Y.+Liauthor=C.+Liuauthor=X.+Liuauthor=C.+A.+Marandoauthor=R.+Newtonauthor=M.+Panauthor=P.+Scherleauthor=N.+Taylorauthor=K.+Vaddiauthor=Z.+R.+Wassermanauthor=R.+Wynnauthor=S.+Yeleswaramauthor=R.+Jalluriauthor=M.+Bowerauthor=B.+B.+Zhouauthor=B.+Metcalf&title=Discovery+of+a+Potent%2C+Selective%2C+and+Orally+Active+Human+Epidermal+Growth+Factor+Receptor-2+Sheddase+Inhibitor+for+the+Treatment+of+Cancer&doi=10.1021%2Fjm061344o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm061344o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061344o%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhuo%26aufirst%3DJ.%26aulast%3DBurns%26aufirst%3DD.%2BM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%2BL.%26aulast%3DQian%26aufirst%3DD.%2BQ.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DWeng%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DAgrios%26aufirst%3DC.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DCovington%26aufirst%3DM.%2BB.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DFriedman%26aufirst%3DS.%26aulast%3DKatiyar%26aufirst%3DK.%26aulast%3DHollis%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMarando%26aufirst%3DC.%2BA.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DPan%26aufirst%3DM.%26aulast%3DScherle%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DWasserman%26aufirst%3DZ.%2BR.%26aulast%3DWynn%26aufirst%3DR.%26aulast%3DYeleswaram%26aufirst%3DS.%26aulast%3DJalluri%26aufirst%3DR.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DB.%2BB.%26aulast%3DMetcalf%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Active%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520Sheddase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D603%26epage%3D606%26doi%3D10.1021%2Fjm061344o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Falkenberg, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Histone Deacetylases and Their Inhibitors in Cancer, Neurological Diseases and Immune Disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1038/nrd4360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fnrd4360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25131830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKrtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=673-691&author=K.+J.+Falkenbergauthor=R.+W.+Johnstone&title=Histone+Deacetylases+and+Their+Inhibitors+in+Cancer%2C+Neurological+Diseases+and+Immune+Disorders&doi=10.1038%2Fnrd4360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders</span></div><div class="casAuthors">Falkenberg, Katrina J.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">673-691</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epigenetic aberrations, which are recognized as key drivers of several human diseases, are often caused by genetic defects that result in functional deregulation of epigenetic proteins, their altered expression and/or their atypical recruitment to certain gene promoters.  Importantly, epigenetic changes are reversible, and epigenetic enzymes and regulatory proteins can be targeted using small mols.  This Review discusses the role of altered expression and/or function of one class of epigenetic regulators - histone deacetylases (HDACs) - and their role in cancer, neurol. diseases and immune disorders.  We highlight the development of small-mol. HDAC inhibitors and their use in the lab., in preclin. models and in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXiWEG49LhebVg90H21EOLACvtfcHk0lidiZAz6GczQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKrtLjI&md5=ccfb68fa3fd4685e2305cdf8a6a9c81a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd4360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4360%26sid%3Dliteratum%253Aachs%26aulast%3DFalkenberg%26aufirst%3DK.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DHistone%2520Deacetylases%2520and%2520Their%2520Inhibitors%2520in%2520Cancer%252C%2520Neurological%2520Diseases%2520and%2520Immune%2520Disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D673%26epage%3D691%26doi%3D10.1038%2Fnrd4360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnachi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, W. V.</span><span> </span><span class="NLM_article-title">B-N-Biaryl Ether Sulfonamide Hydroxamates as Potent Gelatinase Inhibitors: Part 2. Optimization of A-Amino Substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2007.11.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1140-1145&author=S.-M.+Yangauthor=R.+H.+Scannevinauthor=B.+Wangauthor=S.+L.+Burkeauthor=Z.+Huangauthor=P.+Karnachiauthor=L.+J.+Wilsonauthor=K.+J.+Rhodesauthor=B.+Laguauthor=W.+V.+Murray&title=B-N-Biaryl+Ether+Sulfonamide+Hydroxamates+as+Potent+Gelatinase+Inhibitors%3A+Part+2.+Optimization+of+A-Amino+Substituents&doi=10.1016%2Fj.bmcl.2007.11.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.129%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-M.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DS.%2BL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DKarnachi%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26atitle%3DB-N-Biaryl%2520Ether%2520Sulfonamide%2520Hydroxamates%2520as%2520Potent%2520Gelatinase%2520Inhibitors%253A%2520Part%25202.%2520Optimization%2520of%2520A-Amino%2520Substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1140%26epage%3D1145%26doi%3D10.1016%2Fj.bmcl.2007.11.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. Q.</span><span> </span><span class="NLM_article-title">Stability Studies of Vorinostat and Its Two Metabolites in Human Plasma, Serum and Urine</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/j.jpba.2006.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.jpba.2006.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16824724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFers7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=556-564&author=L.+Duauthor=D.+G.+Mussonauthor=A.+Q.+Wang&title=Stability+Studies+of+Vorinostat+and+Its+Two+Metabolites+in+Human+Plasma%2C+Serum+and+Urine&doi=10.1016%2Fj.jpba.2006.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Stability studies of vorinostat and its two metabolites in human plasma, serum and urine</span></div><div class="casAuthors">Du, Lihong; Musson, Donald G.; Wang, Amy Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">556-564</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Effects of storage time and freeze-thaw procedure on the stability of vorinostat (suberoylanilide hydroxamic acid) and its two metabolites, vorinostat O-glucuronide (M1) and 4-anilino-4-oxobutanoic acid (M2), in human plasma, serum and urine have been examd. using high turbulence liq. chromatog. (HTLC) online extn. and tandem mass spectrometry (MS/MS) [L. Du, D.G. Musson, A.Q. Wang, Rapid Commun. Mass Spectrom. 19 (2005) 1779-1787].  Vorinostat was demonstrated not to be stable in human plasma during the process of sample processing and storage.  Acidifying the plasma sample to prevent possible enzymic hydrolysis and using plasma with different anticoagulants were evaluated to increase the stability of vorinostat, but neither of these approaches improved stability.  Human serum was then used as an alternative to plasma to monitor drug concn., and vorinostat and its two metabolites maintained consistent concns. in human serum after 3 freeze-thaw cycles and more than 1 yr storage at -70 °C.  By comparing the stability results of serum, EDTA plasma and heparin plasma, it was deduced that clotting proteins of plasma might be a major cause of vorinostat degrdn.  The stability of the three analytes during the process of serum sample collection was verified indicating that prolonged sample collection (up to 180 min) has no effect on the integrity of these analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj49Hq1PWdqLVg90H21EOLACvtfcHk0lidiZAz6GczQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFers7vI&md5=9317771ea638d773bd38fcd7d9ea7a0c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2006.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2006.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DMusson%26aufirst%3DD.%2BG.%26aulast%3DWang%26aufirst%3DA.%2BQ.%26atitle%3DStability%2520Studies%2520of%2520Vorinostat%2520and%2520Its%2520Two%2520Metabolites%2520in%2520Human%2520Plasma%252C%2520Serum%2520and%2520Urine%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D42%26spage%3D556%26epage%3D564%26doi%3D10.1016%2Fj.jpba.2006.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, K.</span><span> </span><span class="NLM_article-title">Reductase Activity of Aldehyde Oxidase toward the Carcinogen N-Hydroxy-2-Acetylaminofluorene and the Related Hydroxamic Acids</span> <span class="citation_source-journal">Biochem. Mol. Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1197-1203&author=S.+Kitamuraauthor=K.+Sugiharaauthor=K.+Tatsumi&title=Reductase+Activity+of+Aldehyde+Oxidase+toward+the+Carcinogen+N-Hydroxy-2-Acetylaminofluorene+and+the+Related+Hydroxamic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSugihara%26aufirst%3DK.%26aulast%3DTatsumi%26aufirst%3DK.%26atitle%3DReductase%2520Activity%2520of%2520Aldehyde%2520Oxidase%2520toward%2520the%2520Carcinogen%2520N-Hydroxy-2-Acetylaminofluorene%2520and%2520the%2520Related%2520Hydroxamic%2520Acids%26jtitle%3DBiochem.%2520Mol.%2520Biol.%2520Int.%26date%3D1994%26volume%3D34%26spage%3D1197%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mulder, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerman, J. H.</span><span> </span><span class="NLM_article-title">Sulfation and Glucuronidation as Competing Pathways in the Metabolism of Hydroxamic Acids: The Role of N,O-Sulfonation in Chemical Carcinogenesis of Aromatic Amines</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1289/ehp.834927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1289%2Fehp.834927" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1983&pages=27-32&author=G.+J.+Mulderauthor=J.+H.+Meerman&title=Sulfation+and+Glucuronidation+as+Competing+Pathways+in+the+Metabolism+of+Hydroxamic+Acids%3A+The+Role+of+N%2CO-Sulfonation+in+Chemical+Carcinogenesis+of+Aromatic+Amines&doi=10.1289%2Fehp.834927"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1289%2Fehp.834927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.834927%26sid%3Dliteratum%253Aachs%26aulast%3DMulder%26aufirst%3DG.%2BJ.%26aulast%3DMeerman%26aufirst%3DJ.%2BH.%26atitle%3DSulfation%2520and%2520Glucuronidation%2520as%2520Competing%2520Pathways%2520in%2520the%2520Metabolism%2520of%2520Hydroxamic%2520Acids%253A%2520The%2520Role%2520of%2520N%252CO-Sulfonation%2520in%2520Chemical%2520Carcinogenesis%2520of%2520Aromatic%2520Amines%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D1983%26volume%3D49%26spage%3D27%26epage%3D32%26doi%3D10.1289%2Fehp.834927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kook, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G.</span><span> </span><span class="NLM_article-title">Improving Potency and Metabolic Stability by Introducing an Alkenyl Linker to Pyridine-Based Histone Deacetylase Inhibitors for Orally Available Runx3 Modulators</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.ejmech.2016.11.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=997-1010&author=D.+Songauthor=C.+Leeauthor=Y.+J.+Kookauthor=S.+J.+Ohauthor=J.+S.+Kangauthor=H.-J.+Kimauthor=G.+Han&title=Improving+Potency+and+Metabolic+Stability+by+Introducing+an+Alkenyl+Linker+to+Pyridine-Based+Histone+Deacetylase+Inhibitors+for+Orally+Available+Runx3+Modulators&doi=10.1016%2Fj.ejmech.2016.11.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DKook%26aufirst%3DY.%2BJ.%26aulast%3DOh%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DH.-J.%26aulast%3DHan%26aufirst%3DG.%26atitle%3DImproving%2520Potency%2520and%2520Metabolic%2520Stability%2520by%2520Introducing%2520an%2520Alkenyl%2520Linker%2520to%2520Pyridine-Based%2520Histone%2520Deacetylase%2520Inhibitors%2520for%2520Orally%2520Available%2520Runx3%2520Modulators%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D997%26epage%3D1010%26doi%3D10.1016%2Fj.ejmech.2016.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lassalas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasfargeas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayendran, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span> </span><span class="NLM_article-title">Structure Property Relationships of Carboxylic Acid Isosteres</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3183</span><span class="NLM_x">–</span> <span class="NLM_lpage">3203</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3183-3203&author=P.+Lassalasauthor=B.+Gayauthor=C.+Lasfargeasauthor=M.+J.+Jamesauthor=V.+Tranauthor=K.+G.+Vijayendranauthor=K.+R.+Brundenauthor=M.+C.+Kozlowskiauthor=C.+J.+Thomasauthor=A.+B.+Smithauthor=D.+M.+Hurynauthor=C.+Ballatore&title=Structure+Property+Relationships+of+Carboxylic+Acid+Isosteres&doi=10.1021%2Facs.jmedchem.5b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Property Relationships of Carboxylic Acid Isosteres</span></div><div class="casAuthors">Lassalas, Pierrik; Gay, Bryant; Lasfargeas, Caroline; James, Michael J.; Tran, Van; Vijayendran, Krishna G.; Brunden, Kurt R.; Kozlowski, Marisa C.; Thomas, Craig J.; Smith, Amos B.; Huryn, Donna M.; Ballatore, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3183-3203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of a carboxylic acid with a surrogate structure, or (bio)-isostere, is a classical strategy in medicinal chem.  The general underlying principle is that by maintaining the features of the carboxylic acid crit. for biol. activity, but appropriately modifying the physicochem. properties, improved analogs may result.  In this context, a systematic assessment of the physicochem. properties of carboxylic acid isosteres would be desirable to enable more informed decisions of potential replacements to be used for analog design.  Herein we report the structure-property relationships (SPR) of 35 phenylpropionic acid derivs., in which the carboxylic acid moiety is replaced with a series of known isosteres.  The data set generated provides an assessment of the relative impact on the physicochem. properties that these replacements may have compared to the carboxylic acid analog.  As such, this study presents a framework for how to rationally apply isosteric replacements of the carboxylic acid functional group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIF98i2ITNrLVg90H21EOLACvtfcHk0lh9_CDQpZW2Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFartbY%253D&md5=34490fc72fdb321d8c9751bef1bf79c5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01963%26sid%3Dliteratum%253Aachs%26aulast%3DLassalas%26aufirst%3DP.%26aulast%3DGay%26aufirst%3DB.%26aulast%3DLasfargeas%26aufirst%3DC.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DTran%26aufirst%3DV.%26aulast%3DVijayendran%26aufirst%3DK.%2BG.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DKozlowski%26aufirst%3DM.%2BC.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DStructure%2520Property%2520Relationships%2520of%2520Carboxylic%2520Acid%2520Isosteres%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3183%26epage%3D3203%26doi%3D10.1021%2Facs.jmedchem.5b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Hydroxamates: Relationships between Structure and Plasma Stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6790</span><span class="NLM_x">–</span> <span class="NLM_lpage">6802</span><span class="refDoi"> DOI: 10.1021/jm900648x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900648x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6790-6802&author=M.+Flipoauthor=J.+Chartonauthor=A.+Hocineauthor=S.+Dassonnevilleauthor=B.+Deprezauthor=R.+Deprez-Poulain&title=Hydroxamates%3A+Relationships+between+Structure+and+Plasma+Stability&doi=10.1021%2Fjm900648x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamates: Relationships between Structure and Plasma Stability</span></div><div class="casAuthors">Flipo, Marion; Charton, Julie; Hocine, Akila; Dassonneville, Sandrine; Deprez, Benoit; Deprez-Poulain, Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6790-6802</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxamates are valuable tools for chem. biol. as well as interesting leads for medicinal chem.  Although many hydroxamates display nanomolar activities against metalloproteases, only three hydroxamates have reached the market, among which is the HDAC inhibitor vorinostat.  Failures in development are generally attributed to lack of selectivity, toxicity, or poor stability.  To help medicinal chemists with respect to plasma stability, the authors have performed the first and preliminary study on structure-plasma stability for hydroxamates.  The authors define some structural rules to predict or improve the plasma stability in the preclin. stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk66ooWU1NhbVg90H21EOLACvtfcHk0lh9_CDQpZW2Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ&md5=069a87988fbeb68a248d006c7f6307a0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm900648x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900648x%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DHocine%26aufirst%3DA.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DHydroxamates%253A%2520Relationships%2520between%2520Structure%2520and%2520Plasma%2520Stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6790%26epage%3D6802%26doi%3D10.1021%2Fjm900648x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Calvo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Canamaque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjornelund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, L. F.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Metabolism, and Excretion of (14)C-Labeled Belinostat in Patients with Recurrent or Progressive Malignancies</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1007/s10637-015-0321-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1007%2Fs10637-015-0321-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=193-201&author=E.+Calvoauthor=G.+Reddyauthor=V.+Boniauthor=L.+Garcia-Canamaqueauthor=T.+Songauthor=J.+Tjornelundauthor=M.+R.+Choiauthor=L.+F.+Allen&title=Pharmacokinetics%2C+Metabolism%2C+and+Excretion+of+%2814%29C-Labeled+Belinostat+in+Patients+with+Recurrent+or+Progressive+Malignancies&doi=10.1007%2Fs10637-015-0321-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10637-015-0321-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-015-0321-8%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo%26aufirst%3DE.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DBoni%26aufirst%3DV.%26aulast%3DGarcia-Canamaque%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DTjornelund%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DM.%2BR.%26aulast%3DAllen%26aufirst%3DL.%2BF.%26atitle%3DPharmacokinetics%252C%2520Metabolism%252C%2520and%2520Excretion%2520of%2520%252814%2529C-Labeled%2520Belinostat%2520in%2520Patients%2520with%2520Recurrent%2520or%2520Progressive%2520Malignancies%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2016%26volume%3D34%26spage%3D193%26epage%3D201%26doi%3D10.1007%2Fs10637-015-0321-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuker, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Nmr-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5628</span><span class="NLM_x">–</span> <span class="NLM_lpage">5639</span><span class="refDoi"> DOI: 10.1021/jm020160g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020160g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5628-5639&author=P.+J.+Hajdukauthor=S.+B.+Shukerauthor=D.+G.+Nettesheimauthor=R.+Craigauthor=D.+J.+Augeriauthor=D.+Betebennerauthor=D.+H.+Albertauthor=Y.+Guoauthor=R.+P.+Meadowsauthor=L.+Xuauthor=M.+Michaelidesauthor=S.+K.+Davidsenauthor=S.+W.+Fesik&title=Nmr-Based+Modification+of+Matrix+Metalloproteinase+Inhibitors+with+Improved+Bioavailability&doi=10.1021%2Fjm020160g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm020160g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020160g%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBetebenner%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DMichaelides%26aufirst%3DM.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DNmr-Based%2520Modification%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520with%2520Improved%2520Bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5628%26epage%3D5639%26doi%3D10.1021%2Fjm020160g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, T.</span><span> </span><span class="NLM_article-title">The Emerging Role of Human Esterases</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.2133/dmpk.DMPK-12-RV-042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.2133%2Fdmpk.DMPK-12-RV-042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22813719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVykurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=466-477&author=T.+Fukamiauthor=T.+Yokoi&title=The+Emerging+Role+of+Human+Esterases&doi=10.2133%2Fdmpk.DMPK-12-RV-042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of human esterases</span></div><div class="casAuthors">Fukami, Tatsuki; Yokoi, Tsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">466-477</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">In this review, novel aspects of the role of esterases, which contribute to the metab. of 10% of therapeutic drugs, are described.  Esterases hydrolyze the compds. that contain ester, amide, and thioester bonds, which cause prodrug activation or detoxification.  Among esterases, carboxylesterases are well known to be involved in the hydrolysis of a variety of drugs.  Addnl., other esterases have recently received attention for their pharmacol. and toxicol. roles.  Arylacetamide deacetylase (AADAC) is involved in the hydrolysis of flutamide, phenacetin, and rifamycins.  AADAC is assocd. with adverse drug reactions because the hydrolytic metabolites of flutamide and phenacetin appear to be assocd. with hepatotoxicity and nephrotoxicity/hematotoxicity, resp.  Paraoxonase and butyrylcholinesterase hydrolyze pirocarpine/simvastatin and succinylcholine/bambuterol, resp.  Although the esterases that hydrolyze the acyl-glucuronides of drugs have largely been unknown, we recently found that α/β hydrolase domain contg. 10 (ABHD10) is responsible for the hydrolysis of mycophenolic acid acyl-glucuronide in human liver.  Because acyl-glucuronides are assocd. with toxicity, ABHD10 might function as a detoxification enzyme.  Thus, various esterases, which include enzymes that have not been known to hydrolyze drugs, are involved in drug metab. with different substrate specificity.  Further esterase studies should be conducted to promote our understanding in clin. pharmacotherapy and drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDhsUJ4NrYQbVg90H21EOLACvtfcHk0lhzGF8FoeiW9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVykurzE&md5=d760b8a6a3217a4ab9716190800012b0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.DMPK-12-RV-042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.DMPK-12-RV-042%26sid%3Dliteratum%253Aachs%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYokoi%26aufirst%3DT.%26atitle%3DThe%2520Emerging%2520Role%2520of%2520Human%2520Esterases%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2012%26volume%3D27%26spage%3D466%26epage%3D477%26doi%3D10.2133%2Fdmpk.DMPK-12-RV-042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Casey Laizure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witbrodt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. B.</span><span> </span><span class="NLM_article-title">The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1002/phar.1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fphar.1194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=23386599" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=210-222&author=S.+Casey+Laizureauthor=V.+Herringauthor=Z.+Huauthor=K.+Witbrodtauthor=R.+B.+Parker&title=The+Role+of+Human+Carboxylesterases+in+Drug+Metabolism%3A+Have+We+Overlooked+Their+Importance%3F&doi=10.1002%2Fphar.1194"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fphar.1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.1194%26sid%3Dliteratum%253Aachs%26aulast%3DCasey%2BLaizure%26aufirst%3DS.%26aulast%3DHerring%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWitbrodt%26aufirst%3DK.%26aulast%3DParker%26aufirst%3DR.%2BB.%26atitle%3DThe%2520Role%2520of%2520Human%2520Carboxylesterases%2520in%2520Drug%2520Metabolism%253A%2520Have%2520We%2520Overlooked%2520Their%2520Importance%253F%26jtitle%3DPharmacotherapy%26date%3D2013%26volume%3D33%26spage%3D210%26epage%3D222%26doi%3D10.1002%2Fphar.1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hwang, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juhasz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodor, N.</span><span> </span><span class="NLM_article-title">Soft Drugs. 12. Design, Synthesis, and Evaluation of Soft Bufuralol Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">–</span> <span class="NLM_lpage">1532</span><span class="refDoi"> DOI: 10.1021/jm9904654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9904654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1525-1532&author=S.-K.+Hwangauthor=A.+Juhaszauthor=S.-H.+Yoonauthor=N.+Bodor&title=Soft+Drugs.+12.+Design%2C+Synthesis%2C+and+Evaluation+of+Soft+Bufuralol+Analogues&doi=10.1021%2Fjm9904654"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm9904654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904654%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.-K.%26aulast%3DJuhasz%26aufirst%3DA.%26aulast%3DYoon%26aufirst%3DS.-H.%26aulast%3DBodor%26aufirst%3DN.%26atitle%3DSoft%2520Drugs.%252012.%2520Design%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Soft%2520Bufuralol%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1525%26epage%3D1532%26doi%3D10.1021%2Fjm9904654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Boland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraets, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeders, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castermans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panitti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanormelingen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stassen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defert, O.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft Rock Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4309</span><span class="NLM_x">–</span> <span class="NLM_lpage">4324</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00308</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00308" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4309-4324&author=S.+Bolandauthor=A.+Bourinauthor=J.+Alenauthor=J.+Geraetsauthor=P.+Schroedersauthor=K.+Castermansauthor=N.+Kindtauthor=N.+Boumansauthor=L.+Panittiauthor=S.+Fransenauthor=J.+Vanormelingenauthor=J.+M.+Stassenauthor=D.+Leysenauthor=O.+Defert&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel%2C+Highly+Active+Soft+Rock+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors</span></div><div class="casAuthors">Boland, Sandro; Bourin, Arnaud; Alen, Jo; Geraets, Jacques; Schroeders, Pieter; Castermans, Karolien; Kindt, Nele; Boumans, Nicki; Panitti, Laura; Fransen, Silke; Vanormelingen, Jessica; Stassen, Jean Marie; Leysen, Dirk; Defert, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4309-4324</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ROCK1 and ROCK2 play important roles in numerous cellular functions, including smooth muscle cell contraction, cell proliferation, adhesion, and migration.  Consequently, ROCK inhibitors are of interest for treating multiple indications including cardiovascular diseases, inflammatory and autoimmune diseases, lung diseases, and eye diseases.  However, systemic inhibition of ROCK is expected to result in significant side effects.  Strategies allowing reduced systemic exposure are therefore of interest.  In a continuing effort toward identification of ROCK inhibitors, we here report the design, synthesis, and evaluation of novel soft ROCK inhibitors displaying an ester function allowing their rapid inactivation in the systemic circulation.  Those compds., e.g. I, display subnanomolar activity against ROCK and strong differences of functional activity between parent compds. and expected metabolites.  The binding mode of a representative compd. was detd. exptl. in a single-crystal X-ray diffraction study.  Enzymes responsible for inactivation of these compds. once they enter systemic circulation are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWI5LwOkT64rVg90H21EOLACvtfcHk0lhzGF8FoeiW9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOhtbc%253D&md5=320e6fbb1cf87ba8c03fc17795f6802f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00308%26sid%3Dliteratum%253Aachs%26aulast%3DBoland%26aufirst%3DS.%26aulast%3DBourin%26aufirst%3DA.%26aulast%3DAlen%26aufirst%3DJ.%26aulast%3DGeraets%26aufirst%3DJ.%26aulast%3DSchroeders%26aufirst%3DP.%26aulast%3DCastermans%26aufirst%3DK.%26aulast%3DKindt%26aufirst%3DN.%26aulast%3DBoumans%26aufirst%3DN.%26aulast%3DPanitti%26aufirst%3DL.%26aulast%3DFransen%26aufirst%3DS.%26aulast%3DVanormelingen%26aufirst%3DJ.%26aulast%3DStassen%26aufirst%3DJ.%2BM.%26aulast%3DLeysen%26aufirst%3DD.%26aulast%3DDefert%26aufirst%3DO.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%252C%2520Highly%2520Active%2520Soft%2520Rock%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4309%26epage%3D4324%26doi%3D10.1021%2Facs.jmedchem.5b00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lockridge, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydess, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoryan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopfer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichs, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, P.</span><span> </span><span class="NLM_article-title">Pseudo-Esterase Activity of Human Albumin: Slow Turnover on Tyrosine 411 and Stable Acetylation of 82 Residues Including 59 Lysines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">22582</span><span class="NLM_x">–</span> <span class="NLM_lpage">22590</span><span class="refDoi"> DOI: 10.1074/jbc.M802555200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1074%2Fjbc.M802555200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=18577514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVKmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22582-22590&author=O.+Lockridgeauthor=W.+Xueauthor=A.+Gaydessauthor=H.+Grigoryanauthor=S.+J.+Dingauthor=L.+M.+Schopferauthor=S.+H.+Hinrichsauthor=P.+Masson&title=Pseudo-Esterase+Activity+of+Human+Albumin%3A+Slow+Turnover+on+Tyrosine+411+and+Stable+Acetylation+of+82+Residues+Including+59+Lysines&doi=10.1074%2Fjbc.M802555200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudo-esterase Activity of Human Albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines</span></div><div class="casAuthors">Lockridge, Oksana; Xue, Weihua; Gaydess, Andrea; Grigoryan, Hasmik; Ding, Shi-Jian; Schopfer, Lawrence M.; Hinrichs, Steven H.; Masson, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">22582-22590</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human albumin is thought to hydrolyze esters because multiple equiv. of product are formed for each equiv. of albumin.  Esterase activity with p-nitrophenyl acetate has been attributed to turnover at tyrosine 411.  However, p-nitrophenyl acetate creates multiple, stable, acetylated adducts, a property contrary to turnover.  Our goal was to identify residues that become acetylated by p-nitrophenyl acetate and det. the relationship between stable adduct formation and turnover.  Fatty acid-free human albumin was treated with 0.5 mM p-nitrophenyl acetate for 5 min to 2 wk, or with 10 mM p-nitrophenyl acetate for 48 h to 2 wk.  Aliquots were digested with pepsin, trypsin, or GluC and analyzed by mass spectrometry to identify labeled residues.  Only Tyr-411 was acetylated within the first 5 min of reaction with 0.5 mM p-nitrophenyl acetate.  After 0.5-6 h there was partial acetylation of 16-17 residues including Asp-1, Lys-4, Lys-12, Tyr-411, Lys-413, and Lys-414.  Treatment with 10 mM p-nitrophenyl acetate resulted in acetylation of 59 lysines, 10 serines, 8 threonines, 4 tyrosines, and Asp-1.  When Tyr-411 was blocked with diisopropylfluorophosphate or chlorpyrifos oxon, albumin had normal esterase activity with β-naphthyl acetate as visualized on a nondenaturing gel.  However, after 82 residues had been acetylated, esterase activity was almost completely inhibited.  The half-life for deacetylation of Tyr-411 at pH 8.0, 22 °C was 61 ± 4 h.  Acetylated lysines formed adducts that were even more stable.  In conclusion, the pseudo-esterase activity of albumin is the result of irreversible acetylation of 82 residues and is not the result of turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpopadUHptJXLVg90H21EOLACvtfcHk0ljI_aEU9kMRRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVKmsLc%253D&md5=97593568c831b73aebcadd75c7f7ca61</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M802555200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M802555200%26sid%3Dliteratum%253Aachs%26aulast%3DLockridge%26aufirst%3DO.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DGaydess%26aufirst%3DA.%26aulast%3DGrigoryan%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DS.%2BJ.%26aulast%3DSchopfer%26aufirst%3DL.%2BM.%26aulast%3DHinrichs%26aufirst%3DS.%2BH.%26aulast%3DMasson%26aufirst%3DP.%26atitle%3DPseudo-Esterase%2520Activity%2520of%2520Human%2520Albumin%253A%2520Slow%2520Turnover%2520on%2520Tyrosine%2520411%2520and%2520Stable%2520Acetylation%2520of%252082%2520Residues%2520Including%252059%2520Lysines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D22582%26epage%3D22590%26doi%3D10.1074%2Fjbc.M802555200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidukov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumshtein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khersonsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meged, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfik, D. S.</span><span> </span><span class="NLM_article-title">Structure and Evolution of the Serum Paraoxonase Family of Detoxifying and Anti-Atherosclerotic Enzymes</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1038/nsmb767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1038%2Fnsmb767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=15098021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=412-419&author=M.+Harelauthor=A.+Aharoniauthor=L.+Gaidukovauthor=B.+Brumshteinauthor=O.+Khersonskyauthor=R.+Megedauthor=H.+Dvirauthor=R.+B.+Ravelliauthor=A.+McCarthyauthor=L.+Tokerauthor=I.+Silmanauthor=J.+L.+Sussmanauthor=D.+S.+Tawfik&title=Structure+and+Evolution+of+the+Serum+Paraoxonase+Family+of+Detoxifying+and+Anti-Atherosclerotic+Enzymes&doi=10.1038%2Fnsmb767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes</span></div><div class="casAuthors">Harel, Michal; Aharoni, Amir; Gaidukov, Leonid; Brumshtein, Boris; Khersonsky, Olga; Meged, Ran; Dvir, Hay; Ravelli, Raimond B. G.; McCarthy, Andrew; Toker, Lilly; Silman, Israel; Sussman, Joel L.; Tawfik, Dan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the serum paraoxonase (PON) family have been identified in mammals and other vertebrates, and in invertebrates.  PONs exhibit a wide range of physiol. important hydrolytic activities, including drug metab. and detoxification of nerve agents.  PON1 and PON3 reside on high-d. lipoprotein (HDL; 'good cholesterol') and are involved in the prevention of atherosclerosis.  Here, the authors describe the 1st crystal structure of a PON family member, a variant of PON1 obtained by directed evolution, at a resoln. of 2.2 Å.  Recombinant PON1 variant G2E6 was found to be a 6-bladed β-propeller with a unique active site lid that was also involved in HDL binding.  The 3-dimensional structure and directed evolution studies permitted a detailed description of PON1's active site and catalytic mechanism, which were reminiscent of secreted phospholipase A2, and of the routes by which PON family members diverged toward different substrate and reaction selectivities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI851cIlyl0rVg90H21EOLACvtfcHk0ljI_aEU9kMRRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsLg%253D&md5=778fdefc4c131aea944aca577d7bf159</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnsmb767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb767%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DAharoni%26aufirst%3DA.%26aulast%3DGaidukov%26aufirst%3DL.%26aulast%3DBrumshtein%26aufirst%3DB.%26aulast%3DKhersonsky%26aufirst%3DO.%26aulast%3DMeged%26aufirst%3DR.%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DToker%26aufirst%3DL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DTawfik%26aufirst%3DD.%2BS.%26atitle%3DStructure%2520and%2520Evolution%2520of%2520the%2520Serum%2520Paraoxonase%2520Family%2520of%2520Detoxifying%2520and%2520Anti-Atherosclerotic%2520Enzymes%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D412%26epage%3D419%26doi%3D10.1038%2Fnsmb767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Montella, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valle, D.</span><span> </span><span class="NLM_article-title">The Classification of Esterases: An Important Gene Family Involved in Insecticide Resistance--a Review</span> <span class="citation_source-journal">Mem. Inst. Oswaldo Cruz</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1590/S0074-02762012000400001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1590%2FS0074-02762012000400001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22666852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=437-449&author=I.+R.+Montellaauthor=R.+Schamaauthor=D.+Valle&title=The+Classification+of+Esterases%3A+An+Important+Gene+Family+Involved+in+Insecticide+Resistance%2D%2Da+Review&doi=10.1590%2FS0074-02762012000400001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The classification of esterases: an important gene family involved in insecticide resistance - a review</span></div><div class="casAuthors">Montella, Isabela Reis; Schama, Renata; Valle, Denise</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">437-449</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">0074-0276</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">A review.  The use of chem. insecticides continues to play a major role in the control of disease vector populations, which is leading to the global dissemination of insecticide resistance.  A greater capacity to detoxify insecticides, due to an increase in the expression or activity of three major enzyme families, also known as metabolic resistance, is one major resistance mechanisms.  The esterase family of enzymes hydrolyze ester bonds, which are present in a wide range of insecticides; therefore, these enzymes may be involved in resistance to the main chems. employed in control programs.  Historically, insecticide resistance has driven research on insect esterases and schemes for their classification.  Currently, several different nomenclatures are used to describe the esterases of distinct species and a universal std. classification does not exist.  The esterase gene family appears to be rapidly evolving and each insect species has a unique complement of detoxification genes with only a few orthologues across species.  The examples listed in this review cover different aspects of their biochem. nature.  However, they do not appear to contribute to reliably distinguish among the different resistance mechanisms.  Presently, the phylogenetic criterion appears to be the best one for esterase classification.  Joint genomic, biochem. and microarray studies will help unravel the classification of this complex gene family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhxRPi8xpbrVg90H21EOLACvtfcHk0ljI_aEU9kMRRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCrtb8%253D&md5=b6dafff05a03c35318ede9c9aec48652</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1590%2FS0074-02762012000400001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0074-02762012000400001%26sid%3Dliteratum%253Aachs%26aulast%3DMontella%26aufirst%3DI.%2BR.%26aulast%3DSchama%26aufirst%3DR.%26aulast%3DValle%26aufirst%3DD.%26atitle%3DThe%2520Classification%2520of%2520Esterases%253A%2520An%2520Important%2520Gene%2520Family%2520Involved%2520in%2520Insecticide%2520Resistance--a%2520Review%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2012%26volume%3D107%26spage%3D437%26epage%3D449%26doi%3D10.1590%2FS0074-02762012000400001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Yamaori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isobe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span> </span><span class="NLM_article-title">Involvement of Human Blood Arylesterases and Liver Microsomal Carboxylesterases in Nafamostat Hydrolysis</span> <span class="citation_source-journal">Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span><span class="refDoi"> DOI: 10.2133/dmpk.21.147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.2133%2Fdmpk.21.147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16702735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1aku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=147-155&author=S.+Yamaoriauthor=N.+Fujiyamaauthor=M.+Kushiharaauthor=T.+Funahashiauthor=T.+Kimuraauthor=I.+Yamamotoauthor=T.+Soneauthor=M.+Isobeauthor=T.+Ohshimaauthor=K.+Matsumuraauthor=M.+Odaauthor=K.+Watanabe&title=Involvement+of+Human+Blood+Arylesterases+and+Liver+Microsomal+Carboxylesterases+in+Nafamostat+Hydrolysis&doi=10.2133%2Fdmpk.21.147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis</span></div><div class="casAuthors">Yamaori, Satoshi; Fujiyama, Nobuhiro; Kushihara, Mika; Funahashi, Tatsuya; Kimura, Toshiyuki; Yamamoto, Ikuo; Sone, Tomomichi; Isobe, Masakazu; Ohshima, Tohru; Matsumura, Kenji; Oda, Minoru; Watanabe, Kazuhito</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">Metab. of nafamostat, a clin. used serine protease inhibitor, was investigated with human blood and liver enzyme sources.  All the enzyme sources examd. (whole blood, erythrocytes, plasma and liver microsomes) showed nafamostat hydrolytic activity.  Vmax and Km values for the nafamostat hydrolysis in erythrocytes were 278 nmol/min/mL blood fraction and 628 μM; those in plasma were 160 nmol/min/mL blood fraction and 8890 μM, resp.  Human liver microsomes exhibited a Vmax value of 26.9 nmol/min/mg protein and a Km value of 1790 μM.  Hydrolytic activity of the erythrocytes and plasma was inhibited by 5, 5'-dithiobis(2-nitrobenzoic acid), an arylesterase inhibitor, in a concn.-dependent manner.  In contrast, little or no suppression of these activities was seen with phenylmethylsulfonyl fluoride (PMSF), diisopropyl fluorophosphate (DFP), bis(p-nitrophenyl)phosphate (BNPP), BW284C51 and ethopropazine.  The liver microsomal activity was markedly inhibited by PMSF, DFP and BNPP, indicating that carboxylesterase was involved in the nafamostat hydrolysis.  Human carboxylesterase 2 expressed in COS-1 cells was capable of hydrolyzing nafamostat at 10 and 100 μM, whereas recombinant carboxylesterase 1 showed significant activity only at a higher substrate concn. (100 μM).  The nafamostat hydrolysis in 18 human liver microsomes correlated with aspirin hydrolytic activity specific for carboxylesterase 2 (r = 0.815, p < 0.01) but not with imidapril hydrolysis catalyzed by carboxylesterase 1 (r = 0.156, p = 0.54).  These results suggest that human arylesterases and carboxylesterase 2 may be predominantly responsible for the metab. of nafamostat in the blood and liver, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeRbZxBkGzbrVg90H21EOLACvtfcHk0lhz7mEYIw0NsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1aku7g%253D&md5=92bfd97d95143f7631cb2719264bfcf5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.21.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.21.147%26sid%3Dliteratum%253Aachs%26aulast%3DYamaori%26aufirst%3DS.%26aulast%3DFujiyama%26aufirst%3DN.%26aulast%3DKushihara%26aufirst%3DM.%26aulast%3DFunahashi%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DI.%26aulast%3DSone%26aufirst%3DT.%26aulast%3DIsobe%26aufirst%3DM.%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DK.%26atitle%3DInvolvement%2520of%2520Human%2520Blood%2520Arylesterases%2520and%2520Liver%2520Microsomal%2520Carboxylesterases%2520in%2520Nafamostat%2520Hydrolysis%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2006%26volume%3D21%26spage%3D147%26epage%3D155%26doi%3D10.2133%2Fdmpk.21.147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ronco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foucault, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.-Y.</span><span> </span><span class="NLM_article-title">New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span><span class="refDoi"> DOI: 10.1002/cmdc.201000523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fcmdc.201000523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=21344648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=876-888&author=C.+Roncoauthor=R.+Foucaultauthor=E.+Gillonauthor=P.+Bohnauthor=F.+Nachonauthor=L.+Jeanauthor=P.-Y.+Renard&title=New+Huprine+Derivatives+Functionalized+at+Position+9+as+Highly+Potent+Acetylcholinesterase+Inhibitors&doi=10.1002%2Fcmdc.201000523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors</span></div><div class="casAuthors">Ronco, Cyril; Foucault, Richard; Gillon, Emilie; Bohn, Pierre; Nachon, Florian; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">876-888</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of 24 huprine derivs. diversely functionalized at position 9 have been synthesized and evaluated for their inhibitory activity against human recombinant acetylcholinesterase (AChE).  These derivs. were prepd. in one to five steps from huprine 1 bearing an ester function at position 9.  Ten analogs (1, 2, 6-9, 13-15, and 23) are active in the low nanomolar range (IC50 <5 nM), very close to the parent compd. huprine X.  Compds. 2, 6, and 7 show a very good selectivity for AChE, with AChE inhibitory activities 700-1160-fold higher than those for butyrylcholinesterase (BChE).  The inhibitory potency of these compds. decreases with the steric bulk of the substituents at position 9.  According to docking simulations, small substituents fit into the acyl-binding pocket, whereas the larger ones stick out of the active site gorge of AChE.  Detn. of the kinetic parameters of three of the most potent huprines (2, 6, and 7) showed that most of the difference in KD is accounted by a decrease in kon, which is correlated to the increase of the substituent size.  A first in vivo evaluation has been performed in mice for the most active compd. 2 (I, IC50=1.1 nM) and showed a rather weak toxicity (LD50=40 mg kg-1) and an ability to cross the blood-brain barrier with doses above 15 mg kg-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJUII0bHstbVg90H21EOLACvtfcHk0lhz7mEYIw0NsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D&md5=bea8949ab5693c5698a106965160688f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000523%26sid%3Dliteratum%253Aachs%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DFoucault%26aufirst%3DR.%26aulast%3DGillon%26aufirst%3DE.%26aulast%3DBohn%26aufirst%3DP.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DNew%2520Huprine%2520Derivatives%2520Functionalized%2520at%2520Position%25209%2520as%2520Highly%2520Potent%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D876%26epage%3D888%26doi%3D10.1002%2Fcmdc.201000523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Imai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span> </span><span class="NLM_article-title">Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1734</span><span class="NLM_x">–</span> <span class="NLM_lpage">1741</span><span class="refDoi"> DOI: 10.1124/dmd.106.009381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1124%2Fdmd.106.009381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16837570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1734-1741&author=T.+Imaiauthor=M.+Taketaniauthor=M.+Shiiauthor=M.+Hosokawaauthor=K.+Chiba&title=Substrate+Specificity+of+Carboxylesterase+Isozymes+and+Their+Contribution+to+Hydrolase+Activity+in+Human+Liver+and+Small+Intestine&doi=10.1124%2Fdmd.106.009381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine</span></div><div class="casAuthors">Imai, Teruko; Taketani, Megumi; Shii, Mayumi; Hosokawa, Masakiyo; Chiba, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1734-1741</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Hydrolase activity from human liver and small intestine microsomes was compared with that of recombinant human carboxylesterases, hCE-1 and hCE-2.  Although both hCE-1 and hCE-2 are present in human liver, the dominant component was found to be hCE-1, whereas the hydrolase activity of the human small intestine was found to be predominantly hCE-2.  HCE-2 has a limited ability to hydrolyze large acyl compd. substrates.  Interestingly, propranolol derivs., good substrates for hCE-2, were easily hydrolyzed by substitution of the Me group on the 2-position of the acyl moiety, but were barely hydrolyzed when the Me group was substituted on the 3-position.  These findings suggest that hCE-2 does not easily form acylated intermediates because of conformational interference in its active site.  In contrast, hCE-1 could hydrolyze a variety of substrates.  The hydrolytic activity of hCE-2 increased with increasing alc. chain length in benzoic acid deriv. substrates, whereas hCE-1 preferentially catalyzed the hydrolysis of substrates with short alc. chains.  Kinetic data showed that the detg. factor for the rate of hydrolysis of p-aminobenzoic acid esters was Vmax for hCE-1 and Km for hCE-2.  Furthermore, the addn. of hydrophobic alcs. to the reaction mixt. with p-aminobenzoic acid Pr ester induced high and low levels of transesterification by hCE-1 and hCE-2, resp.  When considering the substrate specificities of hCE-1, it is necessary to consider the transesterification ability of hCE-1, in addn. to the binding structure of the substrate in the active site of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_5Qby7_S88LVg90H21EOLACvtfcHk0lhz7mEYIw0NsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI&md5=b2d3c1d2aee89b647e1c8030daee8c3a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.009381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.009381%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26aulast%3DTaketani%26aufirst%3DM.%26aulast%3DShii%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26atitle%3DSubstrate%2520Specificity%2520of%2520Carboxylesterase%2520Isozymes%2520and%2520Their%2520Contribution%2520to%2520Hydrolase%2520Activity%2520in%2520Human%2520Liver%2520and%2520Small%2520Intestine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1734%26epage%3D1741%26doi%3D10.1124%2Fdmd.106.009381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Minagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, A.</span><span> </span><span class="NLM_article-title">Species Differences in Hydrolysis of Isocarbacyclin Methyl Ester (Tei-9090) by Blood Esterases</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.1016/0006-2952(95)00071-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2F0006-2952%2895%2900071-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=1361-1365&author=T.+Minagawaauthor=Y.+Kohnoauthor=T.+Suwaauthor=A.+Tsuji&title=Species+Differences+in+Hydrolysis+of+Isocarbacyclin+Methyl+Ester+%28Tei-9090%29+by+Blood+Esterases&doi=10.1016%2F0006-2952%2895%2900071-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2895%2900071-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252895%252900071-7%26sid%3Dliteratum%253Aachs%26aulast%3DMinagawa%26aufirst%3DT.%26aulast%3DKohno%26aufirst%3DY.%26aulast%3DSuwa%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DA.%26atitle%3DSpecies%2520Differences%2520in%2520Hydrolysis%2520of%2520Isocarbacyclin%2520Methyl%2520Ester%2520%2528Tei-9090%2529%2520by%2520Blood%2520Esterases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26spage%3D1361%26epage%3D1365%26doi%3D10.1016%2F0006-2952%2895%2900071-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Rudakova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boltneva, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhaeva, G. F.</span><span> </span><span class="NLM_article-title">Comparative Analysis of Esterase Activities of Human, Mouse, and Rat Blood</span> <span class="citation_source-journal">Bull. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1007/s10517-011-1457-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1007%2Fs10517-011-1457-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22803044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=73-75&author=E.+V.+Rudakovaauthor=N.+P.+Boltnevaauthor=G.+F.+Makhaeva&title=Comparative+Analysis+of+Esterase+Activities+of+Human%2C+Mouse%2C+and+Rat+Blood&doi=10.1007%2Fs10517-011-1457-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Analysis of Esterase Activities of Human, Mouse, and Rat Blood</span></div><div class="casAuthors">Rudakova, E. V.; Boltneva, N. P.; Makhaeva, G. F.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-75</span>CODEN:
                <span class="NLM_cas:coden">BEXBAN</span>;
        ISSN:<span class="NLM_cas:issn">0007-4888</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Acetylcholinesterase, butyrylcholinesterase, carboxylesterase, and paraoxonase activities in human, mouse, and rat blood were measured.  The proportions of these enzymes activities differed significantly.  In humans, the most significant were cholinesterase activities, while in rats and mice the contribution of carboxylesterase activity was the greatest.  High arylesterase activity of paraoxonase was obsd. in all cases.  Species-specific differences should be taken into consideration when carrying out preclin. trials on rodents for optimization of the pharmacokinetic characteristics of drugs contg. complex ester groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomojhlePQlNbVg90H21EOLACvtfcHk0liZyD53a17WsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylu7vJ&md5=9cf56c1d6ef8aab2ce15ae47f30f30b0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10517-011-1457-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10517-011-1457-y%26sid%3Dliteratum%253Aachs%26aulast%3DRudakova%26aufirst%3DE.%2BV.%26aulast%3DBoltneva%26aufirst%3DN.%2BP.%26aulast%3DMakhaeva%26aufirst%3DG.%2BF.%26atitle%3DComparative%2520Analysis%2520of%2520Esterase%2520Activities%2520of%2520Human%252C%2520Mouse%252C%2520and%2520Rat%2520Blood%26jtitle%3DBull.%2520Exp.%2520Biol.%2520Med.%26date%3D2011%26volume%3D152%26spage%3D73%26epage%3D75%26doi%3D10.1007%2Fs10517-011-1457-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Bahar, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, T.</span><span> </span><span class="NLM_article-title">Species Difference of Esterase Expression and Hydrolase Activity in Plasma</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">3979</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span><span class="refDoi"> DOI: 10.1002/jps.23258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fjps.23258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=22833171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=3979-3988&author=F.+G.+Baharauthor=K.+Ohuraauthor=T.+Ogiharaauthor=T.+Imai&title=Species+Difference+of+Esterase+Expression+and+Hydrolase+Activity+in+Plasma&doi=10.1002%2Fjps.23258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Species difference of esterase expression and hydrolase activity in plasma</span></div><div class="casAuthors">Bahar, Fatma Goksin; Ohura, Kayoko; Ogihara, Takuo; Imai, Teruko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3979-3988</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Differences in esterase expression among human, rhesus monkey, cynomolgus monkey, dog, minipig, rabbit, rat, and mouse plasma were identified using native polyacrylamide gel electrophoresis.  Paraoxonase (PON) and butyrylcholinesterase (BChE) were ubiquitous in all species, but were highly expressed in primates and dogs, whereas carboxylesterase (CES) was only abundant in rabbits, mice, and rats.  Several unknown esterases were obsd. in minipig and mouse plasma.  These differences in plasma esterases and their expression levels result in species differences with respect to hydrolase activity.  These differences were characterized using several different substrates.  In contrast to the high hydrolase activity found for p-nitrophenylacetate (PNPA), a substrate of several hydrolase enzymes, irinotecan, a carbamate compd., was resistant to all plasma esterases.  Oseltamivir, temocapril, and propranolol (PL) derivs. were rapidly hydrolyzed in mouse and rat plasma by their highly active CES enzyme, but rabbit plasma CES hydrolyzed only the PL derivs.  Interestingly, PL derivs. were highly hydrolyzed by monkey plasma BChE, whereas BChE from human, dog, and minipig plasma showed negligible activity.  In conclusion, the esterase expression and hydrolyzing pattern of dog plasma were found to be closest to that of human plasma.  These differences should be considered when selecting model animals for preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIjepKzp5aYLVg90H21EOLACvtfcHk0liZyD53a17WsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyksb7L&md5=6ec3b10b30a3ab7071a426eadb993a11</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjps.23258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23258%26sid%3Dliteratum%253Aachs%26aulast%3DBahar%26aufirst%3DF.%2BG.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DSpecies%2520Difference%2520of%2520Esterase%2520Expression%2520and%2520Hydrolase%2520Activity%2520in%2520Plasma%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D3979%26epage%3D3988%26doi%3D10.1002%2Fjps.23258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hosokawa, M.</span><span> </span><span class="NLM_article-title">Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.3390/molecules13020412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.3390%2Fmolecules13020412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=18305428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=412-431&author=M.+Hosokawa&title=Structure+and+Catalytic+Properties+of+Carboxylesterase+Isozymes+Involved+in+Metabolic+Activation+of+Prodrugs&doi=10.3390%2Fmolecules13020412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs</span></div><div class="casAuthors">Hosokawa, Masakiyo</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">412-431</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Mammalian carboxylesterases (CESs) comprise a multigene family whose gene products play important roles in biotransformation of ester- or amide-type prodrugs.  They are members of an α,β-hydrolase-fold family and are found in various mammals.  It has been suggested that CESs can be classified into 5 major groups denominated CES1-CES5, according to the homol. of the amino acid sequence, and the majority of CESs that have been identified belong to the CES1 or CES2 family.  The substrate specificities of CES1 and CES2 are significantly different.  The CES1 isoenzyme mainly hydrolyzes a substrate with a small alc. group and large acyl group, but its wide active site pocket sometimes allows it to act on structurally distinct compds. of either a large or small alc. moiety.  In contrast, the CES2 isoenzyme recognizes a substrate with a large alc. group and small acyl group, and its substrate specificity may be restricted by the capability of acyl-enzyme conjugate formation due to the presence of conformational interference in the active pocket.  Since pharmacokinetic and pharmacol. data for prodrugs obtained from preclin. expts. using various animals are generally used as refs. for human studies, it is important to clarify the biochem. properties of CES isoenzymes.  Further experimentation for an understanding of detailed substrate specificity of prodrugs for CES isoenzymes and its hydrolyzates will help researchers to design the ideal prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouTX8xLu6R1rVg90H21EOLACvtfcHk0liZyD53a17WsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFahsr4%253D&md5=2737ed528ff2b616b7d256ad01b5c1d1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fmolecules13020412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules13020412%26sid%3Dliteratum%253Aachs%26aulast%3DHosokawa%26aufirst%3DM.%26atitle%3DStructure%2520and%2520Catalytic%2520Properties%2520of%2520Carboxylesterase%2520Isozymes%2520Involved%2520in%2520Metabolic%2520Activation%2520of%2520Prodrugs%26jtitle%3DMolecules%26date%3D2008%26volume%3D13%26spage%3D412%26epage%3D431%26doi%3D10.3390%2Fmolecules13020412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlacek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoharan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boopathy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duysen, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockridge, O.</span><span> </span><span class="NLM_article-title">Butyrylcholinesterase, Paraoxonase, and Albumin Esterase, but Not Carboxylesterase, Are Present in Human Plasma</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span><span class="refDoi"> DOI: 10.1016/j.bcp.2005.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bcp.2005.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=16213467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=1673-1684&author=B.+Liauthor=M.+Sedlacekauthor=I.+Manoharanauthor=R.+Boopathyauthor=E.+G.+Duysenauthor=P.+Massonauthor=O.+Lockridge&title=Butyrylcholinesterase%2C+Paraoxonase%2C+and+Albumin+Esterase%2C+but+Not+Carboxylesterase%2C+Are+Present+in+Human+Plasma&doi=10.1016%2Fj.bcp.2005.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma</span></div><div class="casAuthors">Li, Bin; Sedlacek, Meghan; Manoharan, Indumathi; Boopathy, Rathnam; Duysen, Ellen G.; Masson, Patrick; Lockridge, Oksana</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1673-1684</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The goal of this work was to identify the esterases in human plasma and to clarify common misconceptions.  The method for identifying esterases was nondenaturing gradient gel electrophoresis stained for esterase activity.  We report that human plasma contains four esterases: butyrylcholinesterase (E.C. 3.1.1.8), paraoxonase (E.C. 3.1.8.1), acetylcholinesterase (E.C. 3.1.1.7), and albumin.  Butyrylcholinesterase (BChE), paraoxonase (PON1), and albumin are in high enough concns. to contribute significantly to ester hydrolysis.  However, only trace amts. of acetylcholinesterase (AChE) are present.  Monomeric AChE is seen in wild-type as well as in silent BChE plasma.  Albumin has esterase activity with alpha- and beta-naphthylacetate as well as with p-nitrophenyl acetate.  Misconception #1 is that human plasma contains carboxylesterase.  We demonstrate that human plasma contains no carboxylesterase (E.C. 3.1.1.1), in contrast to mouse, rat, rabbit, horse, cat, and tiger that have high amts. of plasma carboxylesterase.  Misconception #2 is that lab. animals have BChE but no AChE in their plasma.  We demonstrate that mice, unlike humans, have substantial amts. of sol. AChE as well as BChE in their plasma.  Plasma from AChE and BChE knockout mice allowed identification of AChE and BChE bands without the use of inhibitors.  Human BChE is irreversibly inhibited by diisopropylfluorophosphate, echothiophate, and paraoxon, but mouse BChE spontaneously reactivates.  Since human plasma contains no carboxylesterase, only BChE, PON1, and albumin esterases need to be considered when evaluating hydrolysis of an ester drug in human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobFY6T-ENpA7Vg90H21EOLACvtfcHk0liHZnm8JNaynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLzJ&md5=d9d557d16e4e43d82f1c2d391dc3ac89</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DSedlacek%26aufirst%3DM.%26aulast%3DManoharan%26aufirst%3DI.%26aulast%3DBoopathy%26aufirst%3DR.%26aulast%3DDuysen%26aufirst%3DE.%2BG.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DLockridge%26aufirst%3DO.%26atitle%3DButyrylcholinesterase%252C%2520Paraoxonase%252C%2520and%2520Albumin%2520Esterase%252C%2520but%2520Not%2520Carboxylesterase%252C%2520Are%2520Present%2520in%2520Human%2520Plasma%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D1673%26epage%3D1684%26doi%3D10.1016%2Fj.bcp.2005.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Meshorer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soreq, H.</span><span> </span><span class="NLM_article-title">Virtues and Woes of Ache Alternative Splicing in Stress-Related Neuropathologies</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1016/j.tins.2006.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.tins.2006.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=216-224&author=E.+Meshorerauthor=H.+Soreq&title=Virtues+and+Woes+of+Ache+Alternative+Splicing+in+Stress-Related+Neuropathologies&doi=10.1016%2Fj.tins.2006.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2006.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2006.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DMeshorer%26aufirst%3DE.%26aulast%3DSoreq%26aufirst%3DH.%26atitle%3DVirtues%2520and%2520Woes%2520of%2520Ache%2520Alternative%2520Splicing%2520in%2520Stress-Related%2520Neuropathologies%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D216%26epage%3D224%26doi%3D10.1016%2Fj.tins.2006.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Polasek, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doogue, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miners, J. O.</span><span> </span><span class="NLM_article-title">Metabolic Activation of Clopidogrel: In Vitro Data Provide Conflicting Evidence for the Contributions of Cyp2c19 and Pon1</span> <span class="citation_source-journal">Ther. Adv. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1177/2042098611422559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1177%2F2042098611422559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25083217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A280%3ADC%252BC2cbotVGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=253-261&author=T.+M.+Polasekauthor=M.+P.+Doogueauthor=J.+O.+Miners&title=Metabolic+Activation+of+Clopidogrel%3A+In+Vitro+Data+Provide+Conflicting+Evidence+for+the+Contributions+of+Cyp2c19+and+Pon1&doi=10.1177%2F2042098611422559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1</span></div><div class="casAuthors">Polasek Thomas M; Doogue Matthew P; Miners John O</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic advances in drug safety</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">253-61</span>
        ISSN:<span class="NLM_cas:issn">2042-0986</span>.
    </div><div class="casAbstract">The recent report that clopidogrel efficacy may be more dependent on paraoxonase-1 (PON1) than on cytochrome P450 2C19 (CYP2C19) activity raises questions about the roles of these and other enzymes in clopidogrel activation.  To provide insight into the emerging PON1 versus CYP2C19 debate, this commentary summarizes the clinical evidence on the pharmacokinetic determinants of clopidogrel efficacy.  We then review the in vitro studies investigating the enzymes involved in clopidogrel activation, and comment on their strengths and limitations.  There is agreement amongst in vitro studies regarding the involvement of CYP1A2 and CYP2B6 in the metabolism of clopidogrel to 2-oxo-clopidogrel.  However, the evidence for other CYP enzymes in the first activation step (e.g.  CYP2C19 and CYP3A4) is inconsistent and dependent on the in vitro test system and laboratory.  All major drug metabolizing CYP enzymes are capable of converting 2-oxo-clopidogrel to sulfenic acid intermediates that subsequently form the active thiol metabolite.  However, the extent of CYP involvement in this second step has been challenged, and new evidence suggests that CYP-independent hydrolytic cleavage of the thioester bond may be more important than oxidative metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaXk-rgHeYvQWRJ3OJdH_qfW6udTcc2eZBN8wdZOUY8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbotVGktQ%253D%253D&md5=c060df10c5002350d5a7b6867d04241a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1177%2F2042098611422559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2042098611422559%26sid%3Dliteratum%253Aachs%26aulast%3DPolasek%26aufirst%3DT.%2BM.%26aulast%3DDoogue%26aufirst%3DM.%2BP.%26aulast%3DMiners%26aufirst%3DJ.%2BO.%26atitle%3DMetabolic%2520Activation%2520of%2520Clopidogrel%253A%2520In%2520Vitro%2520Data%2520Provide%2520Conflicting%2520Evidence%2520for%2520the%2520Contributions%2520of%2520Cyp2c19%2520and%2520Pon1%26jtitle%3DTher.%2520Adv.%2520Drug%2520Saf.%26date%3D2011%26volume%3D2%26spage%3D253%26epage%3D261%26doi%3D10.1177%2F2042098611422559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Eng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niosi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simila, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Utility of the Carboxylesterase Inhibitor Bis-Para-Nitrophenylphosphate (Bnpp) in the Plasma Unbound Fraction Determination for a Hydrolytically Unstable Amide Derivative and Agonist of the Tgr5 Receptor</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span><span class="refDoi"> DOI: 10.3109/00498251003706598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.3109%2F00498251003706598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=20297923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVGksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=369-380&author=H.+Engauthor=M.+Niosiauthor=T.+S.+McDonaldauthor=A.+Wolfordauthor=Y.+Chenauthor=S.+T.+Similaauthor=J.+N.+Baumanauthor=J.+Warmusauthor=A.+S.+Kalgutkar&title=Utility+of+the+Carboxylesterase+Inhibitor+Bis-Para-Nitrophenylphosphate+%28Bnpp%29+in+the+Plasma+Unbound+Fraction+Determination+for+a+Hydrolytically+Unstable+Amide+Derivative+and+Agonist+of+the+Tgr5+Receptor&doi=10.3109%2F00498251003706598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor</span></div><div class="casAuthors">Eng, H.; Niosi, M.; McDonald, T. S.; Wolford, A.; Chen, Y.; Simila, S. T. M.; Bauman, J. N.; Warmus, J.; Kalgutkar, A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">369-380</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A novel system has been devised to measure for a plasma-labile compd.  The bis-para-nitrophenylphosphate (BNPP) methodol. can be potentially applied to stabilize hydrolytic cleavage of structurally diverse carboxylesterase substrates in the plasma (and other tissue), thereby allowing the characterization of pharmacol. studies on plasma-labile compds. if and when they emerge as hits in exploratory drug-discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeCqPjMIO6lrVg90H21EOLACvtfcHk0liHZnm8JNaynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVGksLk%253D&md5=e91e6ea616181fe2095d5fa876de37d5</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3109%2F00498251003706598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498251003706598%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DH.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DWolford%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSimila%26aufirst%3DS.%2BT.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DWarmus%26aufirst%3DJ.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DUtility%2520of%2520the%2520Carboxylesterase%2520Inhibitor%2520Bis-Para-Nitrophenylphosphate%2520%2528Bnpp%2529%2520in%2520the%2520Plasma%2520Unbound%2520Fraction%2520Determination%2520for%2520a%2520Hydrolytically%2520Unstable%2520Amide%2520Derivative%2520and%2520Agonist%2520of%2520the%2520Tgr5%2520Receptor%26jtitle%3DXenobiotica%26date%3D2010%26volume%3D40%26spage%3D369%26epage%3D380%26doi%3D10.3109%2F00498251003706598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Warmus, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limberakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knafels, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochalkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podoll, T.</span><span> </span><span class="NLM_article-title">Structure-Based Design of an <i>in vivo</i> Active Hydroxamic Acid Inhibitor of <i>P. aeruginosa</i> LpxC</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2536</span><span class="NLM_x">–</span> <span class="NLM_lpage">2543</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2012.01.140" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2536-2543&author=J.+S.+Warmusauthor=C.+L.+Quinnauthor=C.+Taylorauthor=S.+T.+Murphyauthor=T.+A.+Johnsonauthor=C.+Limberakisauthor=D.+Ortwineauthor=J.+Bronsteinauthor=P.+Paganoauthor=J.+D.+Knafelsauthor=S.+Lightleauthor=I.+Mochalkinauthor=R.+Brideauauthor=T.+Podoll&title=Structure-Based+Design+of+an+in+vivo+Active+Hydroxamic+Acid+Inhibitor+of+P.+aeruginosa+LpxC&doi=10.1016%2Fj.bmcl.2012.01.140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.140%26sid%3Dliteratum%253Aachs%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DQuinn%26aufirst%3DC.%2BL.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DJohnson%26aufirst%3DT.%2BA.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DOrtwine%26aufirst%3DD.%26aulast%3DBronstein%26aufirst%3DJ.%26aulast%3DPagano%26aufirst%3DP.%26aulast%3DKnafels%26aufirst%3DJ.%2BD.%26aulast%3DLightle%26aufirst%3DS.%26aulast%3DMochalkin%26aufirst%3DI.%26aulast%3DBrideau%26aufirst%3DR.%26aulast%3DPodoll%26aufirst%3DT.%26atitle%3DStructure-Based%2520Design%2520of%2520an%2520in%2520vivo%2520Active%2520Hydroxamic%2520Acid%2520Inhibitor%2520of%2520P.%2520aeruginosa%2520LpxC%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2536%26epage%3D2543%26doi%3D10.1016%2Fj.bmcl.2012.01.140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, X.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.-R.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Novel Metalloproteinase Inhibitors Based on L-Tyrosine Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5738</span><span class="NLM_x">–</span> <span class="NLM_lpage">5744</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmc.2012.08.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5738-5744&author=X.-C.+Chengauthor=R.-L.+Wangauthor=Z.-K.+Dongauthor=J.+Liauthor=Y.-Y.+Liauthor=R.-R.+Li&title=Design%2C+Synthesis+and+Evaluation+of+Novel+Metalloproteinase+Inhibitors+Based+on+L-Tyrosine+Scaffold&doi=10.1016%2Fj.bmc.2012.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.-C.%26aulast%3DWang%26aufirst%3DR.-L.%26aulast%3DDong%26aufirst%3DZ.-K.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-Y.%26aulast%3DLi%26aufirst%3DR.-R.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Novel%2520Metalloproteinase%2520Inhibitors%2520Based%2520on%2520L-Tyrosine%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5738%26epage%3D5744%26doi%3D10.1016%2Fj.bmc.2012.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komurasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, M.</span><span> </span><span class="NLM_article-title">Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span><span class="refDoi"> DOI: 10.1021/jm9707582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9707582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=640-649&author=Y.+Tamuraauthor=F.+Watanabeauthor=T.+Nakataniauthor=K.+Yasuiauthor=M.+Fujiauthor=T.+Komurasakiauthor=H.+Tsuzukiauthor=R.+Maekawaauthor=T.+Yoshiokaauthor=K.+Kawadaauthor=K.+Sugitaauthor=M.+Ohtani&title=Highly+Selective+and+Orally+Active+Inhibitors+of+Type+IV+Collagenase+%28MMP-9+and+MMP-2%29%3A+N-Sulfonylamino+Acid+Derivatives&doi=10.1021%2Fjm9707582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=10.1021%2Fjm9707582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707582%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DF.%26aulast%3DNakatani%26aufirst%3DT.%26aulast%3DYasui%26aufirst%3DK.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DKomurasaki%26aufirst%3DT.%26aulast%3DTsuzuki%26aufirst%3DH.%26aulast%3DMaekawa%26aufirst%3DR.%26aulast%3DYoshioka%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DK.%26aulast%3DSugita%26aufirst%3DK.%26aulast%3DOhtani%26aufirst%3DM.%26atitle%3DHighly%2520Selective%2520and%2520Orally%2520Active%2520Inhibitors%2520of%2520Type%2520IV%2520Collagenase%2520%2528MMP-9%2520and%2520MMP-2%2529%253A%2520N-Sulfonylamino%2520Acid%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D640%26epage%3D649%26doi%3D10.1021%2Fjm9707582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">Protease inhibitors. Part 7: Inhibition of <i>Clostridium histolyticum</i> Collagenase with Sulfonylated Derivatives of L-Valine Hydroxamate</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/S0928-0987(99)00090-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2FS0928-0987%2899%2900090-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10699384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVans7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=67-76&author=C.+T.+Supuranauthor=A.+Scozzafava&title=Protease+inhibitors.+Part+7%3A+Inhibition+of+Clostridium+histolyticum+Collagenase+with+Sulfonylated+Derivatives+of+L-Valine+Hydroxamate&doi=10.1016%2FS0928-0987%2899%2900090-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46cR"><div class="casContent"><span class="casTitleNuber">46c</span><div class="casTitle"><span class="NLM_cas:atitle">Protease inhibitors. Part 7 Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of l-valine hydroxamate</span></div><div class="casAuthors">Supuran, C. T.; Scozzafava, A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Sulfonylated L-valine hydroxamate derivs. were obtained by reaction of alkyl/arylsulfonyl halides with the title amino acid, followed by treatment with benzyl chloride, and conversion of the COOH moiety to the CONHOH group.  Other derivs. were obtained by reaction of N-benzyl-L-valine with arylisocyanates, arylsulfonylisocyanates or benzoylisothiocyanate, followed by the similar conversion of the COOH into the CONHOH moiety, with hydroxylamine in the presence of carbodiimides.  The obtained compds. were assayed as inhibitors of the Clostridium histolyticum collagenase, ChC (EC 3.4.24.3), a zinc enzyme which degrades triple helical collagen.  The hydroxamate derivs. were generally 100-500 times more active than the corresponding carboxylates.  In the series of synthesized derivs., substitution patterns leading to best ChC inhibitors were those involving perfluoroalkylsulfonyl- and substituted-arylsulfonyl moieties, such as pentafluorophenylsulfonyl; 3- and 4-protected-aminophenylsulfonyl-; 3- and 4-carboxyphenylsulfonyl-; 3-trifluoromethylphenylsulfonyl; or 1- and 2-naphthyl among others.  Similarly to the matrix metalloproteinase hydroxamate inhibitors, ChC inhibitors of the type reported here must incorporate hydrophobic moieties at the P2' and P3' subsites, in order to achieve tight binding to the enzyme.  Such compds. might lead to drugs useful in the treatment of corneal bacterial keratitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtl2jRweK_vrVg90H21EOLACvtfcHk0liTaksx6splbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVans7w%253D&md5=2ec6e3410afec24734ac14a2f779c7ab</span></div><a href="/servlet/linkout?suffix=cit46c&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2899%2900090-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252899%252900090-1%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DProtease%2520inhibitors.%2520Part%25207%253A%2520Inhibition%2520of%2520Clostridium%2520histolyticum%2520Collagenase%2520with%2520Sulfonylated%2520Derivatives%2520of%2520L-Valine%2520Hydroxamate%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D10%26spage%3D67%26epage%3D76%26doi%3D10.1016%2FS0928-0987%2899%2900090-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">MacPherson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayburt, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capparelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doughty, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spirito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blancuzzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Byrne, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D. T.</span><span> </span><span class="NLM_article-title">Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">–</span> <span class="NLM_lpage">2532</span><span class="refDoi"> DOI: 10.1021/jm960871c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960871c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1yntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2525-2532&author=L.+J.+MacPhersonauthor=E.+K.+Bayburtauthor=M.+P.+Capparelliauthor=B.+J.+Carrollauthor=R.+Goldsteinauthor=M.+R.+Justiceauthor=L.+Zhuauthor=S.+Huauthor=R.+A.+Meltonauthor=L.+Fryerauthor=R.+L.+Goldbergauthor=J.+R.+Doughtyauthor=S.+Spiritoauthor=V.+Blancuzziauthor=D.+Wilsonauthor=E.+M.+O%E2%80%99Byrneauthor=V.+Ganuauthor=D.+T.+Parker&title=Discovery+of+CGS+27023A%2C+a+Non-Peptidic%2C+Potent%2C+and+Orally+Active+Stromelysin+Inhibitor+That+Blocks+Cartilage+Degradation+in+Rabbits&doi=10.1021%2Fjm960871c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46dR"><div class="casContent"><span class="casTitleNuber">46d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor that Blocks Cartilage Degradation in Rabbits</span></div><div class="casAuthors">MacPherson, Lawrence J.; Bayburt, Erol K.; Capparelli, Michael P.; Carroll, Brian J.; Goldstein, Robert; Justice, Michael R.; Zhu, Lijuan; Hu, Shou-Ih; Melton, Richard A.; Fryer, Lynn; Goldberg, Ron L.; Doughty, John R.; Spirito, Salvatore; Blancuzzi, Vincent; Wilson, Doug; O'Byrne, Elizabeth M.; Ganu, Vishwas; Parker, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2525-2532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-activity relationships of a lead hydroxamic acid inhibitor of recombinant human stromelysin were systematically defined by taking advantage of a concise synthesis that allowed diverse functionality to be explored at each position in a template.  An ex vivo rat model and an in vivo rabbit model of stromelysin-induced cartilage degrdn. were used to further optimize these analogs for oral activity and duration of action.  The culmination of these modifications resulted in CGS 27023A, a potent, orally active stromelysin inhibitor that blocks the erosion of cartilage matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMDtjlFldPALVg90H21EOLACvtfcHk0liTaksx6splbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1yntbY%253D&md5=219c31bebd8b709c32f00958cb6ea7c1</span></div><a href="/servlet/linkout?suffix=cit46d&amp;dbid=16384&amp;doi=10.1021%2Fjm960871c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960871c%26sid%3Dliteratum%253Aachs%26aulast%3DMacPherson%26aufirst%3DL.%2BJ.%26aulast%3DBayburt%26aufirst%3DE.%2BK.%26aulast%3DCapparelli%26aufirst%3DM.%2BP.%26aulast%3DCarroll%26aufirst%3DB.%2BJ.%26aulast%3DGoldstein%26aufirst%3DR.%26aulast%3DJustice%26aufirst%3DM.%2BR.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DMelton%26aufirst%3DR.%2BA.%26aulast%3DFryer%26aufirst%3DL.%26aulast%3DGoldberg%26aufirst%3DR.%2BL.%26aulast%3DDoughty%26aufirst%3DJ.%2BR.%26aulast%3DSpirito%26aufirst%3DS.%26aulast%3DBlancuzzi%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Byrne%26aufirst%3DE.%2BM.%26aulast%3DGanu%26aufirst%3DV.%26aulast%3DParker%26aufirst%3DD.%2BT.%26atitle%3DDiscovery%2520of%2520CGS%252027023A%252C%2520a%2520Non-Peptidic%252C%2520Potent%252C%2520and%2520Orally%2520Active%2520Stromelysin%2520Inhibitor%2520That%2520Blocks%2520Cartilage%2520Degradation%2520in%2520Rabbits%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2525%26epage%3D2532%26doi%3D10.1021%2Fjm960871c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Dankwardt, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbot, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wart, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, K. A. M.</span><span> </span><span class="NLM_article-title">Amino Acid Derived Sulfonamide Hydroxamates as Inhibitors of Procollagen C-Proteinase. Part 2: Solid-Phase Optimization of Side Chains</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1233</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00117-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2FS0960-894X%2802%2900117-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1233-1235&author=S.+M.+Dankwardtauthor=S.+C.+Abbotauthor=C.+A.+Brokaauthor=R.+L.+Martinauthor=C.+S.+Chanauthor=E.+B.+Springmanauthor=H.+E.+Van+Wartauthor=K.+A.+M.+Walker&title=Amino+Acid+Derived+Sulfonamide+Hydroxamates+as+Inhibitors+of+Procollagen+C-Proteinase.+Part+2%3A+Solid-Phase+Optimization+of+Side+Chains&doi=10.1016%2FS0960-894X%2802%2900117-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46e&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900117-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900117-8%26sid%3Dliteratum%253Aachs%26aulast%3DDankwardt%26aufirst%3DS.%2BM.%26aulast%3DAbbot%26aufirst%3DS.%2BC.%26aulast%3DBroka%26aufirst%3DC.%2BA.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DChan%26aufirst%3DC.%2BS.%26aulast%3DSpringman%26aufirst%3DE.%2BB.%26aulast%3DVan%2BWart%26aufirst%3DH.%2BE.%26aulast%3DWalker%26aufirst%3DK.%2BA.%2BM.%26atitle%3DAmino%2520Acid%2520Derived%2520Sulfonamide%2520Hydroxamates%2520as%2520Inhibitors%2520of%2520Procollagen%2520C-Proteinase.%2520Part%25202%253A%2520Solid-Phase%2520Optimization%2520of%2520Side%2520Chains%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1233%26epage%3D1235%26doi%3D10.1016%2FS0960-894X%2802%2900117-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">El Bakali, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras-Masse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maingot, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Inhibition of Aggrecanase as a Therapeutic Strategy in Osteoarthritis</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.4155/fmc.14.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.4155%2Ffmc.14.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=25329196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1399-1412&author=J.+El+Bakaliauthor=H.+Gras-Masseauthor=L.+Maingotauthor=B.+Deprezauthor=J.+Dumontauthor=F.+Lerouxauthor=R.+Deprez-Poulain&title=Inhibition+of+Aggrecanase+as+a+Therapeutic+Strategy+in+Osteoarthritis&doi=10.4155%2Ffmc.14.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis</span></div><div class="casAuthors">El Bakali Jamal; Gras-Masse Helene; Maingot Lucie; Deprez Benoit; Dumont Julie; Leroux Florence; Deprez-Poulain Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Future medicinal chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1399-412</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the last decade, there has been a large effort to target aggrecanases, which are responsible for the degradation of the aggrecan in the extracellular matrix of joints, in order to hopefully lead to new treatments for osteoarthritis.  Only a few inhibitors have been effective in explants or rodent models and thus only a few have reached the clinic, none of which have proven to be effective.  In this article, a survey of chemical series is described, covering historical and recent inhibitors and highlighting how some of their problems were resolved, with a critical overview of the challenges encountered.  A large effort should be undertaken in designing smaller compounds with higher residence times, defining new interaction sites on the aggrecanases and exploiting target flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc6YFS0apR4JZoeNcnHOQ9fW6udTcc2eadE0kcW3qmuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3itFeisA%253D%253D&md5=85f4d7d300cf08249358f9db09cf3e69</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.84%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BBakali%26aufirst%3DJ.%26aulast%3DGras-Masse%26aufirst%3DH.%26aulast%3DMaingot%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Aggrecanase%2520as%2520a%2520Therapeutic%2520Strategy%2520in%2520Osteoarthritis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1399%26epage%3D1412%26doi%3D10.4155%2Ffmc.14.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Clary, L.; Pascal, J.-C.</span><span> </span><span class="NLM_article-title">4-Alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide Compounds as Selective Tace-Inhibitors for the Treatment of Inflammatory Diseases</span>. WO2011033010 A1 March 24,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.+Clary&author=J.-C.+Pascal&title=4-Alkoxy-N-%282-hydroxycarbamoyl-2-piperidinyl-ethyl%29-benzamide+Compounds+as+Selective+Tace-Inhibitors+for+the+Treatment+of+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClary%26aufirst%3DL.%26atitle%3D4-Alkoxy-N-%25282-hydroxycarbamoyl-2-piperidinyl-ethyl%2529-benzamide%2520Compounds%2520as%2520Selective%2520Tace-Inhibitors%2520for%2520the%2520Treatment%2520of%2520Inflammatory%2520Diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Finn, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollinshead, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrianov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokaldere, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikovska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailite, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piskunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starchenkov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vorona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalvinsh, I.</span><span> </span><span class="NLM_article-title">Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span><span class="refDoi"> DOI: 10.1002/hlca.200590129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1002%2Fhlca.200590129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=1630-1657&author=P.+W.+Finnauthor=M.+Bandaraauthor=C.+Butcherauthor=A.+Finnauthor=R.+Hollinsheadauthor=N.+Khanauthor=N.+Lawauthor=S.+Murthyauthor=R.+Romeroauthor=C.+Watkinsauthor=V.+Andrianovauthor=R.+M.+Bokaldereauthor=K.+Dikovskaauthor=V.+Gailiteauthor=E.+Lozaauthor=I.+Piskunovaauthor=I.+Starchenkovauthor=M.+Voronaauthor=I.+Kalvinsh&title=Novel+Sulfonamide+Derivatives+as+Inhibitors+of+Histone+Deacetylase&doi=10.1002%2Fhlca.200590129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200590129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200590129%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DP.%2BW.%26aulast%3DBandara%26aufirst%3DM.%26aulast%3DButcher%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DA.%26aulast%3DHollinshead%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DN.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DR.%26aulast%3DWatkins%26aufirst%3DC.%26aulast%3DAndrianov%26aufirst%3DV.%26aulast%3DBokaldere%26aufirst%3DR.%2BM.%26aulast%3DDikovska%26aufirst%3DK.%26aulast%3DGailite%26aufirst%3DV.%26aulast%3DLoza%26aufirst%3DE.%26aulast%3DPiskunova%26aufirst%3DI.%26aulast%3DStarchenkov%26aufirst%3DI.%26aulast%3DVorona%26aufirst%3DM.%26aulast%3DKalvinsh%26aufirst%3DI.%26atitle%3DNovel%2520Sulfonamide%2520Derivatives%2520as%2520Inhibitors%2520of%2520Histone%2520Deacetylase%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2005%26volume%3D88%26spage%3D1630%26epage%3D1657%26doi%3D10.1002%2Fhlca.200590129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lye, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoo, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangthongpitag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khng, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonday, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantharaj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span> </span><span class="NLM_article-title">Discovery of (2e)-3-{2-Butyl-1-[2-(Diethylamino)Ethyl]-1h-Benzimidazol-5-Yl}-N-Hydroxyacrylamide (Sb939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4694</span><span class="NLM_x">–</span> <span class="NLM_lpage">4720</span><span class="refDoi"> DOI: 10.1021/jm2003552</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2003552" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1emsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4694-4720&author=H.+Wangauthor=N.+Yuauthor=D.+Chenauthor=K.+C.+L.+Leeauthor=P.+L.+Lyeauthor=J.+W.+W.+Changauthor=W.+Dengauthor=M.+C.+Y.+Ngauthor=T.+Luauthor=M.+L.+Khooauthor=A.+Poulsenauthor=K.+Sangthongpitagauthor=X.+Wuauthor=C.+Huauthor=K.+C.+Gohauthor=X.+Wangauthor=L.+Fangauthor=K.+L.+Gohauthor=H.+H.+Khngauthor=S.+K.+Gohauthor=P.+Yeoauthor=X.+Liuauthor=Z.+Bondayauthor=J.+M.+Woodauthor=B.+W.+Dymockauthor=E.+Kantharajauthor=E.+T.+Sun&title=Discovery+of+%282e%29-3-%7B2-Butyl-1-%5B2-%28Diethylamino%29Ethyl%5D-1h-Benzimidazol-5-Yl%7D-N-Hydroxyacrylamide+%28Sb939%29%2C+an+Orally+Active+Histone+Deacetylase+Inhibitor+with+a+Superior+Preclinical+Profile&doi=10.1021%2Fjm2003552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile</span></div><div class="casAuthors">Wang, Haishan; Yu, Niefang; Chen, Dizhong; Lee, Ken Chi Lik; Lye, Pek Ling; Chang, Joyce Wei Wei; Deng, Weiping; Ng, Melvin Chi Yeh; Lu, Ting; Khoo, Mui Ling; Poulsen, Anders; Sangthongpitag, Kanda; Wu, Xiaofeng; Hu, Changyong; Goh, Kee Chuan; Wang, Xukun; Fang, Lijuan; Goh, Kay Lin; Khng, Hwee Hoon; Goh, Siok Kun; Yeo, Pauline; Liu, Xin; Bonday, Zahid; Wood, Jeanette M.; Dymock, Brian W.; Kantharaj, Ethirajulu; Sun, Eric T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4694-4720</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3-(1,2-disubstituted-1H-benzimidazol-5-yl)-N-hydroxyacrylamides was designed and synthesized as HDAC inhibitors.  Extensive SARs have been established for in vitro potency (HDAC1 enzyme and COLO 205 cellular IC50), liver microsomal stability (t1/2), cytochrome P 450 inhibition (3A4 IC50), and clogP, among others.  These parameters were fine-tuned by carefully adjusting the substituents at positions 1 and 2 of the benzimidazole ring.  After comprehensive in vitro and in vivo profiling of the selected compds., SB939 (I) was identified as a preclin. development candidate.  I is a potent pan-HDAC inhibitor with excellent druglike properties, is highly efficacious in in vivo tumor models (HCT-116, PC-3, A2780, MV4-11, Ramos), and has high and dose-proportional oral exposures and very good ADME, safety, and pharmaceutical properties.  When orally dosed to tumor-bearing mice, I is enriched in tumor tissue which may contribute to its potent antitumor activity and prolonged duration of action.  I is currently being tested in phase I and phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd9r-fRIzdS7Vg90H21EOLACvtfcHk0lg0tOz56azyXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1emsr8%253D&md5=a69bf922fb86c47ddee9c9fc112cc9a2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm2003552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003552%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DK.%2BC.%2BL.%26aulast%3DLye%26aufirst%3DP.%2BL.%26aulast%3DChang%26aufirst%3DJ.%2BW.%2BW.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DNg%26aufirst%3DM.%2BC.%2BY.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DKhoo%26aufirst%3DM.%2BL.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DSangthongpitag%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DGoh%26aufirst%3DK.%2BL.%26aulast%3DKhng%26aufirst%3DH.%2BH.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DYeo%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBonday%26aufirst%3DZ.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DKantharaj%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DE.%2BT.%26atitle%3DDiscovery%2520of%2520%25282e%2529-3-%257B2-Butyl-1-%255B2-%2528Diethylamino%2529Ethyl%255D-1h-Benzimidazol-5-Yl%257D-N-Hydroxyacrylamide%2520%2528Sb939%2529%252C%2520an%2520Orally%2520Active%2520Histone%2520Deacetylase%2520Inhibitor%2520with%2520a%2520Superior%2520Preclinical%2520Profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4694%26epage%3D4720%26doi%3D10.1021%2Fjm2003552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterness, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliven, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskra, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lame, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Anaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGahee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocum, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti-Morrow, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobiassen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn-Bowser, M. L.</span><span> </span><span class="NLM_article-title">Pyran-Containing Sulfonamide Hydroxamic Acids: Potent Mmp Inhibitors That Spare Mmp-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3395</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2004.04.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=15177439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1GntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3389-3395&author=L.+A.+Reiterauthor=R.+P.+Robinsonauthor=K.+F.+McClureauthor=C.+S.+Jonesauthor=M.+R.+Reeseauthor=P.+G.+Mitchellauthor=I.+G.+Otternessauthor=M.+L.+Blivenauthor=J.+Lirasauthor=S.+R.+Cortinaauthor=K.+M.+Donahueauthor=J.+D.+Eskraauthor=R.+J.+Griffithsauthor=M.+E.+Lameauthor=A.+Lopez-Anayaauthor=G.+J.+Martinelliauthor=S.+M.+McGaheeauthor=S.+A.+Yocumauthor=L.+L.+Lopresti-Morrowauthor=L.+M.+Tobiassenauthor=M.+L.+Vaughn-Bowser&title=Pyran-Containing+Sulfonamide+Hydroxamic+Acids%3A+Potent+Mmp+Inhibitors+That+Spare+Mmp-1&doi=10.1016%2Fj.bmcl.2004.04.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1</span></div><div class="casAuthors">Reiter, Lawrence A.; Robinson, Ralph P.; McClure, Kim F.; Jones, Christopher S.; Reese, Matthew R.; Mitchell, Peter G.; Otterness, Ivan G.; Bliven, Marcia L.; Liras, Jennifer; Cortina, Santo R.; Donahue, Kathleen M.; Eskra, James D.; Griffiths, Richard J.; Lame, Mary E.; Lopez-Anaya, Arturo; Martinelli, Gary J.; McGahee, Shunda M.; Yocum, Sue A.; Lopresti-Morrow, Lori L.; Tobiassen, Lisa M.; Vaughn-Bowser, Marcie L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3389-3395</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The SAR of a series of sterically hindered sulfonamide hydroxamic acids with relatively large P1' groups is described.  The compds. typically spare MMP-1 while being potent inhibitors of MMP-13.  The metabolically more stable compds. in the series contain either a monocyclic or bicyclic pyran ring adjacent to the hydroxamate group.  Despite the sparing of MMP-1, pre-clin. and clin. studies revealed that fibrosis in rats and MSS in humans is still produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34-Ar8ooZhLVg90H21EOLACvtfcHk0ljZgQBHrwafvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1GntbY%253D&md5=f980b0e20c45d16605a60791876346f7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.083%26sid%3Dliteratum%253Aachs%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DReese%26aufirst%3DM.%2BR.%26aulast%3DMitchell%26aufirst%3DP.%2BG.%26aulast%3DOtterness%26aufirst%3DI.%2BG.%26aulast%3DBliven%26aufirst%3DM.%2BL.%26aulast%3DLiras%26aufirst%3DJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DEskra%26aufirst%3DJ.%2BD.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DLame%26aufirst%3DM.%2BE.%26aulast%3DLopez-Anaya%26aufirst%3DA.%26aulast%3DMartinelli%26aufirst%3DG.%2BJ.%26aulast%3DMcGahee%26aufirst%3DS.%2BM.%26aulast%3DYocum%26aufirst%3DS.%2BA.%26aulast%3DLopresti-Morrow%26aufirst%3DL.%2BL.%26aulast%3DTobiassen%26aufirst%3DL.%2BM.%26aulast%3DVaughn-Bowser%26aufirst%3DM.%2BL.%26atitle%3DPyran-Containing%2520Sulfonamide%2520Hydroxamic%2520Acids%253A%2520Potent%2520Mmp%2520Inhibitors%2520That%2520Spare%2520Mmp-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3389%26epage%3D3395%26doi%3D10.1016%2Fj.bmcl.2004.04.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schudok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorwart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haase, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neises, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weithmann, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmann, T.</span><span> </span><span class="NLM_article-title">Tetrahydroisoquinoline-3-Carboxylate Based Matrix-Metalloproteinase Inhibitors: Design, Synthesis and Structure–Activity Relationship</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3529</span><span class="NLM_x">–</span> <span class="NLM_lpage">3544</span><span class="refDoi"> DOI: 10.1016/S0968-0896(02)00215-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2FS0968-0896%2802%2900215-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3529-3544&author=H.+Matterauthor=M.+Schudokauthor=W.+Schwabauthor=W.+Thorwartauthor=D.+Barbierauthor=G.+Billenauthor=B.+Haaseauthor=B.+Neisesauthor=K.-U.+Weithmannauthor=T.+Wollmann&title=Tetrahydroisoquinoline-3-Carboxylate+Based+Matrix-Metalloproteinase+Inhibitors%3A+Design%2C+Synthesis+and+Structure%E2%80%93Activity+Relationship&doi=10.1016%2FS0968-0896%2802%2900215-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2802%2900215-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252802%252900215-8%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DSchudok%26aufirst%3DM.%26aulast%3DSchwab%26aufirst%3DW.%26aulast%3DThorwart%26aufirst%3DW.%26aulast%3DBarbier%26aufirst%3DD.%26aulast%3DBillen%26aufirst%3DG.%26aulast%3DHaase%26aufirst%3DB.%26aulast%3DNeises%26aufirst%3DB.%26aulast%3DWeithmann%26aufirst%3DK.-U.%26aulast%3DWollmann%26aufirst%3DT.%26atitle%3DTetrahydroisoquinoline-3-Carboxylate%2520Based%2520Matrix-Metalloproteinase%2520Inhibitors%253A%2520Design%252C%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3529%26epage%3D3544%26doi%3D10.1016%2FS0968-0896%2802%2900215-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Murphy-Benenato, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thresher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span> </span><span class="NLM_article-title">Synthesis, Structure, and Sar of Tetrahydropyran-Based Lpxc Inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span><span class="refDoi"> DOI: 10.1021/ml500210x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500210x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1213-1218&author=K.+E.+Murphy-Benenatoauthor=N.+Olivierauthor=A.+Choyauthor=P.+L.+Rossauthor=M.+D.+Millerauthor=J.+Thresherauthor=N.+Gaoauthor=M.+R.+Hale&title=Synthesis%2C+Structure%2C+and+Sar+of+Tetrahydropyran-Based+Lpxc+Inhibitors&doi=10.1021%2Fml500210x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fml500210x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500210x%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy-Benenato%26aufirst%3DK.%2BE.%26aulast%3DOlivier%26aufirst%3DN.%26aulast%3DChoy%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DP.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DThresher%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DHale%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%252C%2520Structure%252C%2520and%2520Sar%2520of%2520Tetrahydropyran-Based%2520Lpxc%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1213%26epage%3D1218%26doi%3D10.1021%2Fml500210x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traskos, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J. J. W.</span><span> </span><span class="NLM_article-title">A,B-Cyclic-B-Benzamido Hydroxamic Acids: Novel Templates for the Design, Synthesis, and Evaluation of Selective Inhibitors of Tnf-A Converting Enzyme (Tace)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.11.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2007.11.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=694-699&author=G.+R.+Ottauthor=N.+Asakawaauthor=Z.+Luauthor=R.-Q.+Liuauthor=M.+B.+Covingtonauthor=K.+Vaddiauthor=M.+Qianauthor=R.+C.+Newtonauthor=D.+D.+Christauthor=J.+M.+Traskosauthor=C.+P.+Deciccoauthor=J.+J.+W.+Duan&title=A%2CB-Cyclic-B-Benzamido+Hydroxamic+Acids%3A+Novel+Templates+for+the+Design%2C+Synthesis%2C+and+Evaluation+of+Selective+Inhibitors+of+Tnf-A+Converting+Enzyme+%28Tace%29&doi=10.1016%2Fj.bmcl.2007.11.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.11.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.11.059%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DAsakawa%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DR.-Q.%26aulast%3DCovington%26aufirst%3DM.%2BB.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DNewton%26aufirst%3DR.%2BC.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DTraskos%26aufirst%3DJ.%2BM.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%2BW.%26atitle%3DA%252CB-Cyclic-B-Benzamido%2520Hydroxamic%2520Acids%253A%2520Novel%2520Templates%2520for%2520the%2520Design%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Selective%2520Inhibitors%2520of%2520Tnf-A%2520Converting%2520Enzyme%2520%2528Tace%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D694%26epage%3D699%26doi%3D10.1016%2Fj.bmcl.2007.11.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Yang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Mild and Efficient Lewis Acid-Promoted Detritylation in the Synthesis of N-Hydroxy Amides: A Concise Synthesis of (−)-Cobactin T</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">8123</span><span class="NLM_x">–</span> <span class="NLM_lpage">8126</span><span class="refDoi"> DOI: 10.1021/jo701411d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701411d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=8123-8126&author=S.-M.+Yangauthor=B.+Laguauthor=L.+J.+Wilson&title=Mild+and+Efficient+Lewis+Acid-Promoted+Detritylation+in+the+Synthesis+of+N-Hydroxy+Amides%3A+A+Concise+Synthesis+of+%28%E2%88%92%29-Cobactin+T&doi=10.1021%2Fjo701411d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjo701411d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701411d%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-M.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DMild%2520and%2520Efficient%2520Lewis%2520Acid-Promoted%2520Detritylation%2520in%2520the%2520Synthesis%2520of%2520N-Hydroxy%2520Amides%253A%2520A%2520Concise%2520Synthesis%2520of%2520%2528%25E2%2588%2592%2529-Cobactin%2520T%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D8123%26epage%3D8126%26doi%3D10.1021%2Fjo701411d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Levy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobelny, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casabonne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadzan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galardy, R. E.</span><span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors: A Structure–Activity Study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1021/jm970494j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970494j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=199-223&author=D.+E.+Levyauthor=F.+Lapierreauthor=W.+Liangauthor=W.+Yeauthor=C.+W.+Langeauthor=X.+Liauthor=D.+Grobelnyauthor=M.+Casabonneauthor=D.+Tyrrellauthor=K.+Holmeauthor=A.+Nadzanauthor=R.+E.+Galardy&title=Matrix+Metalloproteinase+Inhibitors%3A+A+Structure%E2%80%93Activity+Study&doi=10.1021%2Fjm970494j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm970494j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970494j%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DLapierre%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DLange%26aufirst%3DC.%2BW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGrobelny%26aufirst%3DD.%26aulast%3DCasabonne%26aufirst%3DM.%26aulast%3DTyrrell%26aufirst%3DD.%26aulast%3DHolme%26aufirst%3DK.%26aulast%3DNadzan%26aufirst%3DA.%26aulast%3DGalardy%26aufirst%3DR.%2BE.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%253A%2520A%2520Structure%25E2%2580%2593Activity%2520Study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D199%26epage%3D223%26doi%3D10.1021%2Fjm970494j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Ho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strobel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralbovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.</span><span> </span><span class="NLM_article-title">Improved Solution- and Solid-Phase Preparation of Hydroxamic Acids from Esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">4873</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1021/jo050036f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050036f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFKjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=4873-4875&author=C.+Y.+Hoauthor=E.+Strobelauthor=J.+Ralbovskyauthor=R.+A.+Galemmo&title=Improved+Solution-+and+Solid-Phase+Preparation+of+Hydroxamic+Acids+from+Esters&doi=10.1021%2Fjo050036f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Improved solution- and solid-phase preparation of hydroxamic acids from esters</span></div><div class="casAuthors">Ho, Chih Y.; Strobel, Eric; Ralbovsky, Janet; Galemmo, Robert A., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4873-4875</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The addn. of small amts. of solid KCN to carboxylic esters, either solid-supported or in soln., in THF/MeOH/NH2OH increased the efficiency of their transformation to the corresponding hydroxamic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoyGOhJrr627Vg90H21EOLACvtfcHk0lgzbIBCkNkg5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFKjurs%253D&md5=14fe68273034da24eba2441319a706a4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjo050036f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050036f%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DC.%2BY.%26aulast%3DStrobel%26aufirst%3DE.%26aulast%3DRalbovsky%26aufirst%3DJ.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26atitle%3DImproved%2520Solution-%2520and%2520Solid-Phase%2520Preparation%2520of%2520Hydroxamic%2520Acids%2520from%2520Esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D4873%26epage%3D4875%26doi%3D10.1021%2Fjo050036f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Harris, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthington, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melander, C.</span><span> </span><span class="NLM_article-title">A Facile Synthesis of 1,5-Disubstituted-2-Aminoimidazoles: Antibiotic Activity of a First Generation Library</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4516</span><span class="NLM_x">–</span> <span class="NLM_lpage">4519</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.bmcl.2011.05.123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4516-4519&author=T.+L.+Harrisauthor=R.+J.+Worthingtonauthor=C.+Melander&title=A+Facile+Synthesis+of+1%2C5-Disubstituted-2-Aminoimidazoles%3A+Antibiotic+Activity+of+a+First+Generation+Library&doi=10.1016%2Fj.bmcl.2011.05.123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.123%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DT.%2BL.%26aulast%3DWorthington%26aufirst%3DR.%2BJ.%26aulast%3DMelander%26aufirst%3DC.%26atitle%3DA%2520Facile%2520Synthesis%2520of%25201%252C5-Disubstituted-2-Aminoimidazoles%253A%2520Antibiotic%2520Activity%2520of%2520a%2520First%2520Generation%2520Library%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4516%26epage%3D4519%26doi%3D10.1016%2Fj.bmcl.2011.05.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Boldt, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janda, K. D.</span><span> </span><span class="NLM_article-title">Identification of a Potent Botulinum Neurotoxin a Protease Inhibitor Using in Situ Lead Identification Chemistry</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">–</span> <span class="NLM_lpage">1732</span><span class="refDoi"> DOI: 10.1021/ol0603211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0603211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitl2hsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1729-1732&author=G.+E.+Boldtauthor=J.+P.+Kennedyauthor=K.+D.+Janda&title=Identification+of+a+Potent+Botulinum+Neurotoxin+a+Protease+Inhibitor+Using+in+Situ+Lead+Identification+Chemistry&doi=10.1021%2Fol0603211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Potent Botulinum Neurotoxin A Protease Inhibitor Using in Situ Lead Identification Chemistry</span></div><div class="casAuthors">Boldt, Grant E.; Kennedy, Jack P.; Janda, Kim D.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1729-1732</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Botulinum neurotoxins (BoNTs), etiol. agents of the deadly food poisoning disease botulism, are the most toxic proteins currently known.  By using in situ lead identification chem., we have uncovered the first class of inhibitors that displays nanomolar potency.  From a 15 μM lead compd., structure-activity relationship studies were performed granting the most potent BoNT/A inhibitor reported to date that displays an inhibition const. of 300 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVP2ivVFRqrVg90H21EOLACvtfcHk0lgzbIBCkNkg5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitl2hsrc%253D&md5=e0c3bbc633653ad724a956b98672c29b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fol0603211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0603211%26sid%3Dliteratum%253Aachs%26aulast%3DBoldt%26aufirst%3DG.%2BE.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DJanda%26aufirst%3DK.%2BD.%26atitle%3DIdentification%2520of%2520a%2520Potent%2520Botulinum%2520Neurotoxin%2520a%2520Protease%2520Inhibitor%2520Using%2520in%2520Situ%2520Lead%2520Identification%2520Chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D1729%26epage%3D1732%26doi%3D10.1021%2Fol0603211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Double Arylations of Terminal Olefins in Acetic Acid</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1466</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span><span class="refDoi"> DOI: 10.1016/j.tet.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1016%2Fj.tet.2011.12.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=1466-1474&author=D.+Xuauthor=C.+Luauthor=W.+Chen&title=Palladium-Catalyzed+Double+Arylations+of+Terminal+Olefins+in+Acetic+Acid&doi=10.1016%2Fj.tet.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DPalladium-Catalyzed%2520Double%2520Arylations%2520of%2520Terminal%2520Olefins%2520in%2520Acetic%2520Acid%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D1466%26epage%3D1474%26doi%3D10.1016%2Fj.tet.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Ramachary, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkaiah, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishor, M.</span><span> </span><span class="NLM_article-title">Multi-Catalysis Cascade Reactions Based on the Methoxycarbonylketene Platform: Diversity-Oriented Synthesis of Functionalized Non-Symmetrical Malonates for Agrochemicals and Pharmaceuticals</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2053</span><span class="NLM_x">–</span> <span class="NLM_lpage">2062</span><span class="refDoi"> DOI: 10.1039/b901652j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.1039%2Fb901652j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=2053-2062&author=D.+B.+Ramacharyauthor=C.+Venkaiahauthor=Y.+V.+Reddyauthor=M.+Kishor&title=Multi-Catalysis+Cascade+Reactions+Based+on+the+Methoxycarbonylketene+Platform%3A+Diversity-Oriented+Synthesis+of+Functionalized+Non-Symmetrical+Malonates+for+Agrochemicals+and+Pharmaceuticals&doi=10.1039%2Fb901652j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1039%2Fb901652j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb901652j%26sid%3Dliteratum%253Aachs%26aulast%3DRamachary%26aufirst%3DD.%2BB.%26aulast%3DVenkaiah%26aufirst%3DC.%26aulast%3DReddy%26aufirst%3DY.%2BV.%26aulast%3DKishor%26aufirst%3DM.%26atitle%3DMulti-Catalysis%2520Cascade%2520Reactions%2520Based%2520on%2520the%2520Methoxycarbonylketene%2520Platform%253A%2520Diversity-Oriented%2520Synthesis%2520of%2520Functionalized%2520Non-Symmetrical%2520Malonates%2520for%2520Agrochemicals%2520and%2520Pharmaceuticals%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D2053%26epage%3D2062%26doi%3D10.1039%2Fb901652j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollenberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">Esterase Activities in the Blood, Liver and Intestine of Several Preclinical Species and Humans</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.2174/187231209788654081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=10.2174%2F187231209788654081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=19601867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=70-77&author=L.+M.+Berryauthor=L.+Wollenbergauthor=Z.+Zhao&title=Esterase+Activities+in+the+Blood%2C+Liver+and+Intestine+of+Several+Preclinical+Species+and+Humans&doi=10.2174%2F187231209788654081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Esterase activities in the blood, liver and intestine of several preclinical species and humans</span></div><div class="casAuthors">Berry, Loren M.; Wollenberg, Lance; Zhao, Zhiyang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">70-77</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Species and tissue differences in the activity of three major classes of esterases, carboxylesterase (CE), butyrylcholinesterase (BChE) and paraoxonase (PON), were studied.  Substantial species differences in activity of these esterases were obsd. between the mouse, rat, dog monkey and human.  Such species differences must be considered when using these preclin. species to optimize the pharmacokinetic properties of ester compds. intended for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDFldzEQtQKLVg90H21EOLACvtfcHk0liW-HlHG76I0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGju70%253D&md5=f480d5a0b9f54e7a34eadac588521caa</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F187231209788654081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231209788654081%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DWollenberg%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DEsterase%2520Activities%2520in%2520the%2520Blood%252C%2520Liver%2520and%2520Intestine%2520of%2520Several%2520Preclinical%2520Species%2520and%2520Humans%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2009%26volume%3D3%26spage%3D70%26epage%3D77%26doi%3D10.2174%2F187231209788654081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i92"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01444">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52358"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01444">10.1021/acs.jmedchem.7b01444</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplementary figures, supplementary tables, synthesis of intermediates, and molecular docking and scoring methods (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_001.pdf">jm7b01444_si_001.pdf (1.36 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01444/suppl_file/jm7b01444_si_002.csv">jm7b01444_si_002.csv (1.9 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01444&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-21%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01444%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01444" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c23979133c4c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
